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ABSTRACT
Molecular imaging is established as an indispensable tool in various areas of cancer research, ranging
from basic cancer biology and preclinical research to clinical trials and medical practice. In particular,
the field of fluorescence imaging has experienced exceptional progress during the last three decades
with the development of various in vivo technologies. Within this field, fluorescence microscopy is
primarily of experimental use since it is especially qualified for addressing the fundamental questions
of molecular oncology. As stimulated emission depletion (STED) nanoscopy combines the highest
spatial and temporal resolutions with live specimen compatibility, it is best-suited for real-time
investigations of the differences in the molecular machineries of malignant and normal cells to
eventually translate the acquired knowledge into increased diagnostic and therapeutic efficacy.
This thesis presents the application of STED nanoscopy to two acute topics in cancer research of direct
or indirect clinical interest. The first project has investigated the structure of telomeres, the ends of
the linear eukaryotic chromosomes, in intact human cells at the nanoscale. To protect genome
integrity, a telomere can mask the chromosome end by folding back and sequestering its single-
stranded 3’-overhang in an upstream part of the double-stranded DNA repeat region. The formed t-
loop structure has so far only been visualized by electron microscopy and fluorescence nanoscopy with
cross-linked mammalian telomeric DNA after disruption of cell nuclei and spreading. For the first time,
this work demonstrates the existence of t-loops within their endogenous nuclear environment in intact
human cells. The identification of further telomere conformations has laid the groundwork for
distinguishing cancerous cells that use different telomere maintenance mechanisms based on their
individual telomere populations by a combined STED nanoscopy and deep learning approach. The
population difference was essentially attributed to the promyelocytic leukemia (PML) protein that
significantly perturbs the organization of a subpopulation of telomeres towards an open conformation
in cancer cells that employ a telomerase-independent, alternative telomere lengthening mechanism.
Elucidating the nanoscale topology of telomeres and associated proteins within the nucleus has
provided new insight into telomere structure-function relationships relevant for understanding the
deregulation of telomere maintenance in cancer cells.
After understanding the molecular foundations, this newly gained knowledge can be exploited to
develop novel or refined diagnostic and treatment strategies. The second project has characterized
the intracellular distribution of recently developed prostate cancer tracers. These novel prostate-
specific membrane antigen (PSMA) inhibitors have revolutionized the treatment regimen of prostate
cancer by enabling targeted imaging and therapy approaches. However, the exact internalization
mechanism and the subcellular fate of these tracers have remained elusive. By combining STED
nanoscopy with a newly developed non-standard live cell staining protocol, this work confirmed cell
surface clustering of the targeted membrane antigen upon PSMA inhibitor binding, subsequent
clathrin-dependent endocytosis and endosomal trafficking of the antigen-inhibitor complex. PSMA
inhibitors accumulate in prostate cancer cells at clinically relevant time points, but strikingly and in
contrast to the targeted antigen itself, they eventually distribute homogenously in the cytosol. This
project has revealed the subcellular fate of PSMA/PSMA inhibitor complexes for the first time and
provides crucial knowledge for the future application of these tracers including the development of
new strategies in the field of prostate cancer diagnostics and therapeutics.
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Relying on the photostability and biocompatibility of the applied fluorophores, the performance of live
cell STED nanoscopy in the field of cancer research is boosted by the development of improved
fluorophores. The third project in this thesis introduces a biocompatible, small molecule near-infrared
dye suitable for live cell STED imaging. By the application of a halogen dance rearrangement, a
dihalogenated fluorinatable pyridinyl rhodamine could be synthesized at high yield. The option of
subsequent radiolabeling combined with excellent optical properties and a non-toxic profile renders
this dye an appropriate candidate for medical and bioimaging applications. Providing an intrinsic and
highly specific mitochondrial targeting ability, the radiolabeled analogue is suggested as a vehicle for
multimodal (positron emission tomography and optical imaging) medical imaging of mitochondria for
cancer diagnosis and therapeutic approaches in patients and biopsy tissue.
The absence of cytotoxicity is not only a crucial prerequisite for clinically used fluorophores. To
guarantee the generation of meaningful data mirroring biological reality, the absence of cytotoxicity is
likewise a decisive property of dyes applied in live cell STED nanoscopy. The fourth project in this thesis
proposes a universal approach for cytotoxicity testing based on characterizing the influence of the
compound of interest on the proliferation behavior of human cell lines using digital holographic
cytometry. By applying this approach to recently developed live cell STED compatible dyes,
pronounced cytotoxic effects could be excluded. Looking more closely, some of the tested dyes slightly
altered cell proliferation, so this project provides guidance on the right choice of dye for the least
invasive live cell STED experiments.
Ultimately, live cell STED data should be exploited to extract as much biological information as possible.
However, some information might be partially hidden by image degradation due the dynamics of living
samples and the deliberate choice of rather conservative imaging parameters in order to preserve
sample viability. The fifth project in this thesis presents a novel image restoration method in a Bayesian
framework that simultaneously performs deconvolution, denoising as well as super-resolution, to
restore images suffering from noise with mixed Poisson-Gaussian statistics. Established deconvolution
or denoising methods that consider only one type of noise generally do not perform well on images
degraded significantly by mixed noise. The newly introduced method was validated with live cell STED
telomere data proving that the method can compete with state-of-the-art approaches.
Taken together, this thesis demonstrates the value of an integrated approach for STED nanoscopy
imaging studies. A coordinated workflow including sample preparation, image acquisition and data
analysis provided a reliable platform for deriving meaningful conclusions for current questions in the
field of cancer research. Moreover, this thesis emphasizes the strength of iteratively adapting the
individual components in the operational chain and it particularly points towards those components
that, if further improved, optimize the significance of the final results rendering live cell STED
nanoscopy even more powerful.
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ZUSAMMENFASSUNG
Die molekulare Bildgebung hat sich als unverzichtbares Instrument zahlreicher Felder der
onkologischen Forschung etabliert und erfährt insbesondere Anwendung in der Grundlagenforschung,
in der präklinischen Forschung, in klinischen Studien sowie in der Diagnostik und Therapie. In den
letzten drei Jahrzehnten wurden im Speziellen auf dem Gebiet der Fluoreszenzbildgebung mit der
Entwicklung verschiedener In-vivo-Varianten außergewöhnliche Fortschritte gemacht. Als Teilgebiet
ist die Fluoreszenzmikroskopie in erster Linie ein experimentelles Mittel, welches einen direkten
Zugang zu den zentralen Fragestellungen der molekularen Onkologie eröffnet. Die Stimulated Emission
Depletion (STED) Nanoskopie bietet herausragende räumliche und zeitliche Auflösung bei
gleichzeitiger Eignung für die Bildgebung lebender Proben. Folglich erlaubt sie die
Echtzeituntersuchung von Unterschieden in der molekularen Maschinerie entarteter und gesunder
Zellen und generiert hierbei Wissen, welches schließlich in einer verbesserten diagnostischen und
therapeutischen Wirksamkeit mündet.
Diese Dissertation präsentiert die Anwendung der STED-Nanoskopie auf zwei hochaktuelle
wissenschaftliche Thematiken der Krebsforschung von direktem sowie indirektem klinischen Interesse.
Das erste Projekt widmete sich der Strukturcharakterisierung von Telomeren in intakten menschlichen
Zellen auf molekularer Ebene. Telomere, die Enden der linearen eukaryotischen Chromosomen,
dienen dem Schutz der Genomintegrität. Sie können das jeweilige Chromosomenende maskieren,
indem sie eine schleifenartige Struktur ausbilden, welche durch den Einschub des einzelsträngigen 3'-
Überhangs in einen stromaufwärts gelegenen Abschnitt der doppelsträngigen repetitiven Telomere-
DNA Sequenz stabilisiert wird. Bisher untersucht wurde diese T-Loop-Struktur ausschließlich mittels
Elektronenmikroskopie und optischer Nanoskopie anhand von Telomer-DNA, die aus
Säugetierzellkernen isoliert, chemisch quervernetzt und auf einer Oberfläche präpariert wurde. Die
vorliegende Arbeit dokumentiert zum ersten Mal die Existenz von T-Loops in endogenem Kontext in
intakten menschlichen Zellen. Die Identifizierung weiterer Telomerkonformationen lieferte die
Grundlage für die Unterscheidung von Krebszellen, die verschiedene Telomererhaltungsmechanismen
verwenden. Ein kombinierter Ansatz aus STED-Nanoskopie und Tiefenlernen (Deep Learning) konnte
charakteristische Gegensätze in den individuellen Telomerpopulationen quantifizieren. Diese
Gegensätze wurden im Wesentlichen auf das Promyelozytenleukämie (PML) Protein zurückgeführt,
welches eine offenere DNA-Konformation für eine Subpopulation von Telomeren in Krebszellen
begünstigt, die einen Telomerase-unabhängigen, alternativen Telomerverlängerungsmechanismus
verwenden. Die Aufklärung der molekularen Topologie von Telomeren und assoziierten Proteinen im
Zellkern ermöglichte neue Einblicke in die Struktur-Funktions-Zusammenhänge von Telomeren, die für
das Verständnis der Deregulierung der Telomererhaltung in Krebszellen relevant sind.
Nachdem die molekularen Grundlagen verstanden wurden, kann das neu gewonnene Wissen zur
Entwicklung neuartiger sowie verfeinerter Diagnose- und Behandlungsansätze eingesetzt werden. In
diesem Sinne beschäftigte sich das zweite Projekt mit der Charakterisierung der intrazellulären
Verteilung kürzlich entwickelter Prostatakrebs-Tracer. Diese neuartigen Inhibitoren des Prostata-
spezifischen Membranantigens (PSMA) haben die Behandlung des Prostatakarzinoms revolutioniert,
indem sie zielgerichtete Ansätze für bildgebende Diagnostik und Therapie ermöglichen. Der genaue
Internalisierungsmechanismus sowie der subzelluläre Verbleib dieser Tracer sind bisher allerdings
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noch nicht bekannt gewesen. Die Kombination von STED-Nanoskopie mit einem in dieser Arbeit neu
entwickelten atypischen Protokoll zur Anfärbung lebender Zellen konnte bestätigen, dass PSMA-
Inhibitoren die Aggregation (Clustering) des gebundenen Membranantigens induzieren und dass der
Antigen-Inhibitor-Komplex nach anschließender Clathrin-abhängiger Endozytose den endosomalen
Transportweg durchläuft. PSMA-Inhibitoren reichern sich innerhalb des klinisch relevanten
Zeitrahmens in Prostatakrebszellen an und zeigen bemerkenswerterweise, im Gegensatz zum
Membranantigen, final eine homogene zytosolische Verteilung. Dieses Projekt hat erstmalig den
subzellulären Verbleib von PSMA/PSMA-Inhibitor-Komplexen aufgeklärt und liefert entscheidende
Erkenntnisse für die zukünftige Anwendung der untersuchten Tracer, einschließlich der Entwicklung
neuer Strategien auf dem Gebiet der Diagnostik und Therapie von Prostatakrebs.
Die Leistungsfähigkeit der Lebendzell-STED-Bildgebung in der onkologischen Forschung hängt
maßgeblich von der Photostabilität und Biokompatibilität der verwendeten Fluorophore ab und wird
daher durch die Entwicklung verbesserter Fluorophore weiter gesteigert. Das dritte Projekt dieser
Dissertation stellt einen nicht-toxischen, niedermolekularen Nah-Infrarot-Farbstoff vor, welcher für
die STED-Bildgebung lebender Zellen geeignet ist. Durch Anwendung einer Halogentanz-Umlagerung
konnte ein dihalogeniertes, fluorierbares Pyridinylrhodamin mit hoher Ausbeute synthetisiert werden.
Die optionale Radiomarkierung, hervorragende optische Eigenschaften sowie die Biokompatibilität
qualifizieren diesen Farbstoff für die medizinische und biologische Bildgebung. Aufgrund seiner
intrinsischen, hochspezifischen Affinität zu Mitochondrien, kann das radiomarkierte Analogon
voraussichtlich in der multimodalen medizinischen Bildgebung (Positronen-Emissions-Tomographie
und optische Bildgebung) von Mitochondrien in Krebspatienten sowie in der Pathologie für
diagnostische und therapeutische Ansätze eingesetzt werden.
Die Abwesenheit von Zytotoxizität ist nicht nur für klinisch angewandte Fluorophore eine unerlässliche
Voraussetzung. Sie ist ebenfalls eine entscheidende Eigenschaft von Farbstoffen, die in der Lebendzell-
STED-Bildgebung eingesetzt werden. Je weniger diese Farbstoffe das biologische System stören, umso
getreuer spiegeln die Daten die biologische Realität wider. Das vierte Projekt dieser Dissertation
schlägt einen universellen Ansatz für einen Zytotoxizitätstest vor, der mittels digitaler holographischer
Zytometrie den Einfluss der zu untersuchenden Verbindung auf das Proliferationsverhalten
menschlicher Zelllinien charakterisiert. Durch diesen Ansatz konnten für kürzlich entwickelte
lebendzell-STED-kompatible Farbstoffe ausgeprägte zytotoxische Effekte ausgeschlossen werden. Da
einige der getesteten Farbstoffe die Zellproliferation leicht beeinflussten, bieten die vorliegenden
Ergebnisse eine Unterstützung bei der geeigneten Farbstoffwahl, um minimal-invasive Lebendzell-
STED-Experimente zu gewährleisten.
Im finalen Schritt der Datenanalyse sollten aus Lebendzell-STED-Daten so viele biologische
Informationen wie möglich extrahiert werden. Die gezielte Wahl konservativer Bildgebungsparameter
zum Schutz der Lebensfähigkeit der Proben sowie deren Dynamik führen zu Kompromissen in der
Bildqualität. Hierdurch können gewisse biologische Informationen teilweise verborgen bleiben. In dem
fünften Projekt dieser Dissertation wird eine neuartige Bildwiederherstellungsmethode (image
restoration) mit einem Bayes‘schen Ansatz vorgestellt, die gleichzeitig Entfaltung, Rauschentfernung
sowie Auflösungssteigerung (super-resolution) erlaubt und Bilder mit gemischter Poisson-Gauß'scher
Rauschstatistik wiederherstellt. Etablierte Entfaltungs- sowie Entrauschungsverfahren, die nur eine Art
von Rauschen berücksichtigen, führen bei Bildern, die durch signifikantes Mischrauschen
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beeinträchtigt werden, in der Regel nicht zu zufriedenstellenden Ergebnissen. Dass die neu eingeführte
Methode mit aktuellen Bildverarbeitungsansätzen konkurrieren kann, wurde mittels Anwendung auf
Lebendzell-STED-Telomerdaten nachgewiesen.
Zusammenfassend demonstriert diese Dissertation den Stellenwert eines integrierten Ansatzes für
STED-nanoskopische Studien. Eine koordinierte Vorgehensweise von der Probenvorbereitung über die
Bildaufnahme bis zur Datenanalyse lieferte eine zuverlässige Grundlage, auf der in aktuellen Fragen
der onkologischen Forschung aussagekräftige Rückschlüsse gezogen werden konnten. Diese Arbeit
unterstreicht die Bedeutung einer iterativen Anpassung der einzelnen Schritte und motiviert gezielte
Verbesserungsansätze, um die Signifikanz der Endergebnisse zu optimieren und die Leistungsfähigkeit
von Lebendzell-STED-Bildgebung weiter zu steigern.

xi
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PREFACE
During the course of the 20th century, fluorescence microscopy has established itself as an essential
method in life sciences. Its diverse implementations provide minimally invasive tools for three
dimensional and real-time analysis of structures, processes and dynamics in living cells and organisms,
with exceptionally high selectivity and sensitivity. Creativity in photophysics paired with profound
knowledge in optics have joined in a universal concept for breaking the diffraction limit of far-field
fluorescence microscopy [1].
Rapid technical developments during the turn of the century have led to a set of realizations that
extend the field of application of far-field fluorescence microscopy from the sub-micrometer range
down to even the single-digit nanometer regime [2-6]. At that time, alternative methods like electron
microscopy (EM) or atomic force microscopy (AFM) had already provided resolutions in the single-
nanometer digit range, but these techniques still lack the ease of specificity that fluorescence
microscopy fundamentally offers. Moreover, convincing live cell EM studies remain to be reported and
live cell AFM is limited to observations on the cell surface [7-11].
Similarly, two of the key players yielding the highest resolutions in the field of fluorescence nanoscopy
– stimulated emission depletion microscopy (STED) [12] and stochastic optical reconstruction
microscopy (STORM) [13] – were also limited to fixed samples for a long time. Since the major
advantage of fluorescence microscopy in life sciences is its in cellulo and in vivo applicability, a strong
demand for live cell compatibility of these two methods arose.
True live cell nanoscopy relies on a technique that combines high temporal resolution with
physiological imaging conditions. The crucial point was the lack of adequate organic dyes providing the
required photophysical properties while still maintaining cell membrane permeability. In the 1990s,
the genetic fusion of the green fluorescent protein (GFP) [14] and its variants to proteins of interest
had become the method of choice for live cell imaging [15-17]. And indeed, adaptations of both
nanoscopy methods using fluorescent proteins (FPs) were realized.
Photoactivated localization microscopy (PALM) [18] – a STORM related single molecule localization
microscopy (SMLM) technique – makes use of genetically encoded fusion constructs of
photoconvertible or photoactivatable FPs, but suffers from lengthy acquisition times resulting in
motion blur [6, 19]. Reversible saturable/switchable optical linear fluorescence transitions (RESOLFT)
microscopy [20] – a STED-related deterministic, coordinate-targeted nanoscopy method – employs
reversibly photoswitchable FPs, but its resolution does not meet that of STED or STORM.
Unfortunately, no member of the diverse GFP family [21, 22] truly fulfills the photophysical
requirements for STED yet. Indeed, the technology of self-labeling protein tags like SNAP-tag [23, 24]
and HaloTag [25] or small molecule binders such as jasplakinolide (F-actin) [26], taxol (polymerized
tubulin) [27] or triphenylphosphane (mitochondria) [28] has already allowed live cell labeling.
However, it was their combination with newly developed, STED compatible, non-toxic, cell membrane
permeable carbopyronine and rhodamine dyes [29-33] that paved the way for proper multicolor live
STED imaging. In principle, variants of these rhodamine dyes [34-36] also enable live cell STORM.
However, there have only been a few proofs of concept since the imaging buffers required to
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guarantee their photophysical properties are generally not live cell compatible and, additionally, data
acquisition with STORM is rather slow [37-43].
The thesis presented here achieves live cell STED nanoscopy in two different fashions in the field of
cancer research with direct and indirect clinical interest in close collaboration with the German Cancer
Research Center (DKFZ) in Heidelberg (Germany) and the University Medical Center Freiburg
(Germany).
PART I of this thesis provides the methodological foundation of common aspects shared by all projects
included in this work. It covers theoretical basics and practical expertise of fluorescence nanoscopy
and in particular of STED microscopy applications in the field of biomedical research. Furthermore,
PART I includes common materials and methods that are relevant for all projects.
PART II presents work on human telomere conformations and their implication on genome integrity
and telomere maintenance in cancer. Staining and imaging DNA (deoxyribonucleic acid) and associated
proteins without affecting cellular health is not trivial. Together with the DKFZ Division of Chromatin
Networks, we have developed a new robust staining protocol for novel live cell STED compatible dyes
in the cell’s most delicate environment – the nucleus. This protocol literally sheds light on living cells’
telomeres – long established as the key to aging and cancer [44, 45]. This work deepens the
fundamental understanding of their structure-function relationship in two different aspects.
As a first step and in combination with elaborate fixed staining methods, we have visualized human t-
loop structures in intact cells for the first time. Biological controls and Monte Carlo simulations of
synthetic STED data support the validity of the actual STED data and exclude false positive results
through imaging and staining artefacts. In collaboration with the DKFZ Division of Biomedical Computer
Vision, a neural network classification approach has been established to quantify t-loops and additional
telomere conformations. In the second step, this project has characterized and quantified visual
hallmarks of the rare telomere maintenance mechanism `alternative lengthening of telomeres´ (ALT)
[46, 47]. It is the first to distinguish ALT-positive and ALT-negative cancer cell lines based on
conformational differences in their telomere populations via a joint approach of STED nanoscopy and
deep learning.
PART III reports work on the biological characterization of novel dual-modality radiotracers specifically
targeting prostate cancer and is of direct clinical interest. Together with the DKFZ Division of
Radiopharmaceutical Chemistry and the Department of Nuclear Medicine at the University Medical
Center Freiburg, we have developed a set of innovative live cell staining protocols to investigate the
subcellular fate of dual-labeled tracers for non-invasive diagnosis and fluorescence-guided surgery of
prostate cancer. The bimodality allows the pre-surgical detection of lesions by positron emission
tomography (PET) as well as the intraoperative distinction between tumor and healthy tissue during
resection. For the detailed intracellular characterization, STED compatible derivatives of clinically
relevant dual-labeled tracers [48] based on the PET tracer PSMA-11 [49] were synthesized and applied
in combination with immunofluorescence staining of the targeted membrane protein. Even though
staining with antibodies normally requires chemical fixation of cells, our newly developed antibody
staining protocols have enabled the live investigation of antigen-tracer colocalization and substantiate
clathrin-mediated uptake, lysosomal antigen recycling, antigen clustering and cytosolic tracer
distribution in living cells. Along with complemental biodistribution and small-animal PET imaging
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studies, the results provide valuable knowledge for the design and development of new diagnostic and
therapeutic approaches for prostate cancer.
PART IV addresses different aspects of live cell STED nanoscopy and comprises various smaller projects,
preliminary results and conceptual ideas directly relating to the challenges faced during live cell
imaging. In collaboration with the DKFZ Division of Radiopharmaceutical Chemistry, we have
introduced a novel live cell STED compatible mitochondrial probe based on the popular silicon
rhodamine dye [30]. Together with the DKFZ Division of Biomedical Computer Vision, we have
proposed a novel method for image restoration of noise-degraded images. This part finally presents a
cytotoxicity study of recently published live cell STED compatible dyes that were applied in PART II [29,
32].
In conclusion, PART V emphasizes the common strengths and shared challenges of the different
projects. It further encourages the imaging community to agree on a concordant handling of
phototoxicity in live cell imaging. Taken together, this work demonstrates that live cell STED nanoscopy
is feasible using state-of-the-art labeling and staining procedures spiced with scientific intuition and
creativity. Combined in a coordinated workflow with sophisticated fixed and live cell sample
preparation methods, elaborate imaging schemes, rigorous controls and extended data analysis, STED
nanoscopy has provided valuable insights into two different areas of cancer research.

I – FOUNDATIONS:
FLUORESCENCE NANOSCOPY IN BIOLOGY
Which processes preserve the cell’s homeostasis and how does a cell dynamically react to
environmental cues disturbing this steady state? Life science research aims at answering these
questions both on the molecular scale and inside living organisms. To comprehensively investigate
these biological and biochemical processes, a multiparametric approach is required that addresses
structural as well as spatio-temporal details. However, the relevant timescale and spatial scale span
several orders of magnitude (Figure I-1) [50].
For example, conformational changes of and biochemical reactions within molecules occur in less than
milliseconds [50]. Small molecules like adenosine triphosphate (ATP, radius approx. 0.7 nm) – the
universal energy currency of life – diffuse through the cell’s volume at millisecond timescales with cell
volumes ranging from µm3 for bacterial up to mm3 for mammalian cells (BioNumbers ID (BNID) 106978,
105906, 114924) [51]. In comparison, the diffusion of clustered receptors in the cell membrane
(thickness approx. 10 nm) is slowed down by one order of magnitude to less than 1 µm2/sec (BNID
100787, 114189) [51]. The ribosome (diameter approx. 30 nm) synthesizes an average-sized, nascent
protein in seconds, whereas complex multilayered cellular processes last from minutes to hours (BNID
100483, 113762) [50, 51]. For instance, eukaryotic deoxyribonucleic acid (DNA, diameter approx. 2 nm)
is replicated with a speed of approximately 2-3 kb/min resulting in around 8 h of replication for the
entire human genome (BNID 104136, 111770, 105243, 108484 – 108486, 113435) [51].
Within the diverse field of advanced imaging technologies, different methods are highly specialized in
one or the other spatio-temporal direction. At the lower end of the spatial resolution spectrum,
positron emission tomography (PET), magnetic resonance imaging (MRI) and optical coherence
tomography (OCT) offer real-time, live imaging of intact organisms with resolutions in the mm to µm
range [52-54]. At the upper end, electron microscopy (EM) [55] and scanning probe microscopy (SPM)
resolve biological structures at near-atomic scale. However, EM imaging conditions are not compatible
with any form of true live cell imaging. In contrast, SPM techniques like atomic force microscopy (AFM)
[56, 57], scanning tunneling microscopy (STM) [58] or near-field scanning optical microscopy (NSOM)
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[59, 60] offer millisecond temporal resolutions but with an inevitable, technological restriction to
surface studies [61-63].
Fluorescence microscopy lies in the intermediate range of the spatio-temporal resolution spectrum
uniting the experimental demands of life science research with the smallest tradeoffs. In combination
with its target specificity, imaging flexibility and easy sample preparation techniques, far-field optical
microscopy has for many years been the major contributor to microscopy-based investigations in this
field. It allows the study of biomolecular interactions, structure-function relationships and complex,
dynamic processes at the (sub)cellular level to connect molecular to cellular behavior and bridge the
gap between genetics, developmental biology, biochemistry and pathology [64, 65].
Figure I-1. The spatial and temporal scales of biology and selected fluorescence imaging modalities used in life sciences.
(a) Representative examples of biomolecules, macromolecular complexes and assemblies, cell organelles and cells sorted by
their increasing dimensions. The routine effective resolution levels of important fluorescence microscopy and nanoscopy
techniques obtained with biological samples are shown in red. (b) Representative examples of the kinetics of important
biological processes and of photophysical, photochemical and technical processes involved in fluorescence microscopy
imaging. The range of acquisition speeds of important fluorescence microscopy and nanoscopy techniques is given in red.
The acquisition speed of confocal microscopy is comparable to that of STED nanoscopy. As point-scanning methods, the
acquisition speed of confocal and STED imaging essentially depends on the size of the field of view. The acquisition speed of
MINFLUX is comparable to that of SMLM. The crystal structures were obtained from the Protein Data Bank (PDB) [GFP 5DTY,
GFP chromophore 5DTY and 5DTX, double-stranded DNA (dsDNA) 1W0U, SNAP-tag 3KZY, IgG antibody 1IGT, ribosome 2WDK
and 2WDL, conformational change in calmodulin 1CFD and 1SY9]. For abbreviations, refer to Definition of Abbreviations.
Historically, insight has traditionally been gained through either ensemble measurements and end-
point assays on whole cell populations or via in vitro interaction studies on purified proteins. Yet, the
former approach veils heterogeneity, stochasticity and the complex single molecule behavior by
providing only the sample mean; the latter strategy neglects most environmental and physiologically
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relevant influences. Only native conditions ensure undisturbed processes are witnessed and hence
biologically meaningful conclusions are inferred. By combining both, specific single molecule sensitivity
and physiological experimental conditions, fluorescence microscopy has developed into one of the
most powerful tools to study the individual molecular players involved in the processes of interest [2-
6].
A picture is worth a thousand words. All imaging-based methods share the benefit of generating visual
results qualifying them as rather intuitive techniques. Especially fluorescence microscopy – in its basic
concept – is one of the most direct approaches, since the researcher sees what the researcher gets.
Beyond pure visualization, various fluorescence methods also allow for quantitative measurements
[66-72]. In both cases, selective labeling techniques for proteins, lipids and nucleic acids guarantee
high biomolecular specificity during the imaging process. Major developments in the field of
fluorescent labeling comprising both fluorophores and targeting strategies has strongly contributed
and will continue to contribute strongly to the progress in fluorescence microscopy [64, 73-75].
On the other side of the coin is the necessity of controls proving that the structure or process of interest
remains unaffected by the labeling procedure and by the label itself. With such proof, fluorescence
microscopy shows high biological system compatibility enabling the least-invasive access to the
interior of a cell, which is essentially transparent to light. Fluorescence provides contrast, single
molecule sensitivity and selectivity, but is also a potential source of phototoxicity. If prevented,
fluorescence microscopy allows the recording of four-dimensional (4D) data of living cells, tissues and
even whole organisms in real-time with high spatial resolution covering a large field of view (FOV) over
a long period of time. However, all these parameters are interdependent and tweaking one to the
extreme is only possible at the expense of all the others. While most of these parameters are
technically limited, the spatial resolution barrier was assumed to be fundamental for many years.
I.1 SURVEY OF THE FIELD
I.1.1 Spatial Resolution and Diffraction in Optical Imaging
Commonly, fluorescence microscopy operates in the far-field and uses lenses to discriminate features
by focusing light. Hence, its resolution is determined by the focusing strength of the optics and
governed by diffraction due to the wave nature of electromagnetic radiation. Even with optimal
focusing of an infinitely small point-like light source through a lens, constructive interference of light
waves in one defined spot in space creates a finite-sized intensity pattern ( , , ) in the image plane,
referred to as the point spread function (PSF). The PSF is the fundamental unit in the image formation
process and its full width half maximum (FWHM) defines the microscope’s resolution in real space. The
final image is a convolution of the real image and the PSF of the system. The PSF’s Fourier transform is
the optical transfer function (OTF) specifying the spatial frequencies contained in the final image.
As early as 1835, Airy explained the blurring effect of diffraction on images of point like structures [76].
His description of the main interference maximum (Airy disk) and its surrounding higher-order
diffraction rings (Airy pattern) allows for an intuitive formulation of the Rayleigh criterion for resolution
stated by Lord Rayleigh in 1874. The criterion is met as soon as the main lobe maximum of the intensity
4 I.1 Survey of the Field
pattern of one point source coincides with the first minimum of the intensity pattern of a second point
source (Figure I-2) [77]. However, Abbe in 1873 [78] and Helmholtz in 1874 [79] were the first to
explicitly connect diffraction with resolution in lens-based optical microscopy. Their theoretical
analyses led to the classical resolution limit
in lateral dimension Δ =
2 sin
(I-1)
in axial dimension Δ =
2
sin
(I-2)
with Δ  being the lateral resolution, Δ  the axial resolution,  the wavelength of light, = sin
the numerical aperture comprising  the refractive index of the medium the objective is working in
and  the one-half angular aperture of the objective.
Figure I-2. Illustration of the Rayleigh criterion.
According to Rayleigh, two closely spaced point
sources can be resolved if their Airy disks are
separated by more than the distance at which the
principal maximum of one Airy disk coincides with
the first minimum of the second Airy disk.
For more than a century, science was stuck considering the resolution barrier imposed by diffraction
as impenetrable. Obtaining a spatial resolution in the nanometer range was thought to be impossible
because the resolution barrier was only seen from the perspective of the microscope’s limited
passband of spatial frequencies. According to general conviction, lens-based optical microscopy had
fundamentally reached its limit with resolutions of approximately 200 nm laterally and approximately
500 nm axially [80].
At first glance, near-field optics seemed to be the only way to circumvent the diffraction limit because
it avoids conventional lenses and thereby free wave propagation by mechanically confining the
excitation spot. In near-field scanning optical microscopy (NSOM), the light is focused to the
subwavelength sized aperture of a sharp tip creating a near-field spot with a size on the order of the
tip, which is scanned over the sample. Hence, NSOM is limited to the surface of cells and to structures
directly underneath the cell membrane [60, 81-85].
However, to keep its advantage of being minimally invasive while providing access to the entire cell,
fluorescence microscopy must be applied in the far-field. Thus, attempts to modify the focal spot size
in far-field optics started in the mid-20th century with concepts such as confocal [86-88] and nonlinear
approaches like multiphoton microscopy [89, 90]. In the 1990s, various elaborate techniques pushed
the resolution to the very limits of optics by perfecting focusing, complex imaging schemes and post-
processing. 4Pi [12, 91, 92] and I5M [93-95] microscopy improve the axial resolution three to seven-
fold. Both techniques expand the illumination and/or detection wave front by increasing the aperture
angle of the system  through the usage of two objectives for the respective light path: the more
spherical the wave front, the more isotropic the resolution. Classical, interference-based, linear
structured illumination microscopy (SIM) in two and three dimensions (2D and 3D) improves the lateral
and axial resolution two-fold. Widefield illumination with a sinusoidally modulated pattern that is
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shifted or rotated several times during image acquisition generates Moiré fringes. This extends the
observable region in reciprocal (frequency) space making high spatial frequencies accessible, which –
via Fourier transformation – increases the resolution in real space [59, 96-101]. Through the use of
multi-pixel detectors, SIM (single or multiple) point-scanning approaches avoid the loss of high
frequency information, which in classical confocal systems are rejected at the pinhole [102-106].
However, post-processing always bears the danger of potential artefacts [107-116].
I.1.2 Fluorescence Nanoscopy
To truly cross the diffraction barrier in far-field fluorescence microscopy, a paradigm shift towards an
alternative perspective was necessary. The key was the reformulation of the resolution problem
knowing full well that the physical phenomenon of diffraction will always hold true. It cannot be
eliminated per se and governs both excitation and detection. Instead, it is rather the quasi-
simultaneous emission of all emitters that are collectively excited by the excitation PSF ( , , ) –
be it widefield or confocal – that renders the separation of individual fluorophores virtually impossible
(Figure I-3). Analogously to the illumination, the propagation of emitted photons is governed by a
similar function ( , , ), veiling the exact coordinate of the respective emitter of individual
photons, irrespective of detection by a camera (widefield) or by a point detector (beam-scanning
system). As a consequence, all fluorophores in closer proximity than the diffraction limit are not
separable.
Figure I-3. Essence of the resolution problem in fluorescence microscopy.
In classical diffraction-limited fluorescence microcopy, the fluorophores are
collectively excited and emit quasi-simultaneously. Thus, emitters spaced by less
than the diffraction limit cannot be individually distinguished.
It is not diffraction itself that has to be challenged, but rather discrimination of individual markers
within a densely packed accumulation smaller than /2 . If these markers differ spectrally, single
fluorophore separation is easily realized by the implementation of different filters [117-119]. Thus, the
key to success is confinement of molecular states rather than confinement of light.
All nanoscopy methods transiently prepare neighboring fluorescent markers in different photophysical
states rendering them discernable. Usually, transitions between a signal-giving, fluorescent ON state
(A) and a dark, non-fluorescent OFF state (B) are exploited to make them emit time-sequentially from
areas that are much smaller than the diffraction limit [120, 121]. None of these states necessarily need
to be fluorescent [122]. A series of different photophysical states qualify for the implementation of
this focal ON-OFF switch. However, the shorter the lifetimes of these states are, the harder the readout
becomes. Virtual states are the extreme example; their transient nature makes them essentially non-
observable [1, 123, 124].
Introducing a focal switch neutralizes the limiting effect of diffraction. The determination of the
molecular coordinate with arbitrary precision is not hindered if the next emitters reside at a distance
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larger than /2  [125, 126]. Although this concept in no way refutes the physics work of the 19th
century, the vision of diffraction-unlimited fluorescence imaging was confronted with a lot of
skepticism in the beginning. Teaming up of chemistry and optics has proven to be the solution to the
diffraction problem in far-field fluorescence microscopy. Fluorescent markers are no longer seen as
simple reporters for image generation, but as active components in image formation [1, 127].
With the advent and evolution of fluorescence nanoscopy, scientific research has gained access to new
fields in biology, chemistry, (bio)physical and (bio)medical research. The new level of unprecedented
detail is literally changing views in cellular and molecular biology. Finally, mapping the spatial
organization and the interactions of all molecules in a cell becomes possible. While being one of the
most momentous developments in these fields nowadays, fluorescence nanoscopy also introduces
new challenges. However, due to their non-fundamental nature and to the fast pace of progress, none
of these problems are expected to persist.
The challenges faced are not only technical but multi-faceted, involving specimen characteristics, dye
choice, labeling method, sample preparation, imaging conditions, aberration correction, post-
processing and data analysis. Considering these issues thoroughly is more critical with fluorescence
nanoscopy than with diffraction-limited fluorescence microscopy, since potential artefacts are more
easily exposed by the increased sensitivity and resolution. Whereas certain fixation artefacts might be
hidden by diffraction blur in conventional fluorescence microscopy, they are disclosed at nanoscopic
resolutions [128]. Parameters like spatial resolution, temporal resolution, signal-to-noise ratio (SNR),
FOV, observation time and cell viability are interdependent and competing (Figure I-4).
While high irradiation intensities are likely to compromise cell health during live cell imaging, they are
commonly required for high spatial resolutions. Spatial resolution in general is limited by the
photostability of the dye. The photostability of the dye also sets an upper bound for following
individual molecules over a certain period, whereas the photon flux of the dye sets a lower bound on
the observation of molecular dynamics. It affects minimum exposure times and scanning speed, thus
limiting the observation rate.
Figure I-4. Interdependent imaging parameters of fluorescence microcopy.
Extension of the ̀ triangle/pyramid of frustration´ commonly encountered in live
cell fluorescence imaging. The effective image resolution, the temporal
resolution, the observation time, the SNR, the FOV and the sample health are
interdependent. No single parameter can be changed without affecting the
others. For live cell imaging, cell viability should be awarded the highest priority
but is clearly irrelevant in fixed cell imaging.
The acquisition speed differs amongst the various nanoscopy methods and applications, but they are
all per se slower than regular epifluorescence microscopy due to the time-sequential readout of the
diffraction-limited zone. To avoid motion blur during live cell imaging, the time to acquire an image
must be faster than the time in which the structure of interest moves one measure of resolution [129].
Just as the temporal resolution is subjected to the Nyquist-Shannon sampling theorem [130, 131], so
is the spatial resolution of an image. Consequently, the image resolution cannot be better than double
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the distance between neighboring emitters [132-134]. Thus, a high labeling density is very important
to infer the true topological structure of the target and it is essential for quantitative imaging. In this
context, it is important to point out that the resolving power of the imaging technique itself, the
resolution in its true optical meaning, is independent of the fluorescence labeling (refer to also I.1.6.2).
To distinguish thoroughly in the following, the term `image resolution´ is used when describing the
effective resolution obtained in the final fluorescence image; the term `biological resolution´ is used
when discussing the effects of labeling on the effective image resolution.
The label itself can hamper complete labeling due to steric hindrance. In contrast to diffraction-limited
approaches, the label size participates significantly in fluorescence nanoscopy. Conventional
fluorescence microscopy only knows sterical problems concerning protein folding and interactions
with genetic labels. Fluorescence nanoscopy, however, is also confronted with a `steric resolution
limit´, since its spatial resolution lies in the range of conventional label sizes. Depending on the labeling
method, the fluorophore is placed at a certain distance to its target. Nanoscopic imaging records the
position of the emitter, which is in no case identical with the position of the molecule of interest. The
more precise the determination of the emitter’s coordinates and the larger the label size, the greater
the recorded mismatch to the coordinates of the target of interest [135]. Thus, progress in
(bio)chemistry is desperately desired to live up to the current state in optics.
I.1.2.1 Coordinate-Targeted Approach
The field of fluorescence nanoscopy, in the literature also commonly referred to as super-resolution
microscopy, distinguishes two main approaches, albeit conceptually identical, to truly cross the
diffraction limit. They differ in the nature of emitter readout being either deterministic or stochastic.
The deterministic, coordinate-targeted approach is generalized under the acronym RESOLFT
(reversible saturable/switchable optical linear (fluorescence) transitions). It pools various techniques
that exploit reversible, saturable or photoswitchable transitions A↔B (Figure I-5a) [123]. All of them
are based on point-scanning acquisition and confocal detection targeting defined positions  in space.
By initiating the transition A→B, the popula on of A (e.g. emissive state) is prevented everywhere in 
the sample except for one (several) particular spot(s) of sub-diffraction size at the coordinate(s) . The
forced transition to B is applied via a light-intensity distribution ( , ) providing ideally an intensity
zero (or several up to many) around  where no switching happens, leaving the fluorophores in their
initial state A at ± /2 with ≪ /2 . Signal (e.g. fluorescence) is only detected from this
(these) specific region(s) (Figure I-5b). The saturation intensity ( , ) sets a certain threshold for
outperforming all competing A→B transitions (e.g. spontaneous fluorescence) everywhere except at
. Scanning of  across the sample sequentially detects neighboring features and determines their
coordinates through the position of the zero.
Without the need for post-processing, a super-resolved image is created with the lateral resolution
Δ ≈
2 sin 1 +
(I-3)
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with the factor > 0 determining the actual shape of the zero (e.g. zero spot, zero line) [136]. In either
case, the intensity distribution around the zero  can be parabolically approximated leading to the
square root factor in the denominator of equation (I-3).
To double the resolution, ( , ) must be quadrupled. Routinely, the RESOLFT approach reaches
effective lateral image resolutions between 20 to 50 nm in biological samples [137-147]. Practically
limiting is the SNR [148], but in ideal cases and under certain conditions, lateral resolutions of
< 10 nm can be achieved [149, 150]. Additional improvement of  is possible in selected 3D
implementations (for further details, refer to I.1.3).
The RESOLFT approach is an ensemble-based imaging scheme and thus relies on state population
probabilities. In the majority of biological samples, more than one emitter resides within . Hence,
several fluorophores are recorded simultaneously. By varying ( , ), the resolution  and therefore
the number of emitters within the intensity zero can be tuned to the biological question of interest. In
principle, strongly increasing ( , ) should eventually lead to a single molecule within the zero.
Theoretically, infinite resolution is attainable with ≫  and thus / → ∞ expanding the OTF with
an infinite frequency passband [12, 120, 123, 143]. Assuming this extreme, the orbitals of a single
molecule within the zero will experience different strengths of the electric field. Therefore, the
photophysical transition becomes a function of the orbital structure and the dipole approximation will
no longer hold. Consequently, the spatial distribution of intensity cannot be ignored with respect to
the molecules’ size [127].
The first theoretical RESOLFT proposal introduced the game changing rationale of diffraction-unlimited
microscopy in the form of stimulated emission depletion (STED) nanoscopy in 1994 [12, 137, 141, 151,
152]. Only five years later, STED was practically demonstrated for the first time [153]. It was followed
by ground state depletion (GSD) nanoscopy, theoretically introduced in 1995 [154] and technically
realized in 2007 [142]. While STED involves the electronic ground state  (B) and the first electronically
excited state  (A) (refer to I.1.3), GSD exploits the metastable, dark triplet state  (B) as counterpart
to the singlet system ( / ) (A). Since ( , ) scales inversely with the lifetimes of the involved states,
the intensity ( , ) used in GSD to operate the focal switch is markedly lower (~100 kW/cm2 vs.
~10 MW/cm2) [1].
Introduced at the beginning of this century, saturated patterned excitation microscopy (SPEM) [155]
and saturated structured illumination microscopy (SSIM) [144] parallelize the RESOLFT principle in one
possible implementation. As nonlinear variants of SIM, the techniques use saturated excitation to
deplete  (A) and populate  (B). This inverse RESOLFT scheme records `negative data´ exemplifying
that the ON state does not necessarily need to be a fluorescent one as the coordinates are defined
solely by the zero position.
Around the same time, RESOLFT nanoscopy based on photochromism was theoretically proposed
[121]. Photoswitchable fluorescent proteins (psFPs) [20, 120, 121, 123, 145, 147] or photoswitchable
organic dyes [146, 156] offer metastable fluorescent and non-fluorescent states that differ in their
molecular configuration (e.g. cis-trans isomerization). Optical transitions in these bistable molecular
systems demand dramatically lower switching intensities ( , ) (~10 W/cm2) compared to STED due
to the longevity of the involved states [121, 123].
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Figure I-5. Data acquisition schemes of the coordinate-targeted and coordinate-stochastic nanoscopy approaches.
(a) All emitters residing within a diffraction-limited spot are simultaneously excited by a regularly focused excitation beam
and thus emit collectively. The implementation of a focal switch that exploits a photophysical transition between A (ON state)
and B (OFF state) allows distinguishing of subsets of/individual emitters within the collective by time-sequential readout. (b)
In the coordinate-targeted approach, the initially established state A (e.g. emissive state) is prevented everywhere in the
sample except for the intensity zero position(s) of the light intensity distribution that initiates the transition A→B. Thereby,
the presence of A is restricted to one (several) subdiffraction-sized spot(s) (e.g. effective excitation). Time-sequential readout
is realized by deliberately scanning the intensity zero position(s) across the sample. (c) In the coordinate-stochastic approach,
time-sequential readout is achieved by preventing the presence of A (emissive state) everywhere except from single emitters
stochastically distributed in the sample (separated by at least one unit of diffraction limit /2 ). The emitters are localized
with sub-diffraction accuracy by centroid fitting of their individual photon distributions. The repetition of the imaging scheme
allows finally for the reconstruction of the super-resolved image.
I.1.2.2 Coordinate-Stochastic Approach
The stochastic approach, generally referred to as single molecule localization microscopy (SMLM),
differs from the RESOLFT approach not by concept but only by implementation. Likewise, it exploits
the transition between two distinct photophysical states and uses photon distributions to infer
precisely the molecules’ positions in space. In RESOLFT, the coordinate information is defined by the
intensity pattern of the depletion beam, whereas, in SMLM, this information derives from the PSF of a
single molecule. A priori dealing with single molecules is the main advantage of SMLM compared to
the ensemble based RESOLFT approach. Yet, in both cases, the number of photons matters. RESOLFT
builds on a sufficient number of photons provided by the depletion laser, whereas SMLM relies on a
sufficient number of photons obtained from each single emitter. In the latter case, dye stability and
photobleaching limit the number of photons whereas for RESOLFT, the laser supplies a virtually infinite
number of photons directly injecting the coordinates into the system.
The SMLM approach prevents the occupation of a certain photophysical state A (emissive state)
everywhere except for single emitters stochastically distributed in the sample and separated by at least
one unit of diffraction limit. Thus, their signals are recorded as distinct diffraction spots on a camera.
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During the acquisition of one frame, the molecules are repeatedly excited (A→A*) providing
detected photons per single diffraction-limited fluorescence spot. These data allow the emitters’
localization with sub-diffraction accuracy by centroid fitting providing their positions with precision
in coordinate space [118, 125, 126]. Switching the registered molecules to their OFF state enables the
repetition of the imaging procedure and reconstruction finally yields the super-resolved image (Figure
I-5c). Since all molecules are originally in their OFF state B, no initial OFF switching event is needed and
one single switching cycle B→A→B’ per emi er is commonly enough. The probability for ON switching
must correlate inversely with the fluorophore density to avoid ON switching of two molecules within
a diffraction-limited spot [18].
The number of collected photons  per ON switching event strongly governs the precision of
localization  and therefore the spatial resolution . Neglecting background,  is given by:
Δ ≈
2 sin √
(I-4)
However, the switching properties and the orientation of the fluorophore’s dipole also directly affect
the spatial resolution attained [39, 40, 157]. As events with poor photon output are excluded from the
image formation process, this post-processing procedure additionally influences . Routinely, SMLM
reaches an effective lateral image resolution of ~20 nm in biological samples [18, 158, 159]. Under
optimized conditions, lateral resolutions < 10 nm can be obtained [160].
As a widefield technique, its SNR benefits from total internal reflection fluorescence (TIRF) [161] or
highly inclined and laminated optical sheet (HILO) illumination [162]. However, the out-of-focus blur
can be exploited to extend SMLM imaging to 3D introducing astigmatic [163] or helical [164] optical
distortions or bi-plane detection [165]. For both 2D and 3D SMLM imaging, data collection and image
assembly are more challenging than technical implementation [166]. Complex post-processing is
necessary and is always accompanied by the danger of introducing artefacts due to false localizations
[167].
How to precisely determine single molecule coordinates has already been known for many decades
[125, 126]. Yet, it was no earlier than 1995 that single molecule localization has been suggested to
provide nanoscale resolution in combination with sequential readout through photoswitching [118]
and to enable theoretically `infinite´ resolution with → ∞ [168].
The first demonstrations of the SMLM approach were realized in 2006. (Fluorescence) photoactivated
localization microscopy ((F)PALM) traditionally employs photoactivatable or photoconvertible
fluorescent proteins (paFPs, pcFPs) [18, 169], but photoactivatable organic dyes are equally applicable
[159, 170]. In both cases, OFF switching after emitter detection is done by deliberate photobleaching
(B’≠B). Stochastic optical reconstruction microscopy (STORM) [13, 158] traditionally uses tandem dye
pairs with an activator dye reversibly enhancing the activation rate of a reporter dye, a
photoswitchable organic fluorophore [171]. In contrast to (F)PALM, the OFF state of the reporter is
identical to its initial state (B’ = B).
Nowadays, most SMLM applications exploit the blinking of fluorophores under illumination with
excitation light in well-defined redox buffer conditions. Although all fluorophores blink, not all
fluorophores are suitable for these SMLM techniques as certain switching kinetics are required [172].
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In ground state depletion with individual molecular return (GSDIM) [173-175], also called direct
STORM (dSTORM) [176], the electronic ground state  (A) is depleted and all molecules are forced
into long-lived triplet or radical states (B). Spontaneous return (B→A) either happens with back-
pumping in dSTORM or without optical activation in GSDIM.
Transient stochastic ON switching can also be implemented via specific molecular interactions as
realized in point accumulation for imaging in nanoscale topography (PAINT) [177] and its variants [178-
182] or in (fluctuation-assisted) binding-activated localization microscopy ((f)BALM) [183, 184]. The
reversible binding to the structure of interest equals the ON state while the unbound population
constitutes the OFF state.
I.1.2.3 Pooling Forces
Pioneering, launching and driving the `super-resolution revolution´ was recognized with the Nobel
Prize in chemistry in 2014. Yet, that is not the end of the story. Both approaches, coordinate-targeted
and stochastic, have substantially crossed the diffraction-barrier but “there’s [still] plenty of room at
the bottom” [185]. Smartly combining their advantages in a new concept will eventually push the
resolution to its ultimate extreme. Single molecule localization with minimal emission fluxes
(MINFLUX) elegantly circumvents the limitations enforced by the finite photon budget. It alleviates the
photon demand on both, the excitation (high in RESOLFT) and the detection side (high in SMLM).
Conceptually different from the established approaches and without any constraints on wavelength or
, MINFLUX probes the emitters with an excitation light intensity minimum after stochastic ON-OFF
switching instead of reading out the fluorophores’ information via high light intensities [186-188].
As the ̀ super-resolution revolution´ progresses, various creative combinations of the methods pushing
and crossing the diffraction limit have been developed (e.g. PA NL-SIM, ExSTED, ROSE, …) [140, 189-
209]. Fusing these methods bundles the individual strengths of each but indeed also compounds
complexity and accumulates the individual disadvantages. These hybrid techniques focus on one (or a
few) of the crucial imaging parameters namely spatial resolution, temporal resolution, SNR, FOV, 3D
imaging, observation time and cell viability.
Every technique – classic or hybrid – has its own niche due to an individual combination of advantages
and disadvantages. The biological question of interest should guide the choice of method. Although,
fluorescence nanoscopy is still young and rapidly evolving, it has already had a prominent impact in
life sciences. Serving the tools to unravel long-standing secrets, fluorescence nanoscopy can revisit and
refine existing biological models that are either incomplete or simplified due to the limited resolution
at the time of data acquisition [6]. Motivations in method development drastically diverge, but the
ultimate goal is the combination of quantitative multicolor imaging at the single molecule level in
tissues and whole organisms in real-time to enable the dynamic mapping of true molecular
colocalization patterns. As instrumentation, sample preparation and fluorophore properties are
equally critical, fluorescence nanoscopy continues to benefit from both technical and (bio)chemical
advancements [2].
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I.1.3 STED Nanoscopy
It was not much more than 20 years ago that the principle of STED nanoscopy was proposed and still
less than 20 years ago that it was realized. Yet, already more than 600 publications deal with the
technique in one fashion or another. More than 90% of these studies have been published in the last
ten years, but only approximately 15% involve live cell STED imaging. A combination of complexity and
high cost of the first implementations, along with skepticism regarding long-term live cell imaging, due
to the high laser intensities potentially photodamaging the sample, slowed down the broad adoption
in the beginning [210, 211].
I.1.3.1 Photophysics
STED nanoscopy was the first modality of the RESOLFT approach to be proposed and realized (for
details on the basic RESOLFT principle, refer to I.1.2.1). Its focal switch exploits the transition between
 (A) and  (B) induced via stimulated emission. During stimulated emission an incoming photon
matching the emitters emission spectrum forces an electronically excited energy state (here ) to de-
excite (basically) instantaneously via the emission of a second photon having the same phase,
frequency, polarization and direction as the stimulating photon. In contrast, spontaneous emission
occurs stochastically during the lifetime of the excited state (here ). The emitted photon has a
random phase and is angularly distributed according to the dipole radiation pattern. One of the key
strengths of STED nanoscopy is the universality of its focal switch. In contrast to other nanoscopy
methods requiring designated emitters, STED imaging works in principle with any fluorescent
molecule.
In a standard 2D STED implementation as illustrated in Figure I-6, the excitation beam is Gaussian-
shaped and overlaid with the red-shifted, donut-shaped STED beam confining the effective excitation
and its spontaneous emission to the intensity zero of the donut. Shaping of the still diffraction-limited
STED beam is achieved either by phase and/or by polarization engineering. For lateral resolution
enhancements, vortex phase plates are mostly used. Axial resolution enhancements are generally
attained via annular phase plates. Their combination enables 3D STED. Other beam shaping options
include segmented wave plates and liquid crystal spatial light modulators (SLM). The narrow spectral
band width of the STED laser ensures a high quality intensity zero [211], but aberrations potentially fill
up the donut’s center impairing the attainable resolution. For a resolution < 30 nm, the intensity zero
must be < 2% of the STED laser intensity  at the donut crest.
The wavelength of the STED beam lies in the far-red part of the fluorophore’s emission spectrum and
represents a compromise between the cross section  for stimulated emission from  to  being
as large as possible and the probability of re-excitation from  to  being as low as possible. As all
photons coming from stimulated emission and from the STED beam have the same wavelength, they
can be filtered out efficiently before detection. For an actual resolution improvement, the STED rate
must outperform the spontaneous emission rate from  with  ≈ 109 s-1. This narrow temporal
window in combination with small optical cross sections for STED in the range of  ≈ 10-17 cm2
require high STED laser intensities as ≡ . The saturation intensity  typically ranges
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between 1-10 MW/cm2. The depletion probability scales with ( ⁄ ) and the STED laser intensity  is
chosen such that the transition is saturated, establishing a nonlinear dependence on the number of
STED photons (  > 5  guarantees a depletion probability of > 99%).
In contrast, SMLM does not display nonlinearity in switching as saturating conditions are strictly
avoided, but a nonlinear dependence is generated in the emitted fluorescence intensity, as events with
too few detected photons are discarded [127]. Thus, the final SMLM image nonlinearly represents the
fluorescence emission being rather pointillistic [212, 213] and background free. In contrast, STED
imaging always produces a linear representation of the fluorescence emission.
Figure I-6. Schematic illustration of STED nanoscopy and its photophysical foundation.
In the basic 2D implementation of pulsed STED nanoscopy, a regularly focused excitation beam (exc, green) is overlaid with
a donut-shaped STED beam (red) featuring a short delay time (∆t). A beam shaping device (e.g. vortex phase plate) in the
STED beam path introduces the donut-profile. The STED beam confines the area from which spontaneous emission (orange,
①) is allowed to sub-diffraction dimensions by quenching all excited molecules at the periphery of the excitation spot via
stimulated depletion (②). The STED laser delay allows excitation and vibrational relaxation to be completed before STED
photons hit the fluorophores while being in the lowest vibrational state of . By opening the detection gate with an additional
time delay, early spontaneous emission from the periphery of the excitation spot is discarded. By closing the detection gate
after the fluorescence decay, unspecific background signal is reduced. The inverse of the pulse repetition rate (PRR)
represents the temporal pulse spacing (bottom right).
As any electronic transition is always a function of its corresponding dipole moment, the emission of
every fluorophore depends on its orientation. While freely rotating molecules average out any
orientation dependence, both excitation and stimulated emission rates of rotation-hampered
fluorophores show a dependence on the direction of the electric field of the lasers. Thus, STED
commonly uses circularly polarized light to even out excitation and depletion selection [143]. In any
case, potential emission shifts of single fluorophores do not alter the detected position as its
coordinates are injected by the STED laser itself. In contrast, SMLM is more prone to potential artefacts
originating from the fluorophore’s dipole orientation and its localization accuracy is directly affected
[214].
In theory, the spatial resolution of STED nanoscopy is unlimited (refer to equation (I-3)). However, with
increasing resolution, contrast usually deteriorates. At some point, the signal drowns in noise as the
increasingly smaller focal volume contains fewer fluorophores. Sources of noise include
autofluorescence of the sample, scattering of laser light, background fluorescence from unspecific
labeling and Poisson noise (refer to IV.4) [215]. As an ensemble method, STED does not depend on the
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photon flux from single molecules as SMLM methods do [216]. Instead, the emitted photons of all
molecules residing within the intensity zero determine the pixel brightness at . However, only a few
photons above the noise need to be detected per pixel/voxel.
In SMLM one switching cycle (B→A→B’) per molecule is in principle sufficient and theoretically, all
emitted photons contribute to image formation. In STED, each fluorophore is switched several times
while the intensity zero is scanned over the sample and most of the emitted photons are discarded as
they come from stimulated emission. Every emitter cycles only a finite number of times before it
irreversibly bleaches, constituting the vulnerable point of STED (refer to I.1.4). However, one of the
key strengths of STED nanoscopy is its free choice of depletion intensity, which allows tuning of the
spatial resolution to counteract signal loss from photobleaching. By balancing the resolution, STED can
be individually adapted to each respective biological question.
STED imaging permits the visualization of cellular structures with an effective image resolution of down
to 20 nm [137, 141], opening up avenues for new biological discoveries [152, 202, 217-223]. Even single
digit nanometer resolution has been achieved by imaging nitrogen vacancy (NV) centers in diamonds
[150, 224, 225]. While these exotic emitters are not only extremely photostable with essentially no
photobleaching or dark state transitions, they are also biocompatible [226, 227] and internalized by
cells [228-231]. However, the lack of biochemical surface modifications for specific targeting, size and
heterogeneity still hamper routine fluorescence imaging application [232]. Yet, STED nanoscopy is also
employed outside of biology in nanoscale imaging of inanimate material [233-236] or in solid state
physics [237].
I.1.3.2 Technical Implementation
In general, synchronized pulsed excitation and pulsed STED lasers with high repetition rates and
narrow STED pulse widths guarantee fast image acquisition and high depletion efficiencies [238]. Yet,
the exact timing of the lasers is crucial to optimize the efficiency of stimulated emission and to
minimize unwanted influences due to polarization effects, jitters in the timing of the laser pulses,
multiphoton processes, nonlinear photobleaching (refer to I.1.4.1 and I.1.4.3) and direct excitation by
the STED beam [239]. The bottom line is that the fluorophores’ photophysics determine the choice of
STED laser and how to operate it.
Depletion is most efficient if the STED pulse hits the fluorophores shortly after excitation and
vibrational relaxation within . The delay (approx. a few tens of picoseconds) is necessary due to the
width of the excitation pulse and the vibrational lifetime ( ~ 1012 s-1). STED pulses arriving too early
waste STED photons as excitation and/or vibrational relaxation are still ongoing rendering only a
fraction of fluorophores susceptible to depletion. STED pulses arriving too late do not entirely suppress
spontaneous emission from the periphery, thereby reducing the SNR. Pulse durations must fall in the
time frame between vibrational relaxation and spontaneous emission. Pulses shorter than the
vibrational lifetime do not deplete efficiently as a fraction of fluorophores has either not vibrationally
relaxed yet or already has spontaneously emitted. Moreover, associated high peak intensities increase
the chance of immediate re-excitation by the STED laser.
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Pulses with durations longer than the fluorescence lifetime of the fluorophore waste STED photons
and thus burden the sample with more light than necessary as the later STED photons mainly hit
fluorophores that have already spontaneously emitted. Within the reasonable time frame, short pulses
deplete efficiently but associated high peak intensities open further pathways for photobleaching. At
the same average power, longer pulses lower the probability for nonlinear photobleaching as peak
intensities are reduced (refer to I.1.4.1 and I.1.4.3). However, if the STED pulse duration falls in the
range of the fluorescence lifetime, time-gated detection becomes necessary to discard early
spontaneous emission from the periphery [240]. Concomitantly, early spontaneous emission from the
intensity zero is rejected, and thus the SNR is lowered (see below).
The wavelength of the STED laser preferably ensures efficient stimulated emission with no re-
excitation. If the wavelength is too short with respect to the fluorophore’s spectral properties,
depletion intensities are increased as vibrationally excited emitters are also targeted, but pronounced
re-excitation promotes nonlinear photobleaching and decreases image contrast [241]. If the STED
wavelength is too long, de-excitation becomes inefficient. High pulse repetition rates in the tens of
MHz range enable fast imaging but increase linear photobleaching from the triplet state. Lowering the
repetition rate decreases linear photobleaching and increases image quality at the expense of a
decreased imaging speed.
While implementation of STED nanoscopy is technically and optically more sophisticated than the
implementation of SMLM, its usage is straightforward. During imaging, the labeling density does not
need to be considered. After imaging, no post-processing is necessary true to the dogma WYSIWYG
(`what you see is what you get´). Optionally for STED data, post-processing might be used to increase
image quality. Yet, careful application is crucial to avoid the introduction of artefacts. Deconvolution
can be used to increase the SNR and the final image resolution; linear unmixing removes crosstalk
between different color channels (refer to I.1.3.3).
The first implementation of STED nanoscopy used pulsed excitation and pulsed STED lasers [153].
However, in the early days, continuous wave (CW) lasers simplified the setups and reduced the costs
[242]. With CW excitation and CW depletion, a dynamic equilibrium is created that allows for fast
imaging and thus potentially less photobleaching. Yet, to attain the same efficiency for stimulated
emission as in the pulsed STED case, higher average laser powers have to be applied and thus
photobleaching and re-excitation by the STED laser is increased. Moreover, the image contrast is lower
than in the pulsed STED case because a non-negligible fraction of the fluorophores spontaneously
emits before they can be depleted. The consequence is an unwanted fluorescence in the periphery of
the intensity zero and a confocal pedestal in the final image [215].
Combining CW STED with pulsed excitation and time-gating mitigates the drawbacks by discarding the
early spontaneous fluorescence. Time-gated detection is a temporal filter that acts like a spatial filter
discarding low spatial frequencies. However, as desired photons emitted from the intensity zero region
are rejected as well, the SNR is lowered. Furthermore, in CW STED, all fluorophores are constantly
exposed to STED photons and thus increase STED-light induced excitation and photobleaching
between excitation pulses. Yet, time-gating suppresses the detection of scattered excitation light by
opening the gate after the excitation pulse and suppresses the detection of re-excitation by the STED
laser by closing it after the fluorescence lifetime.
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Improved phase/wave plate designs not only simplified but also rendered STED implementations more
compact and robust. Shaping the STED beam without affecting the excitation beam was achieved
either by a phase plate consisting of different glass materials with different refractive indices for the
excitation and STED wavelengths [243] or by the combination of conventional and segmented wave
plates. This birefringent device not only implements the easySTED principle but at the same time infers
the fluorophore orientation [244]. Phase/wave plates that modulate only the STED beam co-align the
excitation and the STED beam by design. Insensitivity to mechanical drift in the alignment is beneficial,
as the SNR and therefore effectively the resolution depends on the nanometer precision overlap of
both beams. Other beam-shaping devices enabled the parallelization of STED increasing scanning
speed by the number of intensity zeros either modestly [245] or extensively [246, 247].
As switching in STED nanoscopy happens basically instantaneously, the temporal resolution is limited
by the scanning speed. With resonant scanners [248] and electro-optical deflectors [249], the pixel
dwell time reaches the fluorescence lifetime of the emitter and thus the imaging speed is only dictated
by the SNR [211]. As a point scanning method, the acquisition time of STED nanoscopy scales with the
FOV. Parallelization of the illumination scheme to accelerate the imaging process is possible since only
the intensity zero determines the resolution [245]. With one zero at  and the next zero at ± /2 ,
the collective of intensity zeros must only be translated by /2  [1]. Yet, in current implementations
of parallelization, confocality is lost and thus the image SNR is decreased [246, 247].
As a coordinate-targeted method, STED nanoscopy – except its parallelized version – preserves the
aspect of optical sectioning. This quality is highly valuable in biological imaging as most samples are
three-dimensional. Yet, in the standard 2D implementation, the axial resolution is still diffraction-
limited. To achieve an (quasi-)isotropic resolution, 3D STED imaging can be realized via two
approaches. The first one incoherently combines a donut-shaped STED profile confining the effective
emission laterally with a bottle-shaped STED profile confining the effective emission axially [233, 250].
The second approach unites 2D STED with 4Pi imaging in isoSTED and is therefore not only technically
more demanding but also more sensitive [140, 201-204].
I.1.3.3 Multicolor STED Imaging
Multicolor imaging is essential for biology as it highlights not only a specific structure but visualizes as
much cellular context as possible. Various options for color separation exist [251]. In general, different
fluorophore types are distinguished based on their spectral properties. Distinct spectral detection
windows allow the discrimination based on emission spectra and enable simultaneous recording.
Separation solely based on the excitation requires sequential acquisition. However, spectral separation
is usually not perfect due to overlapping absorption/emission spectra of the different fluorophore
types.
By combining selective excitation with separation of the emission in an appropriate acquisition
scheme, only 2nd-order crosstalk remains. Linear unmixing eliminates crosstalk by approximating the
signal of each pixel as a linear superposition of signals from the involved fluorophores. This
approximation is only valid if the PSFs of the fluorophores are very similar [252]. For STED, the shape
of the effective PSF is co-determined by the excitation and STED wavelength and by the light-
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fluorophore interaction. The latter varies with the cross sections for absorption and stimulated
emission and thus differs between the fluorophore types. Therefore, channel unmixing in STED must
take different PSFs into account [251]. Alternative options exploit the differences in the fluorescence
lifetimes and include pulse-interleaved excitation (PIE) with time-gated detection or fluorescence
lifetime imaging [251, 253].
The possible realizations of dual-color STED imaging comprise the combinations of either two
excitation and two STED lines, two excitation and one STED line, or one excitation and one STED line.
The first approach requires the most complex setup and proper alignment of four lasers. Yet, it allows
for spectrally well-separated fluorophores. Usually, the shorter wavelength STED light strongly excites
and drastically bleaches the longer wavelength dye. Hence, sequential imaging is necessary but affords
only a single shot [254, 255]. Optimization of the STED wavelengths and reasonable emitter choices
reduce photobleaching but forces the handling of more crosstalk [256-258]. The second approach is
particularly valuable for colocalization experiments. By using the same STED beam to deplete both
excitation channels, their signals are inherently co-aligned. Potential residual chromatic aberrations
do not alter the colocalization results as the intensity zero defines the position of effective excitation
for both channels [29, 137, 202, 259-262]. Image acquisition is done by (quasi-)simultaneously
recording both colors either line-by-line or via a PIE scheme. The third approach separates the channels
by spectral detection. Crosstalk is eliminated either by simple channel subtraction [31] or by linear
unmixing [263]. A creative alternative employs psFPs with very similar spectral but opposite activation
properties to separate the channels by means of photochromism [264].
The more colors are added, the smarter the separation strategies must be. Multicolor STED imaging
with three and four colors is made possible by spectrally separating regular fluorophores with long
Stokes shift dyes [265, 266], by combining spectral and fluorescence lifetime separation [251], by
exploiting photostability differences in excitation-based separation [267] and by applying rigorous
mathematical unmixing in emission-based separation [268]. Simplification of multicolor STED imaging
can be achieved by the implementation of a supercontinuum laser source for excitation [251, 256]. On
the one hand, the respective system becomes very flexible regarding wavelength optimizations; on the
other hand, only two lasers must be synchronized in the case of pulsed STED [269, 270].
With every additional color, information content but also complexity increases. Therefore, most
multicolor STED experiments with more than two colors have been conducted with fixed samples.
Hence, the dimension of cellular context is extended but the temporal dimension is frozen at one
specific point in time. To attain actual information on dynamics, live cell imaging must be performed.
However, properly imaging living specimens is challenging on many levels and phototoxicity is
receiving increasing attention as a major issue relevant to the field of fluorescence nanoscopy.
I.1.4 Phototoxicity in Fluorescence Microscopy
Fluorescence microscopy is generally emphasized in literature to be essentially non-invasive. However,
live cell imaging entails two main factors of potential cell damage. While direct chemical toxicity is
triggered by the fluorescent label (ligand plus fluorophore) and the imaging buffer, phototoxicity is
induced by the light energy deposited in the sample.
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The breakthrough from diffraction-limited fluorescence microscopy to diffraction-unlimited
fluorescence nanoscopy is directly associated with light doses that are orders of magnitude higher than
the light dose biological specimens experience by their very nature (solar flux on earth < 1.4 kW/m2)
[271]. The consequence of the increased photon demand is potential photodamage and phototoxicity
meaning impaired sample viability just by looking at it. The biological process, the biological structure
or its dynamics of interest might be affected and the imaging results altered, no longer describing
biological reality [272]. Amongst all interdependent imaging parameters discussed above (refer to I.1.2
and Figure I-4), cell viability should be of major interest for live cell imaging and parameters like
spatiotemporal resolution or contrast optimized for the biological question but not overdone.
I.1.4.1 Photophysical Cause
Upon absorption of a photon, fluorescent markers or endogenous chromophores (e.g. flavins,
porphyrins, nicotinamide adenine dinucleotide (phosphate) (NAD(P)H), aromatic amino acids)
populate an electronically excited state (usually ) with a certain vibrational and rotational
configuration ( ~ 1015 s-1). Most favorable for standard fluorescence microscopy applications is the
subsequent relaxation back to the electronic ground state  via emission of a photon ( ~ 109 s-1)
(Figure I-7). Both, absorption and fluorescence emission obey the Franck-Condon principle (Born-
Oppenheimer approximation). The emitted photon is Stokes shifted to longer wavelengths compared
to the absorbed photon due to internal conversion and vibrational relaxation ( ~ 1012 s-1) according
to Kasha’s rule and due to solvent relaxation following the Franck-Condon principle.
However, as electronically excited fluorophores can also relax via other intermolecular and
intramolecular pathways, competing de-excitation processes cause a quantum yield < 1.
Intersystem crossing ( ~ 108 s-1) can disengage the fluorophore from continuous cycling between
 and . Entering long-lived dark states like the triplet state  ( ~ 103 s-1) renders the fluorophore
more reactive. It becomes prone to react with molecular oxygen generating singlet oxygen via spin flip
followed by the build-up of other reactive oxygen species (ROS). Electron transfer reactions produce
radical ions of the fluorophore itself and radical ions of surrounding molecules with a lifetime of several
seconds to minutes. In the worst case, this photosensitizing process leads to irreversible,
photochemical modifications of the fluorophore accompanied by loss of fluorescence (Figure I-7).
Photobleaching caps the number of excitation and fluorescence emission cycles. The absolute number
of photons emitted and hence signal strength and observation time are limited.
At non-saturating excitation intensities, the photobleaching quantum yield  (probability for
photobleaching) is small (10-7-10-5 for most organic dyes) and can be considered constant under
defined conditions. However, saturated excitation, which is commonly reached in confocal
microscopy, departs from linear dependencies and promotes photobleaching. Transitions to triplet
or radical ion states ̇/  increase  and photobleaching often starts from these states in reaction
with oxygen or ROS. Yet, it is suggested that photobleaching also happens from the excited state via
the absorption of a second photon and transition to higher excited states (  and ) (Figure I-7). The
underlying photophysics is complex, nonlinear and strongly dependent on the fluorophore, its
concentration and the environment [273-275].
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Figure I-7. Major electronic state transitions of common fluorophores.
Radiative transitions are illustrated as solid arrows, non-radiative processes are illustrated as dotted arrows. Excitation from
 (singlet ground state) to  (first excited singlet state) is desired upon illumination by the excitation laser ( → ~1015 s-1).
The excited state can relax back to  via the emission of spontaneous fluorescence ( → ~109 s-1) or via non-radiative decay
processes (e.g. internal conversion, → ). Intersystem crossing ( ) competes with fluorescence and populates  (lowest
triplet state). The excited state can be additionally depleted via stimulated emission ( → ) forced by the STED laser.
Additionally, the STED laser can induce undesirable excitation from  to  ( → ), from  to  ( → ), from  to
(two photon absorption, → ) and from  to  ( → ). The extended triplet state lifetime promotes the build-up of
reactive oxygen species (ROS), and electron transfer reactions ( / , / , presumably also / , / ) produce
radical ions ̇/  of the fluorophore. If  is not rescued from  or ̇/  via triplet quencher ( ) or via redox reaction
( /  , / ), irreversible photochemical modifications of the fluorophore lead to a loss of fluorescence.
Photobleaching presumably also occurs as a consequence of transitions to higher excited states.
I.1.4.2 Physiological Effect
As ROS are a regular metabolic product, cells have a certain buffer capacity which allows their disposal
to some extent [276]. A key player on that front is the glutathione disulfide/glutathione (GSSG/GSH)
couple. The GSSG/GSH concentration differs between organelles (e.g. 1-10 mM in cytosol) as well as
between cell lines [277], but as soon as it is used to capacity, ROS start to accumulate. At low
concentrations, ROS interfere with the cell’s metabolism and redox state, cell signaling and cell cycle
control [278-280]. At higher concentrations, ROS react with surrounding biomolecules (proteins, lipids,
DNA) and impair their biological function [281-284]. This oxygen dependent photodamage (type II
phototoxicity [285]) is more critical than oxygen independent photodamage (type I phototoxicity
[285]), during which the excited state fluorophore directly reacts with neighboring cellular
components.
The observation of photobleaching is an unmistakable sign of phototoxicity. However, its absence does
not necessarily exclude photodamage [286-288]. Even unlabeled biological samples experience
phototoxicity since photosensitizing effects are also mediated by endogenous chromophores [289]
(e.g. chemical alterations of DNA upon ultraviolet (UV) illumination like dimerization of thymine base
pairs [290]). For the sake of completeness, thermal damage shall be mentioned as an additional
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primary consequence of phototoxicity. Yet, it is usually uncritical and only prominent during imaging
of strongly absorbing, pigment rich tissue [291].
Taken together, all primary photophysical and photochemical reactions manifest themselves in
secondary physiological impacts on cellular homeostasis. Disturbances are expressed in the form of
ATP depletion, membrane depolarization [292], cytoplasmatic Ca2+ increase [293], morphological
changes of mitochondria [294] and eventually cell hydropic swelling and blebbing [289]. If a certain
tolerance level is crossed, pathologic changes like DNA mutations accumulate, lead to cell cycle arrest
and ultimately to apoptosis or necrosis [295-298].
I.1.4.3 Phototoxicity in STED Nanoscopy
Most fluorescence nanoscopy techniques depend on high irradiation intensities and are therefore
susceptible to phototoxicity. Indeed, in biology, they are often applied in short-term experiments and
their results are usually considered meaningful as long as the sample is not negatively affected during
the experiment. At this point, long-term controls should be handled rather pragmatically than
categorically and within the scope of the biological question [289]. Still, long-term validation of cell
health will always be supportive of the particular study and is hence desirable [299, 300].
As stimulated emission effectively shortens the excited state lifetime, it theoretically protects the
fluorophore from photobleaching compared to the excitation only case. Unfortunately, excited state
absorption counteracts this and parasitic transitions to higher electronic states occur even if the cross
sections for transitions to  and  are small. Certainly, not only the combination of excitation and
STED lasers photobleaches, but also the STED light alone. Depending on the STED peak intensity,
distinct photobleaching mechanisms contribute to different extents. At low STED powers, STED
photons mainly de-excite and other interactions of STED photons can be neglected. Photobleaching is
intensity-independent, of low-order and associated with dark state population of mainly [4, 301].
However, STED nanoscopy works under saturating conditions, and excess intensities at the donut crest
must be applied to efficiently deplete the fluorophores in the proximity of the intensity zero. Especially
this excess exposure promotes the population of , ̇/ ,  and . via multi-step and/or multi-
photon absorption processes of STED light leading to higher-order, intensity-dependent
photobleaching [302]. As photobleaching is more pronounced from  and  reducing the population
of any other electronic state than  reduces photobleaching (Figure I-7).
Until now, only one study has extensively dealt with the issue of photodamage in STED nanoscopy
[303]. Kilian et al. showed that – under the right conditions – STED can be conducted without significant
short-term photodamage. Changes in cytoplasmatic Ca2+ concentrations were used as a measure for
phototoxicity since Ca2+ release into the cytosol is one of the earliest stress indications of cells on their
way to apoptotic or necrotic cell death [304]. Similar to a previous study examining cell viability under
SMLM conditions [305], Kilian et al. observed long-term photodamage evident through an increased
rate of cell death. However, the study clearly proves that STED imaging does not inevitably cause cell
death. However, comprehensive data are missing, and the effects of excitation and STED laser were
not assessed separately. Yet, the work by Kilian et al. is highly important as it is pointing the way to a
systematic characterization of phototoxicity in STED.
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I.1.5 Live Cell Imaging
The imaging community is still divided over the question whether true live cell nanoscopy is actually
feasible [306] as every increase in resolution comes at the cost of more exposures, longer acquisition
times, and higher laser intensities endangering the sample viability [6]. Regardless of the answer, a lot
of effort is invested to render existing methods live cell compatible and to come up with new concepts
discarding the drawbacks of established techniques and uniting their strengths technically,
methodologically [186-188] and computationally [307-309]. Beyond the requirement of a reduced
photon burden to achieve diminished phototoxicity (refer to I.1.4 and IV.1), major demands include
also an increase in imaging speed to capture the whole temporal range of biological dynamics and an
isotropically expanded FOV to capture as much biological context as possible, both without impairing
the spatial resolution.
For intermediate resolution gains, SIM is very popular amongst biologists. It is a photon-efficient and
thus gentle method using 103-106 times lower intensities than diffraction-unlimited techniques. SIM
provides a high throughput, multicolor, live cell imaging option with acquisition speeds for volumetric
imaging of large FOVs, which is compatible with conventional dyes and easily accessible [104, 105, 310-
312]. To further speed up acquisition in 3D imaging, multifocus (multiplane) imaging [313] can be
combined with SIM [314]. However, SIM is sensitive to out-of-focus light arising from emitting
fluorophores above and below the focal plane. This unwanted excitation triggers excess phototoxicity
throughout the whole preparation.
In contrast, light sheet fluorescence microscopy (LSFM) [315] and selective plane illumination
microscopy (SPIM) [316] illuminate the specimen orthogonally to the detection, thus exciting only the
detected fluorophores, which drastically lowers the energy load to the specimen and reduces
photobleaching and phototoxicity. LSFM and SPIM are the gentlest fluorescence microscopy
techniques available to date [271, 317] and combine unprecedented imaging speed and a high SNR
with inherent optical sectioning allowing 3D in vivo imaging of small organisms and embryos [318].
Different approaches have been realized to improve the lateral and axial resolution of LSFM/SPIM
[194, 319-321]. The combination of LSFM with SIM, lattice light sheet microscopy (LLSM), doubles the
lateral resolution in every xy plane [192, 193].
Other options restricting the excitation to the focal plane include TIRF illumination and two-photon
excitation (2PE). Imaging in TIRF mode has proven to be less phototoxic than widefield illumination
[322, 323], but limits the observation (close) to the basal membrane as the evanescent field penetrates
only 100-300 nm into the sample [324]. Imaging with 2PE is advantageous for deep tissue imaging as
scattering is reduced at longer wavelengths, but nonlinear photodamage occurs due to the obligatory
high peak intensities [325, 326].
I.1.5.1 Live Cell SMLM Imaging
Aiming for high resolution gains requires either live cell SMLM or live cell STED/RESOLFT. In general,
the time to acquire a super-resolved image must be faster than the time in which the structure of
interest moves one measure of resolution. Otherwise, motion blur compromises image quality and
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specifically for SMLM, localization errors and artefacts are the consequence. Typical intensities applied
in SMLM range between 1-15 kW/cm2 at 405-640 nm [18, 41, 42, 327, 328], while the
switching/activation rate depends on the laser intensities [329]. TIRF illumination can reduce
photodamage but spatially restricts imaging. SMLM collects thousands of camera frames to
reconstruct one super-resolved image and potentially long acquisition times constrain its live cell
imaging compatibility. Furthermore, adjustment of the switching/activation rates to the labeling
density is required to guarantee the desired image and temporal resolutions.
The emitter ON state (OFF state) lifetime in living cells usually ranges between 10-50 ms (0.5-10 s),
corresponding to a frame rate of 20-100 Hz [40]. For low fluorophore densities (e.g. labeling of low-
copy number proteins) an effective image resolution of 20 nm in combination with a temporal
resolution of 0.5-1.0 s can be achieved. However, the fluorophore concentration increases with the
abundance of the protein of interest (POI) and thus effective image resolution can only be maintained
at the expense of temporal resolution [39].
Clearly, higher laser intensities accelerate switching but technical progress in the means of faster
cameras [330] and/or computational development in the sense of new post-processing strategies [331,
332] are necessary to exploit it. Alternatively, super-resolution optical fluctuation imaging (SOFI) [333,
334] and super-resolution radial fluctuation (SRRF) analysis [335] tolerate high labeling densities and
still allow a moderate temporal resolution. These approaches analyze fluorescence fluctuations over
time to derive additional spatial information. As they do not work strictly at the single molecule level,
typical resolution enhancements are limited to 2-3 fold and artefacts can be expected [336].
Specifically for STORM, blinking buffers are not truly live cell compatible as single molecule switching
requires an oxygen depleted, redox environment often created by toxic thiols. However, dye selection
rules facilitate live cell STORM in different cellular compartments based on the fluorophores’ redox
potential [337]. Despite the drawbacks hampering routine application of SMLM for living samples,
successful live cell SMLM has been performed [37, 38, 41, 42, 337-339].
I.1.5.2 Live Cell STED Imaging
Amongst all nanoscopy techniques, STED is one of the fastest and most suited for live cell imaging and
imaging deeper within living tissues or living animals [340]. However, at the beginning of the century,
STED was considered not live-cell compatible due to the high STED laser intensities and associated
photobleaching [4]. To achieve a resolution in the tens of nanometer range, donut crest intensities up
to 1 GW/cm2 are necessary. Still, 2PE as the method of choice for in vivo deep tissue imaging uses even
higher doses of light. The live cell compatibility of STED cannot be generally judged as it individually
depends on the STED wavelength, the required resolution (i.e. STED laser intensity), the observation
time and frequency (i.e. total exposure time), the FOV and the specimen (refer to I.1.4 and IV.1).
After the first proof of live cell STED in 2008 [341], numerous live cell STED experiments have applied
FPs [263, 264, 342-349], self-labeling protein tags [29, 30, 32, 33, 259, 260, 350, 351] or small molecule
binders [31, 352-354] in both single-color and multicolor approaches [29, 31-33, 260, 263, 264, 342].
The dynamics of different cellular molecules, of molecular assemblies, of structures like the
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cytoskeleton, vesicles and the cell membrane, and of organelles such as the endoplasmatic reticulum
(ER), mitochondria and peroxisomes have been observed in living cell lines and even in brains of living
mice [355, 356]. Deep tissue and in vivo STED imaging is mainly challenged by scattering and
aberrations degrading the intensity zero, impairing the beam alignment, and thus reducing image
contrast and resolution. Adaptive optics using either deformable mirrors or SLMs can correct for
sample-induced aberrations from refractive index mismatch [2, 357-362] and 2PE counteracts light
scattering [363].
The huge advantage of STED over SMLM is the free choice of the number of simultaneously recorded
fluorophores via adaptation of the intensity zero. Individually tuning the spatial resolution allows for
matching the respective biological dynamics. (Ultra)fast scanning units enable video-rate STED with a
temporal resolution of 80-200 frames per second rendering STED the fastest reported nanoscopy
method to date [340, 364, 365]. Alternatively, parallelization of the illumination scheme also speeds
up the acquisition [245, 246].
To attain the respective STED intensity for efficient OFF switching around the donut zero, the intensity
at the donut crest can be orders of magnitude higher than . Yet, photobleaching, phototoxicity, dark
state accumulation and switching fatigue can be lowered by either reducing excess STED photons or
protecting the fluorophores (refer to IV.1). For example, in D-Rex (dark state relaxation) [141, 366] and
T-Rex (triplet state relaxation) STED [238], low-repetition-pulsed laser light or ultra-fast scanning give
the fluorophores time to relax back from dark states and triplet states to . Long pulses in
combination with time-gating can reduce STED peak intensities up to one order of magnitude. Other
measures to lower the light dose to the sample include sophisticated light exposure schemes applying
adaptive illumination (AI), which are conceptually related to controlled light exposure microscopy
[286].
Reduction of state transition cycles (RESCue) STED locally adapts the sample exposure by modifying
the intensities of the STED and excitation beams. An online decision is taken based on the number of
photons detected during a first fraction of the dwell time, which shuts off the STED and excitation
beams if the photon flux is lower than a certain threshold. Thus, the fluorophores cycle less often and
their exposure to the donut crest is significantly reduced. However, neighboring regions are still
negatively affected [367].
By contrast, molecular states for multiple off-state transitions (MOST) nanoscopy exploits the presence
of a second (protective) OFF state to prevent designated OFF state fluorophores from populating the
ON state. Thereby, neighboring fluorophores are efficiently protected, and resolution and ON-OFF
contrast are enhanced. Protected STED combines the MOST concept with STED imaging and introduces
the protective OFF state by utilizing the ability of psFPs to reversibly switch between an activated
(`fluorescent´) and a deactivated (`dark´) form. In addition to  of the activated form, the deactivated
form is implemented as the second OFF state, which efficiently protects the psFPs from photobleaching
as the deactivated form either does not absorb the excitation or the STED wavelength or absorption is
followed by instantaneous relaxation to . An additional donut-shaped beam restricts the area of
psFPs susceptible to the excitation and STED beam to a subdiffraction-sized region by sending all psFPs
to their deactivated form except the ones in the center of the donut. The illumination scheme is rather
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complex and requires the optimization of numerous parameters, but protected STED enables 2D and
3D live cell imaging of light sensitive samples [368].
STED with minimized FOV and minimized fluorophore exposure to the STED beam (MINFIELD) strongly
reduces, as in the case of RESCue STED, the number of excitation and emission suppression cycles.
However, MINFIELD records only subdiffraction-sized FOVs determined in advance based on low
resolution confocal images. Thereby, the relevant fluorophores are not exposed to the excess
intensities of the donut crest and photobleaching is reduced up to 100-fold [369]. STED with dynamic
intensity minimum (DyMIN) synergistically combines RESCue and MINFIELD STED without being
restricted to subdiffraction-sized FOVs but avoiding excess STED photons. The sample is dynamically
probed by confocal scanning with low light intensities and STED power is gradually increased while
scanning across a fluorophore. Full STED power is reached only at the moment when the fluorophore
is centered in the middle of the donut. Thereby, DyMIN STED reduces the STED laser dose 20-fold in
common biological samples. Yet, it works most efficiently in sparsely labeled 2D and 3D samples with
STED dose reductions of more than 100-fold [370]. Moreover, refined AI variants of STED nanoscopy
exist that are specialized to individual biological problems (e.g. guided STED [371]).
Compared to STED imaging, RESOLFT with psFPs significantly reduces the laser intensities required for
efficiently driving the focal switch. It typically exploits the photoinduced cis-trans isomerization
between a fluorescent and a non-fluorescent psFP chromophore isomer with lifetimes in the ms range.
As  inversely scales with the lifetime of the involved states, switching intensities are roughly an order
of magnitude lower compared to STED imaging assuming that the corresponding cross sections of
stimulated depletion and psFP switching are comparable [372]. While every STED switching cycle yields
only one photon, psFPs in RESOLFT emit more than one photon per cis-trans switching cycle. However,
the decreased intensities come at the expense of a reduced imaging speed and near-UV light (for
switching). Further limitations potentially appear as crosstalk between ON-OFF switching,
photofatigue and FP oligomerization. Any decrease in imaging speed can be compensated by
parallelization of the RESOLFT illumination scheme [373, 374].
MINFLUX minimizes the fluorophore input and output by probing single emitters with an excitation
light intensity minimum [186, 187]. Therefore, it is at the moment still challenged by samples with
background, common for living specimens. Still, the first live cell MINFLUX imaging has recently been
published [188].
For successful live cell imaging, the imaging modality must be chosen with respect to the biological
question to answer. In any case, minimization of the cells’ stress level should be the guiding principle
(refer to IV.1) [375]. Besides current technical, methodological and computational innovations, the
choices of fluorophore and labeling strategies greatly influence the success of live cell imaging. Further
improvements and/or new developments from the (bio)chemical side will strongly advance the
progress in the field of live cell imaging.
I.1 Survey of the Field 25
I.1.6 Specific Targeting in Live Cell Nanoscopy
As a molecular switch is the secret to success for every nanoscopy method, improvements on the
fluorophores are one of the major keys to boosting the performance of current methods [376-380].
Spatial resolution is directly linked to the fluorophores’ properties regarding state-transfer efficiency,
photophysical and photochemical kinetics, photochemical stability, photon yield (i.e. absorption cross
section and fluorescence quantum yield) and environmental sensitivity. Thus, there is a strong urge in
(bio)chemistry to improve the existing and develop new water-soluble markers that can flexibly be
linked to the target of interest.
While every fluorescence nanoscopy method is built on the common principle of the focal switch, the
individual demands on the detailed photophysics of the emitters differ between methods. SMLM
requires fluorophores with a maximal photon burst in a minimal time and dark times long enough to
ensure sufficient spatial separation of single molecule events. MINFLUX depends especially on reliable
switching characteristics and strongly benefits from the absence of stochastic blinking behavior.
For all coordinate-targeted methods, a high photostability, a low photobleaching quantum yield
and a maximal number of switching cycles is advantageous. The higher the desired effective image
resolution is, the higher the STED intensity and the smaller the pixel size must be, thus the more cycles
a single fluorophore has to undergo [4, 50]. In particular, STED imaging profits from a high stimulated
emission cross section, from low dark state transition possibilities, and from a low cross section for
excitation to  and  [381], characteristics that are mainly found with organic dyes.
As no single fluorophore fulfills all criteria at once, conscious compromises must be taken for each
concrete application. Ongoing developments push especially for new organic dyes with beneficial
photophysical properties for fluorescence nanoscopy [382-386].
I.1.6.1 Live Dyes
To draw conclusions as close as possible to biological reality, live cell imaging attracts an increasing
amount of attention (refer to I.1.5). However, while labeling techniques for living cells were in place,
truly biocompatible organic dyes were missing in the early days of fluorescence nanoscopy [387].
Molecular specificity and cell permeability were therefore the two most cited limitations of organic
fluorophores for live cell imaging at the end of the last century [388]. The diffusion through cell
membranes is either size or charge hampered and, for a long time, only very few cell permeable dyes
like TMR-STAR, Oregon Green and ATTO 655 were available. Alternative but invasive strategies deliver
the fluorophore inside the cell via cell squeezing [389], biophotonic laser-assisted surgery tool (BLAST)
[390], transient membrane pore formation [391], electroporation [392], glass-bead loading [393],
membrane transfer [394], micro-/nano-injection [395, 396], cell-penetrating peptides [397], and
pinosomelysis [398]. However, these techniques are elaborate, suffer from low efficiency and subject
the cells to a high level of stress.
Longer wavelength light unites several characteristics particularly advantageous for live cell, deep
tissue and in vivo imaging. (Far-)red illumination is less phototoxic and reduces autofluorescence and
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scattering [305]. With the beginning of the 2010s, various near-infrared (NIR) synthetic dyes were
available, but they were either membrane impermeable or suffered from unspecific binding [260].
Therefore, the development of (far-)red emitting live-cell probes [29-36, 353, 354] and FPs [347-349,
399] for fluorescence nanoscopy has been and still is greatly pushed.
In the field of organic dyes, Lukinavicius et al. set the kick-off in 2013 with the synthesis of a far-red
silicon-based rhodamine (6-carboxy-tetramethylsiliconrhodamine, SiR-COOH) [30]. The SiR dye is
membrane permeable, bright, fluorogenic, photostable, essentially non-toxic, absorbs and emits in the
NIR spectral range, and enables no-wash experiments. These characteristics render the SiR dye a
potent candidate for NIR live cell STED imaging. It exists in an equilibrium between a non-fluorescent,
`cyclized´ spirolactone form and a fluorescent, `open´ zwitterionic form with the dielectric constant of
the environment governing the equilibrium’s position (Figure I-8a). In the unbound state, which
comprises free diffusion in the cytoplasm and binding to off-target proteins or hydrophobic structures,
the SiR dye adopts the non-fluorescent form. Upon binding to its target, the fluorescent form is
favored. Versatile implementations in cellulo and in vivo are possible as specific targeting can be
achieved with self-labeling protein tags (refer to I.1.6.2) [30], via click chemistry [30] or via small
molecule binders [353, 354, 400-403]. Nowadays, the SiR dye is commercially available as a substrate
for SNAP-tagged fusion proteins [404].
To expand the color palette of what are colloquially called `live dyes´ and enable multicolor live cell
imaging, the development of SiR-related and SiR-inspired fluorophores with different spectral
properties has been strongly boosted. On the one hand, red-shifted derivatives of the SiR dye were
developed enabling 810 nm STED of cytoskeletal structures [31, 33]. On the other hand, Butkevich et
al. extended the spectral scope also to shorter wavelengths, synthesized (hydroxylated) rhodamines,
carbopyronines, silicorhodamines and germanorhodamines in the same spectral range and introduced
the favorable live dye pairs 580CP/SiR and 610CP/640SiRH for live cell dual-color STED with 775 nm
de-excitation (Figure I-8b) [29, 32].
To quantify the fluorogenicity of the different derivatives, Butkevich et al. defined the measure D0.5.
It states the dielectric constant of a dioxane-water mixture with an absorption (or extinction
coefficient) of half the maximum absorption (or extinction coefficient) measured for the entire
dioxane-water gradient [29]. By investigating the structure-property relationship of the different dye
derivatives, Butkevich et al. could predict the spectral properties and D0.5 values of new dye
derivatives based on a simple additive scheme. The synthesis and characterization of these dyes
proved the prediction to be more accurate than current computational methods like density functional
theory (DFT) [32].
Additional effort was taken by Grimm et al. to improve the brightness and photostability of existing
live dyes without changing their spectral properties and cell permeability [34]. The final result was a
series of derivatives called Janelia Fluor (JF) dyes [405]. Further development by Grimm et al. yielded
a photoactivatable SiR dye [36] and photoactivatable variants of the JF dyes [35], enabling fixed cell
PALM imaging and live cell single particle tracking (SPT) PALM. Adaptations of the intramolecular
nucleophilicity and electrophilicity of the SiR dye tuned the equilibrium constant for the intramolecular
spirocyclization and the lifetime of the zwitterionic form, providing the first-in-class spontaneously
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blinking HMSiR dye. This rationally designed derivative allows live cell dSTORM without the need for
toxic additives or high-intensity laser irradiation to induce blinking [406].
Conjugation of a sulforhodamine fluorophore with the DNA targeting ligand Hoechst yielded the
nucleus DNA specific live dye HoeSR. Transient DNA binding results in a fluorescence turn on and
allowed for live cell dSTORM imaging of mitosis [37]. The combination of the SiR dye with genetically
encoded light-up RNA aptamers provided the remarkably photostable and bright aptamer/ligand pair
SiRA, enabling live cell STED imaging of tRNAs and mRNAs [407].
Figure I-8. Structures of selected live dyes and
their application via the SNAP-tag technology.
(a) The popular silicone rhodamine (SiR) live dye
exists in an equilibrium between a `cyclized´
spirolactone form (non-fluorescent) and an `open´
zwitterionic form (fluorescent), which is governed
by the polarity of the medium. The excitation and
fluorescence emission maxima of the zwitterionic
form peak at 645 nm and 661 nm [30]. (b) Chemical
structures of the three live dyes used in this thesis.
The carbopyronines 580CP and 610CP display
maximal absorptions at 582 nm and 609 nm and
maximal fluorescence emissions at 607 nm and
634 nm [29]. The hydroxylated silicorhodamine
640SiRH shows maximal absorption at 641 nm and
maximal fluorescence emission at 662 nm [32]. (c)
The enzyme specific substrates of HaloTag (chloro-
alkanes) and of SNAP-tag (benzylguanine, BG) can
be conjugated to the live dyes. (d) The protein of
interest (POI) is genetically fused to the SNAP-tag
(or any other self-labeling protein tag) and the
fusion construct is synthesized by the protein
expression machinery of the transfected or
genetically engineered cell. The BG-dye derivative is
supplied with the cell culture medium. The SNAP-
tag reacts with its substrate, releases guanine and
covalently labels itself with the dye.
I.1.6.2 Targeting Strategies
To visualize a structure or process of interest in cells, tissue or even a whole organism, fluorescent
markers must be specifically attached to the respective target. As it is always the emitter that is imaged
and not the molecule of interest, the individual targeting strategy greatly influences the results (refer
to I.1.2). The `how precisely and accurately´ a biological structure can be visualized with fluorescence
nanoscopy, hereinafter referred to as the biological resolution, strongly depends on the label size, the
labeling efficiency, the dynamic range, the contrast, the sample’s spatial structure and potential
biological and/or stage drift. Yet, no consensus has been reached on how exactly to define the
biological resolution [408]. It is crucial to emphasize that the resolution of the optical system can
strongly differ from the biological resolution (refer to I.1.2).
Intrinsic standards like microtubules are often chosen as a measure for the biological resolution and
their FWHM is extracted from line profiles fitted by Gaussian or Lorentzian functions. However, the
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results should be handled with caution as firstly, the actual PSF might differ from the Gaussian or
Lorentzian description, secondly, the biological resolution may vary within one image and finally,
selection of suitable line profiles is biased [99, 132, 409]. More reliable and comparable approaches
are based on the Fourier ring correlation, commonly used for assessing the resolution of EM
reconstructions [410], which computes the biological resolution directly from the super-resolved
image [148, 408, 411, 412].
In all fluorescence nanoscopy methods, selection of suitable labels and thorough sample preparation
are significantly more crucial than for diffraction-limited imaging, as the increase in resolution exposes
potential, previously unknown labeling artefacts (refer to I.1.2) [413]. To guarantee the best possible
biological resolution, an ideal affinity probe is small, live cell compatible, does not induce steric
hinderance, targets specifically, binds monovalently, labels quantitatively – and is not known to exist.
Therefore, the labeling method must be selected with respect to the biological question, the
preparation options for the sample and the required spatial resolution.
FPs revolutionized the field of live cell imaging and since the 1990s have been established as the
labeling method of choice for living specimens. Their key strengths are genetic encodability,
straightforward expression in fusion constructs with the POI, and autocatalytic chromophore
formation rendering additional dye labeling steps redundant. FPs are small compared to antibodies
(Table I-1, Figure I-9), but large compared to organic dyes (~1 kDa).
Major efforts in protein engineering have been and still are invested to optimize the photophysical and
biochemical properties of FPs, such that today an extensive color palette, various photochromic
variants and a large variety of sensor probes are available [21, 22]. Endogenous tagging via genome
editing allows for stoichiometric labeling of the POI. Yet, quantitative imaging is only guaranteed if the
chromophore maturation efficiency is high. As chromophore maturation depends on the presence of
oxygen, its speed sets a temporal limit on the observed processes. Additionally, FP-tagging potentially
perturbs folding, stability, interactions and localization of the POI. These problems can be partially to
fully circumvented by antibody fragment/FP fusions like fluorobodies or chromobodies [414].
However, the intrinsic tendency of FPs to oligomerize can lead to FP aggregation particularly during
overexpression [415]. In general, FPs display more complex photophysics, reduced brightness and
lowered photostability compared to organic dyes [416]. Still, rational design and directed evolution
with focus on fluorescence nanoscopy applications try to render FPs photophysically compatible with
their synthetic counterparts and optimized versions for PALM [417], RESOLFT [138] and STED [347,
348] have been developed. Indeed, STED nanoscopy has been using FPs for a long time as they feature
a low excited state absorption for both the excitation and STED wavelengths [341, 345, 418].
Antibodies are the most widely employed affinity probes in fluorescence microscopy as they combine
high specificity with enormous flexibility in targeting virtually any cellular compartment.
Immunohistochemistry offers the best option for quantitative imaging of endogenous protein levels.
While immunostaining is compatible with any organic dye, it is limited to fixed samples as antibodies
are not cell membrane permeable. Standard indirect immunofluorescence (IF) with a primary antibody
targeting the POI and a fluorescently labeled secondary antibody targeting the primary antibody offers
modular staining with strong signal amplification.
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However, the primary/secondary complex physically displaces the fluorophore approximately 20-
30 nm from the structure of interest. Thus, the imaged coordinates and the structure coordinates are
not identical. Furthermore, the primary/secondary complex may sterically hinder labeling of denser
regions in the sample where epitopes are not accessible for bulky probes [419, 420]. Incomplete
labeling in combination with multiple binding capabilities potentially produce artefacts in nanoscopic
imaging [421]. Smaller alternatives recognizing epitopes with monovalent binding can partially to fully
circumvent these limitations (Table I-1, Figure I-9) [408].
For certain cellular targets, small molecule binders offer an additional solution to targeting problems.
The labels are small as they only consist of a binding motif (often a chemical inhibitor) conjugated to
an organic dye. These small molecule binders allow for direct, non-covalent labeling and imaging of
living cells, if cell permeable and biocompatible dyes are attached. Yet, compared to the number of
targets in a cell, only a very small library is available by now including small molecule binders for
organelles (mitochondria, ER, Golgi, endosomes/lysosomes) [31, 38, 422-424], cytoskeleton structures
[31, 354], DNA [37, 353] and membranes [422, 425, 426].
More target flexibility is given by click chemistry, which enables fast, irreversible, highly site-specific
and direct labeling of proteins and protein subdomains [427-429], of DNA [430], and of lipids [431] in
both fixed and living cells with minimal target modification and essentially no label size. Yet,
biomolecule labeling via click chemistry is still in its infancy. As soon as it can be routinely applied, click
chemistry (or similar approaches) certainly will evolve to the staining method of choice for
fluorescence nanoscopy since it alleviates any potential perturbations by bulky tags.
Table I-1. Size comparison of different affinity probes.
label targeting modality size [nm] Mw [kDa] reference
fluorescent protein genetic fusion 2-5 27 [432]
SNAP-tag/CLIP-tag genetic fusion 3-4 20 [23, 24]
HaloTag genetic fusion 3-5 33 [25]
IgG antibody epitope recognition 10-15 150 [433]
antibody fragment (Fab) epitope recognition 9 50 [434]
single-chain variable fragment
(scFv) epitope recognition 6 30 [435]
camelid heavy-chain variable
fragments (VHH, nanobody) epitope recognition 3 13 [436]
designed ankyrin repeat protein
(DARPin) epitope recognition 2-3 10-30 [437]
affibody epitope recognition 2 6 [438]
fibronectin type III domain (FN3,
monobody) epitope recognition 2 10 [439]
aptamer epitope recognition 4 15 [421, 440]
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Due to the limitations, drawbacks and challenges of the above-mentioned targeting strategies, strong
effort has been and still is invested to develop alternative strategies based on genetically encoded
protein tags specifically binding their substrates, covalently or non-covalently. Particularly for non-
covalently binding tags, fluorogenic ligands are preferred as they keep background minimal even at
excess fluorophore concentrations and thus guarantee a high imaging contrast [441].
Reversible binding allows for SMLM at low fluorogen concentrations without the need for special
imaging buffers or photoactivation/photoswitching with a second laser [442]. Moreover, reversible
binding reduces apparent photobleaching via constant dye renewal, which has been proven to be
beneficial for live cell STED imaging [443, 444]. However, as photobleached fluorogens are only
replaced and not prevented, ROS are still produced damaging both the sample and the tag itself [445].
Distinction can be made between protein tags that bind endogenous chromophores like flavin-based
FPs (FbFPs, iLOV (improved light, oxygen or voltage sensing) domain, miniSOG (mini singlet oxygen
generator)) [446-448], bilirubin-binding tags (UnaG (Unagi green FP)) [449] and biliverdin-binding FPs
(IFP1.4 (infrared FP 1.4), iRFP (near-infrared FP)) [450-452], and protein tags that bind exogeneous,
synthetic fluorophores like the yellow fluorescence-activating and absorption-shifting tag (Y-FAST)
[453, 454] and fluorogen activating proteins (FAPs) [455]. Yet, in both cases, substrate and
chromophore are identical, imposing no free dye choice, spectral and photophysical constraints and
limitations for molecular engineering of the fluorophore. Thus, it is highly beneficial to use tags binding
a substrate that can be linked to the desired fluorophore.
Self-labeling protein tags like SNAP [23, 24], Halo [25], CLIP [456] and Escherichia coli dihydrofolate
reductase (eDHFR) [457, 458] covalently bind enzyme specific substrates (benzylguanine (BG),
benzylcytosine (BC), chloroalkanes, trimethoprim), which can be conjugated to any freely chosen
fluorophore (or any other chemical moiety) (Figure I-8c,d). Certainly, if live cell imaging is the aim, the
fluorophore must be cell membrane permeable and biocompatible. All tags originate from enzymes
optimized via directed evolution and/or rational protein engineering; SNAP- and CLIP-tags are
derivatives of the human DNA repair enzyme O6-alkylguanine-DNA-alkyltransferase, HaloTag of the
bacterial haloalkane dehalogenase from Rhodococcus rhodochrous. Hence, the different self-labeling
protein tags allow for orthogonal labeling reactions crucial for multicolor imaging. The labeling is
typically fast and rather quantitative. Self-labeling protein tags unite the key strengths of FPs and
Figure I-9. Label sizes of selected affinity probes.
The different affinity probes commonly used for
targeting cellular structures in fluorescence
microscopy are shown to scale and in comparison
to a short stretch of double-stranded DNA. All
crystal structures were obtained from the PDB [Fab
1FDL, scFv 5VF6, nanobody 1MEL, IgG 1IGT, DARPin
5FIN, affibody 2KZJ, monobody 3RZW, aptamer
2JWV, HaloTag 5UY1, SNAP-tag 3KZY, GFP 5DTY,
DNA 1W0U].
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immunolabeling, namely genetic encoding and bright and photostable organic dyes, while being small,
live cell compatible, target specific and modular (Table I-1, Figure I-9).
The category of self-labeling tags further includes tetra-cysteine and tetra-serine tags. These small
peptides non-covalently bind the cell-permeable, fluorogenic biarsenical FlAsH (fluorescein arsenical
hairpin binder) and ReAsH (resorufin arsenical hairpin binder) dyes [459] and the bis-boronic RhoBo
(rhodamine-derived bis-boronic acid) dye [460]. While the tetra-serine/RhoBo system has more
background problems through non-specific dye interactions, the tetra-cysteine/FlAsH/ReAsH systems
show more cytotoxicity.
All genetically encoded tags must be introduced at the DNA level. Genetic transfection with plasmids
encoding for the fusion construct of tag and POI is the faster and easier option but allows only for
exogeneous expression of the fusion protein. Thus, labeled and unlabeled proteins expressed from the
native locus are simultaneously present in the cell. The native protein level is altered and in extreme
cases, overexpression leads to incorrect localization, accumulation and cell stress provoking
uncontrolled regulatory effects. Transient transfections are the quick and dirty variant providing for
fast and easy, but hard to reproduce and potentially heterogeneous samples; stable transfections are
more time consuming but guarantee reproducibility.
In contrast, genome editing enables the site-specific insertion of the tag’s sequence in the genome.
The most popular molecular scissor is the clustered, regularly interspaced, short palindromic repeats
(CRISPR/Cas9) system [461, 462]. Other options make use of meganucleases [463], zinc finger
nucleases (ZFNs) [464] or transcription activator-like effector-based nucleases (TALENs) [463, 465].
Genetic engineering allows for stoichiometric labeling in case the specimen has been homozygously
tagged. The endogenous protein level remains undisturbed and the fusion protein is expressed at the
native transcription level and under the native pattern. Yet, genome editing is often the second choice
as it is challenging and time consuming.
32 I.2 Materials and Methods
I.2 MATERIALS AND METHODS
I.2.1 Materials
I.2.1.1 Machines and Equipment
All standard optics equipment was ordered from Thorlabs (Newton, New Jersey, USA).
Table I-2. Components of the custom-built STED system.
components company
Onefive Katana 08 HP, 775 nm STED laser NKT Photonics, Birkerød, Denmark
Solea, supercontinuum laser PicoQuant, Berlin, Germany
LDH-D-C470, 470 nm diode laser PicoQuant, Berlin, Germany
ICS-6 Laser Interlock® System Lasermet, Bournemouth, United Kingdom
525/50 nm BrightLine® single-band bandpass filter Semrock, Rochester, New York, USA
628/32 nm BrightLine® single-band bandpass filter Semrock, Rochester, New York, USA
708/75 nm BrightLine® single-band bandpass filter Semrock, Rochester, New York, USA
775 nm blocking edge BrightLine® shortpass filter Semrock, Rochester, New York, USA
561 nm laser BrightLine® single-edge super-resolution
laser dichroic beamsplitter Semrock, Rochester, New York, USA
ZT405/473-491/NIRrpc Chroma Technology, Bellow Falls, Vermont, USA
PCle-7852, field-programmable gate array (FPGA) based PC
board National Instruments, Austin, Texas, USA
SMARPOD 70.42, hexapod-like positioning system SmarAct, Oldenburg, Germany
SPCM-AQRH-15/13-FC, avalanche photodiodes (APDs) Excelitas Technologies, PerkinElmer, Waltham,Massachusetts, USA
MPH16, motorized pinhole Thorlabs, Newton, New Jersey, USA
HCX PL APO 100×/1.44 Oil CORR CS, objective Leica, Wetzlar, Germany
Leica DMI6000 CS Leica, Wetzlar, Germany
EL6000, fluorescence lamp Leica, Wetzlar, Germany
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Table I-3. Further instrumentation and equipment.
equipment company
Agilent 1100 series, HPLC Agilent Technologies, Santa Clara, California, USA
LaPrep-System P110, HPLC VWR International, Radnor, Pennsylvania, USA
NUCLEODUR® Sphinx RP column VWR International, Radnor, Pennsylvania, USA
Chromolith RP-18e, 100×10 mm Merck, Darmstadt, Germany
Chromolith RP-18e, 100×4.6 mm Merck, Darmstadt, Germany
P314, variable UV detector VWR International, Radnor, Pennsylvania, USA
Sep-Pack C18 cartridge Waters, Milford, Massachusetts, USA
Avance III, 400 MHz NMR Bruker Daltonics, Billerica, Massachusetts, USA
APEX-Qe hybrid 9.4 T FT-ICR, mass spectrometer Bruker Daltonics, Billerica, Massachusetts, USA
Microflex LT, MALDI-MS Bruker Daltonics, Billerica, Massachusetts, USA
JMS-700 MStation Mass Spectrometer JEOL, Akishima, Tokyo, Japan
Varian Cary 500 UV-VIS NIR Spectrophotometer Agilent, Santa Clara, California, USA
Varian Cary Eclipse Fluorescence-Spectrophotometer Agilent, Santa Clara, California, USA
FluoTime 300 Fluorescence Lifetime Spectrometer PicoQuant, Berlin, Germany
BD FACS Canto II Flow Cytometer BD Biosciences, Becton Dickinson, Franklin Lakes, NewYork, USA
Chef DRII Pulse Field Electrophoresis chamber BioRad, Hercules, California, USA
Chemi-Doc MP Imaging System BioRad, Hercules, California, USA
PET-scanner Inveon PET Siemens, München, Germany
Packard Cobra II, gamma counter GMI, Ramsey, Minnesota, USA
HoloMonitor® M4 cytometer, holographic microscope Phase Holographic Imaging, Lund, Sweden
BBD 6220 CO2 incubator Thermo Fisher Scientific, Waltham, Massachusetts, USA
Safe 2020 Class II Biological Safety Cabinet Thermo Fisher Scientific, Waltham, Massachusetts, USA
Countess II FL Automated Cell Counter Thermo Fisher Scientific, Waltham, Massachusetts, USA
Micro Star 12, microcentrifuge VWR International, Radnor, Pennsylvania, USA
Megafuge 1.0R, benchtop centrifuge Heraeus, Hanau, Germany
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equipment company
Sartorius Basic BA 210S FN, analytical balance Sartorius, Göttingen, Germany
precision balances L4202 and L2001 VWR International, Radnor, Pennsylvania, USA
Vortex-Genie 2 Scientific Industries, Bohemia, New York, USA
PMR-30 platform rocker Grant Instruments, Shepreth, United Kingdom
INCU-Line® ILS 4, shaking incubator VWR International, Radnor, Pennsylvania, USA
Slide MoatTM, slide hybridizer 240000 Boekel Scientific, Feasterville, Pennsylvania, USA
VWB2 12 water bath, 12 l VWR International, Radnor, Pennsylvania, USA
PURELAB flex 2 Polisher, ultrapure type I water dispenser Veolia Water, Paris, France
I.2.1.2 Consumables
Table I-4. Consumables.
consumable company
4/8-well NUNCTM Lab-TekTM II Chambered Coverglasses Thermo Fisher Scientific, Waltham, Massachusetts, USA
4-well NUNCTM Lab-TekTM II Chamber SlideTM Systems Thermo Fisher Scientific, Waltham, Massachusetts, USA
96-well filter plate Millipore, Merck, Darmstadt, Germany
NUNC 24-well cell culture plates Thermo Fisher Scientific, Waltham, Massachusetts, USA
lumox® 24-well cell culture plates Sarstedt, Nümbrecht, Germany
PHI HoloLidsTM Phase Holographic Imaging, Lund, Sweden
Countess™ Cell Counting Chamber Slides Thermo Fisher Scientific, Waltham, Massachusetts, USA
CELLSTAR®cell culture flasks with filter cap, T25/T75 Greiner Bio One International, Kremsmünster, Austria
Protein LoBind Tubes Eppendorf, Hamburg, Germany
SafetySpaceTM Low Retention Filter Tips Sartorius, Göttingen, Germany
Costar® Stripette® serological pipettes Corning, New York, USA
Menzel #1.5 coverslips, 12 mm diameter Thermo Fisher Scientific, Waltham, Massachusetts, USA
Menzel microscope slides (76×26 mm) Thermo Fisher Scientific, Waltham, Massachusetts, USA
ProLong Diamond Antifade Mountant with DAPI Thermo Fisher Scientific, Waltham, Massachusetts, USA
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consumable company
4/8-well NUNCTM Lab-TekTM II Chambered Coverglasses Thermo Fisher Scientific, Waltham, Massachusetts, USA
IMMOIL-F30CC immersion oil Olympus, Tokyo, Japan
alugram-DC-plates (40×80 mm, RP-18 W/UV254, 0.15 mm) Machery-Nagel, Düren, Germany
polygram-DC-plates (40×80 mm, SIL G/UV254, 0.2 mm) Machery-Nagel, Düren, Germany
Matrigel Becton Dickinson, Franklin Lakes, New York USA
silica gel (0.032 mm–0.062 mm) Machery-Nagel, Düren, Germany
Biozym Gold Agarose Biozym Scientific, Hessisch Oldendorf, Germany
I.2.1.3 Buffers, Solutions and Reagents
All commercially available chemicals, reagents and solvents were ordered from Carl Roth (Karlsruhe,
Germany), CheMatech (Dijon, France), Iris Biotech (Marktredwitz, Germany), Merck (Darmstadt,
Germany), Sigma-Aldrich/Merck (Darmstadt, Germany), VWR International (Radnor, Pennsylvania,
USA), AppliChem (Darmstadt, Germany), abcr (Karlsruhe, Germany) and Acros Organics (Geel,
Belgium) and were of analytical grade and used as received without further purification. Deuterated
solvents were obtained from Deutero (Kastellaun, Germany).
Table I-5. Buffer recipes.
buffer recipe
phosphate-buffered saline (PBS) pH 7.4
1 tablet (Sigma-Aldrich, Merck, Darmstadt, Germany) per 200 ml ultrapure
H2O yields 0.01 M phosphate buffer, 0.0027 M potassium chloride, 0.137 M
sodium chloride
sodium acetate (NaAc) buffer, 0.1 M
13.6 g sodium acetate trihydrate (Sigma-Aldrich, Merck, Darmstadt,
Germany) and 5.75 ml glacial acetic acid (Sigma-Aldrich, Merck, Darmstadt,
Germany) in ultrapure H2O, final volume 1 l, pH 4.6
tris-acetate-EDTA (TAE) buffer 1× 50× TAE buffer (BioRad, Hercules, California, USA) diluted 1:50 in ultrapureH2O
glycine buffer 50 mM glycine (Merck, Darmstadt, Germany) in ultrapure H2O, pH 2.8
hybridization buffer for PNA FISH 75% formamide in 20 mM NaCl, 20 mM Tris-HCl, 0.1% bovine serumalbumin (BSA), pH 7.4
washing buffer for PNA FISH 70% formamide in 10 mM Tris-HCl, pH 7.4
SSC buffer, 2× and 0.1×
premixed powder pack (Santa Cruz Biotechnology, Dallas Texas, USA)
dissolved in 1 l ultrapure H2O yields 20× SSC buffer (3 M NaCl, 300 mM
sodium citrate), further diluted 1:10 and 1:100 in ultrapure H2O
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Table I-6. Solutions.
solution recipe
paraformaldehyde (PFA) solution, 2% and
3.7% (v/v)
diluted in PBS from 37% formaldehyde solution (AppliChem, Darmstadt,
Germany)
ethanol (EtOH), 70, 85, 100% (v/v) EtOH diluted in ultrapure H2O
goat serum, 10% (v/v) normal goat serum (Abcam, Cambridge, United Kingdom) diluted 1:10 inPBS
NP-40, 0.002% (v/v) NP-40 (IGEPAL CA-630, Sigma-Aldrich, Merck, Darmstadt, Germany) diluted1:50000 in PBS
TritonX-100, 0.1% (v/v) TritonX-100 (VWR International, Radnor, Pennsylvania, USA) diluted 1:1000PBS
Tween-20, 0.05% (v/v) Tween-20 (Sigma-Aldrich, Merck, Darmstadt, Germany) diluted 1:2000 in2× SSC buffer
propidium iodide (PI) solution 1 mg PI (Thermo Fisher Scientific, Waltham, Massachusetts, USA) in 1 mlultrapure H2O
Mowiol [466]
Table I-7. Specialty chemicals.
chemical company
STAR 600-NHS-ester Abberior, Göttingen, Germany
STAR 635P NHS-ester Abberior, Göttingen, Germany
STAR RED NHS-ester Abberior, Göttingen, Germany
HBED-CC-tris(tBu)ester1 ABX, Radeberg, Germany
PSMA-10 ([Glu-urea-Lys(Ahx)]2-HBED-CC) ABX, Radeberg, Germany
sevoflurane Abbott Laboratories, Chicago, Illinois, USA
I.2.1.4 Kits and Dyes
Table I-8. Biochemical kits.
kit company
Effectene Transfection Reagent Kit Qiagen, Hilden, Germany
Puregene Core Kit Qiagen, Hilden, Germany
Telomere Length Assay Kit Roche, Basel, Switzerland
13-(3-{[(2-{[5-(2-tert-Butoxycarbonyl-ethyl)-2-hydroxy-benzyl]-tert-butoxycarbonylmethyl-amino}-ethyl)-tert-butoxy-
carbonylmethyl-amino]-methyl}-4-hydroxy-phenyl)-propionic acid
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Table I-9. Live dyes.
live dye company/reference
580CP-BG/-Halo [29]
610CP-BG/-Halo/-BC [29]
640SiRH-BG/-Halo/-BC [32]
SNAP-Cell® 647-SiR New England Biolabs, Ipswich, Massachusetts, USA
LysoTrackerTM Green DND-26 Thermo Fisher Scientific, Waltham, Massachusetts, USA
MitoTracker® Green FM Thermo Fisher Scientific, Waltham, Massachusetts, USA
SiR-Lysosome Spirochrome, Stein am Rhein, Switzerland
I.2.1.5 Antibodies
Table I-10. Primary antibodies.
antibody # company
monoclonal mouse anti-TRF1 GTX10579 GeneTex, Irvine, California, USA
monoclonal mouse anti-TRF1 04-638 Merck, Darmstadt, Germany
monoclonal mouse anti-TRF2 05-521 Merck, Darmstadt, Germany
polyclonal rabbit anti-TRF2 NB110-57130 Novus Biologicals, Centennial, Colorado, USA
polyclonal rabbit anti-PMLIII sc-5621 Santa Cruz Biotechnology, Dallas Texas, USA
monoclonal mouse anti-PSMA SAB4200257 Sigma-Aldrich, Merck, Darmstadt, Germany
Table I-11. Secondary antibodies.
antibody # company
goat anti-rabbit-IgG coupled to
Alexa Fluor 488 A-11034 Thermo Fisher Scientific, Waltham, Massachusetts, USA
goat anti-mouse-IgG coupled to STAR 600 2-0002-010-5 Abberior, Göttingen, Germany
goat anti-rabbit-IgG coupled to STAR 600 2-0012-010-2 Abberior, Göttingen, Germany
goat anti-mouse-IgG coupled to STAR 635P 2-0032-052-6 Abberior, Göttingen, Germany
goat anti-rabbit-IgG coupled to STAR 635P 2-0022-052-9 Abberior, Göttingen, Germany
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antibody # company
goat anti-mouse-IgG coupled to STAR RED 2-0002-011-2 Abberior, Göttingen, Germany
goat anti-rabbit-IgG coupled to Atto 488 custom labeled
ATTO 488 NHS-ester (ATTO Technology, Amherst, New
York, USA) coupled to goat anti-rabbit-IgG (111-005-
003, Dianova, Hamburg, Germany)
I.2.1.6 Peptide Nucleic Acid (PNA) Probes
Table I-12. PNA probes.
PNA probe sequence company
TelC (CCCTAA)3-OO PNA Bio, Thousand Oaks, California, USA
LacO TTGTTATCCGCTCACAA-OO PNA Bio, Thousand Oaks, California, USA
I.2.1.7 Plasmids
Table I-13. Plasmids.
plasmid company/reference
pHTN HaloTag CMV-neo Promega, Madison, Wisconsin, USA
pSNAPf New England Biolabs, Ipswich, Massachusetts, USA
SNAP-CLC [259]
I.2.1.8 Cell Culture
Table I-14. Cell culture reagents.
solution/reagent company
Dulbecco's modified Eagle medium (DMEM) high
glucose/GlutaMAX™/pyruvate Gibco, Thermo Fisher Scientific, Waltham, Massachusetts, USA
FluoroBriteTM DMEM Gibco, Thermo Fisher Scientific, Waltham, Massachusetts, USA
Roswell Park Memorial Institute (RPMI) 1640
medium Gibco, Thermo Fisher Scientific, Waltham, Massachusetts, USA
fetal bovine serum (FBS) Merck, Darmstadt, Germany
penicillin/streptomycin (100×) AppliChem, Darmstadt, Germany
sodium pyruvate (100 mM) Gibco, Thermo Fisher Scientific, Waltham, Massachusetts, USA
GlutaMAXTM Supplement (100×) Gibco, Thermo Fisher Scientific, Waltham, Massachusetts, USA
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solution/reagent company
trypsin 2.5%, no phenol red (10×) Gibco, Thermo Fisher Scientific, Waltham, Massachusetts, USA
trypsin 0.05%, ethylenediaminetetraacetic acid
(EDTA) 0.02%, with phenol red (1×) Sigma-Aldrich, Merck, Darmstadt, Germany
poly-L-lysine Sigma-Aldrich, Merck, Darmstadt, Germany
Trypan Blue stain 0.4% Invitrogen, Thermo Fisher Scientific, Waltham, Massachusetts, USA
dimethyl sulfoxide (DMSO), sterile Sigma-Aldrich, Merck, Darmstadt, Germany
Table I-15. Composition of cell culture media.
medium supplementation
DMEM++ DMEM high glucose/GlutaMAX™/pyruvate + 10% FBS + 1% penicillin/streptomycin
FluoroBrite++ FluoroBriteTM DMEM + 10% FBS + 4 mM GlutaMAXTM
RPMI+++ RPMI 1640 medium + 5% FBS + 1% penicillin/streptomycin + 1% sodium pyruvate
Table I-16. Cell lines.
cell line description medium reference
U2OS human bone osteosarcoma epithelial cells (telomere length ~2-50 kb) DMEM++ ATCCHTB-96
F6B2
human bone osteosarcoma epithelial cell line with three stably integrated
bacterial lac operator (lacO) repeat arrays at the subtelomeric region (STR) of
chromosomes 6q, 11p and 12q
DMEM++ [467]
HeLa human cervical adenocarcinoma epithelial cells (normal telomere length, ~7 kb) DMEM++ ATTCCCL-2
HeLa VST human cervical adenocarcinoma epithelial cells with very short telomeres (~4 kb) DMEM++ [468]
HeLa LT human cervical adenocarcinoma epithelial cells with long telomeres (~20 kb) DMEM++ [468]
LNCaP PSMA-overexpressing androgen-sensitive human prostate adenocarcinoma cells RPMI+++ ATCCCRL-1740
PC3 PSMA-negative human prostate adenocarcinoma cells RPMI+++ ATCCCRL-1435
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I.2.1.9 Animals
All animal experiments throughout the thesis complied with the current laws of the Federal Republic
of Germany and the German Animal Welfare guidelines were followed.
Table I-17. Animals.
animal company
BALB/c nu/nu mice, male Charles River Laboratories, Wilmington, Massachusetts, USA
I.2.1.10 Software
Table I-18. Software.
software company
Adobe Illustrator CC 22.0.1 Adobe, San José, California, USA
ChemDraw Professional 16.0.1.4 PerkinElmer, Waltham, Massachusetts, USA
Excel 2016 Microsoft, Redmond, Washington, USA
Fiji 1.52n [469]
GraphPad Prism (version 7) GraphPad Software, San Diego, California, USA
ImageJ 1.47v [470]
Imspector 0.11.9825 Abberior Instruments, Göttingen, Germany
LabVIEWTM 2017 National Instruments, Austin, Texas, USA
Octave 5.1.0 [471]
Origin 2017 OriginLab, Northampton, Massachusetts, USA
Python 2.7.15 and 3.6 Python Software Foundation, Wilmington, Delaware, USA
SciPy (scipy.stats) [472]
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I.2.2 Methods
I.2.2.1 STED Microscope System
All confocal and STED data were acquired with a custom-built setup closely related to the one
published by Görlitz et al. [473] (Figure I-10). It is controlled by a field-programmable gate array (FPGA)
based PC board (PCIe-7852R, National Instruments) which guarantees real-time capability down to the
nanosecond regime. The FPGA adjusts the pulse timing between excitation (master) and STED (slave)
lasers, allows for time-gated detection, and manages beam scanning and focus control. It is operated
by a custom application software written in LabVIEW (National Instruments).
The system features a picosecond pulsed supercontinuum laser (Solea, PicoQuant) and a pulsed
470 nm diode laser (LDH-D-C470, PicoQuant) for excitation. The white light laser offers a free choice
of excitation wavelengths to individually adapt to the desired fluorophores. For stimulated depletion,
a 775 nm pulsed fiber laser (Onefive Katana 08 HP, NKT) guarantees optical stability and reliability. The
STED laser provides 700 ps pulses of > 37 nJ pulse energy and can be electronically triggered over a
broad frequency range. The pulse repetition rate was set to 40 MHz for all experiments.
An acousto-optical tunable filter (AOTF) selects the desired excitation wavelengths out of the white
light spectrum of the supercontinuum laser. The beam passes the AOTF three times in order to
suppress efficiently any undesired wavelengths. For excitation of the dye combinations given in Table
I-19, the wavelengths 600 nm and 650 nm were chosen. After the AOTF, the beams of the
supercontinuum laser and the STED laser are jointly coupled into a polarization maintaining optical
fiber while the path of the 470 nm laser runs independently.
Beam shaping is achieved by a segmented (easySTED) waveplate placed between the tube lens and
the objective (HCX PL APO 100×/1.44 Oil CORR CS, Leica). While donut-focusing the STED beam, the
waveplate leaves the polarization of all excitation wavelengths (mostly) unaffected and thus renders
their beams normally focused. The easySTED implementation provides a robust, virtually alignment-
free system.
A Quadscanner at the sideport of the microscope body (DMI6000 CS, Leica) beam-scans the sample.
Placed in the intermediate image plane, the Quadscanner provides a stationary beam all the way to
the side port making scan lenses obsolete and rendering the system compact, robust and effectively
alignment-free. By avoiding beam shifting in the pupil, the Quadscanner guarantees a high-quality
STED intensity zero over the entire FOV (80×80 µm).
A hexapod-like positioning system (SMARPOD 70.42, SmarAct) translates and rotates the sample in six
degrees of freedom while guaranteeing high rigidity, linear repeatability, and absolute accuracy.
A directional beam splitter (DBS) guides the supercontinuum and STED laser light towards the
microscope body and the fluorescence emission towards the detection path. The DBS combines a
Faraday rotator with two polarizing beam splitters to separate by propagation direction rather than by
wavelength. Thereby, it offers flexibility in the choice of excitation wavelengths but avoids degradation
of the STED intensity zero. A 561 nm laser BrightLine® single-edge super-resolution laser dichroic
beamsplitter (Semrock) separates excitation and fluorescence of the 470 nm beam path.
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The detection path contains a motorized pinhole (MPH16, Thorlabs), which allows for flexible
adaptation to the brightness of the sample by finding a compromise between signal and contrast. For
all experiments, it was set to 125 µm, which corresponds to the size of one Airy. Detection is done via
three avalanche photodiodes (APDs) (SPCM-AQRH-15/13-FC, Excelitas Technologies/PerkinElmer).
After a 775 nm blocking edge BrightLine® shortpass filter (Semrock) to block the major proportion of
the STED laser light, the following double filter combinations are used to guarantee comprehensive
extinction of the STED laser light:
· APD1: ZT405/473-491/NIRrpc (Chroma Technology) and 525/50 nm BrightLine® single-band
bandpass filter (Semrock)
· APD2: 2× 628/32 nm BrightLine® single-band bandpass filter (Semrock)
· APD3: 2× 708/75 nm BrightLine® single-band bandpass filter (Semrock)
The system is tailored to fluorophores with peak emissions between 600-700 nm. Excitation and
depletion in the far-red spectrum are beneficial since scattering, autofluorescence and phototoxicity
are reduced as compared to shorter wavelengths. The filter combination enables dual-color recordings
of the dye combinations given in Table I-19 with virtually no crosstalk including the delicate
combination of 610CP/640SiRH [32]. By using a single STED beam to deplete both excitation channels,
their signals are inherently co-aligned and any influence from residual chromatic aberrations is
excluded.
For regular diagnostics, the laser power was measured before the beam enters the microscope body
using a digital optical power and energy meter (Thorlabs). As the laser beam passes the Quadscanner,
further mirrors in the microscope body, the tube lens, and the objective, the laser power decreases
due to reflection and transmission losses. An attenuation factor of approximately 0.36 was
experimentally determined. The respective power range for excitation and depletion is given in the
methods sections of the individual projects (II.4.7, III.4.7, IV.2.3 and IV.4.3).
Table I-19. Organic dye combinations for live cell and fixed cell STED imaging.
The dyes are ordered according to their excitation (exc) wavelength and their detection (det) window (APD2 – 628/32, APD3
– 708/75) of the STED system. The values for absorption (abs) and emission (em) are given for PBS, pH 7.4.
exc 600 nm / det APD2 exc 650 nm / det APD3
dye abs/em [nm/nm] dye abs/em [nm/nm]
580CP [29] 582/607
640SiRH [32] 641/662
610CP [29] 609/634
Abberior STAR 600 604/623
Abberior STAR RED
(KK114) [382] 638/655
Abberior STAR 635P [382] 638/651
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Figure I-10. Schematic description of the custom-built STED system.
The asterisk indicates the position of regular laser power measurements. SC – supercontinuum laser, SS – safety shutter,
M – mirror, L – lens with focal length in mm, BP – bandpass filter with bandpass wavelength region given in nm,
SP – shortpass filter with cutoff wavelength given in nm, LP – longpass filter with cutoff frequency given in nm, λ/2 – λ/2 plate,
λ/4 – λ/4 plate, OF – optical fiber, FCp – fiber coupler, FCol – fiber collimator, DBS – directional beam splitter, PBS – polarizing
beam splitter cube, FR – Faraday rotator, AOTF – acousto-optic tunable filter, QS – Quadscanner, (m)PH – (motorized)
pinhole, APD – avalanche photodiode, PMT – photomultiplier tube.
I.2.2.2 Data Presentation
All image processing was performed in ImageJ 1.47v [470] and Fiji 1.52n [469] except for linear
deconvolution and image smoothing. Unless otherwise stated, all confocal data shown are raw data
and all STED data shown are background corrected and linearly deconvolved. Figure I-11 illustrates the
post-processing steps on raw STED data for selected examples.
Background correction was performed by subtracting at most 10% of the maximum fluorescence
signal. Linear deconvolution (Wiener filter) was performed with the Imspector software (Abberior
Instruments) applying a 2D Lorentzian point spread function (PSF)
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( , ) = 2
( − ) + ( − ) + 2
(I-5)
with  and  determining the peak position and  being the PSF’s full width half maximum in
lateral dimension. All quantities are specified in compatible units of lengths, e.g. in nanometers. Linear
deconvolution was applied only to the extent that data were smoothed, and noise was reduced but
image resolution was not increased. Alternatively, smoothing was performed with a Gaussian low pass
filter with a width of one pixel in the custom application software of the STED system.
Figure I-11. STED image post-processing steps.
The post-processing steps are exemplified on STED images of PART II and PART III. First, the background is corrected by
subtracting at most 10% of the maximum fluorescence signal of each channel. Second, the background corrected images are
linearly deconvolved (Wiener filter) by applying a Lorentzian PSF. The respective FWHMs are given in the corresponding
methods sections. From left to right: exemplary LNCaP cell STAR 600-immunolabeled for PSMA (cyan) and incubated with
PSMA inhibitor (red), scale bar is 5 µm. Next: exemplary t-loops stained via TelC-KK114 PNA FISH, scale bar is 250 nm. Next:
exemplary APBs stained for telomere repeats (cyan) via TelC-KK114 PNA FISH and for PML (magenta) via IF with STAR 600,
scale bar is 250 nm. Next: exemplary telomeres stained via TelC-KK114 PNA FISH (cyan) decorated with TRF2 stained via IF
with STAR 600 (red), scale bar is 250 nm. For abbreviations, see Definition of Abbreviations. For details, refer to respective
PART.
Potential color shift between the 470 nm excitation channel and the 600/650 nm excitation channel
was corrected for with a custom-written ImageJ routine that correlates the images using the plugin FD
Math and shifts them based on the maxima found with the plugin Find Maxima. All line profiles on
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STED and confocal data were drawn on raw data and averaged over several pixels (details are given in
the individual methods sections II.4, III.4 and IV.2.3).
Data fitting and graphing was performed with Origin 2017 (OriginLab), all chemical structures were
drawn with ChemDraw Professional 16.0.1.4 (PerkinElmer) and all figures were composed in Adobe
Illustrator CC 22.0.1 (Adobe).
I.2.2.3 Statistical Aspects
All experiments were performed at least in triplicate and quantitative data are expressed as mean ±
standard deviation (SD). The respective n-values are given in the corresponding figure or table
captions. The Shapiro-Wilk test was used to test the data populations for normality [474]. For normally
distributed data, statistical significance was assessed by unpaired, two-tailed Student’s t-tests [475] or
by unpaired, two-tailed Welch’s t-tests in case of unequal sample sizes [476]. Gaussian error
propagation was applied for calculations based on the measurement data. For non-Gaussian data
populations, means were compared with the Wilcoxon-Mann-Whitney U test [477]. For comparing
more than two data populations, the Kruskal-Wallis test was used in a first step to determine whether
significant differences exist in general [478]. If so, the Dunn’s test was performed as a post hoc test to
compare all data populations with each other [479]. P-values < 0.05 were marked.
Statistical analysis was performed in GraphPad Prism (Version 7, GraphPad Software), Excel 2016
(Microsoft) and SciPy (scipy.stats) [472].

II – APPLICATION:
THE HUMAN TELOMERE CONFORMATION AT THE
NANOSCALE
II.1 INTRODUCTION
As the canonical DNA replication machinery lacks the ability to complete DNA duplication until the very
end of linear chromosomes, eukaryotic cells rely on telomeres to shield their genome from replication-
associated shortening. Without self-protection, they would be recognized as sites of DNA damage and
inappropriately treated by the DNA damage response (DDR) machinery. A comprehensive
understanding of nature’s solution to the end-protection problem remains elusive and contradicting
findings regarding the role of telomere compaction are discussed in the literature [480-482].
Nonetheless, consensus exists that sequestration of the telomeres’ 3’-overhang within lariat telomere
structures contributes to end protection by masking the chromosome ends. T-loop formation and
maintenance has been extensively investigated in vitro and mammalian t-loops have been visualized
by EM [483, 484] and different fluorescence nanoscopy methods [485, 486], albeit after cross-linking
and spreading. However, t-loops have so far not been visualized within intact cells. Moreover, the
driving forces for telomere (de)compaction and clustering are not entirely understood and open
questions remain concerning the influence of shelterins [480-482] and of the promyelocytic leukemia
(PML) protein on the telomeric DNA conformation.
In tumor cells that elongate their telomeres via the telomerase-independent alternative lengthening
of telomeres (ALT) mechanism [45], PML associates with telomeres to form ALT-associated PML (APB)
complexes [487]. APBs are suggested to play an important role in ALT-related DNA recombination and
repair synthesis, but the topology of APBs has not been visualized yet at nanoscale resolution.
Investigating telomere conformation and organization in its native environment reduces the chances
of investigating preparation artefacts and allows the collection of biological relevant data. Identifying
structural differences between healthy and diseased cells may finally lead to a better understanding
of structure-function relationships relevant for the deregulation of telomere maintenance in cancer
and other telomere dysfunction related diseases and syndromes.
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II.2 SURVEY OF THE FIELD
II.2.1 Human Telomere Biology
Human telomeres consist of 2-20 kb double-stranded TTAGGG tandem repeats serving as buffer
material at the end of human linear chromosomes. They terminate in a G-rich 3’-overhang due to the
unidirectionality of the DNA polymerase. Telomeric repeats are decorated with the six-membered
shelterin protein complex. This `telosome’ structure ensures genome integrity as it protects the
chromosome ends from being processed as double-strand breaks by the DNA repair machinery [488].
At least seven different DDR pathways threaten telomeres but the shelterin complex uses distinct
molecular mechanisms to individually block each pathway by targeting the respective initiation step of
DNA damage signaling.
The human shelterin complex comprises TRF1 (telomeric repeat binding factor 1), TRF2 (telomeric
repeat binding factor 2), RAP1 (repressor/activator protein 1), TIN2 (TRF1-interaction nuclear factor
2), TPP1 (TINT1 (TIN2-interacting protein 1)/PIP1 (POT1-interacting protein 1)/PTOP1 (POT1 and TIN2
organizing protein 1)) and POT1 (protection of telomeres 1) [489]. TRF1 and TRF2 form homodimers
and bind with nanomolar affinity to duplex telomeric DNA while POT1 binds single-stranded telomeric
DNA (Figure II-1a). TRF1, TRF2, TIN2 and RAP1 are ten times more abundant than TPP1 and POT1
suggesting a core complex of the four proteins [490].
In relation to the overall population of telomeric repeats, shelterin proteins are overabundant and
thus, most telomeric DNA is assumed to be decorated [491]. However, the nucleosomal structure of
telomeres seems to be unaffected by the presence of shelterin proteins [492]. Human telomeres carry
the canonical core histone components, but the nucleosomal repeat length is short and nucleosomes
are more mobile [493]. The nucleosomes display heterochromatin-associated histone marks that are
similar but not identical to constitutive heterochromatin [494].
The detailed topological organization of the telomere repeats within the telosome is crucial. The 3’-
overhang sequesters in an upstream region of the telomere, displacing the G-rich strand in a D-loop to
form a lariat telomere structure that masks the chromosome end (Figure II-1b) [489, 495, 496]. As the
position of invasion of the 3’-overhang is not strictly defined, the loop’s size and tail length varies. The
shelterin protein TRF2 is both crucial and sufficient for t-loop formation [485] and necessary for t-loop
maintenance as it protects the tail-loop junction from enzymatic cleavage [491].
It is suggested that TRF2 promotes t-loop formation via the low affinity DNA interaction of its TRFH
domain, which locally unwinds the double-stranded telomeric DNA by wrapping it around itself,
thereby facilitating 3’-overhang invasion (Figure II-1c) [497]. However, the exact structure at the loop-
tail junction remains elusive and the minimal telomere length for successful t-loop formation is not
known. Indeed, t-loops exist throughout the cell cycle [498] but it is uncertain what fraction of the
telomere population adopts this conformation effectively [491].
Telomere replication is performed by the canonical replication machinery and starts from a
subtelomeric origin. It is challenged by the G-rich sequence of the telomeric repeats, which is likely to
form quadruplex (G4) secondary structures, which potentially stall the replication fork. Yet, TRF1
removes these obstacles by indirectly unwinding G4 structures, promoting telomere replication [491].
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However, with each cycle of replication, telomeres progressively
shorten due to incomplete lagging strand synthesis, oxidative
damage and other factors. Telomere erosion during cell division
equips the cell with a `clocking’ mechanism, which limits the
maximum number of cell divisions. With increased aging, too short
telomeres activate DNA damage signals that eventually induce
replicative senescence thus setting the initial proliferative barrier
to tumor formation [499].
Figure II-1. Schematic illustration of the topology of the human telosome.
(a) The six-membered shelterin complex associates with double-stranded
telomere repeats via TRF1 and TRF2 and with single-stranded telomere repeats
via POT1. (b) In the t-loop conformation, the 3’-overhang is sequestered into an
upstream region of the duplex-repeat array masking the chromosome end. (c)
TRF2 presumably promotes t-loop formation by wrapping the telomeric DNA
around its TRFH domain. The torsional stress potentially facilitates invasion of
the 3’-overhang.
Telomere shortening likewise affects gene regulation. Telomeres exert repressive effects on proximal
and distal gene expression, which decline with telomere erosion. The telomere position effect (TPE) is
involved in transcriptional repression of genes close to telomeres and is induced by the spreading of
heterochromatin to the subtelomeric regions (Figure II-2a) [500, 501]. The concept of telomere
position effect over long distances (TPE-OLD) is similar to the long-range interactions within the
genome, which modulate gene expression by bringing distal genomic regions into close proximity via
3D chromatin looping involving the CCCTC-binding factor (CTCF) and cohesion [502, 503]. Amongst the
different 3D looping interactions of telomeres [504, 505], TPE-OLD mediates telomere interactions
with interstitial telomere sequences (ITSs) in distal genomic regions involving the shelterin protein
TRF2. Telomeres can only form interstitial telomere loops (ITLs) if they are long enough and ITS
interactions are terminated upon telomere erosion [506, 507], thus modulating gene regulation in a
telomere length dependent manner (Figure II-2b). Moreover, telomeres are often associated with the
nuclear envelope via (in)direct interactions with lamins, the intermediate filaments associated with
the inner membrane of the mammalian nucleus, and thereby contribute to higher-order chromatin
organization [508].
Cellular growth arrest can be circumvented via the activation of oncogenes and the loss of function of
tumor suppressor genes. Further telomere shortening leads to genome instability increasing the risk
of cancer. In rare cases, the cells do not die but activate a telomere maintenance mechanism (TMM),
which provides unlimited proliferation. A minority of tumors elongate their telomeres via the
alternative lengthening of telomeres (ALT) pathway based on telomere recombination (refer to II.2.2)
[509]. The vast majority of tumors reactivate and/or upregulate the telomerase reverse transcriptase
(TERT) gene encoding for the catalytic component of telomerase [510, 511]. This ribonucleoprotein
complex synthesizes telomeric DNA using its integral telomerase RNA component TERC. Telomerase
activity in all somatic tissues is restricted to the early stages of human development and silencing
occurs during fetal development [512].
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Figure II-2. Telomere position effects.
Telomeres control proximal and distal gene
expression as a function of telomere length. With
telomere erosion, the repressive influence
declines. (a) In the classic TPE, telomeric
heterochromatin spreads and invades the
subtelomeric region, where it silences proximal
genes. (b) In TPE-OLD, telomeres regulate the
expression of distal genes via interactions with
interstitial telomere sequences (ITS) mediated by
TRF2 and lamins.
Telomere biology evolved to a highly important research field [45] not only due its key role in cancer
[513, 514]. A variety of other medical conditions are based on genetic disorders related to mutations
in either TMM proteins or telomerase components [515]. These telomere spectrum disorders, also
called telomeropathies, display signatures of premature aging. Primary telomeropathies are caused by
mutations within the TMM and often combine genetic anticipation and an early stage of onset.
Secondary telomeropathies have overlapping syndromes with primary diseases, but are caused by
mutations in DNA repair proteins or structural proteins that usually provide telomere preservation
[516-518]. A popular example is the telomere-associated premature aging syndrome Hutchinson-
Gilford progeria [519]. However, as the network of proteins associated with TMM is so extensive, new
telomere disorders are currently and will continue to be identified [520].
A mechanistic understanding of disease pathology requires quantitative methods to measure telomere
shortening. The terminal restriction fragment analysis (TRF) is the gold standard for assessing telomere
length, although it is impeded by low throughput [521, 522]. In contrast, quantitative polymerase chain
reaction (qPCR) allows for greater throughput, but only provides an average telomere length and, thus,
it is not sensitive to the shortest telomeres [523, 524]. However, as the shortest telomeres are the
ones to trigger senescence, assays sensitive to the shortest telomeres are crucial to understanding the
correlation of age-associated pathologies with telomere erosion.
Newer techniques, namely universal single-telomere length analysis (U-STELA) [525] and telomere
shortest-length assay (TeSLA) [521], measure the telomere length of every individual chromosome,
and hence monitor changes even in the shortest telomeres. However, they again suffer from a lowered
throughput. Alternative options include fluorescence in situ hybridization (FISH) [526, 527]. It
guarantees higher throughput but depends on probe hybridization kinetics and suffers from a
detection limit for the shortest telomeres [521, 522]. Yet, FISH is an extremely powerful technique for
imaging of telomeres via fluorescence nanoscopy (refer to II.2.3.1).
II.2.2 Alternative Lengthening of Telomeres
The TMM type of a tumor partially correlates with the tumor origin. ALT activity is often found in
tumors of mesenchymal and neuroepithelial origin like osteosarcomas, liposarcomas or astrocytomas,
but rarely occurs in carcinomas [528, 529]. Only 10-15% of all human cancers employ the ALT pathway
to elongate telomeres in the absence of telomerase via DNA recombination and repair processes [509].
ALT-positive tumors feature a set of hallmarks comprising
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· a heterogeneous telomere length within one cell [530],
· a globally reduced level of telomere compaction compared to telomerase-positive cells [531],
· extrachromosomal telomeric repeats (ECTRs) [532],
· C-rich 5’ overhangs [533],
· mutations of the alpha thalassemia/mental retardation syndrome X-linked (ATRX) chromatin
remodeler [534],
· genome instability [535],
· an elevated level of telomere recombination [536],
· increased telomere sister chromatid exchange (T-SCE) [536] and
· the presence of APBs [537, 538].
ECTRs are generated by homologous recombination events and exist in both linear and circular forms
[484, 532, 539]. It is suggested that C-rich, (partially) single-stranded telomeric (CCCTAA)n DNA circles
serve as a template for telomere extension in rolling-circle replication [540]. Together with APBs, C-
circles are accepted as robust biomarkers for ALT activity [541, 542]. APBs are associations of PML
nuclear bodies (PML-NBs) with telomere repeats and, like ECTRs, are solely found in ALT-positive cells.
PML-NBs occur as distinct, spherical subcompartments in the cell nucleus [543]. Imaged with 4Pi
microscopy, they display a diameter of approximately 0.2-1.0 µm and a diameter-independent shell
thickness of 50-100 nm [544]. Their number varies with cell type, cell cycle phase, differentiation phase
and various stimuli, but totals between 5-30 PML-NBs per cell [545]. Excluding disease related
exceptions, normal PML-NBs do not contain nucleic acids. The key components of PML-NBs are PML
and SP100 (speckled 100 kDa). Both proteins are not tightly bound, but rather exchange steadily [546]
and more than 100 other factors have been identified that transiently associate with PML-NBs [547].
These multi-protein complexes are sumoylation hotspots [548]. Post-translational modifications by the
small ubiquitin-like modifier (SUMO) equip PML and SP100 with SUMO interacting motifs (SIMs) that
allow non-covalent linking with other SIM-containing proteins thereby promoting assembly and
stability of PML-NBs. Sumoylation is mediated by the interplay of several enzymes including among
others the SUMO E3 ligase MMS21 (methyl methanesulfonate-sensitivity protein 21) [549].
The association of PML-NBs with telomeres in ALT-positive cells occurs presumably also in a SUMO-
SIM-interaction-dependent manner, but only for a subset of telomeres and PML-NBs within one cell.
Upon APB formation, PML-NB components like PML, SP100 and SUMO as well as telomere-associated
proteins such as the shelterin complex are also included into APBs. As imaged with 4Pi microscopy, the
entire telomere is enclosed in the PML shell and fully occupies the PML-NB without significantly
changing its overall diameter or thickness. APBs are suggested to promote telomere lengthening via
repair-associated DNA synthesis [550], as depletion of APBs by long-term PML knockdown promotes
telomere erosion in ALT cells [551]. Nevertheless, the molecular and mechanistic details of the ALT
pathway are not yet comprehensively understood. However, many key players have been identified
including the shelterin complex [552], the SUMO E3 ligase MMS21 [553], several DNA repair proteins
[554] and proteins from the heterochromatin protein 1 (HP1) family [555].
It is assumed that partial telomere deprotection is crucial for ALT-related repair processes [556, 557].
While complete TRF2 deletion leads to genome instability, which is apparent in the short term in
telomere attrition via T-SCE [558] and in the long term in chromosome fusions via non-homologous
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end joining (NHEJ) [532, 559], PML only reduces TRF2 binding thereby creating a favorable
intermediate state for ALT. As TRF2 inhibits the ataxia-telangiectasia mutated (ATM) kinase, a central
DDR regulator, the reduced TRF2 population in APBs initiates the DDR machinery. Senescence and cell
cycle arrest are prevented since ALT activation also coincides with the loss of normal p53 function
[560]. PML is further suggested to mediate clustering and compaction of telomeres inside APBs [551].
However, controversial findings exist on the role of (de)compaction and DDR signaling [480-482].
Certainly, APB formation is not sufficient to trigger ALT activity as other deregulation events are
likewise involved. APBs rather emerge with ALT initiation, which is presumably connected to several
loss of function events affecting the DDR pathway and the telomeric chromatin state [537]. However,
exceptions in the form of telomerase-independent telomere maintenance in the absence of APBs
and/or other classic ALT hallmarks are known to occur, suggesting the existence of potentially more
than one ALT mechanism. While the canonical ALT pathway involves APBs, ECTRs, T-SCEs and a
heterogeneous telomere length, non-canonical ALT pathways lack at least one of these classical ALT
features [561-563]. For the canonical pathway, T-SCE and homologous recombination dependent DNA
synthesis have been proposed as mutually non-exclusive mechanisms for telomere elongation [487].
Different templates for recombination comprise the respective telomere itself via t-loop formation,
the telomere of the sister chromatid, the telomere of another chromosome and presumably ECTRs
[538, 541, 564, 565]. It is suggested that break-induced telomere synthesis is the underlying
mechanism of ALT homologous recombination with a specialized replisome unidirectionally
synthesizing long tracts of nascent telomeric DNA [566].
In summary, the following mechanism of APB-mediated telomere lengthening has been proposed
(Figure II-3) [551]:
· In a first step, PML encases telomeres and induces compaction and clustering of telomeres
and potentially ECTRs [567].
· In a second step, the associated telomeres are partially depleted of TRF2 potentially involving
post-translational sumoylation by MMS21 [553].
· In a third step, ATM activation triggers DDR [568, 569].
· In a fourth step, telomeres are elongated via repair-associated DNA synthesis and homologous
recombination enabled by telomere clustering.
· Last but not least, APBs disassemble and the extended telomeres regain full TRF2 decoration
and thus, protection from DDR.
Indeed, TMMs present an ideal target for clinical purposes and approaches inhibiting telomerase
activity have in fact already led to clinical applications [570-574]. However, exploiting ALT key players
as targets for diagnostics and therapeutics is challenged by the complexity of the ALT mechanism and
by the heterogeneity of ALT tumors [542]. So far, APBs have only been used as a prognostic marker to
a very limited extent [575, 576], but they potentially represent a novel target for therapeutics, as
disruption of APBs reduces the proliferation potential of tumor cells using the canonical ALT pathway.
Moreover, cell populations within initially strictly ALT-negative tumors can transform under treatment
with telomerase inhibitors to ALT-positive cells [577]. Thus, comprehensive understanding of the
molecular and mechanistic details of the ALT pathway is crucial for the identification of potential
diagnostic, prognostic and therapeutic strategies for the respective tumors [542].
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Figure II-3. Proposed mechanism of APB-
mediated telomere lengthening in ALT cells.
Before APB formation, telomere protection is
ensured by extensive TRF2 (and thus shelterin)
decoration. APB assembly is triggered via the
sumoylation of telomeric proteins, PML and other
APB components by the SUMO E3 ligase MMS21.
A sumoylation feedback loop is established
through SUMO-SIM interactions. APB formation
induces clustering of telomeres (presumably also
ECTRs) and promotes partial depletion of TRF2.
Telomere deprotection by partial TRF2 depletion
is assumed to involve post-translational
modifications by the SUMO E3 ligase MMS21.
These changes lead to ATM activation, DDR
signaling and recruitment of recombination and
repair factors to the APB. In the functional APB,
telomere elongation occurs via DNA repair
processes, non-replicative DNA synthesis and
homologous recombination. After telomere
extension, the APB disassembles and TRF2 binding
is increased thereby reestablishing a fully
protected telomere.
II.2.3 Chromatin Imaging
As nuclear structure and nuclear function are two sides of the same coin, any changes in higher-order
chromatin organization are either followed or preceded by changes in nuclear function. Therefore,
sophisticated imaging strategies for chromatin are highly valuable for the investigation of nuclear
structure-function relationships. First insights into nuclear organization were gained with EM [578-
580] and current, specialized EM approaches still have and will maintain an essential role in the
chromatin imaging field [581-585]. Besides EM, major progress must be attributed to fluorescence
nanoscopy techniques currently revolutionizing structure-function studies, as they add specificity
combined with the options of multicolor and live imaging [37, 586-589].
By now, most chromatin imaging studies applying advanced fluorescence microscopy or fluorescence
nanoscopy techniques have either used SIM [590-592] or SMLM [339, 593-595], as most established
DNA labeling strategies require no to only little adaptation to these methods. However, both
techniques suffer from background which is drastically elevated by out-of-focus signal when imaging
global chromatin with widefield illumination. Yet, this limitation can be overcome by combination with
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smart illumination schemes like TIRF or LSFM [192, 596]. In contrast, STED nanoscopy inherently
provides optical sectioning, but has been applied only very little in chromatin imaging [353, 597, 598]
(for details on the individual imaging modalities, refer to I.1.2, I.1.3 and I.1.5).
II.2.3.1 PNA FISH
FISH has opened the door for cytogenetics to enter the molecular era and multicolor 3D DNA FISH has
established itself as the workhorse for sequence specific imaging of chromatin structures and
organization [599]. Primarily, FISH is a very general technique based on the hybridization of
fluorescently labeled oligonucleotides to their complementary target structures via Watson-Crick base
pairing and thus requires denaturation of double-stranded DNA. FISH probes are traditionally
generated in a `top down’ approach in which genomic DNA fragments of the locus of interest are
amplified yielding random short DNA target probes. In the newer `bottom up´ approaches, synthetic
oligonucleotides are designed against known sequences, which are often bioinformatically chosen
from sequenced genome data [600]. In principle, the probe can be conjugated via a short linker to any
desired organic dye, not only rendering DNA FISH highly adaptable to the imaging modality of choice
but also placing the fluorophore only a few atoms away from the target structure.
However, as the probe to dye stoichiometry is generally 1:1, basic FISH suffers from an unfavorable
SNR for low copy-number targets. Oligopaint amplifies the signal by equipping the probe with non-
hybridizing, flanking regions of non-genomic sequences that can be additionally targeted by dye-
labeled, complementary, secondary oligonucleotides [601]. With respective probe design, the binding
kinetics of the secondary oligonucleotides can be adapted for BALM imaging [602, 603]. Molecular
beacon FISH (mbFISH) avoids the background from unbound probes by incorporating a quencher in
addition to the fluorophore at the opposite probe end. In the unbound state, the molecular beacon
forms a hairpin structure, which brings quencher and fluorophore in close proximity allowing for
efficient quenching. Upon binding, the hairpin structure resolves, and fluorescence is resumed [604].
An alternative approach to enhance the performance of DNA FISH is the application of peptide nucleic
acid (PNA) probes instead of regular oligonucleotides [605]. This synthetic nucleic acid analogue
features a radically altered backbone structure with the sugar-phosphate backbone being replaced by
N-(2-aminoethyl)glycine (AEG) units linked by peptide bonds. The natural nucleobases are covalently
attached to the backbone via carboxymethyl spacers and thus allow for Watson-Crick base pairing with
DNA or RNA. PNA does not occur naturally, but the AEG backbone is found in cyanobacteria and is
hypothesized to be the first genetic molecule for life on earth [606]. For FISH, PNA probes are superior
to oligonucleotide probes as they provide higher sequence specificity, improved stability, enhanced
reproducibility, and lower background. Moreover, PNA probes depend less on the ionic strength of the
medium and PNA/DNA duplexes display higher melting temperatures than the corresponding
DNA/DNA duplex. The enhanced affinity is at least partially attributed to the neutrally charged AEG
backbone, which avoids electrostatic repulsion with its complementary DNA strand [607, 608]. The
improved sequence specificity leads to an elevated level of mismatch intolerance and can be translated
into shorter probes. Consequently, more dye is recruited to the target structure improving the image
SNR [609].
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PNA is highly resistant to cleavage by chemicals and in particular by enzymes, as PNA is bio-orthogonal
and can withstand both nucleases and proteases. Besides locus-specific chromatin imaging, PNA
probes thus provide valuable diagnostic [610-612] and therapeutic [610, 611, 613-616] tools including
anticancer, antisense, antigene, antibacterial and antiviral agents with a superior lifetime in vivo. The
development of modified PNA derivatives has improved the suitability for structure-function studies
and medical and biochemical applications [617]. The introduction of chirality into the AEG backbone
at the γ carbon atom provides γPNA probes with enhanced affinity and thus increases strand invasion
capability. Due to their right-handed helical structure, which already preorganizes the probe for
hybridization with its complementary target, γPNA probes can virtually invade any double-stranded
DNA sequence [618-621]. Yet, a general problem is the poor membrane permeability and thus limited
cellular uptake. To improve delivery into the cell, several measures can be taken including AEG
backbone modifications, coupling to cell penetrating peptides or glass bead loading [622].
Using carefully adapted FISH protocols, PNA FISH allows for good preservation of key nuclear
characteristics and ultrastructures [590, 623]. However, the overall aim is to either make DNA FISH
truly live cell compatible or replace FISH experiments in fixed cells with equally powerful multicolor
live cell experiments [624].
II.2.3.2 Alternative Chromatin Targeting Strategies
To visualize definite loci in living cells, the sequence specificity of certain DNA binding proteins must
be exploited. Histones restricted to a certain genome region (e.g. centromeres) and other specifically
binding proteins characteristic for defined genomic elements can be fused to FPs or self-labeling tags
[625-627]. In case the region of interest does not offer an individual protein decoration, artificial target
loci (e.g. lacO or tetO repeats) can be inserted and labeled with the respective transcription factor (e.g.
Lac or Tet repressor) fused to FPs or self-labeling tags. Such repressor-operator assays can be either
randomly introduced or site-specifically inserted via genome engineering [625-627]. Along the same
line, the ParB/INT system is based on the insertion of a 1 kb small INT sequence with ParB not only
specifically binding to INT but additionally oligomerizing and thus amplifying the signal [628]. In
contrast to targeting strategies relying on the insertion of artificial sites, a series of modular proteins
with the ability to specifically recognize DNA sequences permit the targeting of endogenous elements,
namely zinc finger proteins (ZFPs) [629, 630], transcription activator-like effectors (TALEs) [631-633],
and CRISPR/Cas9 [634-636]. These proteins are established scissors in genome editing, but in the
absence of the active form of their nucleases and fused to FPs or self-labeling tags, they offer powerful
tools for locus-specific chromatin labeling.
To visualize the global nuclear structure, several sequence unspecific chromatin labeling approaches
have been established. Organic dyes either intercalating into DNA or binding the minor or major groove
allow for direct chromatin imaging [37, 184, 353, 586, 637-639]. In principle, many sequence
independent DNA stains are compatible with SMLM as they are either photoswitchable or transiently
binding. Yet, most suffer from low brightness, low photostability and/or low cell membrane
permeability. Moreover, intercalating dyes may induce DNA unwinding and elongation [640, 641],
potentially interfere with cell cycle progression and initiate DDR in live cell imaging [642]. An
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alternative approach for high density, direct labeling of nuclear chromatin, is given by click chemistry
with a clickable nucleotide analogue metabolically incorporated into the chromosomal DNA [587, 643].
Furthermore, globally abundant, DNA associated proteins like histones can be targeted via IF [588,
594], with FPs [644] or self-labeling tags [42, 327] in live and fixed cells (for details on targeting
strategies in general, refer to I.1.6.2). A pragmatic alternative is label free imaging of chromatin using
the intrinsic nucleotide fluorescence [645].
II.2.3.3 Telomere Imaging
As telomeres are unambiguously identified by their repetitive sequence, telomere imaging has been
revolutionized by PNA FISH, enabling detailed probing of location, recombination and conformation
[522, 622, 646]. The telomere length can be measured via quantitative FISH (Q-FISH), combining the
power of PNA probes with software analysis [647, 648]. In general, PNA FISH is limited to fixed samples,
but exceptions prove the rule and PNA probes attached to telomeres have been used to observe
mitosis in living cells [622]. Telomere PNA FISH is usually performed with organic dyes and in
combination with SMLM, reaching an effective image resolution of 20-30 nm [480, 481, 485, 486].
Fewer studies have applied STED, achieving effective image resolutions of only > 50 nm. The
fluorophores used, however, were significantly less suitable compared to the current STED dyes of
choice [486, 649, 650].
Attaching quantum dots (QDs) to PNA provides photostable telomere probes for SMLM with narrow
emission bands ideal for multicolor imaging and without the need for special blinking buffers or a
second laser to enable blinking [651]. A more exotic conjugation combines a gold nanoparticle and an
organic dye in a dual purpose PNA probe uniting X-ray fluorescence (XRF) for telomere length
quantification with SMLM for assessing the biophysical nanometer dimensions of telomeres [652].
Telomere PNA FISH has revealed relevant differences in telomere biology between normal and cancer
cells and interesting aspects of DDR at telomeres [567, 653, 654]. It has enabled imaging of human and
murine t-loops with STORM, STED, SIM and Airyscan, but only after cell nuclei disruption and telomeric
DNA spreading [485, 486, 655]. The first visualization of t-loops was achieved with EM [483] and shortly
afterwards with AFM [656], but in both cases also only for isolated human and murine telomeres
(Figure II-4).
Imaging of telomeres in living cells is often realized via tagging TRF2 (less often TRF1) with FPs [482,
622, 657, 658]. TALE-based or CRISPR/Cas-based targeting strategies offer a more sophisticated but
more complex alternative. While rationally engineered TALEs recognize telomere repeats via a two-
amino-acids-one-base-pair code, a single guide RNA (sgRNA) complementary to the telomeric repeats
directs the catalytically inert Cas9. Certainly, TALE [631, 632] and Cas9 [659, 660] fusion constructs
with FPs or self-labeling tags are frequently applied. Yet, with the CRISPR/Cas-system, the sgRNA can
be alternatively labeled with an organic dye and transfected allowing for STED imaging in living cells
[661]. A rather exotic option is the tandem hairpin pyrrole-imidazole polyamide probe, a minor groove
binder, specifically targeting telomeric DNA. It can be flexibly conjugated to the desired organic dye
for labeling telomeres without DNA denaturation and thus is potentially applicable in living cells [662].
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Figure II-4. T-loops as imaged by EM, SMLM, STED and Airyscan microscopy after crosslinking, isolation and spreading.
Until now, t-loops have only been visualized for human and murine telomeres after psoralen crosslinking, disruption of cell
nuclei and spreading of telomeric DNA onto a surface. (a) EM micrographs of t-loops as imaged by Griffith et al. [483] and
Cesare et al. [484]. From left to right: synthetic telomeric DNA model with TRF2 binding restricted to the loop-tail-junction
(black arrow); t-loops from HeLa 1.2.11 cells; t-loop from mouse liver with a short tail (white arrow); t-loop from ALT-positive
GM847 cells. All scale bars are 1 kb. (b) STORM images of murine t-loops from MEF cells as imaged by Doksani et al. [485].
Unless otherwise stated, scale bars are 1 µm. (c) Airyscan, STORM and STED images of human and murine t-loops as imaged
by Van Ly et al. [486]. All scale bars are 1 µm. Figure adapted from [483-486].
II.2.4 Deep Learning in Fluorescence Microscopy
Artificial intelligence (AI) based on deep learning (DL) is slowly invading the field of fluorescence
microscopy bringing along the potential to sustainably shape the way data acquisition and image
analysis is performed [663]. AI replicates the human ability of recognizing meaning in patterns and
adapting prior knowledge to new situations. Machine learning (ML) belongs to AI and extracts relevant
information out of large data sets to make predictions or decisions on unseen data [664]. DL based on
neural networks (NNs) is in turn a part of ML and is currently becoming increasingly popular as an
image classification tool with super-human capabilities [665].
II.2.4.1 Neural Network Basics
While a classic algorithm converts the input data to output data via a known routine with defined rules
and parameters, a NN is initially not only confronted with an input data set but additionally with the
corresponding desired output (ground truth). After learning from these training data how to map each
input into its corresponding output, a NN is subsequently treated with unseen input data and in the
process of inference, creates the output of interest (Figure II-5). The generation of the training data
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and the training of a NN are the crucial and time-consuming steps. In general, the more comprehensive
the training data are, the higher the NN’s prediction accuracy is in the end. Still, data augmentation
can be used to supplement the training data [663].
NNs consist of complex networks of connected `neurons´ arranged in `layers´. A neuron can be
described as a mathematical function featuring adjustable parameters. A layer is the collection of
neurons that receive the same input data and operate together passing the output to the subsequent
layer. The input layer contains the raw data, the output layer presents the result(s) and the hidden
layers do the computation, including nonlinear operations, in between. With each additional layer, the
NN depth increases, the representation of the data gains more abstraction, and more complex
information can be extracted [664, 665]. Especially for deep NNs, the danger of over-fitting the data,
i.e. imprinting the entire training data set instead of learning generalizable features, potentially
weakens the predictive power. Thus, the NN architecture must be reasonably adapted to the training
data set and during training, the NN performance must be monitored with an unseen validation data
set [663].
Figure II-5. Schematic of neural network architecture, training and inference.
The neural network design (i.e. number of hidden layers, neuron activation functions) is determined by its future purpose
(i.e. data input, desired data output). Network training is performed by providing the desired pairs of input and output data
(training data) and determines the neuron input weights and the neuron bias threshold by minimizing the cost function.
During inference, the trained network determines from a given input data set the output that is best compatible with the
training set.
Certainly, the deeper the NN is, the more parameters it contains and the less trivial its training
becomes. For deep NNs, up to millions of parameters must be iteratively adjusted to match the output
with the training data to the best possible extent. The source of discrepancies between the output and
training data are difficult to localize in the NN structure, but the backpropagation method delivers
corrections to the contributions of individual neurons [666]. Subsequent adaptation of the neuron’s
parameters is achieved via a gradient descent method. Often, the stochastic gradient descent is
applied, which iteratively uses a random example from the training data to adjust the neuron’s
parameters [667].
For image analysis including feature recognition, convolutional NNs (CNNs) are particularly important.
Here, successive feature extraction is often combined with data reduction. Convolutional layers extract
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image features by performing convolutions on the input image and following pooling layers simplify
the feature representation by reducing the number of pixels. The result is a barcode like simplified
version of the input image from which the CNN infers the desired output [664, 668].
II.2.4.2 Neural Network Applications in Fluorescence Microscopy
The application of NNs in the field of fluorescence microscopy promises to overcome current
limitations in the interdependence of phototoxicity, temporal resolution, spatial resolution, SNR and
live cell imaging and to enable unbiased high-throughput analysis, extraction of relevant but complex
information, and the handling of big data (for details on current challenges in fluorescence nanoscopy,
refer to I.1.2 and I.1.5).
In image segmentation, every pixel of the image is assigned to a structural category, for example signal
and background [669, 670]. Thus, NNs are applied to segment cells in co-cultures of multiple cell types
[671] or in histopathology with clinical relevance [672-674]. Segmentation is often followed by
classification to recognize relevant features in an image and assign an identity. As manual annotation
is very time-consuming, biased and limited in throughput, NN classification is highly valuable, e.g. in
biomedical imaging for cancer detection [675-677], or for the identification of cellular state or fate
from transmitted light data [678, 679].
Furthermore, NNs allow for artificial labeling, i.e. the extraction of cellular structures like plasma
membrane, nuclear membrane and mitochondria from label free images. While the task itself is similar
to segmentation, the training data strongly differ. For artificial labeling, the respective NN learns with
paired images of brightfield and fluorescence data from the same cell. Light sensitive samples in long
term live cell imaging strongly benefit from this type of NN-based structure extraction [680, 681] as
well as from NN-based image restoration. Here, NNs are applied to increase the SNR and/or the spatial
image resolution. The respective NN is often trained with paired images of the same cell acquired at
high and low SNR or at high and low spatial resolution [307, 308, 682]. Image restoration can be used
to reduce the photon burden in STED imaging [308] or allow for faster data acquisition in densely
labeled SMLM samples [683, 684].
The output of any DL application in fluorescence microscopy must be critically considered, especially
in terms of resolution enhancing image restoration, as the presence of artefacts in the output images
cannot be excluded per se. The rigorous identification of potential artefacts is crucial [112, 685]. Yet,
only input and output are accessible, but the `in-between´ is not. Due to the abstraction of data
representation within deep NNs, the interpretation on how the NN created the output is very difficult.
Moreover, the NN performance strongly depends on the quality of the training data, which is usually
manually composed by the user. Any bias in the training data will automatically be adopted by the NN.
However, reasonably handled, DL is an extremely versatile and powerful tool to address current
challenges of fluorescence microscopy. At the moment, the field of AI is undergoing exponential
development and many areas of the latest AI research have not yet been transferred to the imaging
community. With the fusion of fluorescence microscopy and AI in its infancy, the application of DL is
still bound to experts but the future will lower the accessibility barrier for non-expert users [663].
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II.3 AIM
Telomere conformations have direct implications on telomere properties and functions. Thus,
dissecting structural features of telomeres and associated proteins in their native cellular environment
at the nanoscale opens up new avenues for understanding the role of the respective component in
either aging, tumor suppression or telomere maintenance in cancer. Fluorescence nanoscopy has
already significantly contributed, but open questions remain: To which extent do t-loops represent the
native telomere conformation? Which other telomere conformations exist? How is the telomere
conformation triggered? What causes telomere (de)compaction and clustering? Extending the
knowledge in these fields will pave the way for the development of alternative diagnostics and
treatments for telomere dysfunction related diseases.
The aim of this project was to elucidate the topology of telomere repeats, telomere associated proteins
and subtelomeric DNA in fixed and living human cells at the nanoscale. We specifically optimized
labeling and imaging conditions for visualizing human t-loops in intact cells with STED nanoscopy and
confirmed our results with biological and computational controls. To quantify telomere conformations
and highlight structural differences of telomere populations between ALT-positive and ALT-negative
cell lines, we performed a neural network classification of the STED data. We further visualized APB
topology and quantitatively assessed the perturbing influence of PML on telomere conformation in
ALT-positive cells to deduce potential PML participation in telomere maintenance in ALT tumors.
II.4 METHODS
This project was conceived in close collaboration with the DKFZ Division of Chromatin Networks
(Heidelberg, Germany) and plasmid cloning as well as TRF analysis were performed in this group. The
Monte Carlo simulations were conceptualized in close collaboration with and conducted by Dr. Rifka
Vlijm2. Data analysis was conducted in close collaboration with Roman Spilger3. Detailed information
on materials is given in I.2.1.
II.4.1 Plasmids
To create the N-terminal fusion constructs pHTN-HaloTag-TRF2, pHTN-HaloTag-PMLIII, pHTN-HaloTag-
LacI, pSNAPf-TRF2, pSNAPf-PMLIII and pSNAPf-LacI, human TRF2, PMLIII and LacI were cloned into
pHTN HaloTag CMV-neo (Promega) and pSNAPf (New England Biolabs) vectors from previous plasmid
constructs [467]. For confocal imaging of PML-NBs, pEGFP-C1-PMLIII was used [467] (Table II-1).
2 affiliation: Max Planck Institute for Medical Research, Department of Optical Nanoscopy, Heidelberg, Germany;
current address: University of Groningen, Zernike Institute, Department of Molecular Biophysics, Groningen, Netherlands
3 University of Heidelberg, BioQuant, IPMB and German Cancer Research Center, Division of Biomedical Computer Vision,
Heidelberg, Germany
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Table II-1. List of plasmids used for visualizing telomeres, APBs and subtelomeric regions.
plasmid backbone insert fusion construct
pHTN-HaloTag-TRF2 pHTN HaloTag CMV-neo TRF2 N-terminal Halo-TRF2
pHTN-HaloTag-PMLIII pHTN HaloTag CMV-neo PMLIII N-terminal Halo-PMLIII
pHTN-HaloTag-LacI pHTN HaloTag CMV-neo LacI N-terminal Halo-LacI
pSNAPf-TRF2 pSNAPf TRF2 N-terminal SNAP-TRF2
pSNAPf-PMLIII pSNAPf PMLIII N-terminal SNAP-PMLIII
pSNAPf-LacI pSNAPf LacI N-terminal SNAP-LacI
II.4.2 Cell Culture
The cell lines U2OS, F6B2, HeLa (hereinafter referred to as HeLa NT), HeLa VST and HeLa LT (Table I-16)
were cultured in Gibco Dulbecco's modified Eagle medium (DMEM) high glucose/GlutaMAX™/
pyruvate (Thermo Fisher Scientific) supplemented with 10% fetal bovine serum (FBS) and 1%
penicillin/streptomycin (hereinafter referred to as DMEM++) at 37°C in humidified air with 5% CO2. All
HeLa cells were harvested with trypsin 0.25% (no phenol red, Gibco/Thermo Fisher Scientific); U2OS
and F6B2 cells were harvested with trypsin 0.05% ethylenediaminetetraacetic acid (EDTA) 0.02% (with
phenol red, Sigma-Aldrich/Merck). A Countess II FL Automated Cell Counter (Thermo Fisher Scientific)
was used to count cells and to assess the live-to-dead cell ratio via Trypan Blue stain (0.4%).
For fixed sample preparation, approximately 105 cells/well were seeded on #1.5 coverslips in 24-well
cell culture plates one day prior to PNA FISH and/or IF staining and kept at 37°C in humidified air with
5% CO2 until fixation. For live sample preparation, approximately 104 cells/well were seeded on 8-well
chambered coverglasses one day prior to transfection and kept at 37°C in humidified air with 5% CO2
until transfection.
II.4.3 Terminal Restriction Fragment (TRF) Analysis
Extraction and purification of genomic DNA was performed after cell lysis with the Puregene Core Kit
(Qiagen). Purified DNA (4 µg) was digested with RsaI & HinfII (Telomere Length Assay Kit, Roche) and
resolved on a 0.6% agarose gel in 1× tris-acetate-EDTA (TAE) buffer using a Chef DRII Pulse Field
Electrophoresis chamber (BioRad) with the following settings: pump 70-80, Volt 4 V/cm, b1 initial
switch time 1 s, final switch time 6 s, run time 13 h. The Telomere Length Assay Kit (Roche) was used
for Southern blotting and chemiluminescent detection. The blot was visualized via the Chemi-Doc MP
System (BioRad).
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II.4.4 Immunofluorescence
II.4.4.1 Antibodies
For IF, the following primary antibodies were used: monoclonal mouse anti-TRF2 (05-521, Merck, 1:50,
1 h) in combination with polyclonal rabbit anti-PMLIII (sc-5621, Santa Cruz Biotechnology, 1:50,
30 min), monoclonal mouse anti-TRF1 (GTX10579, GeneTex, 1:50, 1 h) or monoclonal mouse anti-TRF1
(04-638, Merck, 1:50, 1 h) in combination with polyclonal rabbit anti-TRF2 (NB110-57130, Novus
Biologicals, 1:50, 1 h).
The following secondary antibodies were used: goat anti-mouse-IgG coupled to STAR 600 (Abberior,
1:50, 1 h), goat anti-rabbit-IgG coupled to STAR 600 (Abberior, 1:50, 1 h), goat anti-mouse-IgG coupled
to STAR 635P (Abberior, 1:50, 1 h), goat anti-rabbit-IgG coupled to STAR 635P (Abberior, 1:50, 1 h),
goat anti-rabbit-IgG coupled to Alexa Fluor 488 (Thermo Fisher Scientific, 1:50, 1 h) and goat anti-
rabbit-IgG coupled to Atto 488 (ATTO 488 NHS-ester (ATTO Technology) custom-coupled to goat anti-
rabbit-IgG (111-005-003, Dianova), 1:50, 1 h).
II.4.4.2 Immunofluorescence Staining
After washing three times with phosphate-buffered saline (PBS), the cells were fixed with 3.7%
paraformaldehyde (PFA) in PBS for 12 min at room temperature (RT) and subsequently again washed
three times with PBS. Permeabilization was performed with 0.1% (v/v) TritonX-100 in PBS for 5 min at
RT and unspecific binding was blocked afterwards with 10% goat serum (GS) in PBS for at least 1 h at
RT. Subsequently, the primary antibodies were incubated in 10% GS in PBS for 30 min to 1 h in a humid
chamber (for individual dilution and incubation time, refer to II.4.4.1). After extensive washing with
PBS, additional blocking was performed with 10% GS in PBS for at least 10 min at RT. Subsequently,
the secondary antibodies were incubated in 10% GS in PBS for 1 h in a humid chamber (for individual
dilution and incubation time, refer to II.4.4.1). Finally, the cells were extensively washed with PBS and
the samples were mounted in Mowiol [466].
II.4.5 Fluorescence in situ Hybridization (FISH)
The unlabeled TelC PNA probes (CCCTAA)3 (PNA Bio) and the custom-designed and unlabeled LacO
PNA probe TTGTTATCCGCTCACAA (PNA Bio) were labeled via O-linker with the fluorescent dyes KK114
[382] and Alexa Fluor 594 at the Facility for Synthetic Chemistry at the Max Planck Institute for
Biophysical Chemistry in Göttingen, Germany.
After washing three times with PBS, the cells were fixed with 3.7% PFA in PBS for 12 min at RT,
subsequently again washed three times with PBS and permeabilized with ice-cold 0.2% (v/v) TritonX-
100 in PBS for 5 min. After washing three times with PBS, dehydration was performed in three steps
(70%, 85%, 100% ethanol (EtOH) in H2O ultrapure) each 2 min long. Air-drying was followed by
incubation with 0.1 µM TelC and/or 0.1 µM LacO probe in freshly prepared hybridization buffer (75%
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formamide in 20 mM NaCl, 20 mM Tris-HCl, 0.1% bovine serum albumin (BSA), pH 7.4). After 3 min
denaturation at 80°C, hybridization was allowed overnight at 30°C.
The next day, the cells were washed twice with freshly prepared 70% formamide in 10 mM Tris-HCl
(pH 7.4) for 15 min at RT, once with 2× SSC buffer for 1 min at RT, once with 0.1× SSC buffer for 5 min
at 55°C, twice with 0.05% (v/v) Tween-20 in 2× SSC buffer for 5 min at RT and three times with PBS at
RT. The samples were either mounted in Mowiol or subjected to subsequent IF staining similar as
described in II.4.4.2. Briefly, after blocking and primary antibody incubation, the samples were washed
three times with 0.002% (v/v) NP-40 in PBS for 5 min at RT followed by secondary antibody incubation.
Finally, the samples were dipped into ultrapure H2O, dehydrated with 100% EtOH for 1 min, air-dried
and mounted in Mowiol [466].
II.4.6 Live Cell Staining
One day prior to live cell imaging, the cells were transiently transfected at 40-60% confluency using
the Effectene Transfection Reagent Kit (Qiagen) according to the manufacturer’s protocol. At 24 h post
transfection, the cells were incubated for 30 min with a 1 µM staining solution of the respective
combination of live dyes 580CP-BG [29], 610CP-BG [29] and 640SiRH-Halo [32] (BG = SNAP-tag ligand,
Halo = HaloTag ligand) in DMEM++ at 37°C in humidified air with 5% CO2. The fluorescent live dyes
were kindly provided by Dr. Alexey Butkevich4 and Dr. Vladimir Belov5. Following a 10 min washing
step with prewarmed Gibco FluoroBriteTM DMEM (Thermo Fisher Scientific) supplemented with 10%
FBS and 4 mM Gibco GlutaMAXTM (Thermo Fisher Scientific) (hereinafter referred to as FluoroBrite++)
at 37°C in humidified air with 5% CO2, the cells were either subjected to live cell imaging or were fixed
with 3.7% PFA in PBS for 12 min at RT.
II.4.7 STED and Confocal Microscopy
The custom-built STED system is described in detail in I.2.2.1. The power range for all lasers used during
live and fixed cell confocal and STED imaging is given in Table II-2. Unless otherwise stated, fixed and
live cell confocal and STED imaging was performed with the measurement parameters given in Table
II-3. No frame accumulation was used.
4 Max Planck Institute for Biophysical Chemistry, Department of NanoBiophotonics, Göttingen, Germany;
current address: Max Planck Institute for Medical Research, Department of Optical Nanoscopy, Heidelberg, Germany
5 Max Planck Institute for Biophysical Chemistry, Department of NanoBiophotonics, Göttingen, Germany;
Facility for Synthetic Chemistry at the Max Planck Institute for Biophysical Chemistry in Göttingen, Germany
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Table II-2. Range of laser powers used for fixed and live cell confocal and STED imaging of telomeres and APBs.
The values given describe the estimated laser power in the sample focus based on laser power measurements in front of
the microscope body.
excitation STED
470 nm [µW] 600 nm [µW] 650 nm [µW] 775 nm [mW]
confocal, fixed samples 140 0.5-4 0.2-2 ---
STED, fixed samples --- 2-12 0.5-12 70-100
confocal, live samples 140 0.5-4 0.2-2 ---
STED, live samples --- 2-12 0.5-8 35-70
Table II-3. Standard measurement parameters used for fixed and live cell confocal and STED imaging of telomeres and
APBs.
pixel size [nm] dwell time [µs] line accumulation
confocal, fixed samples 50 50 1
STED, fixed samples 15 10-30 10-20
confocal, live samples 50 30 1
STED, live samples 20 30 1
II.4.8 Monte Carlo Experiments
Monte Carlo simulations of nucleosome chains with subsequent FISH labeling were performed to
generate synthetic STED data. On scales ≫ 50nm, the DNA path can be described as a polymer of
segments with subsequent segments being uncorrelated in their direction (Figure II-6). Random DNA
configurations were simulated for various conditions by building up a chain of segments with the next
segment starting where the last segment ended.
Figure II-6. Polymer chain model of DNA.
Insights into many properties of the genome can be gained by modelling DNA
in a coarse-grained procedure. DNA can be described as a polymer with N
segments of a certain length called the Kuhn length . Each segment  has
a direction unrelated to the previous one.
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As telomeric DNA is wrapped around nucleosomes, previously estimated values for the polymer-like
behavior of DNA with nucleosomes were used (Table II-4) [686]. Any other protein decoration and its
effect on the DNA persistence-length were ignored, as these effects are not well understood.
Table II-4. Monte Carlo simulation parameters used to describe nucleosome chains.
simulated DNA lengths (bp) 3864, 9821, 19803, 49749
base pair rise 0.13 nm [686]
persistence length 10.5 nm [686]
Kuhn length (2 ∙ = ) 21 nm / 162 bp
available bp per Kuhn segment for labeling 162 ∙ = 38 bp
nucleosome repeat length 191 bp
length of core DNA 146 bp
Randomly picking  and  between 0 and 1, the direction of each segment is defined by  and :
= 2 · · (II-1)
= (2 − 1) (II-2)
The change in position of each new segment with the length  (Kuhn length, refer to Table II-4) is
given with respect to the previous position by:
= · ( ) · ( ) (II-3)
= · ( ) · ( ) (II-4)
= · ( ) (II-5)
Based on the different average telomere lengths of the cell lines used (Table I-16), data were generated
for roughly  = 4, 10, 20 and 50 kb long stretches of DNA.
After simulating the random 3D paths of nucleosome chains, the position of each base pair available
for labeling was listed. For nucleosome-DNA, only the linker DNA is available for labeling. The number
of base pairs available for labeling is thus defined by the repeat length , the length of the core
DNA  and the total DNA length  (Figure II-7):
=
−
(II-6)
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Figure II-7. Schematic illustration of nucleosomal DNA.
The nucleosome constitutes the fundamental packing unit of DNA and consists
of the nucleosome core particle and linker DNA. The nucleosome core particle
comprises core DNA wrapped around an octamer of core histones.
Next, the number of `dyes´ to be positioned was calculated for different labeling densities :
= · (II-7)
The label size  was chosen to be 18 bp in accordance with the length of the TelC probe used in
the actual PNA FISH STED experiments. The labeling density was varied between  = 10, 20, 30
and 60% of all available base pairs .
For each randomly formed nucleosome chain, the decoration with labels was simulated by
subsequently choosing random dye locations from the list of base pair positions available for labeling
under the following constraint. After a location was chosen, 18 consecutive base pairs were marked as
`labeled´ defining these positions are unavailable for any `dye binding´ in all following labeling steps.
After all `dyes´ had been randomly positioned along the simulated nucleosome chain, each dye
position was blurred by a Gaussian PSF as it is expected in a STED microscope. Based on the actual
STED data, a combined Gaussian PSF of 0.93 times a FWHM of 28 nm and 0.07 times a FWHM of
200 nm was assumed to give the best representation.
After labeling, a 2D projection of the expected photon counts (normalized) was created for each
simulated 3D nucleosome chain path. Not all positions of exceptionally large structures can be
simultaneously in focus, and thus equally detected. Therefore, `dyes´ within a z-range of 450 nm were
fully shown, ̀ dyes´ at positions between 450 and 550 nm were decreasingly represented, and all ̀ dyes´
outside the focal center of 550 nm were excluded in the 2D projection of the 3D nucleosome chain.
In a final step, every resulting 2D representation was binned into 15 nm-squared pixels in accordance
to the actual STED data. In total, 20000 synthetic STED images were simulated per condition of DNA
length and labeling degree.
II.4.9 Neural Network (NN) Classification
Telomere conformations were analyzed by a deep learning method (Figure II-8). A convolutional NN
was used for automatic classification [687] into different telomere classes. The network architecture
comprises ten convolutional layers and two fully-connected layers. The convolutional layers are
interleaved with three max pooling layers. Between the last convolutional layer and the first fully-
connected layer, one global max pooling layer is used. After each convolutional layer, instance
normalization is employed [688]. Except for the softmax output layer [689], all nonlinearities are leaky
rectified linear units (ReLUs, leakiness 0.3) [690]. The network was trained using a stochastic gradient
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descent optimizer and a cosine annealing learning rate scheduler with periodic restarts (learning rates
lmax = 10-2 and lmin = 10-6) [691]. Overfitting was prevented by employing early stopping and by using a
dropout layer (pdrop = 0.25) [692] after the first fully-connected layer during network training.
Training data for supervised learning were prepared by sorting a fraction of experimentally acquired
raw TelC PNA FISH STED data (independent of cell line) into four different classes (namely loop, rod,
coil, globule) based on the following conformational criteria of the telomere signals (Figure II-8).
· The class loop comprises lariat telomere signals with similarity to previous super-resolution
data confirming the existence of t-loops with isolated telomeric DNA (Figure II-4) [485, 486].
Partially imaged lariat telomere signals were filed as `ambiguous´ and excluded from the
training data.
· The class rod comprises linear telomere signals of fully unfolded telomeres.
· The class coil comprises heterogeneous telomere signals of decondensed telomeres with an
apparent substructure.
· The class globule comprises compact telomere signals of fully condensed telomeres without
any apparent substructure.
After training, the performance of a NN can be described by comparing its prediction with the ground
truth. Based on the number of true positives , false positives  and false negatives , the
measures precision and recall can be calculated by:
=
+
(II-8)
=
+
(II-9)
To seek a balance between precision and recall, especially for uneven class distributions, the 1 score
is given by:
1 = 2 ∙
∙
+ (II-10)
After training of several NNs that differed in hyperparameters such as number of filters, dropout rate,
learning rate scheduling and kernel size, the NN with the highest 1 score for loop classification was
chosen under the premise that precision > recall.
The neural network classification was performed individually for the raw telomere PNA FISH STED data
of each cell line and for the raw PNA FISH STED data of the subtelomeric regions (STRs) of the F6B2 cell
line. For the U2OS data, no discrimination was initially made between PML-encased and free
telomeres. Subsequently, U2OS telomeres were grouped into encased and free telomeres based on
dual-color stainings for telomeres (TelC-KK114 PNA FISH) and PML (IF STAR 600). Both groups were
individually classified to investigate the influence of PML-encasing on telomere conformation (Figure
II-8). To assess the loop frequency of the synthetic STED data, sorting was performed identically to the
training data of the neural network analysis and the average loop frequency was calculated for the
different DNA lengths.
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II.4.10 Quantitative Image Analysis
II.4.10.1 Determination of Telomere Size
For quantitative analysis, Otsu's thresholding in combination with subsequent morphological
operations were used to segment telomere signals. To quantitatively describe the telomere size,
different size measures were calculated based on the computed binary images from segmentation:
· The area  of telomere signals was determined by the number of signal-containing pixels of
the segmented regions.
· The convex hull area ℎ  of telomere signals was determined as the area of the minimum
circumscribing convex polygon.
· The radius of gyration  was determined as the root mean square distance of all signal
containing pixels to the center (first moment) of the pixel distribution.
· The convex hull volume ℎ  was determined by raising the convex hull area to the 3/2 power
as previously described [480, 481].
To investigate the influence of PML-encasing on telomere size, the U2OS telomere STED data were
grouped into encased and free telomeres based on dual-color stainings for telomeres (TelC-KK114 PNA
FISH) and PML (IF STAR 600). For both groups, the four different size measures were calculated (Figure
II-8).
II.4.10.2 Estimation of Telomere Volume Density
According to Vancevska et al. [481], the ratio of volume densities of telomeric chromatin between two
cell lines was estimated by
= (II-11)
with  ( ) being the volume density of cell line 1 (2),  ( ) being the average telomere length of
cell line 1 (2) and  ( ) being the radius of gyration of cell line 1 (2). The average telomere lengths
and their errors of HeLa VST, HeLa NT and HeLa LT cells were estimated from the Southern blot of the
TRF analysis (refer to II.4.3). For U2OS cells, a rectangular telomere length distribution between 2-
50 kb was assumed and the average length and its error accordingly estimated.
II.4.10.3 Determination of T-Loop Diameter
All telomere signals classified as loop by NN analysis together with the respective loop training data
were used to quantify the average size of the loop portion (t-loop without tail) for each cell line. After
background subtraction and deconvolution (refer to I.2.2.2), ellipses were fitted to the loops by
performing skeletonization [693] and least-squares fitting [694]. The ellipse fitting provided values for
the semi-major axis  and the semi-minor axis  of each loop for each cell line (Figure II-8).
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Based on these results, the average ellipse circumference  was computed by
= 4 ( ) = 4 1 − sin
⁄
(II-12)
with  being the complete elliptic integral of the second kind and  the eccentricity of the ellipse
= 1 − (II-13)
as implemented in Octave 5.1.0 [471].
Figure II-8. Schematic illustration of the workflow of data analysis for characterizing human telomere conformations.
After data acquisition, the NN training data were prepared by assigning the raw telomere STED images of a data subset to
either the loop, rod, coil or globule conformation. After NN training, all raw telomere STED data (light orange), excluding the
training data, were classified by NN analysis. The output of the NN as well as the unclassified STED data were subjected to
quantitative image analysis after segmentation and binarization to compute the different measures of telomere size. In both
cases, the U2OS STED data (light blue) were additionally sorted for PML-encasing. All telomere STED images identified as loop
by NN analysis as well as the loop training data were subjected to ellipse fitting after linear deconvolution (Wiener filter),
segmentation and binarization, and morphological operations. Based on the semi-major and semi-minor axes as determined
by the ellipse fitting, the average t-loop circumference was calculated.
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II.4.11 Colocalization Experiments
For colocalization analysis of immunolabeled TRF1 and TRF2, minor crosstalk of the STAR 635P dye into
the shorter wavelength channel (APD2, STAR 600) was corrected for via the linear unmixing algorithm
implemented in the custom application software of the STED system (LabVIEW, National Instruments).
For colocalization analysis of immunolabeled TRF2 and TelC, potential crosstalk between the STAR 600
dye and the KK114 dye [382] was excluded by single-color stainings and raw data were used for the
colocalization analysis. In both cases, the analysis was restricted to regions of interest (ROIs) with
relevant signals and the Pearson correlation coefficient (PCC) was calculated with the ImageJ plugin
JACoP [470, 695].
II.4.12 Data Presentation
Detailed information on data presentation is given in I.2.2.2. Linear deconvolution of the
experimentally acquired STED (confocal) data was performed by applying a Lorentzian PSF (refer to
equation (I-5)) with FWHM = 30 nm (FWHM = 250 nm) in lateral dimension. All line profiles were
drawn on raw data and averaged over 5 pixels.
II.4.13 Statistical Aspects
Detailed information on general statistical aspects is given in I.2.2.3. NN classification was performed
on 699 STED images of HeLa VST telomeres, 427 STED images of HeLa NT telomeres, 697 STED images
of HeLa LT telomeres, 1672 STED images of U2OS telomeres (no distinction between encased and free),
780 STED images of free U2OS telomeres, 190 STED images of encased U2OS telomeres and 135 STED
images of F6B2 STRs.
The 1-score was used as a measure of quality of the classification. The relative frequency of  and
 determined during neural network training was used to estimate the error in frequency given in
the bar plots in the results section (refer to II.5.2 and II.5.5.1) with false positives (negatives)
determining the negative (positive) error. The differences between the individual telomere
populations as classified by neural network analysis was tested for significance by calculating the log-
likelihood ratio (G-test) [696]. The difference between two cell lines for a given conformation was
tested for significance with a similarity measure (normalized weighted ) based on the histograms of
the predicted frequency, the frequency of  and the frequency of  for the respective telomere
conformation and the respective cell lines (for derivation, refer to VI.1.1).
The loop frequency of the synthetic STED data is based on the sorting of 1600 randomly chosen images
(100 per condition of DNA length and labeling degree).
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II.5 RESULTS
II.5.1 Visualizing Human Telomere Conformations
To study human telomere conformations, five human cancer cell
lines were chosen based on their differing average telomere length
and TMM. While the three telomerase-positive HeLa cell lines
feature either normal telomere length (HeLa NT, literature: ~7 kb),
very short telomeres (HeLa VST, literature: ~4 kb) or long
telomeres (HeLa LT, literature: ~20 kb) [468], the ALT cell lines
U2OS and its derivative F6B2 [467] show a broad telomere length
distribution of 2-50 kb for different chromosomes in one cell.
While the TRF analysis confirmed the literature values of the
average telomere length for HeLa NT and HeLa LT, it revealed a
shorter average telomere length for HeLa VST (~2 kb) (Figure II-9).
All following calculations are based on the average telomere
lengths as estimated from the TRF analysis (for details on average
telomere length estimation, refer to II.4.10.2).
Figure II-9. TRF analysis.
The Southern blot of the terminal restriction fragment analysis compares the
different average telomere lengths of the cell lines used in this part of the thesis
(HeLa ST cells were not used). HeLa LT and HeLa NT cells display average
telomere lengths of approx. 20 kb and 7 kb agreeing well with the literature
values. HeLa VST cells show an average telomere length of approx. 2 kb roughly
matching the literature value of 4 kb [468]. Typical for ALT cell lines, U2OS cells
feature a broader telomere length distribution with most telomeres being
> 20 kb.
II.5.1.1 Live Cell STED Imaging of Human Telomeres
Specific targeting of telomeres in living cells was achieved by transiently transfecting and
overexpressing a SNAP-tag or HaloTag fusion of the shelterin protein TRF2. Staining with the respective
SNAP- or Halo-derivatives of the live dyes 580CP [29], 610CP [29], 640SiRH [32] and SiR [30] allowed
for confocal and STED imaging of telomeres in living cells. While single telomeres appeared as blurred
diffraction-limited spots without any apparent structure in the confocal images, STED imaging resolved
single telomeres with individual structural characteristics (Figure II-10a). To provide complementary
fixed cell data, TRF2 was additionally STAR 600- or STAR 635P-immunolabeled and imaged in confocal
and STED mode (Figure II-10b).
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Figure II-10. Live and fixed cell imaging of
human telomeres by targeting TRF2.
(a) Living U2OS cells were transiently transfected
with a SNAP-TRF2 fusion construct, subsequently
labeled with the live dye 610CP-BG and subjected
to live cell confocal and STED imaging. The three
exemplary TRF2 spots marked in the confocal
overview (left) are shown as magnified images in
confocal and STED mode. (b) Fixed U2OS cells
were STAR 600-immunolabeled for TRF2. The
three exemplary TRF2 spots marked in the
confocal overview (left) are shown as magnified
images in confocal and STED mode. All confocal
data shown are raw data, all STED data shown are
background corrected and linearly deconvolved.
Scale bars overviews are 2 µm, scale bars close-
ups are 500 nm.
To estimate the degree of TRF2 IF
labeling, U2OS cells were additionally
immunolabeled for TRF1. Both proteins
directly bind to double-stranded
telomeric DNA and are connected via
TIN2 in the shelterin complex. Thus, TRF1
and TRF2 strongly colocalize on the
molecular level. Dual-color STED imaging
also revealed a prevalent colocalization of
the fluorescent signals of the
immunolabeled proteins. To quantify
colocalization in dual-color fluorescence
imaging, the PCC is an established
measure with values ranging from -1
(negatively correlated), to 0
(uncorrelated) and 1 (positively
correlated) [697]. The average PCC for
colocalization of the IF signals of TRF1 and
TRF2 of r = 0.68 ± 0.07 (n = 8 nuclei)
suggests rather quantitative staining of
both proteins (Figure II-11).
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Figure II-11. Colocalization experiments
between TRF1 and TRF2.
Fixed U2OS cells were co-stained via IF for TRF1
(STAR 63P, gray) and TRF2 (STAR 600, red). Dual-
color STED imaging suggests close to quantitative
staining of both shelterin proteins via IF. To
quantify the degree of colocalization, the PCC was
calculated with an average of r = 0.68 ± 0.07 (n = 8
nuclei). While many TRF1/TRF2 associations show
a PCC of r > 0.8 (bottom), only a few show a PCC of
r < 0.4 (top). Unless otherwise stated, all STED data
shown are background corrected and linearly
deconvolved. Scale bar is 500 nm.
Upon comparison of the live cell STED
imaging with SNAP- and Halo-tagged TRF2
with the fixed cell STED imaging of
immunolabeled TRF2, image quality
differences become apparent. The live cell
data did not suffer from off-target staining,
whereas the IF data showed a background
of single, unspecifically bound antibodies.
Still, the live data displayed a lower SNR
and a decreased spatial resolution. On the
one hand, image acquisition must be
adapted to living samples implying shorter
total dwell times to avoid motion blur due to (sub)cellular dynamics, and lower laser intensities to
prevent photobleaching and thus phototoxicity. On the other, the newly developed live cell dyes are
less bright and photostable compared to the well-established dyes used for fixed cell STED imaging.
II.5.1.2 PNA FISH STED Imaging of Human Telomeres
As neither SNAP- and Halo-tagging of TRF2 nor IF of TRF1 and TRF2 provided the required biological
resolution to analyze conformational details of human telomeres, PNA FISH of telomeres was adapted
for STED imaging. In detail, a PNA probe directed against telomere repeats (TelC probe) was conjugated
with the STED compatible fluorophores KK114 [382] or Alexa Fluor 594 (Figure II-12a,b).
STED imaging of TelC-KK114 labeled telomeres enabled visualization of conformational details of
individual telomeres and differences between cell lines at nanoscale resolution (Figure II-12c-f). In
contrast to SNAP- and Halo-tagging or IF staining of TRF2, TelC PNA FISH allowed for the identification
of four distinct telomere conformations in all cell lines with STED nanoscopy (Figure II-13a):
· loop: circular and lasso-like telomeres
· rod: linear telomeres
· coil: open and decondensed telomeres
· globule: compact and condensed telomeres
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The loop conformation is assumed to correspond to t-loop structures and the invasion site of the 3’-
overhang determines their circular or lasso-like appearance (Figure II-13b). Partially imaged lariat
telomere structures were filed as `ambiguous´ loop conformations (Figure II-13c).
Figure II-12. PNA FISH staining of human telomeres.
(a) PNA is a synthetic nucleic acid analogue with the sugar-phosphate backbone being replaced by AEG units linked by peptide
bonds. The nucleobases are natural and thus allow for Watson-Crick base pairing with DNA or RNA. The TelC probe (18 bp)
specifically binding to telomere repeats places the fluorophores only two O-linker lengths away from the target. (b) The
fluorescent dyes KK114 [382] and the commercially available Alexa Fluor 594 (AF594) were conjugated to the PNA probe via
two O-linkers. (c) HeLa VST (d) HeLa LT (e) HeLa NT and (f) U2OS cells were stained for telomeric repeats via TelC-KK114 PNA
FISH. Three exemplary telomere spots marked in each confocal overview (left) are shown in magnification (right) as imaged
in STED mode. All confocal data shown are raw data, all STED data shown are background corrected and linearly deconvolved.
Scale bars overviews are 2 µm, scale bars close-ups are 250 nm.
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Figure II-13. PNA FISH STED identifies t-loops and other human telomere conformations in intact cells.
(a) Exemplary images of the four distinct telomere conformations (from left to right: loop, rod, coil, globule) as imaged by
STED nanoscopy in TelC-KK114 PNA FISH stained, fixed U2OS cells. (b) Exemplary t-loops visualized by STED nanoscopy and
TelC-KK114 PNA FISH staining in HeLa VST, HeLa NT, HeLa LT and U2OS cells (left to right). (c) Incomplete PNA FISH labeling,
occupation of dark states, photobleaching, unfavorable 3D orientation and overlap with other telomere signals complicate
the t-loop classification and require exclusion of potential t-loop signals filed as `ambiguous´. The dotted red lines follow their
presumed shapes on 50% opaque images. All STED data shown are background corrected and linearly deconvolved. All scale
bars are 250 nm.
To investigate the t-loop substructure, U2OS cells were stained for telomeres via PNA FISH and for
TRF2 via IF. Overall, STED imaging revealed a surprisingly heterogenous telomere decoration by TRF2
ranging from full TRF2 coverage to almost TRF2-free telomeric DNA (Figure VI-1, Figure VI-2). PCC
calculations were performed to quantify the colocalization between the TelC labeled telomere signal
and immunolabeled TRF2 signal. The results confirmed the qualitative observation with PCCs from
r = 0.16 to r = 0.91 and an average PCC of r = 0.52 ± 0.14 (n = 310 TelC/TRF2 signals) (Figure II-14).
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For all t-loop structures identified in the TelC channel of the dual-color STED data, the TRF2 signal
displayed two distinct distribution patterns. While TRF2 was diffusely distributed over the t-loop in
most cases (Figure II-15a), a small but significant fraction of the data showed a TRF2 signal clearly
restricted to the loop-tail junction (Figure II-15b).
Figure II-14. TRF2 decoration of human
telomeres.
Representative dual-color STED images
visualizing the heterogeneity of telomere
decoration by TRF2 in intact, fixed U2OS cells.
Telomeres (cyan) were stained via TelC-KK114
PNA FISH and TRF2 (red) was STAR 600-
immunolabeled. To quantify the degree of
colocalization, the PCC was calculated ranging
from r < 0.3 to r > 0.8 with an average of
r = 0.52 ± 0.14 (n = 310 TelC/TRF2 signals). All
STED data shown are background corrected and
linearly deconvolved. Scale bar is 500 nm.
Figure II-15. TRF2 decoration of t-loops in
intact human cells.
U2OS telomeres (cyan) were stained via TelC-
KK114 PNA FISH and TRF2 (red) was STAR 600-
immunolabeled. Dual-color STED imaging
distinguishes two different TRF2 binding patterns
at t-loops. (a) For the majority of t-loops, TRF2 is
diffusely distributed over the entire t-loop
structure. (b) Exclusive TRF2 binding at the loop-
tail junction is restricted to a small but significant
subset of t-loops. All STED data shown are
background corrected and linearly deconvolved.
Scale bar is 250 nm.
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II.5.2 Classifying Human Telomere Conformations
To quantify the contribution of the different telomere conformations to the entire telomere
population of each cell line, a NN-based image analysis was performed. It classified the raw TelC-KK114
STED data into the four predefined conformations (globule, coil, rod, loop) with an average scoring
parameter 1 = 0.86 ± 0.08. Amongst different NNs with individual sets of hyperparameters, the
neural network with the highest 1 score for loop classification was chosen under the conservative
premise that false negatives  outweigh false positives  (precision > recall). Table VI-1 summarizes
the performance of the NN classification and Figure II-16 shows the corresponding confusion matrix
based on the NN training.
Figure II-16. Normalized confusion matrix of NN training for classification
of telomere conformations.
The normalized confusion matrix illustrates the performance of the NN training.
The diagonal displays the frequency of correct predictions (recall) out of the
provided ground truth (true label). The values outside the diagonal represent
the frequencies of false positives (column) and false negatives (row) for the
respective classes. The results including precision, recall and  1 score are
further summarized in Table VI-1.
To identify significant differences of the frequency of individual telomere conformations between the
cell lines, we introduced a similarity measure based on histograms of the predicted frequency and the
frequencies of  and  for each telomere conformation of each cell line (refer to VI.1.1).
The results of the NN analysis display a correlation between loop frequency and average telomere
length. The abundance of the loop conformation increased from HeLa VST (5%) and HeLa NT (7%) to
HeLa LT (12%) and U2OS (11%) cells. In contrast, the contribution of the rod conformation is similar for
the four cell lines (5-8%). However, striking differences in the basic composition of the telomere
populations between the three HeLa cell lines and the U2OS cell line were observed. U2OS cells
featured a more heterogeneous and decondensed telomere population apparent by the
approximately ten-fold elevated level of coil telomeres (26%) and a corresponding decrease in globule
conformation (55%). In contrast, all HeLa cell lines displayed only minor frequencies of coil telomeres
(1-4%) while the globule state (80-85%) provided the greatest contribution to the HeLa telomere
populations (Figure II-17, Table VI-2, Table VI-3).
Figure II-17. Classification of human telomere conformations by combining STED imaging and NN analysis.
Neural network analysis classified telomere conformations (loop, rod, coil, globule) as visualized by STED imaging of TelC-
KK114 PNA FISH stained telomeres in intact HeLa VST (n = 699), HeLa NT (n = 427), HeLa LT (n = 697) and U2OS (n = 1672)
cells. The lacO repeat arrays at the subtelomeric regions of F6B2 cells were identically labeled and classified serving as
biological control (ctrl) (n = 135). Error bars are based on the frequency of false positives (negative error) and false negatives
(positive error) identified during NN training. A detailed summary of the results is given in Table VI-2 and Table VI-3.
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II.5.3 Validating Human Telomere Conformations
To estimate the level of false positive loop contributions due to randomly formed lariat structures
and/or imaging artefacts, two fundamentally different controls were conceived. For the biological
control, the F6B2 cell line was used which carries three stably integrated bacterial lac operator (lacO)
repeat arrays at the subtelomeric regions (STRs) of chromosomes 6q, 11p and 12q [467]. To label and
image the lacO arrays analogously to the telomere repeats via PNA FISH STED, a PNA probe against
lacO repeats (LacO probe) was conjugated with the STED compatible fluorophores KK114 [382] or
Alexa Fluor 594. Upon visual inspection of the imaging results, essentially no loop structures were
detected and the lacO repeats appeared overall less condensed than telomeric DNA (Figure II-18). To
quantitatively analyze the conformation of the STRs, the raw LacO PNA FISH STED data were classified
with the same NN as the TelC PNA FISH STED data. The results displayed a significantly reduced loop
frequency of 1% in comparison to the telomere populations of the three HeLa cell lines and the U2OS
cell line (Figure II-17, Table VI-2, Table VI-3).
Figure II-18. LacO PNA FISH labeling and STED imaging of STRs.
F6B2 cells carry three stably integrated lacO repeat arrays at the STRs of chromosomes 12q, 6q and 11p differing in their
number of repeats (s – small, m – medium, b – big) [467]. The lacO inserts were labeled via LacO-KK114 PNA FISH and imaged
via STED nanoscopy to serve as biological control for assessing the frequency of detecting randomly formed lariat structures
and/or false positive loop structures. All STED data shown are background corrected and linearly deconvolved. Scale bar is
250 nm.
For the computational control, Monte Carlo simulations of nucleosome chains were conducted
generating synthetic telomere PNA FISH STED data for 4, 10, 20 and 50 kb length with labeling degrees
of 10, 20, 30 and 60%. The visual appearance of the simulation data corresponded well to the visual
appearance of the actual STED data (Figure II-19). Still, classification with the same NN was not
possible. The NN sorted the synthetic data into patently incorrect categories. Since the NN was trained
with actual data, there was likely a subtle difference between synthetic and actual data, which limits
the classification capability of the NN to the actual data alone. Therefore, the synthetic STED data were
sorted analogously to the neural network training data revealing a low average frequency of apparent
loop conformations of 2% (Figure VI-3).
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Figure II-19. Comparison of synthetic and actual telomere PNA FISH STED data.
Monte Carlo simulations of nucleosome chains (4, 10, 20, 50 kb) with subsequent PNA FISH labeling (10, 20, 30, 60% labeling
degree) generated synthetic telomere STED data that correspond well in visual appearance to the actual telomere PNA FISH
STED data. Exemplary images of synthetic (left) and actual (right) data are shown as a composite illustration on black
background. Only the actual STED data are background corrected. From left to right and top to bottom, the minimal and
maximal (min/max) counts are 13/133, 5/54, 5/59, 5/57, 2/26, 7/71, 3/30, 6/66, 6/67, 17/177, 6/65, 8/85, 4/47, 3/34, 4/45,
8/85. Scale bar is 250 nm.
II.5.4 Quantifying Human Telomere Conformations
To quantitatively characterize the telomere populations and the different conformations of each cell
line, several telomere measures were calculated from the TelC PNA FISH STED data. For all
conformations, the size of the individual telomere signals was assessed via the area  of the
fluorescence signal, the convex hull area ℎ  and the radius of gyration . The volume density
was determined as previously described [481]. Additionally, the t-loop dimensions were determined
by ellipse fitting of all STED images of the loop conformation.
II.5.4.1 Measures of Telomere Size
All three measures of telomere size ( , ℎ , ) correlated well with an average size increase of the
telomere signals with increasing average telomere length from HeLa VST, to HeLa NT, HeLa LT and
U2OS. Yet, no direct proportionality between the average telomere length and the average size of the
telomere signals was observed. While the average telomere size increased from HeLa VST to HeLa NT
and from HeLa NT to HeLa LT by approximately 30%, it increased from HeLa LT to U2OS by more than
80%. To compare the results with previous studies, the convex hull volume ℎ  was additionally
calculated by raising the convex hull area to the power of 3/2 as described in these studies [480, 481]
(Figure II-20a, Table VI-4, Table VI-5).
To characterize the size increase in detail, the telomere STED data of each cell line were first classified
by NN analysis as described in II.5.2. Subsequently, the size measures were computed individually for
the different telomere conformations. As already observed for the entire telomere populations, the
average telomere signal size likewise increased for each individual conformation in the order HeLa VST,
HeLa NT, HeLa LT and U2OS. Specifically, the coil conformation displayed the most prominent increase
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with a doubling from HeLa VST and HeLa NT to HeLa LT and an almost doubling from HeLa LT to U2OS.
As the coil and the globule conformations are most closely tied to the level of telomeric DNA
(de)compaction, their size measures are displayed in Figure II-20b (Table VI-6, Table VI-7). The average
size of rod telomere signals increased approximately 20% from cell line to cell line in the order HeLa
VST, HeLa NT, HeLa LT and U2OS. For a more tailored size characterization of the loop telomere signals,
ellipse fitting was performed (refer to II.5.4.3).
Figure II-20. Measures of telomere size as determined by quantitative STED image analysis.
The area of fluorescent signal , the convex hull area ℎ , the radius of gyration  and the convex hull volume ℎ  were
calculated based on the TelC-KK114 PNA FISH STED data of (a) the entire telomere population for the HeLa VST (n = 699),
HeLa NT (n = 427), HeLa LT (n = 697) and U2OS (n = 712) cell line and (b) after NN classification for the coil conformation (HeLa
VST n = 4, HeLa NT n =  17, HeLa LT n =  18, U2OS n = 222) and the globule conformation (HeLa VST n = 595, HeLa NT n =  353,
HeLa LT n =  558, U2OS n = 366) of each cell line. All results and p-values are summarized in Table VI-4, Table VI-5, Table VI-6
and Table VI-7.
II.5.4.2 Measures of Telomere Density
Based on the average telomere length and the radius of gyration, an estimate of the ratio of volume
densities of telomeric chromatin was calculated for all possible cell line combinations (refer to
equation (II-11)). Surprisingly, the ratio of HeLa NT and U2OS cells was close to 1:1 implying similar
volume densities of telomeric chromatin for both cell lines. Compared to these, the volume density of
HeLa VST telomeres was less than half and the volume density of HeLa LT telomeres was approximately
double (Figure II-21a, Table VI-8).
To validate the approach of analyzing the (de)compaction level of the telomere populations via NN
classification, the ratio of volume densities between coil and globule telomeres was compared for each
cell line. In all cases, the volume density of the coil conformation was lower than the volume density
of the globule conformation. U2OS cells displayed the highest ratio with coil telomeres being almost
four-fold less dense than globule telomeres. The density of the coil conformation for HeLa VST and
HeLa LT telomeres was approximately three-fold lower compared to the density of the globule state.
II.5 Results 81
For HeLa NT cells, the volume density decrease from the globule to the coil conformation was only
two-fold (Figure II-21b, Table VI-9a).
To further analyze the nature of U2OS telomere (de)compaction, the volume density of the U2OS coil
and globule state was compared to the volume densities of the coil and globule states of the three
HeLa cell lines. As expected from the ratio of volume densities between the entire telomere
populations, the volume densities of the two telomere conformations were both lower for HeLa VST
and higher for HeLa LT. In comparison with HeLa NT, however, U2OS cells displayed a reduced coil
volume density but an increased globule volume density (Figure II-21c, Table VI-9b).
Figure II-21. Ratios of volume densities.
The ratios of volume densities  were calculated
based on the average telomere length as
determined by the TRF analysis (refer to Figure
II-9) and the quantitative image analysis results
of the radius of gyration  (refer to Figure II-20).
(a) Ratios of  (cell line 1 to cell line 2) between
the entire telomere populations of the four cell
lines studied (HeLa VST n = 699, HeLa NT n = 427,
HeLa LT n = 697 and U2OS n = 712). (b) Ratios of
 of the coil conformation to globule
conformation per cell line and (c) ratios of  of
the U2OS coil / globule conformation to the coil /
globule conformation of the three HeLa cell lines
as classified by NN analysis (refer to II.5.2) (coil
conformation HeLa VST n = 4, HeLa NT n =  17,
HeLa LT n =  18, U2OS n = 222; globule
conformation HeLa VST n = 595, HeLa NT
n =  353, HeLa LT n =  558, U2OS n = 366). All
results and p-values are summarized in Table VI-8
and Table VI-9.
II.5.4.3 T-Loop Dimensions
To determine the average sizes of the loop portion (t-loop without tail) of the four cell lines, ellipse
fitting was performed on all t-loop TelC PNA FISH STED images per cell line including both the loop
output of the NN analysis and the loop training data. The fit provided average values and SDs for the
semi-major and semi-minor axes, which were used to calculate an average ellipse circumference  for
each cell line (Figure II-22). The results increased with increasing telomere length from HeLa VST
(C = (267 ± 74) nm) and HeLa NT (C = (241 ± 62) nm) to HeLa LT (C = (312 ± 99) nm) and U2OS cells
(C = (342 ± 87) nm) with no significant difference between HeLa VST and HeLa NT (Table VI-10, Table
VI-11).
Assuming that telomeric DNA in intact cells is present in the form of unfolded nucleosome chains, the
loop size can be expressed in units of base pairs. With a nucleosome repeat length of  = 191 bp,
a core DNA length of  = 146 bp, a linker DNA length of  = 45 bp, a base pair rise of
 = 0.34 nm for bare DNA, and an entry-exit distance in the nucleosome of approximately
 = 9 nm, the base pair rise  of an unfolded nucleosome chain
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=
− ∙ +
= 0.13 ⁄ (II-14)
can be calculated (refer to Figure II-7 and Table II-4) [686].
Table II-5 presents the results of the average t-loop
circumference obtained from ellipse fitting divided by
for each cell line.
Figure II-22. Quantifying t-loop dimensions by ellipse fitting.
The size of the loop portion of t-loops can be determined by ellipse fitting of
the t-loop STED data. The fitting results provide values for the semi-major axis
 and the semi-minor axis , which can be used to calculate the t-loop
circumference. Scale bar is 250 nm.
Table II-5. Estimated average t-loop sizes in units of base pairs.
SD – standard deviation.
cell line mean [kb] SD [kb]
HeLa VST 2.1 0.6
HeLa NT 1.9 0.5
HeLa LT 2.4 0.8
U2OS 2.6 0.7
II.5.5 Human Telomere Conformations in APBs
To investigate the influence of PML-encasing on the telomere conformation and to resolve the
topology of telomere repeats in APBs, ALT-positive U2OS cells were co-stained for telomeres and PML.
For live cell confocal and STED imaging, specific targeting of telomeres and PML was achieved by
transiently transfecting and overexpressing SNAP-tag or HaloTag fusions of the shelterin protein TRF2
and PML and subsequent staining with the respective SNAP- or Halo-derivatives of the live dyes 580CP
[29], 610CP [29], 640SiRH [32] and SiR [30] (Figure II-23a,b, Figure VI-4). For fixed cell STED imaging
followed by quantitative image analysis, telomeres were labeled via TelC-KK114 PNA FISH and PML via
STAR 600-IF (Figure II-23a,c). Based on the dual-color stainings, telomere signals were sorted into ̀ free´
telomeres not associated with PML and `encased´ telomeres located within APBs.
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Figure II-23. Live and fixed cell STED imaging of APBs in U2OS cells.
(a) To resolve the topology of APBs, PML was targeted via either self-labeling protein tags or antibodies; telomeres were
targeted either directly via TelC PNA FISH or indirectly via staining TRF2 through self-labeling protein tags or antibodies.
(b) Comparison of a representative live cell STED (top) and live cell confocal (bottom) image of telomeres and APBs in a U2OS
nucleus expressing a SNAP-tag/TRF2 (cyan) and a HaloTag/PML (magenta) fusion construct labeled with 610CP-BG and
640SiRH-Halo [29, 32]. Magnifications of the marked region in the overview are shown as STED (top) and confocal (bottom)
close-ups on the right. Scale bar overview is 2 µm, scale bars close-ups are 250 nm. (c) For an exemplary APB stained by PNA
FISH (TelC-KK114, cyan) and IF (PML STAR 600, magenta), raw confocal data (top row), and background corrected and linearly
deconvolved STED data (middle row) are compared. In the STED image, the telomere trace (drawn by hand) through the PML
cavities (segmented and binarized STED image) inside the APB can be followed as illustrated in the bottom row. Scale bar is
500 nm. All confocal data shown are raw data. All STED data shown are background corrected and linearly deconvolved.
II.5.5.1 PML Influence on Telomere Conformation
The groups of free and encased telomeres were separately classified with the same NN as used in II.5.2.
In both cases, all four telomere conformations (loop, rod, coil, globule) were present (Figure II-24).
Figure II-24. PML-mediated telomere decompaction.
(a) NN analysis classifies telomere conformations (loop, rod, coil, globule) as visualized by STED imaging of TelC-KK114 PNA
FISH stained free and encased telomeres in intact U2OS cells. PML-encasing drastically increases the frequency of the coil
conformation at the expense of a declining rod and globule frequency and thus mediates telomere decompaction. The loop
frequency is not strongly altered upon APB formation. Error bars are based on the frequency of false positives (negative error)
and false negatives (positive error) identified during NN training. The results are summarized in Table VI-12 and Table VI-13.
(b) Exemplary STED images of undisturbed t-loops within APBs. Telomeres (cyan) were stained via TelC-KK114 PNA FISH and
PML (magenta) via STAR 600-IF. All STED data shown are background corrected and linearly deconvolved. Scale bar is 250 nm.
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While PML-encasing did not strongly alter the frequency of loop telomeres (10% free ↓ 7% encased),
essential differences were observed between the abundance of the rod, coil and globule states. In
association with APBs, the U2OS telomeres preferred a more decondensed conformation, as was
apparent by a six-fold elevation of the coil conformation level (11% free ↑ 65% encased) at the
expense of the globule (67% free ↓ 26% encased) and the rod states (12% free ↓ 2% encased, Figure
II-24, Table VI-12, Table VI-13).
II.5.5.2 PML Influence on Telomere Size
To study the influence of PML-encasing on the telomere size, the size measures introduced in II.5.4.1
were calculated for free and encased telomeres. The results for the area of the fluorescence signal ,
the convex hull area ℎ  and the radius of gyration  consistently displayed almost four times larger
telomere signals within APBs (Figure II-25a, Table VI-14).
To investigate the size increase in detail, the three size measures were calculated for the individual
conformations of free and encased telomeres as classified by NN analysis (refer to II.5.5.1). Similar to
the effect on conformation frequencies, PML-encasing affected the average signal size of coil and
globule telomeres more strongly than the average signal size of loop telomeres. For all three size
measures, the average size of coil telomere signals increased more than three-fold and the average
size of globule telomere signals more than doubled. The small number (n = 4) of encased telomeres
classified as rod prevents significant statements on potential differences in the average size of the rod
conformation between free and encased telomeres (Figure II-25b, Table VI-15).
Figure II-25. Size measures of free and encased U2OS telomeres as determined by quantitative STED image analysis.
The area of fluorescent signal , the convex hull area ℎ  and the radius of gyration  were calculated based on the TelC-
KK114 PNA FISH STED data of free and encased U2OS telomeres of (a) the entire telomere population (free n = 780, encased
n = 190) and (b) after NN classification for the coil conformation (free n = 83, encased n = 123) and the globule conformation
(free n = 521, encased n = 50) (* p < 0.005, ** p < 10-19, *** p < 10-76, n.a. p-value not available due to small n). All results and
p-values are summarized in Table VI-14 and Table VI-15.
II.5.5.3 APB Topology
Dual-color STED imaging of telomeres and PML revealed a surprisingly high structural heterogeneity
of APBs and allowed the identification of four main structural classes for the organization of the
telomeric repeats in APBs (Figure II-26):
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· Globular. PML forms an intact, spherical shell around the complete telomere, which occupies
the entire internal APB space. The globular APB appears as a two-component system with clear
separation between telomere repeats inside and PML outside.
· Partially hollow. PML forms an intact, spherical shell around the telomere, but for parts of the
APB interior, the telomere signal is absent. The `empty space´ strongly varies in size between
different partially hollow APBs and can take up almost the entire APB interior. The partially
hollow APB appears as a multicomponent system with clear separation between telomere
repeats and `empty space´ inside and PML outside.
· Granular. PML does not form a shell around the telomere. Instead, the telomere displays an
`open´ DNA conformation in which the decondensed telomere repeats intermingle with PML.
The granular APB does not show any distinct separation between telomere and PML.
· Clustered. PML encases repeats from two different telomeres. This structural class is the most
diverse and includes APBs with more than one telomeric DNA protrusion, APBs with two
discrete telomere spots within one APB, and complexes of two (or more) APBs. The clustered
APB brings different telomeres together with clear separation between telomere repeats and
PML.
Figure II-26. The four main structural classes for the organization of telomeric repeats within APBs.
STED images of representative examples of the four main structural classes of APBs (globular, partially hollow, granular,
clustered) in U2OS cells. For clustered APBs, two telomere protrusions are marked by white arrows in the first image. Line
profiles (right) illustrate the topology of telomere (cyan, TelC-KK114) and PML (magenta, IF STAR600). Line profiles were
drawn on raw data (indicated by yellow arrows on overlay) and averaged over 5 pixels. All STED data shown are background
corrected and linearly deconvolved. Scale bar is 500 nm.
To confirm the results of the PNA FISH / IF hybrid staining approach, APBs in U2OS cells were
additionally visualized by IF only and by live staining of SNAP- and Halo-fusion constructs. In both cases,
the telomere had to be indirectly visualized via TRF1/2 targeting. Still, the results of fixed cell STED
imaging of immunolabeled APBs and of live cell STED imaging of SNAP- and Halo-tagged APBs
qualitatively confirm the presence of the four distinct APB structural classes (Figure II-27).
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To investigate potential cell cycle dependence of the presence of the individual APB structural classes,
their temporal coincidence in U2OS cell nuclei was investigated. All four APB structural classes were
simultaneously observed in individual U2OS nuclei with different staining approaches (Figure VI-5 and
Figure VI-6).
Figure II-27. Further examples for the four main APB structural classes.
Live and fixed cell STED images of representative examples of the four main structural classes of APBs (globular, partially
hollow, granular, clustered) in U2OS cells. For clustered APBs, two telomere protrusions are marked by white arrows in the
second and fifth images. The number at the bottom right states the respective labeling approach. 1: TelC-KK114 / PML IF
STAR 600, 2: TRF2 IF STAR 600 / PML IF STAR35P, 3: TRF2 IF STAR 635P / PML IF STAR 600, 4: TRF1 IF STAR 600 / PML IF
STAR 635P, 5: TRF1 IF STAR 635P / PML IF STAR 600, 6: TRF2-Halo 640SiRH / PML-SNAP 610CP, 7: TRF2-SNAP 610CP / PML-
Halo 640SiRH. All STED data shown are background corrected and linearly deconvolved. Scale bar is 500 nm.
Figure II-28. Characterization of the topology of the subtelomeric region of APBs (figure on opposite page).
(a) To resolve the topology of APBs and STRs in F6B2 cells, PML was targeted via either fluorescent proteins, self-labeling
protein tags or antibodies; telomeres were targeted either directly via TelC PNA FISH or indirectly via staining TRF2 through
self-labeling protein tags or antibodies; the lacO repeat arrays at the STRs were targeted either directly via LacO PNA FISH or
indirectly via LacI fusions with self-labeling protein tags. (b) F6B2 cells are lacO-tagged directly adjacent to the telomeres of
chromosomes 11p (b), 6q (m) and 12q (s) [467]. Triple-color STED/confocal image of a representative F6B2 nucleus of PNA
FISH stained telomeres (TelC-Alexa Fluor 594 (AF594), cyan) and STRs (LacO-KK114, yellow), and Alexa Fluor 488-
immunolabeled PML (magenta). Bottom left: Telomeres, STRs and PML were imaged in confocal mode. Top right: Telomeres
and STRs were imaged in STED mode, PML in confocal mode. The marked telomere/STR in the overview is shown in
magnification as imaged in confocal mode (bottom left) and STED mode (top right). (c) Representative live and fixed cell close-
ups of APBs and STRs. Telomeres and STRs were imaged in STED mode, PML in confocal mode. The number at the bottom
right states the respective labeling approach (numbering continued from Figure II-27): 8: TelC Alexa Fluor 594 / LacO KK114
/ PML IF Alexa Fluor 488, 9: TRF2-SNAP 610CP / LacI-Halo 640SiRH / PML-eGFP, 10: TRF2-SNAP 580CP / LacI-Halo 640SiRH /
PML-eGFP, 11: TRF2-Halo 640SiRH / LacI-SNAP 610CP / PML-eGFP. The STR is either excluded from or (partially) included in
the APB. Thus, the content of APBs is not restricted to telomeric repeats. The combined STED and confocal data are
background corrected and linearly deconvolved; the confocal only data in (b) are raw data. Scale bar nucleus is 2 µm, all scale
bars close-ups are 500 nm.
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To study the spatial organization of the subtelomeric DNA relative to the APB complex, combined STED
and confocal imaging of telomeres with three color labels in living and fixed ALT-positive F6B2 cells
was performed (Figure II-28). For fixed samples, the telomere repeats and the lacO repeats at the STRs
were labeled via PNA FISH and imaged in STED mode, whereas PML was immunolabeled and imaged
in confocal mode. For live samples, the telomere and lacO repeats were indirectly labeled via SNAP-
tag or HaloTag fusions of TRF2 and LacI (Lac repressor) and imaged in STED mode, whereas PML was
visualized in fusion with eGFP by confocal imaging (Figure II-28a,b).
Both staining approaches provided complementary results showing that APBs do not strictly include
or exclude STRs. The F6B2 APB population rather displayed the entire spectrum, comprising fully
excluded STRs, partially included STRs and completely included STRs in APBs (Figure II-28c). NN analysis
as performed in II.5.2 showed that the repetitive sequences at the STRs were even less compact and
more open (coil 84%, globule 3%) than telomeric DNA within APBs (Figure II-17).
II.6 DISCUSSION
The telomeres at the end of linear human chromosomes assemble with the six-membered shelterin
protein complex and buffer the loss of DNA during replication [488, 491]. Yet, comprehensive
understanding of nature’s solution to the end-protection problem remains elusive and contradicting
findings regarding the role of shelterin-mediated telomere compaction have been reported [480-482].
A crucial aspect in this regard is the organization of telomere repeat DNA within the telosome. The
sequestration of the 3’-overhang within t-loop structures masks the chromosome ends and thereby
protects genome integrity[496].
T-loop structures have been first visualized by EM [483, 484] and more than a decade later by STORM,
STED, SIM and Airyscan [485, 486, 655] but solely in vitro with purified mammalian telomeric DNA after
cross-linking and spreading. These studies have identified TRF2 as the critical factor for t-loop
formation and/or maintenance [483, 485, 486]. The majority of these experiments have investigated
mouse telomeres. Since the human telomere repeat length (10-15 kb) is significantly shorter than that
of mouse cells (40-50 kb), resolving human t-loops is more challenging [486]. So far, t-loop structures
have not been imaged within intact cells, neither human nor mouse. Certainly, investigating telomeric
structure and organization in the native cellular environment is desirable as it decreases the chances
of studying preparation artefacts.
II.6.1 Staining Human Telomeres
Here, we combined STED nanoscopy with NN classification and quantitative image analysis to visualize
and characterize telomere conformations in three different telomerase-positive HeLa cell lines and
two different ALT-positive U2OS cell lines. Three distinct labeling approaches were tested for their
informative value on the topology of telomeres and associated proteins. Certainly, all three labeling
approaches guaranteed a significant gain in structural information comparing confocal and STED
II.6 Discussion 89
imaging. Yet, the level of structural detail in the telomere STED images increased from live cell staining
using SNAP-tag and HaloTag fusions of TRF2 over immunolabeled TRF2 to TelC PNA FISH.
In general, telomeres are often indirectly stained for fluorescence imaging by targeting TRF2 with
antibodies or FPs [482, 622, 657, 658]. TRF2 specifically binds to double-stranded telomeric DNA, but
the finite size of the TRF2/antibody complex or the TRF2/FP fusion protein positions the fluorophore
up to tens of nanometers away from the telomere repeats, distances that fall in the range of the STED
resolution. Precise determination of the telomere structure is thus impaired in these labeling
approaches, as every fluorescence imaging technique never records the structure of interest but
always the attached fluorophore itself. In contrast to FP-tagging or IF of TRF2, direct telomeric DNA
staining with TelC PNA FISH places the fluorophore only 15 atoms (< 3 nm, two O-linkers) away from
the telomere repeats.
Indeed, not only the distance between fluorophore and telomeric DNA matters, but also the labeling
density does, i.e. the ratio between the numbers of labels and the number of telomere repeat base
pairs. Based on biochemical assays investigating the in vivo stoichiometry of telomere repeats and
shelterin proteins in human cells, an (over)abundance of the shelterin proteins suggests that most of
the telomeric DNA is associated TRF2 [491].
However, we observed a surprisingly high heterogeneity of TRF2 coverage of telomeric DNA
represented in a broad distribution of the PCC between TelC-KK114 stained telomeric DNA and
STAR 600-immunolabeled TRF2 around r = 0.52. Certainly, the results of PCC calculations are
additionally affected by the size of TRF2 decorated with primary and secondary antibody displacing
STAR 600 away from the telomeric DNA and thus from KK114. Both dyes are comparably bright and
photostable, but in STED imaging, the performance of KK114 should be superior to the performance
of STAR 600 as the cross section for STED is smaller for STAR 600. Yet, this difference only accounts for
a minor change in resolution.
Based on colocalization control experiments with TRF1 and TRF2, we are convinced that the
discrepancies between the TelC PNA signal and the TRF2-IF signal are real and not due to incomplete
TRF2 staining. As we investigated the TRF2 decoration only for U2OS telomeres, it cannot be excluded
that the heterogeneity in TRF2 coverage is a characteristic feature restricted to ALT-positive cells.
Indeed, it is suggested that partial telomere deprotection through reduced levels of TRF2 is crucial for
initiating ALT-related repair processes [556, 557]. Still, for the purpose of telomere structure
determination in U2OS cells, TRF2 represents no valid target and can only be stained to assess
telomere positions. Certainly, co-stainings of TRF2 and telomeric DNA provide valuable insights into
the telomere decoration by TRF2 allowing to infer structure-function relationships (see below).
With a size of 18 bp, the TelC probe should provide for a high labeling density. In practice, quantitative
telomere covering is usually not achieved. Comparing the visual appearance of our actual STED data
with the synthetic STED data of the Monte Carlo simulations for different labeling densities, we assume
a labeling degree between 30-60%. Moreover, the TelC probes are very likely not homogeneously
distributed over the telomere. Human telomeres carry the canonical core histone components and we
speculate that the linker DNA is more accessible for PNA FISH than the core DNA wrapped around the
histone octamer.
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Finally, the level of structural detail in the telomere STED images further depends on the fluorophore’s
photophysical properties, namely high photostability, low dark state transition probability, and large
cross section for stimulated emission. The methods of IF and PNA FISH can freely choose any desired
organic dye. In contrast, live cell telomere staining based on SNAP- and Halo-fusions of TRF2 relies on
biocompatible and cell membrane permeable fluorophores. Live dyes such as 580CP, 610CP and
640SiRH [29, 32] used in the present study, were just recently developed and hence are not yet as
advanced in terms of photostability and brightness as the well-established organic dyes for fixed cell
STED imaging. Consequently, the effective image resolution is commonly lower for live cell STED data.
However, the amount of information that can be extracted from the live cell imaging data is not only
affected by the dyes’ photophysical properties. It is further reduced due to the need for faster image
acquisition and more conservative imaging parameters to avoid motion blur and phototoxicity.
Summarizing the arguments, PNA FISH in combination with a STED compatible, bright and photostable
fluorophore like KK114 [382] is the best choice for STED imaging of telomere repeats. The telomere
topology can be resolved with a high level of structural detail as the fluorophore is placed directly at
the telomeric DNA. We could thus distinguish separate telomeric DNA strands at distances of 30 nm.
The major drawback of PNA FISH of telomeres is its limitation to fixed cells, although exceptions have
previously been shown [622].
II.6.2 Visualizing T-Loops in Intact Human Cells
STED imaging of TelC PNA FISH labeled telomeric DNA revealed structural characteristics of individual
telomeres and structural variations between the different cell lines at nanoscale resolution. Thus, we
could tackle the long-standing question of the existence of t-loops in their native cellular environment.
For all cell lines studied, t-loop structures were observed. For each cell line, the loop-to-tail ratio varied,
and t-loops appeared either lasso-like or circular, depending on the position of the 3’-overhang
sequestration. This observation is in good accordance with results from previous EM and STORM
studies on isolated telomeric DNA [483, 485, 496]. Hence, we conclude that during t-loop formation,
there is no predefined invasion site for the 3’-overhang along the double-stranded telomeric DNA.
II.6.2.1 T-Loop Frequency
The NN classification allowed us to quantitatively describe the contribution of the t-loop conformation
to the telomere population of each cell line. The positive correlation observed between t-loop
frequency and average telomere length is consistent with the expectation that for shorter telomere
lengths the resolution of smaller loop structures becomes more challenging.
Our experimentally observed t-loop frequencies of 5-12% were lower than the results of previous EM
and STORM studies on isolated telomeric DNA stating frequencies of 15-40% for HeLa (S3 and 1.2.11)
telomeres and 10-40% for mouse telomeres [483, 485]. Moreover, we did not observe the negative
correlation between t-loop presence and telomere decondensation in ALT-positive cells that previous
EM and 2D gel electrophoresis studies reported. These experiments observed approximately three-
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fold decreased t-loop frequencies in ALT-positive cells as compared to telomerase-positive cells [483,
484, 498].
We can rationalize these discrepancies by noting the following influences and dependences on t-loop
detection in intact human cells with 2D STED imaging. It is not only the actual fraction of the telomere
population adopting a t-loop conformation that determined our observed t-loop frequency, but
additionally, several other aspects affected our results and in summary rather underestimate the
actual t-loop frequency of our samples.
First, t-loop imaging in intact cells was significantly hampered by folded up and not `exposed´ t-loops.
The chances of detecting t-loops was additionally reduced as we studied human samples with mostly
shorter telomeres, thus smaller t-loops, than the previous imaging studies. However, with an elevated
level of telomere decompaction in U2OS cells, the probability of t-loop detection was increased as
compared to all HeLa cell lines with more compact telomeric DNA. Additionally, ALT cells feature
extrachromosomal duplex or single-stranded circular arrays of telomere repeats [487]. These circular
ECTRs can be distinguished from t-loop structures by 2D gel electrophoresis but not conclusively by
our PNA FISH STED imaging approach. While single-stranded C-circles were not detected by the TelC
PNA probe, which only targeted the G-rich strand, the duplex t-circles were detected and thus slightly
increased the frequency of imaged loop structures in ALT cells. Theoretically, t-circles can be
distinguished from t-loop structures as they are true DNA circles without a tail. However, as the loop-
to-tail ratio of t-loops strongly varies and tails can be extremely short [483], we could not decide
whether circular fluorescence signals without any apparent tail represented t-circles or t-loops (Figure
II-29a). In these aspects, we underestimate the t-loop frequency of the three HeLa cell lines more
strongly than the t-loop frequency of the U2OS cells.
Second, comprehensive mapping of each t-loop with TelC PNA FISH was potentially hampered by
incomplete telomere labeling, occupation of dark states and/or photobleaching. We decided on
stringent sorting criteria that filed partially imaged loop structures as `ambiguous´ and excluded these
STED images from the training data. Thereby, we underestimate the t-loop frequency in this aspect.
Third, we recorded samples with unperturbed spatial 3D telomere orientations using a 2D STED
imaging approach. For every fluorescence microscopy technique, the detected fluorescence signal is
always a 2D projection of the 3D distribution of the fluorophores within the focal volume along z. The
number of fluorophores contributing to the detected signal decreases with shrinking focal volume,
which is given by the PSF of the respective system. For all 2D fluorescence nanoscopy techniques, the
PSF is still diffraction-limited in the axial dimension and measures approximately 550 nm for 2D STED.
Thus, within the 3D distribution of loop structures, we detected only the fraction of loops within the
focal plane that featured the right orientation towards the focal plane. To be resolved as a lariat
structure by our 2D STED system, t-loops had to be roughly aligned with the imaging plane (xy-plane).
In perpendicular orientation (i.e. 90° rotated along x or y), t-loops generated rather linear fluorescence
signals (Figure II-29b). In this aspect, we underestimate the t-loop frequency.
The fourth point partially relates to the previous one. Not all detected loop signals necessarily
represented true t-loop structures. It is conceivable that certain non-lariat telomere conformations in
3D (e.g. helical telomere conformation along z) also generated lariat fluorescence signals upon 2D
projection. A second source of false positive loop signals were random telomeric DNA conformations
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incidentally forming lariat structures (Figure II-29c). Consequently, in this aspect we rather
overestimate the t-loop frequency.
Fifth, the detected t-loop frequency is further affected by the performance of the NN classification. To
be deliberately conservative in our statement concerning the t-loop frequency, we have chosen the
NN with the highest 1 score but greater precision than recall. As false negatives had outweighed false
positives during NN training, the NN also underestimated the t-loop frequency during inference.
Figure II-29. Different telomere repeat loop
structures of ALT cells and the consequences of
2D image acquisition in quantitative t-loop
imaging.
(a) Besides the universal t-loop structure, ALT
cells additionally feature extrachromosomal
single-stranded (C-circle) and duplex (t-circle)
circular arrays of telomere repeats. (b) The 2D
detection of t-loops does not resolve lariat
structures if the t-loops are perpendicularly
oriented with respect to the imaging (xy) plane.
The closer the t-loop orientation is towards a
parallel orientation (i.e. 90° rotated along x or y),
the less perspective distortion the t-loop image
displays. (c) Certain non-lariat telomere
conformations (e.g. helical conformation along z)
as well as incidentally formed lariat structures
through random telomeric DNA conformations
also generate lariat fluorescence signals upon 2D
image acquisition. Thus, not all detected loop
signals necessarily represent true t-loop
structures.
With respect to the fourth aspect, the contribution of false positive loop structures was estimated in a
biological and a computational control. The NN classification of the STED images of LacO PNA FISH
labeled STRs in F6B2 cells showed only a minor fraction of the loop conformation; the synthetic
telomere STED data generated by Monte Carlo simulations revealed a low average frequency of
apparent loop conformations. We thus conclude that the number of false positive loop signals detected
in our analysis due to random DNA loop formation and/or due to imaging artefacts is < 2%.
We expect the influence of cell cycle dependent t-loop formation and/or maintenance on our results
to be negligible. This assumption is based on biochemical assays in recent literature showing that t-
loops are closed throughout the cell cycle and only open in two very short time frames during S phase
for replication and during late S/G2 phase for C-strand fill-in DNA synthesis before they immediately
refold again [484, 498, 698, 699].
II.6.2.2 T-Loop Size
The increase in t-loop circumference with increasing average telomere length of the four cell lines
studied qualitatively confirms previous findings on a correlation between the dimensions of the loop
portion of t-loops and the average telomere length [483]. However, our results did not mirror the ratio
of the average telomere lengths of HeLa VST, HeLa NT, HeLa LT and U2OS as initially expected. The
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differences in the average loop size between the four cell lines were markedly smaller. This can be
partially explained by noting that the loop portion of t-loops in ALT-positive cell lines is generally small
with respect to the total telomere length [484].
Comparing our results to literature values is not straightforward as previous studies have only
characterized t-loops consisting of bare telomeric DNA after isolation and spreading. In contrast, we
had to make assumptions on the state of the telomeric DNA in intact cells to derive the number of
base pairs contained in the loop portion of t-loops from our results of the ellipse fitting. In accordance
to our Monte Carlo simulations, we described the telomeric DNA as nucleosome chains with a defined
base pair rise based on established literature values [686].
However, this model deviates from the biological reality as the majority of telomere repeats are
organized in an unusual chromatin structure. The nucleosome repeat length is smaller than in bulk
DNA and telomeric nucleosomes are more mobile and less stable than regular nucleosomes sliding
along the telomeres. Deeper insights into the higher-order organization of telomeric chromatin remain
elusive, but the short nucleosomal spacing rather suggests the absence of higher-order chromatin
condensation [700, 701].
Therefore, we assume that our results rather underestimate the number of base pairs contained in the
loop portion. The comparison with literature values supports this assumption. As we did not use the
same cell lines as previous studies did, cell lines with similar average telomere lengths are compared
(Table II-6). The most prominent difference is found between the average loop size of HeLa LT cells
and the average loop size of HeLa 1.2.11 cells as determined by Griffith et al. [483]. Despite a
comparable average telomere length, the average loop size of HeLa LT cells is almost six times smaller.
In contrast, our results for HeLa NT and U2OS cells are around half of the respective average loop sizes
of HeLa S3 cells and normal human peripheral blood leukocytes (PBLs) as determined by Griffith et al.
[483] and the mean loop size of the ALT-positive cell lines GM847 and GM847-Tert as determined by
Cesare et al. [484].
Table II-6. Comparison of the average size of the loop portion of t-loops to results from previous studies.
The average telomere length is given as stated in the respective reference. The mean ± SD for the loop size of GM847 and
GM847-Tert were estimated from the histogram presented in the respective reference.
this study literature
cell line average telomerelength [kb] loop size [kb] cell line
average telomere
length [kb] loop size [kb] reference
HeLa LT ~20 2.4 ± 0.8 HeLa1.2.11 ~23 13.8±6.2 [483]
HeLa NT ~7 1.9 ± 0.5
HeLa S3 ~10 5.8±3.5 [483]
human
PBL ~7 2.9±1.9 [483]
U2OS 2-50 2.6 ± 0.7
GM847 10-50 6.4±0.5 [484]
GM847-
Tert 10-50 5.8±0.6 [484]
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For HeLa VST, the reviewed literature does not contain any experiments on t-loops from cells that
feature a comparable average telomere length. The average circumference of HeLa VST t-loops is
similar to the average HeLa VST telomere length as determined by the TRF analysis. However, as we
assume systematic underestimation of the number of base pairs contained in the loop portion, we are
led to presume a larger number of base pairs in the HeLa VST t-loops than determined by TRF analysis
for the average HeLa VST telomere. This observation is certainly explained with the finite resolution of
our imaging approach, which sets a lower limit to the detectable t-loop size. Thus, the smallest HeLa
VST t-loops are missed. Additionally, we speculate that the shorter the telomere is, the more unlikely
t-loop formation gets [702].
Except for the average loop size of HeLa LT, our results are compatible with the results from previous
studies for two reasons. On the one hand, the SDs of the literature values reach up to 60% of the
calculated means. On the other hand, our approach systematically underestimates the size of the loop
portion of t-loops. First, our results for the number of base pairs contained in the loop portion are
based on general assumptions on bulk chromatin structure not tailored to the true biological nature
of the telomeric chromatin. Second, many of the t-loops imaged in intact cells were likely not fully
exposed and still partially folded up thereby hiding their actual size. This aspect is presumably more
pronounced with longer telomeres of HeLa LT cells and U2OS cells. Third, all t-loops not perfectly
aligned with the imaging plane generated skewed loop images upon 2D projection with circumferences
of the loop signals smaller than the actual t-loop circumferences (Figure II-29b).
To estimate the maximum error of 2D projection, the idealized assumption of circular t-loops was
made. In this approach, the semi-major axis  as determined by fitting to an ellipse represents the
radius of the circular t-loop, as we defined the tilting axis to run parallel to . For the four cell lines
studied, the circumference = 2  of the circular t-loop is ~25% larger than the circumference
 calculated from the semi-major and semi-minor axes determined by the ellipse fitting (Table VI-11).
However, we assume the error based on compaction and folding of telomeric chromatin to be larger.
II.6.2.3 T-Loop Substructure
Based on several in vitro studies, TRF2 is suggested to mediate t-loop formation. In these experiments,
TRF2 was shown to remodel artificial telomeric DNA substrates into t-loop like structures [483, 703],
to promote supercoiling in telomeric DNA and to induce strand invasion [704-706]. This suggestion
was recently supported by two STORM imaging studies with isolated mouse telomeric DNA showing
that t-loop formation and/or maintenance critically depend on TRF2 [485, 486]. As Holliday junctions
are bound and protected by TRF2 in vitro [705, 707], TRF2 presumably functions as `glue´ closing and
stabilizing the t-loop structure. However, TRF2 decoration of exclusively the loop-tail junction (the
position of 3’-overhang invasion) has yet been visualized only by EM with an artificial telomeric DNA
substrate in vitro [483].
Thus, we set out to investigate the t-loop substructure with STED nanoscopy and map the localization
of TRF2 at t-loops in intact U2OS cells in dual-color STED experiments. The two distinct TRF2
distributions at t-loops suggest cell cycle dependent TRF2 binding patterns. We assume that TRF2 is
diffusely distributed over the entire t-loop during most of the cell cycle but accumulates at the loop-
II.6 Discussion 95
tail junction during specified, short stages. As t-loops are suggested to rapidly unfold and refold twice
during the cell cycle (refer to II.6.2.1) [498], we hypothesize that for refolding, TRF2 forms hotspots at
the future loop-tail-junction to promote 3’-overhang invasion and thus t-loop formation of the
unfolded telomeres. We further speculate the rod telomere conformation as classified by NN analysis
to represent unfolded t-loops during replication as the rod and loop frequency are similar for each cell
line. Yet, to address this issue in detail, further cell cycle dependent studies will be needed.
To the best of our knowledge, this is the first time that substructural features of t-loops have been
visualized in their native cellular environment.
II.6.3 Comparing Human Telomere Populations
All measures of telomere size mirrored the increase in average telomere length ranging from HeLa VST,
to HeLa NT, HeLa LT and U2OS cells. Yet, we must note at this point that the area of fluorescent signal,
the convex hull area and the radius of gyration each probe slightly different telomere size
characteristics. While the convex hull area is sensitive to the compaction state of the telomeres as it
only uses the edge points of the telomere signals, i.e. the telomere repeats at the boundary of the
telomere spots, the area of fluorescent signal takes into account that telomere outlines have
concavities. Similarly, the radius of gyration makes no assumptions on the telomere shape and uses
every signal containing pixel to determine the telomere size, but it strongly depends on the level of
compaction of the respective telomere. Thus, we only observed a weak proportionality of the three
size measures indicating differences in the compaction state of the telomeric chromatin between the
four cell lines studied (see below).
To compare our results to previous findings from SMLM studies investigating telomere sizes in intact
human cells, we additionally computed the convex hull volume. For HeLa NT and HeLa LT, the convex
hull volume and especially the radius of gyration nicely agree with the respective size measures for
regular HeLa and HeLa 1.2.11 cells as determined by Bandaria et al. [482] and for HeLa S and HeLa L
cells as determined by Vancevska et al. [481] (Table II-7). For HeLa VST and U2OS, the reviewed
literature does not provide any information on measures of telomere size for comparable cell lines.
The absence of direct proportionality between the average telomere length and the measures of
telomere size as well as between the size measures themselves indicated changes in the compaction
state of telomeric DNA between the four cell lines studied. Based on histone and DNA modifications,
it is accepted that telomeres generally exist as heterochromatin [494]. However, biochemical assays
have identified telomeric DNA in ALT-positive cells to adopt a less compacted state than in telomerase-
positive cells. These results have fueled the speculation that telomeric chromatin decompaction might
be one of the driving events of ALT occurrence [531]. Still, contradicting findings exist concerning the
correlation between the average telomere lengths and telomere compaction of different HeLa cell
lines [481, 482].
While previous telomere SMLM imaging studies have assessed the extent of telomere decompaction
by calculating different measures of telomere size from the fluorescence signals [480-482], we
investigated an alternative approach based on telomere conformation classification, which has not
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been pursued previously. Besides quantifying t-loop frequencies, our NN analysis additionally allowed
characterization and comparison of the telomere populations of the individual cell lines studied. The
striking difference of the coil-to-globule ratio between U2OS cells (2:3) and the three HeLa cell lines
(> 1:20) strongly points to variations in the level of telomeric chromatin compaction. The ratio of the
volume densities of the coil and globule state unambiguously confirm the coil conformation to be less
compact and more open than the globule conformation. Thus, these results clearly indicate an overall
decompaction of U2OS telomeric DNA.
Table II-7. Comparison of the average size of telomere signals to results from previous studies.
The average telomere length is given as stated in the respective reference. The mean ± SD for the convex hull volume of HeLa
1.2.11 was estimated from the bar plot given in the respective reference. The means for the convex hull volume of HeLa S
and HeLa L were estimated from the bar plot (no SDs given) in the respective reference.  – radius of gyration,
ℎ  – convex hull volume.
this study literature
cell
line
average telomere
length [kb] [nm] [nm3×106]
cell
line
average telomere
length [kb] [nm] [nm3×106]
reference
HeLa
NT ~7 68±13 5.1±2.6
HeLa ~6 --- 2.3±0.2 [482]
HeLa S ~11 68±20 4.2 [481]
HeLa
LT ~20 77±16 7.7±4.8
HeLa
1.2.11 ~20 --- 6.1±0.4 [482]
HeLa L ~33 88±22 10.0 [481]
This conclusion from NN analysis was compared with the measure of volume density of telomeric DNA
as defined by Vancevska et al. [481]. In contrast to the NN classification results, the ratios of volume
densities for the entire telomere populations did not represent the outstanding status of the U2OS cell
line regarding the degree of telomere decompaction. On closer examination though, the ratio of coil-
to-globule volume densities confirms that U2OS cells feature an elevated level of decompacted
telomeric chromatin. However, bulk telomere population analysis hides this important subpopulation
as the U2OS globule conformation is strongly decompacted.
This observation demonstrates the importance of studying the characteristics of telomere ensembles
based on their individual subpopulations. By analyzing the entire telomere ensemble solely at once,
relevant information from subpopulations are averaged out. For HeLa NT and U2OS, the bulk analysis
of volume densities did not suggest significant variations in the level of telomere (de)compaction
whereas the analysis of the individual telomere conformations revealed important differences in the
degree of (de)compaction.
As we compare cell lines with different average telomere lengths, we must consider that the level of
telomere (de)compaction presumably correlates to a certain degree with the average telomere length.
Vancevska et al. have shown that the volume density of telomeric chromatin increases by a factor of
1.4 ± 0.6 from HeLa S (~11 kb) to HeLa L cells (~33 kb) [481]. Our results for the ratios of volume
densities between HeLa VST, HeLa NT and HeLa LT qualitatively confirm this finding. However,
contradicting conclusions concerning the correlation of telomere compaction and average telomere
II.6 Discussion 97
length exist. Bandaria et al. have not observed an increase in telomere compaction from regular HeLa
(~6 kb) to HeLa 1.2.11 cells (~20 kb) [482]. This discrepancy might originate from the fact that Bandaria
et al. have stained telomeres by fusing TRF2 to the pcFP mEos2 to allow for PALM imaging, while in
this work, as in Vancevska et al., telomeres have been stained via PNA FISH.
Strictly speaking, by assuming a correlation between telomere (de)compaction and average telomere
length, the volume density of U2OS telomeres should be compared only to the volume density of HeLa
LT telomeres. The ratios of volume densities between the U2OS and the HeLa LT cell line for the entire
telomere populations as well as for the coil and globule states strongly support the initial hypothesis
that ALT-positive cells feature less compact telomeric DNA than telomerase-positive cells.
Taken together, our NN analysis enabled us to distinguish ALT-positive and telomerase-positive cancer
cell lines based on conformational characteristics of their individual telomere populations. To the best
of our knowledge, this is the first study to differentiate the two different TMMs using a combination
of fluorescence microscopy and deep learning.
II.6.4 Interpreting Human Telomere Conformations
Besides the direct function of t-loops in genome integrity protection, further structure-function
relationships are inherently linked to the telomere repeat topology but are only partially understood.
The role of telomere decompaction in DDR signaling is still under debate and the driving force for
telomere clustering remains elusive [480-482]. The clustering of telomere repeats from different
chromosomes is suggested to play a significant role in telomere maintenance via the ALT pathway. The
formation of APB complexes is assumed to promote telomere elongation by DNA recombination
involving telomere clustering and DNA repair processes [45, 487]. Still, the telomere repeat topology
within APBs has not yet been resolved at the nanoscale.
The combination of dual-color STED imaging, neural network classification and quantitative image
analysis revealed an additional subpopulation of the U2OS telomere ensemble defined by PML-
encasing. The presence of an extra telomere subgroup explains the larger SDs of the measures of U2OS
telomere size as observed in the first round of quantitative U2OS telomere image analysis.
PML-encasing correlated with an increased average size of the telomere signal and an elevated average
degree of decompaction. While the average size of free U2OS telomeres is in good accordance with
our results for HeLa LT telomeres, telomeres within APBs are significantly larger and less compact. Our
results do not unambiguously tell if PML preferentially encases longer and more decondensed
telomeres or if PML-encasing induces telomere elongation and decompaction. Yet, we speculate that
the telomere size difference between free and encased telomeres hints at telomere elongation and/or
telomere clustering within APBs. Based on previous suggestions, we further assume that APB
formation promotes an open telomeric DNA state, which facilitates ALT-related DNA recombination
and/or repair synthesis [531]. As PML-encasing had no significant influence on the classified loop
frequency but essentially reduced the rod and globule population, we reason that the t-loop structure
is insensitive to PML-induced decompaction.
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Although of great interest, we did not calculate the ratio of volume densities between free and encased
telomeres as the results of the NN classification and the quantitative image analysis indicate significant
differences in both average telomere length and compaction state. By knowing one of the two
quantities, the other quantity can be inferred. Certainly, the level of (de)compaction directly influences
the convex hull area and the radius of gyration. Therefore, these size measures cannot be used to
calculate a ratio of average telomere length between free and encased telomeres. In principle, the
area of fluorescent signal is insensitive to the compaction state. However, the nature of 2D image
acquisition as discussed above also introduces a dependence of the area of fluorescent signal on the
level of (de)compaction. Analyzing fluorescence intensity potentially allows for conclusions on the
amount of FISH labeled DNA. Yet, strong differences in the compaction state render the individual
telomere populations more or less accessible to the PNA probes making quantitative fluorescence
intensity analysis impossible.
The detailed analysis of APBs identified four main structural classes for the PML-DNA topology.
Globular APBs represent the only structural class that has been characterized previously. Using 4Pi
microscopy, Lang et al. have pictured APBs as spherical structures of varying size with the PML shell
clearly separated from the enclosed telomere, which occupies the entire internal APB space [544].
While our results confirm this topology description for a subgroup of APBs, they further revealed the
presence of unknown APB structural classes. These other APB types have previously been missed by
Lang et al. since the 4Pi imaging approach was limited to a resolution of ~110 nm axially and 150-
170 nm laterally [544].
In partially hollow APBs, the APB interior displays telomere-free regions. We speculate that this
`empty´ space is in fact occupied by other protein complexes presumably involved in ALT telomere
maintenance as it is known that APBs colocalize with a long list of factors involved in homologous
recombination (e.g. MUS81, replication protein A, RAD51 and RAD52), DNA damage response and DNA
damage repair (e.g. 9-1-1 complex, hRAD17, γH2A.X, HP1) [537]. We hypothesize that PML-NBs
support efficient telomere recombination by ensuring that the respective repair and recombination
factors are at the right location, in the right combination and at the right concentration. This
assumption is supported by a recent study showing that repair and recombination factors are client
molecules recruited to the APB after APB formation by DDR signaling [708]. As we could show that the
APB content occasionally expands to partially include also STRs, we conclude that part of the `empty´
space can be additionally occupied by STRs.
In granular APBs, telomere and PML are blended into each other creating a meshwork of both
components. We reason that the interaction of PML and telomere (and potentially other ALT specific
factors) decondenses the telomeric chromatin. Less compact telomeres are more accessible to
proteins involved in ALT-related recombination and repair synthesis as strong condensation efficiently
suppresses extensive interactions by simple protein exclusion. Interspersion of the decondensed
telomere with PML presumably stabilizes its open DNA conformation and supports the access of ALT-
specific factors.
The topology of clustered APBs implicates the presence of more than one telomere per APB. This
structural class supports previous conclusions about APBs promoting interactions between telomeres.
We reason that it displays telomere clustering required for the homologous recombination of
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telomeres in the ALT maintenance mechanism by providing repair templates for telomere DNA
synthesis. It has been previously shown that APB formation can be triggered by DNA damage at the
telomeres induced by either replication stress or double-strand breaks. It entails telomere clustering
and telomere elongation within the induced APBs [567]. However, the physical mechanisms underlying
telomere clustering remain elusive [468, 567]. We cannot exclude that clustered APBs also involve
APBs nucleated on ECTRs and telomeres. It can be assumed that ECTRs cluster more efficiently with
telomeres, as they are more mobile than telomeres [708].
These APB structural classes commonly underline the fundamental role of PML in the ALT pathway by
implicating PML-dependent recruitment of ALT-related factors and promotion of telomere
recombination. As the different APB types were simultaneously observed in individual U2OS nuclei, we
do not assume any cell cycle dependence. Yet, further cell cycle dependent studies will be needed to
address this issue in detail.
Analyzing the nature and spatial localization of the subtelomeric DNA relative to the APB complex
provided new insights into the APB topology. Our results suggest that the DNA content of APBs can
expand to include subtelomeric DNA sequences beyond the telomere repeats. Fixed and live cell STED
data are mutually supportive but certainly display a difference in image quality due to the reasons
discussed in II.6.1. However, acquiring large data sets was challenged by the fact that F6B2 cells carry
only three stably integrated lacO repeat arrays at their STRs and display solely 3-5 APBs per nucleus
while featuring chromosome counts in the hypertriploid range.
Based on histone and DNA modifications it is accepted that STRs just like telomeres exist as condensed
heterochromatin [494]. However, contradicting findings persist on the methylation pattern at the STRs
of ALT-positive cells and its implication for the ALT pathway [531, 709, 710]. As DNA methylation is
affiliated with chromatin compaction [711], we speculate that at least for certain ALT cells,
hypomethylation causes decompaction of the STRs as revealed by our NN classification analysis for
non-lariat telomere and STR structures. The results show an overall elevated level of decompacted
DNA conformations of the repetitive sequences at the STRs as compared to the telomere repeats
within APBs. The ratio of volume densities was not calculated as the only estimate of the lacO insert
lengths is based on confocal imaging and the assumption of a bulk chromatin density for the STRs
[467], which contradicts our findings.
In summary, by combining PNA FISH, STED imaging, neural network classification and sophisticated
image analysis, we quantitatively characterized t-loops and different non-lariat telomere
conformations in intact human cells. As our approach did not depend on artificial telomere
preparations, we could exclude potential artefacts introduced by psoralen cross-linking, DNA isolation
and sample spreading. Characterizing the topology of telomere subpopulations in their native cellular
environment is important for the identification of structural differences between different TMMs. As
emerging anti-cancer therapies target telomere maintenance, it is crucial to understand the defects
that underlie telomeric recombination deregulation in human cells. Disclosing structural differences
between healthy and diseased cells may finally lead to a better understanding of telomere dysfunction
in aging or cancer and pave the way for new diagnostic and therapeutic developments.
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II.7 CONCLUSION
Our telomere STED imaging study afforded the visualization of the structure and organization of
telomere repeats in fixed and living cells at the nanoscale. In particular, PNA FISH combined with STED
imaging, neural network classification and sophisticated image analysis allowed us to quantitatively
distinguish and characterize t-loops and distinct non-lariat telomere structures. To the best of our
knowledge, this is the first visualization of t-loops in intact human cells. Dual-color STED experiments
further provided the first visual evidence for TRF2-dependent t-loop formation and/or maintenance.
In contrast to artificial ex cellulo telomere preparations, our experiments preserved the topology of
telomeric DNA throughout the entire telomere population and did not favor one conformation over
any other. Our approach excluded artefacts potentially introduced by the established sample
preparation method of psoralen cross-linking, DNA isolation and sample spreading onto a surface.
Accordingly, we could investigate the structural characteristics of telomere populations in their native
environment.
By that very fact, our study further revealed the topology of telomere repeats within APBs of ALT-
positive cells. APB complex formation was observed to significantly perturb the organization of
telomeric DNA towards an open conformation, which potentially promotes ALT-related DNA repair
and recombination. Our NN analysis was able to detect this conformational difference between ALT-
positive and telomerase-positive cell lines. For the first time, the two TMMs were distinguished by a
combined approach of fluorescence imaging and deep learning. Moreover, our nanoscale STED image
analysis obtained additional evidence suggesting telomere elongation within APBs.
In summary, we demonstrated that STED imaging in combination with an adequate labeling approach
is a powerful method to investigate the topology of telomeres, associated proteins and subtelomeric
DNA. This study provides a combination of tools that will unravel the structural organization of key
player proteins at telomeres in their native cellular context. As structure and function are intrinsically
connected, any insight into the topology of the telosome will shed light on the role of the respective
proteins and telomere conformations in either aging, tumor suppression or telomere maintenance in
cancer. Extended knowledge in these fields will pave the way for the development of alternative
diagnostics and treatments for telomere dysfunction related diseases.
III – APPLICATION:
THE SUBCELLULAR FATE OF DUAL-LABELED PSMA
INHIBITORS AT THE NANOSCALE
III.1 INTRODUCTION
Prostate cancer (PCa) is one of the most prevalent male cancer types and figures among the main
causes of cancer-related mortality [712]. In particular, therapeutic options for metastatic, hormone-
refractory PCa patients have been limited, but the development of novel prostate-specific membrane
antigen (PSMA) inhibitors has revolutionized the diagnostic and treatment regimen of these patients
over the last decade [713-717].
Radiolabeling turns these molecules into powerful tools enabling targeted imaging and therapy
approaches based on PSMA. The membrane protein represents an attractive target because it is
strongly upregulated in poorly differentiated, hormone-refractory and metastasized lesions of almost
all PCa types [718-722] and its physiological expression is limited to a few organs, with significantly
lower expression levels as compared to cancer tissue [718, 723].
The specificity of PSMA can be further exploited in the surgical removal of PCa lesions, a potential cure
for patients with metastatic PCa. However, only precise detection and resection of all malignant tissue
guarantee patient survival. These requirements are elegantly met with novel dual-labeled PSMA
inhibitors featuring radioactive and/or fluorescent reporter modalities to combine pre-operative
imaging with intra-operative guidance (Figure III-1) [48, 724].
However, mechanistic details of PSMA inhibitor internalization and intracellular distribution remain
elusive as the subcellular fate of the PSMA/PSMA inhibitor complex has not yet been studied at the
nanoscale. Deeper insights are clinically interesting since cell binding and internalization properties as
well as the subcellular localization strongly affect the diagnostic and therapeutic efficiency of PSMA
inhibitors.
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Figure III-1. Concept of clinical application of dual-labeled PSMA inhibitors.
The two modalities of the dual-labeled PSMA inhibitors allow for their detection via both fluorescence and radioactivity. After
① injection of the dual-labeled PSMA inhibitor, ② preoperative imaging such as PET/CT is applied for PCa localization, PCa
staging and surgical planning. ③ Intraoperative guidance based on the fluorescence and/or radioactive signal of the PSMA
inhibitor allows for the precise localization of the lesions improving surgical accuracy.
III.2 SURVEY OF THE FIELD
III.2.1 Prostate Cancer
Prostate cancer derives from malignant transformation in the epithelium of the prostate, the exocrine
gland in the male reproductive system producing the seminal fluid [725]. PCa constitutes one out of
five newly diagnosed cancer cases [712] and strongly contributes to the overall cancer-related death
rate. Risk factors comprise exogenous influences including dietary habits and socioeconomic factors,
as well as endogenous influences including age, chronic inflammation, family history and race [726].
Different molecular pathways for carcinogenesis are discussed [727, 728], with the androgen receptor
playing a pivotal role, especially in castration-resistant prostate cancer (CRPCa). PCa feeds on
androgens, but mechanistic details in their contribution to carcinogenesis are controversially discussed
[729-731].
As PCa is typically a slow-growing cancer with asymptomatic progression at early stages, it is often
unnoticed for years. Early detection is crucial, though, since the chances of curative treatment
decrease with spreading. The cancer cells can travel through the lymphatic system or the blood stream
and the majority of metastases occur in lymph nodes or bones [732]. Yet, early detection is possible
by measuring the blood level of prostate-specific antigen (PSA) and by digital rectal exam (DRE). If one
of the results is abnormal, further testing is necessary and diagnosis is eventually done by biopsy to
determine the stage of the tumor [733, 734].
Clinical staging of PCa is performed according to the Union for International Cancer Control (UICC) via
the TNM system, a global classification standard taking into account the size of the primary tumor (T),
the number of affected lymph nodes (N), the presence of distal metastases (M), the PSA level and the
Gleason score [735]. The Gleason grading system histopathologically compares to which extent the
tumor biopsy tissue resembles healthy tissue. The system defines five grades assigned to the
morphology of the tumor tissue. With increasing grades, the differentiation of the tumor tissue
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decreases, heterogeneity increases, and tissue architecture is lost. The total score is the sum of two
grades referring to the dominant cell morphology and to the cell morphology with the highest grade.
The higher the Gleason score counts, the more aggressive the tumor is [725, 732]. The clinical staging
directly affects the subsequent treatment regimen with options including hormone therapy [736, 737],
chemotherapy [738, 739], radiotherapy [740], endoradiotherapy (III.2.5), cryotherapy [741] or
resection (III.2.6).
III.2.2 Prostate-Specific Membrane Antigen
PSMA is a type II transmembrane glycoprotein (100–120 kDa) moderately expressed in all types of
healthy prostate tissue, but greatly upregulated in PCa, especially in metastatic castration-resistant
PCa (mCRPCa) [742]. The level of overexpression correlates with the aggressiveness of the tumor and
thus with the Gleason score suggesting PSMA contribution to increasing invasiveness of PCa [718, 743].
Additionally, PSMA displays low expression levels in other organs including kidneys [718], salivary
glands [744], spleen [745], small intestine [744], liver [742], testicles [745], ovaries [745] and brain
[744]. While the physiological function of PSMA is well understood for the nervous and digestive
system, it remains unknown for the other tissues.
PSMA displays two distinct enzymatic functions both resulting in the release of glutamate from the
enzyme substrates. As folate hydrolase I (FOLH1), it enables the absorption of dietary folate [743, 746];
as N-acetyl-L-aspartyl-L-glutamate peptidase I (NAALADase), it regulates the concentration of the
neurotransmitter N-acetyl-L-aspartyl-L-glutamate (α-NAAG) in the synaptic cleft [747, 748]. PSMA is
further known as glutamate carboxypeptidase II (GCP II) [749]. Its enzymatic activity depends on PSMA
dimerization and is additionally affected by the glycosylation pattern [750, 751].
PSMA is an established biomarker for the diagnosis and therapy of PCa [752]. Among other PCa
biomarkers, PSMA has proven to be an excellent target structure due to
· its overexpression on PCa,
· absent or low expression rates in healthy tissue [718],
· increasing expression rates with tumor aggressiveness, androgen-independence, metastatic
disease as well as disease recurrence [743, 753],
· favorable internalization and binding properties for PSMA-specific ligands [746, 754], and
· significant correlation of PSMA expression and Gleason score [755].
The extensive extracellular domain of PSMA (amino acids 44–750) features several glycosylation sites
and consists of an apical, a helical and a protease domain. The active site and substrate-binding cavity
is formed with contribution from all three domains (Figure III-2) [756, 757]. Upon ligand binding, PSMA
is activated and undergoes clathrin-dependent internalization [723, 754, 758], which is mediated by a
novel MXXXL motif of N-terminal amino acids formed by the cytoplasmic tail. The active site is
structurally well-characterized allowing for the rational design of PSMA targeting ligands [759-761].
The more interactions a potential ligand offers, the better its affinity to the active site of PSMA [762].
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Figure III-2. The PSMA ectodomain.
PSMA is a type II transmembrane protein with a
19-amino-acid internal portion, a 24-amino-acid
transmembrane portion and a 706-amino-acid
external portion. The ectodomain (shown here)
features an active site, which binds substrates
such as low molecular weight PSMA inhibitors
(shown in red). The crystal structure was
obtained from the PDB [PSMA 5O5T].
The first targeted approach exploiting PSMA for diagnosis and therapy of PCa is also the only one that
has yet gained approval by the Food and Drug Administration (FDA) [763, 764]. However, the
respective antibody targets an intracellular PSMA epitope and thus only binds necrotic cells with
disrupted cell membranes strongly limiting its sensitivity [765, 766]. Hence, the subsequent tracer
development has especially focused on the extracellular domain and given rise to low molecular weight
PSMA inhibitors [767-771], several generations of antibodies [772-775], RNA aptamer conjugates [776,
777], prodrugs [778] and nanoparticles [779-781] with PSMA specificity.
III.2.3 Positron Emission Tomography
Imaging modalities such as ultrasound, computed tomography (CT) and MRI allow the investigation of
PCa by visualizing lesion foci, assisting staging, and localizing disease after biochemical recurrence.
However, many conventional imaging techniques fail particularly in the detection of metastases. In
this regard, positron emission tomography (PET) is a powerful addition to PCa management. It is one
of the most common imaging modalities in nuclear medicine for the non-invasive 3D visualization of
the spatial distribution of a radiotracer in the patient’s body. In combination with suitable targeting
strategies, PET imaging allows for quantitative detection of biomarkers and biochemical changes, and
for discrimination between physiological and pathological processes with high sensitivity via local
radioactivity. The combination with CT or MRI allows for a clear anatomical assignment of the PET data
[782]. These hybrid imaging approaches enable individualized treatment regimens with beneficial
impact on the therapy outcome.
PET imaging is based on the radioactive  decay, during which a proton  is converted into a neutron
. In this process, a positron  and an electron neutrino  are emitted:
→ + + (III-1)
When the positron  collides with an electron , both elementary particles annihilate, emitting two
photons  into opposite directions:
+ → + (III-2)
If the ring-shaped PET scanner, positioned around the patient, detects both photons within a defined
time window, they are assigned to the same annihilation event in the patient. This coincidence
detection is used to determine the line of response (LOR) along which annihilation occurred (Figure
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III-3) [783]. The raw data are a list of LORs, which are organized in a sinogram displaying the
superposition of all sinusoids weighted by the amount of activity at each point in the patient. On the
level of the sinogram, the data can be corrected for attenuation due to more or denser material.
Reconstruction finally yields the radiotracer’s in vivo distribution [784].
Figure III-3. Function principle of PET imaging.
For positron emission tomography, a
radiopharmaceutical is injected intravenously
into a patient. (a) The isotope (here 18F)
distributes in the patient (e.g. according to a
carrier molecule) and undergoes  decay. (b)
The emitted positron scatters through matter,
loses energy and annihilates with an electron.
Two photons  (511 keV each) are emitted in
almost opposite directions. (c) A ring of detectors
registers the radiation. The directionality of the
annihilation photons allows for localizing their
origin as it is assumed that annihilation occurred
along the line of response.
Data quality strongly correlates with the choice of tracer, which is usually based on a small molecule
that (closely) resembles its biological counterpart. PET tracers either mimic key players of crucial
metabolic or signaling pathways, or they specifically bind to target structures including antigens,
receptors and other sites of drug action. Labeling of these compounds with a suitable radionuclide
creates the radiopharmaceuticals that allow the visualization of metabolic pathways, organ functions,
biomarker distributions and other biological processes and structures (tracer principle) [785].
In the design of an efficient radiotracer, good target accessibility, low tracer metabolism, and a suitable
radionuclide are desirable. The radionuclide potentially limits measurement time by its half-life and its
branching ratio (Table III-1). Despite radiolabeling, the biological activity (e.g. specific target binding or
metabolic participation) of the tracer should be maintained. Hence, radioactive isotopes of biologically
abundant atoms like 11C, 13N and 15O are potentially favored as they feature little or no sterical
hindrance or electronic perturbation of the biological system. However, especially 13N and 15O are very
short-lived and hence cannot be included into complex tracer syntheses. The radioisotopes 11C and 18F
allow the synthesis of tracers chemically similar and biochemically identical to their biological
counterparts, and thus find broad application despite their rather short half-lives [786, 787]. Especially
18F is popular due to its introduction into the glucose analogue [18F]FDG6. Tumors are characterized by
an elevated glucose metabolism and an upregulated expression of glucose transporters leading to an
increased uptake and intracellular accumulation of [18F]FDG in tumor cells [788], which allows
distinguishing healthy tissue from tumor tissue.
As an alternative to short-lived radionuclides that usually require a cyclotron on site for generation
and application, radionuclide generators like the 68Ge/68Ga generator [789] are an easy to use and
cheap option. They are based on a parent-daughter radionuclide pair (68Ge/68Ga) contained in a device
6 2-[18F]fluoro-2-deoxy-D-glucose
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that permits separation and extraction of the daughter product (68Ga). The daughter activity is
replenished continuously by decay of the parent (68Ge) and repeated extraction is possible. However,
tracer radiolabeling with radiometals like 68Ga require a chelator, which is large in relation to small
molecule tracer structures. To not structurally influence the tracer, chelators are often used together
with antibodies and targeting proteins or peptides.
Table III-1. Important PET radionuclides decaying by positron emission ( ) and electron capture (EC).
radionuclide half-life decay
 branching
ratio [%]
radionuclide half-life decay
 branching
ratio [%]
11C 20.3 min 99 64Cu 12.7 h /EC 19
13N 10.0 min 100 68Ga 68.1 min 89
15O 2.0 min 100 89Zr 3.3 d /EC 23
18F 110.0 min /EC 97 124I 4.2 d /EC 24
III.2.4 Diagnosis of Prostate Cancer
Due to the above-mentioned advantages, PETC/CT and PET/MRI are powerful tools offered by nuclear
medicine for the diagnosis of PCa. The applied radiotracers visualize either the increased metabolic
activity of PCa tumor cells, PCa specific receptors or antigens such as PSMA, or tissue with angiogenesis
or hypoxia [790, 791]. While PCa cells display a low rate of glycolysis making the application of [18F]FDG
unsuitable [792, 793], they are characterized by an enhanced uptake of choline, a precursor of the cell
membrane lipids phosphatidylcholine and sphingomyelin. The upregulation of choline transporters
and the choline kinase allows for the accumulation of choline-based tracers labeled with either 11C or
18F in PCa tumor tissue [791, 794]. General applications of [11C]choline-PET and [18F]choline-PET suffer
from limited specificity [795, 796], but both approaches allow for an efficient detection of bone
metastases [797].
In contrast, non-metabolic tracers specifically bind to overexpressed target structures preferentially
located on the outside of PCa cells. PSMA is the current flagship amongst all PCa biomarkers (refer to
III.2.2) with clinical application. Its enzymatic domain can be specifically targeted by diagnostic PET
tracers either labeled with 68Ga or 18F [790]. While 18F can be directly integrated into the chemical
structure of the tracer, 68Ga depends on complexation. HBED-CC7 [768] is an efficient radiometal
chelator allowing for fast formation of thermodynamically stable complexes with 68Ga at room
temperature [798]. The conjugation with a potent urea-based PSMA inhibitor [799] has yielded the
novel radiotracer [68Ga]Ga-PSMA-118 featuring highly specific tumor internalization and strong tumor
signal over background organs (Figure III-4) [800, 801]. It is further characterized by minor
accumulation in healthy tissues like small intestine, cervical ganglia, salivary glands and kidneys as well
as little internalization in other solid tumors of the salivary gland, colon and kidney, and in
7 N,N'-bis-[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N'-diacetic acid
8 Glu-NH-CO-NH-Lys(Ahx)-[[68Ga]Ga(HBED-CC)]
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glioblastomas [715, 802, 803]. [68Ga]Ga-PSMA-11 allows for superior imaging in terms of specificity
and sensitivity as compared to established modalities like choline-PET [715, 802, 804-807]. Thus, in
diagnostics of all stages of PCa, [68Ga]Ga-PSMA-11 has become the most widely used PET/CT imaging
agent [768]. In patients with primary or biochemically recurrent PCa, [68Ga]Ga-PSMA-11 based PET/CT
outperforms conventional imaging techniques like CT or MRI in the detection of intraprostatic tumors,
malignant lymph nodes and bone metastases [713-716] and is especially powerful in the detection of
biochemical recurrence due to its high sensitivity [808]. This new diagnostic approach strongly affects
the subsequent treatment regimen and allows for individualized therapy [717].
Figure III-4. Chemical structure of PSMA-11.
The low molecular weight PSMA inhibitor PSMA-
11 consists of the binding motif Glu-urea-Lys
directly targeting PSMA and the radiometal
chelator HBED-CC allowing for complex formation
with 68Ga. It is applied as PET/CT imaging agent in
non-invasive diagnostics of PCa.
III.2.5 Endoradiotherapy of Prostate Cancer
Exchanging the radionuclides of diagnostic radiotracers with therapeutic radionuclides allows for their
application in endoradiotherapy. This systemic approach delivers therapeutically effective radiation
doses directly to the target tissue thereby minimizing off-target tissue effects. The concept of
theranostics integrates diagnostic imaging and therapy in a single system. Labeled with either - or
positron-emitters, the tracer is used to identify patients suitable for the respective endoradiotherapy.
The selected patients are subsequently treated with the same tracer labeled with either - or -
emitters.
Radioactive decay occurs in unstable atomic nuclei. In simplified terms, nuclear stability is based on
the balance between the electromagnetic and the nuclear force. If the Coulomb repulsion outweighs
the attractive nuclear force in elements with high atomic numbers, an  particle is emitted to restore
the balance. The  particle is a subatomic fragment consisting of two neutrons and two protons
(helium-4-nucleus). It is highly ionizing but relatively heavy and slow, and therefore  radiation shows
low tissue penetrating power [809].
In contrast,  particles are less damaging and display greater tissue penetration depths as they carry
half the charge of an  particle and typically begin with a lesser initial kinetic energy [810]. The  decay
is a consequence of the weak interaction. Unstable atomic nuclei with an excess of neutrons undergo
 decay, which converts a neutron  into a proton , emitting an electron  and an electron
antineutrino  ̅in the process:
→ + + ̅ (III-3)
Unstable atomic nuclei with an excess of protons undergo  decay (refer to equation (III-1)). The
binding energy per nucleon influences the probability of a nuclide to experience radioactive decay. For
any spontaneous particle emission, the final binding energy per nucleon must be larger than in the
initial state [811].
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The long range of  particles leads to crossfire effects, during which the radiation from one cell also
affects the neighboring cells. Crossfire effects are beneficial for heterogeneous tumors in which only a
subpopulation of cells can be efficiently targeted by the radiotracer. However, surrounding healthy
tissue is likewise subjected to crossfire. Moreover, even non-targeted cells not directly hit by radiation
may also exhibit effects of radiation, which is known as the radiation-induced bystander effect (RIBE)
[812, 813].
As a second-generation antibody, monoclonal anti-PSMA J591 allows for vascular targeting of PCa by
binding to the extracellular domain of PSMA. Labeled with the -emitter 177Lu, it has extended patient
survival in phase I and II trials. Yet, a broad clinical application of [177Lu]Lu-J591 is limited by adverse
events including hematological toxicity and thrombocytopenia. Moreover, the large size of antibodies
(150 kDa) generally hampers tumor penetration. Systemic clearance is slow and thus a damaging
radiation dose is deposited in the bone marrow [814-816].
In line with the radiotracer development for non-invasive PCa diagnostics, new strategies for
endoradiotherapy rely on low molecular weight PSMA inhibitors. Their smaller size provides more
rapid pharmacokinetics, an increased tumor penetration and thus high tumor-to-background ratios.
For complexation of therapeutic radiometals like the -emitters 90Y and 177Lu or the -emitter 225Ac,
HBED-CC is unsuitable and the chelators DOTA9 or DOTAGA10 represent the favorable alternatives [762,
769, 770]. The theranostic strategy is realized in the low molecular weight radiotracer PSMA I&T
(imaging and therapy) using DOTAGA and the low molecular weight radiotracer PSMA-617 using DOTA.
Responses to therapy based on [177Lu]Lu-PSMA I&T include decreasing PSA levels and a reduced tumor
burden [817]. Correspondingly, [68Ga]Ga-PSMA I&T can be used for PCa diagnosis but PSMA-11 is more
sensitive in the detection of smaller lesions [818].
[177Lu]Lu-PSMA-617 and [225Ac]Ac-PSMA-617 are especially promising for the therapy of late stage
mCRPCa patients beyond established treatment options [819-823]. First studies with [177Lu]Lu-PSMA-
617 suggest a high efficacy with a favorable safety profile [819, 820] and the radiopharmaceutical has
recently entered phase III after successfully passing a phase II multicenter clinical study [819].
III.2.6 Surgical Guidance
For localized PCa, radical prostatectomy is the second treatment option besides radiotherapy [824].
The comprehensive removal of the prostate including all tumor tissue should be favored over ̀ watchful
waiting´ [825, 826]. Watchful waiting is a form of active surveillance as PCa often grows very slowly,
and especially older men might never need treatment. With parasympathetic nerve-sparing
techniques during surgery, adverse side effects like erectile dysfunction and urinary incontinence can
be avoided. Laparoscopic surgery allows for a minimally invasive procedure benefiting from smaller
incisions, reduced risk for infections, faster recovery times as well as reduced pain and scarring.
Challenges like hand-eye coordination, lack of tactile sense, and the projected 2D view of the surgical
field [827-829] are addressed with robot-assisted laparoscopic prostatectomy using robotic
9 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
10 1,4,7,10-tetraazacyclododececane,1-(glutaric acid)−4,7,10-triacetic acid
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telemanipulation systems like the da Vinci robot (Intuitive Surgical, Inc., Sunnyvale, California, USA)
[830, 831].
Sentinel lymph nodes are the first lymph node(s) to be infiltrated by cancer cells spreading from a
primary tumor. According to the sentinel lymph node concept, tumor-free sentinel lymph nodes imply
that downstream lymph nodes are likewise unaffected. Hence, prostatectomy includes a template for
sentinel lymph dissection [832]. While the removal of healthy lymph nodes can have adverse effects,
remaining malignant lymph nodes are worse as they usually involve follow-up surgery and/or disease
reoccurrence [833].
Thus, the precise detection and resection of all malignant tissue directly affect the treatment outcome
and patient survival. Both can be strongly improved using surgical guidance by fluorescence or
radioactivity (Figure III-5). As the first radiotracer for sentinel lymph node identification labeled also
healthy lymph nodes downstream while missing lesions outside the lymph system, the development
of PSMA targeting radiotracers for intraoperative guidance was strongly pushed [770, 817, 834, 835].
Figure III-5. In vivo proof of concept study of
dual-labeled PSMA inhibitors.
(a) Guidance by radioactivity. Whole-body
maximum intensity projection of small-animal
PET imaging acquired 120 min p.i. of 0.5 nmol
68Ga-radiolabeled Glu-urea-Lys-HBED-CC-PEG2-
IRDye800CW (∼50 MBq) in a LNCaP-tumor
bearing BALB/c nu/nu mouse model. (b)
Guidance by fluorescence. NIR-fluorescence
detection at 2 h p.i. of 0.5-2 nmol Glu-urea-Lys-
HBED-CC-PEG2-IRDye800CW. (c-f) Proof of
concept in a clinical operation theatre at 1 h p.i.
of Glu-urea-Lys-HBED-CC-PEG2-IRDye800CW (30
µg/kg) in pigs ((c,d) prostate, (e,f) kidney). (c,e)
White light images. (d,f) Fluorescent tissue could
be precisely delineated from surrounding tissue
using the da Vinci FireFly system.
Low molecular weight compounds like [111In]In-PSMA I&T and its refined variant [99mTc]Tc-PSMA I&S
(imaging and surgery) enable the intraoperative detection of small lesions that were initially identified
using PET/CT [834-837]. However, gamma probes (hand-held detection device) suffer from a high
sensitivity towards background, which is especially increased in the area of injection or the renal
pathway. Thus, the detection of lesions in these regions is particularly impaired. The exact localization
and precise distinction from healthy tissue is further hampered as gamma probes produce only
acoustic and no visual signals. Moreover, the patient and the medical staff is exposed to radioactivity
[838, 839].
In contrast, fluorescence-guided surgery allows for the visualization of the tracer’s signal and thus
facilitates the precise detection of malignant tissue. Furthermore, fluorescent dyes are not subjected
to short half-lives as radionuclides are. They offer easy handling, repetitive excitation and detection as
well as high sensitivity. NIR dyes are favored as scattering, absorption by endogenous chromophores
and autofluorescence decrease with increasing wavelength, allowing for comparatively deep tissue
penetration with a good SNR (refer to I.1.6.1). A large Stokes shift is desired to guarantee a good
separation of excitation and emission [840-844]. Currently, the only clinically approved NIR dye is
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indocyanine green (ICG) [845]. Similar to radionuclides in diagnosis or therapy, ICG can be specifically
targeted to PCa tissue via conjugation to the J591 antibody [846] or to low molecular weight PSMA
inhibitors [847-853].
Disadvantages of fluorescence-only surgical guidance include photobleaching, residual absorption and
scattering, background due to stray light, and a limited tissue penetration depth as compared to -rays
[828, 841, 854, 855]. Moreover, conjugation with the fluorescent dye can affect the pharmacokinetic
and binding properties. Thus, hybrid approaches were developed combining -emitter and fluorescent
dye in one compound to unite the strengths of both guiding modalities and bypass the individual
weaknesses. These dual-modality tracers allow for pre-operative imaging and intraoperative (radio- or
fluorescence-) guidance, and guarantee precise detection and resection to the best possible extent
[832, 854, 856].
The first approaches suffered from unspecific distribution in sentinel lymph nodes and from the
photophysical and chemical drawbacks of ICG such as low photostability, small Stokes shift, and
aggregation in aqueous solutions [839, 857]. The subsequently developed dual-modality antibodies
and nanoparticles specifically targeting PSMA used IRDye800CW as fluorescent reporter. Both
strategies have enabled the visualization of tumor tissue, but only with time delay, as antibodies and
nanoparticles feature extended systemic circulation times (refer to III.2.5) [858, 859].
In contrast, low molecular weight tracers offer more rapid pharmacokinetics and fast systemic
clearance, allowing for a high contrast at early time points. Thus, dual-modality PSMA inhibitors
featuring radioactive and fluorescent reporter entities, namely [68Ga]Ga-Glu-urea-Lys-HBED-CC-PEG2-
IRDye800CW and [68Ga]Ga-PSMA I&F (imaging and fluorescence), have recently been developed and
are currently in preparation for clinical translation [48, 724]. The new class of dual-labeled low
molecular weight PSMA inhibitors promises huge advances in the diagnosis and therapy of PCa.
However, the conjugation with chelator and fluorescent moiety can easily affect the biological and
pharmacological properties of the low molecular weight compounds. Thus, in the design of low weight
hybrid approaches, special care must be taken to preserve the pharmacokinetics and tumor-specific
accumulation of the original tracer.
III.3 AIM
Targeted imaging and therapy based on novel PSMA inhibitors have been a game changer in
diagnostics and treatment of PCa, but the subcellular fate of PSMA/PSMA inhibitor complexes remains
an open question. Yet, the exact mechanism of internalization and intracellular distribution is of great
clinical interest to provide deeper insight into the mode of action during endoradiotherapy. Dual-
modality PSMA inhibitors in particular promise huge advances in the diagnostic and treatment regimen
of PCa as they combine pre-operative imaging with intra-operative guidance.
Thus, this project sought to follow the trafficking of PSMA and of dual-modality PSMA inhibitors at the
molecular level. Therefore, we designed, synthesized and comprehensively characterized STED
compatible dual-modality PSMA inhibitors mimicking clinically applied PSMA inhibitors. Binding,
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internalization and retention properties were assessed in fixed and live cell confocal and STED
experiments, radioactive biodistribution studies, small PET-imaging experiments and flow cytometry
studies. The PSMA inhibitors’ subcellular fate was analyzed via long-term internalization experiments
and colocalization studies with PSMA and other relevant components of the endocytic pathway by
developing a novel non-standard live cell staining protocol and applying fixed and live cell STED
nanoscopy.
As of September 2019, the work presented in the following sections has been submitted for publication
as Matthias, J., Engelhardt, J., Schäfer, M., Bauder-Wüst, U., Meyer, P.T., Haberkorn, U., Eder, M.,
Kopka, K., Hell, S.W., Eder, A.C., The intracellular fate of PSMA inhibitors as revealed by STED
nanoscopy.
III.4 METHODS
This project was conceived and conducted in close collaboration with Dr. Ann-Christin Eder, previously
Baranski11. The synthesis, the compound characterization based on radioactive properties and the flow
cytometry studies were performed by Dr. Ann-Christin Eder. The fluorescence microscopy samples
were prepared together with Dr. Ann-Christin Eder. Detailed information on materials is given in I.2.1.
III.4.1 Synthesis
Preparative HPLC (high performance liquid chromatography) was carried out with a LaPrep-System
P110 (VWR International) equipped with a NUCLEODUR® Sphinx RP column and a variable UV detector
(P314, VWR International) with a flow rate of 20 ml/min. For semipreparative HPLC, the system Agilent
1100 series (Agilent Technologies) was equipped with a Chromolith RP-18e (100×10 mm, Merck), for
analytical HPLC with a Chromolith RP-18e (100×4.6 mm, Merck). UV absorbance was measured at
wavelengths of 214 nm and 254 nm. The dual-labeled dye conjugates were derived from PSMA-11 and
synthesized as described by Baranski et al. [48]:
Briefly, starting with bis-tetrafluorophenyl (TFP)-functionalized HBED-CC, the synthesis of the
precursor Glu-urea-Lys[Fe(HBED-CC)]-PEG2 was performed by reaction of the TFP activated sites with
tri-tert-butyl protected Glu-urea-Lys (0.9 eq., ABX) and subsequently with an excess of 2,2ʹ-
(ethylenedioxy)bis(ethylamine) in N,N-dimethylformamide (DMF). Incubation with trifluoroacetic acid
(TFA) for 3 h at RT removed the tri-tert-butyl protecting groups. STAR RED-NHS-ester (1 eq., 1 mg,
Abberior) was conjugated to Glu-urea-Lys[Fe(HBED-CC)]-PEG2 (3 eq.) in DMF (300 µl) and N,N-
diisopropylethylamine (DIPEA) (15 µl) for 24 h at RT. STAR 635P-NHS-ester (1 eq., 1 mg, Abberior) was
11 German Cancer Research Center, Division of Radiopharmaceutical Chemistry, Heidelberg, Germany;
current address: University Medical Center Freiburg, Department of Nuclear Medicine, University of Freiburg, Faculty of
Medicine, Freiburg, Germany;
German Cancer Consortium, partner site Freiburg, and German Cancer Research Center, Division of Radiopharmaceutical
Development, Heidelberg, Germany
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dissolved in 50 µl dimethyl sulfoxide (DMSO) and conjugated to Glu-urea-Lys[Fe(HBED-CC)]-PEG2
(3 eq.) in PBS (pH 8.5) for 24 h at RT. Complexed Fe3+ was removed on a Sep-Pack C18 cartridge
(Waters) with 1 M HCl as previously described [860]. Reversed-phase HPLC (RP-HPLC) and matrix-
assisted laser desorption/ionization mass spectrometry (MALDI-MS, Bruker) were used for purification
and analytics of the final compounds.
III.4.2 Radiolabeling
68Ga (half-life 68 min, β+ 89%, Eβ+ max. 1.9 MeV) was obtained from a 68Ge/68Ga generator based on a
pyrogallol resin support [789]. For radiolabeling with 68Ga, Glu-urea-Lys-HBED-CC-PEG2-STAR RED or -
STAR 635P (1 nmol in 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES buffer) (580 mg/ml)
with 5 mg ascorbic acid, 90 µl) was added to 40 µl [68Ga]Ga3+ eluate (~40 MBq). The pH of the labeling
solution was adjusted with NaOH to pH 3.8 and incubated at 98°C for 10 min. Analytical RP-HPLC was
used to determine the radiochemical yield (RCY). The lipophilicity of the 68Ga-radiolabeled PSMA
inhibitors was determined via the 2-phase system n-octanol and PBS.
III.4.3 Fluorescence Properties
Glu-urea-Lys-HBED-CC-PEG2-STAR RED and -STAR 635P were diluted to 10 µM in PBS (pH 7.4) or
sodium acetate (NaAc) buffer (0.1 M, pH 4.6) and measured in standard 1 cm quartz cuvettes. The
absorbance of the compounds was recorded with a Varian Cary 500 UV-VIS NIR Spectrophotometer
(Agilent) equipped with the software Cary 500 (EPROM Version 8.01) in the 200-1000 nm interval. The
fluorescence emission of the compounds was measured with a Varian Cary Eclipse Fluorescence-
Spectrophotometer (Agilent) equipped with the software Cary Eclipse (Version 1.1) with excitation at
590 nm in the 600-1000 nm interval. To additionally determine potential temperature and pH
dependence of the fluorescence properties, the compounds were incubated for 6 h at RT or 37°C in
PBS or NaAc prior to absorbance and fluorescence emission recordings.
III.4.4 Cell Culture
PSMA-overexpressing androgen-sensitive human prostate adenocarcinoma cells (LNCaP cells, ATCC
CRL-1740) and PSMA-negative human prostate adenocarcinoma cells (PC3 cells, ATCC CRL-1435) were
grown in Roswell Park Memorial Institute (RPMI) 1640 medium (Thermo Fisher Scientific) enriched
with 5% FBS, 1% penicillin/streptomycin and 1% sodium pyruvate (hereinafter referred to as RPMI+++)
at 37°C in humidified air with 5% CO2. The cells were harvested using trypsin (0.25%, no phenol red).
A Countess II FL Automated Cell Counter (Thermo Fisher Scientific) was used to count cells and to
determine the live-to-dead cell ratio via Trypan Blue stain (0.4%).
For fixed sample preparation, 105 cells/well were seeded two days prior to imaging on poly-L-Lysine
(Sigma-Aldrich/Merck) coated 4-well removable chamber slides (Nunc Lab-Tek II Chamber Slides,
Thermo Fisher Scientific) and kept at 37°C in humidified air with 5% CO2 until fixation. For live cell
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sample preparation, 105 cells/well were seeded two days prior to imaging on poly-L-lysine (Sigma-
Aldrich/Merck) coated 4-well chambered coverslips (Nunc Lab-Tek II chambered coverglasses, Thermo
Fisher Scientific) and kept at 37°C and 5% CO2 until live cell staining.
III.4.5 Cell Binding and Internalization
The competitive cell binding assay and internalization experiments were performed according to Eder
et al. [768].
III.4.5.1 Cell Binding Assay
For competitive binding, 105 LNCaP cells/well were incubated with various concentrations (0, 0.5, 1,
2.5, 5, 10, 25, 50, 100, 500, 1000, 5000 nM) of Glu-urea-Lys-HBED-CC-PEG2-STAR RED or -STAR 635P in
the presence of 0.75 nM 68Ga-labeled radioligand [Glu-urea-Lys(Ahx)]2-HBED-CC (PSMA-10, ABX) [860]
on 96-well filter plates for 45 min at RT. After washing twice with ice-cold PBS, the radioactivity of the
punched filters was assessed via gamma counter (Packard Cobra II, GMI). The half maximal inhibitory
concentration ( ) was determined via nonlinear regression. The  values were converted to the
binding affinities  of the PSMA inhibitors by
=
1 + (III-4)
with  = 0.75 nM being the concentration of the 68Ga-labeled radioligand PSMA-10 and
 = 3.8 ±1 .8 nM being the dissociation constant of the 68Ga-labeled radioligand PSMA-10 [860].
III.4.5.2 Internalization Assay
To determine the internalization properties, LNCaP cells were incubated with 30 nM 68Ga-radiolabeled
Glu-urea-Lys-HBED-CC-PEG2-STAR RED or -STAR 635P for 45 min at 37°C. For blocking studies, 500 µM
of the highly efficient PSMA inhibitor 2-(phosphonomethyl)-pentanedioic acid (2-PMPA) were co-
incubated. Subsequently, cells were washed with ice-cold PBS and the membrane bound fraction was
collected via glycine (pH 2.8) washes. The internalized fraction was collected via cell lysis with 0.3 M
NaOH. The radioactivity of the collected fractions was measured using a gamma counter (Packard
Cobra II, GMI) and expressed as percent of applied radioactivity (%IA) bound to 105 cells.
III.4.6 Biodistribution and PET Imaging Studies
For the in vivo mouse tumor model, 5×106 LNCaP or PC3 cells (in 50% Matrigel) were subcutaneously
inoculated into the right trunk of 7- to 8-week-old male BALB/c nu/nu mice (Charles River
Laboratories). The tumors were allowed to grow until reaching a size of approximately 1 cm3.
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III.4.6.1 Biodistribution
To analyze the biodistribution of 68Ga-labeled Glu-urea-Lys-HBED-CC-PEG2-STAR RED or -STAR 635P,
the radiolabeled compounds (in 0.9% NaCl, pH 7) were injected into the tail vein of LNCaP or PC3
tumor-bearing mice (per mouse 1-2 MBq, 60 pmol). The animals were sacrificed 1 h post injection (p.i.)
and blood was collected. The organs/tissues of interest (heart, lung, spleen, liver, kidney, muscle, small
intestine, brain, tumor) were dissected, blotted dry, and weighed. A gamma counter (Packard Cobra
II, GMI) was used to measure the radioactivity. The data were corrected for the half-life of 68Ga and
the results were expressed as the mean percent injected dose per gram of tissue (%ID/g).
III.4.6.2 PET Imaging
For small-animal PET studies, LNCaP or PC3 tumor-bearing mice were anaesthetized with 2%
sevoflurane (Abbott) and placed into a PET scanner (Inveon PET, Siemens). After a 10 min transmission
scan, 0.5 nmol of 68Ga-labeled Glu-urea-Lys-HBED-CC-PEG2-STAR RED or -STAR 635P (0.9% NaCl, pH 7)
were injected into the tail vein. A 60 min dynamic scan as well as a static scan between 120 to 140 min
p.i. were recorded. Image reconstruction was done iteratively (16 subsets, 4 iterations) by applying
median root prior correction. The results were converted to standardized uptake value (SUV) images.
III.4.7 STED and Confocal Microscopy
The custom-built STED system is described in detail in I.2.2.1. The power range for all lasers used during
live and fixed cell confocal and STED imaging is given in Table III-2. Unless otherwise stated, fixed and
live cell confocal and STED imaging was performed with the measurement parameters given in Table
III-3. No frame accumulation was used.
Table III-2. Range of laser powers used for fixed and live cell confocal and STED imaging of PSMA, PSMA inhibitors and
components of the endosomal pathway.
The values given describe the estimated laser power in the sample focus based on laser power measurements in front of the
microscope body.
excitation STED
470 nm [µW] 600 nm [µW] 650 nm [µW] 775 nm [mW]
confocal, fixed samples 140 8-10 15-20 ---
STED, fixed samples --- 8-10 15-20 70-100
confocal, live samples 140 2-10
0.5 (SiR-Lysosome)
15-20 (conjugate RED/635P)
---
STED, live samples --- 2-10
1.5 (SiR-Lysosome)
15-20 (conjugate RED/635P)
35-70
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Table III-3. Standard measurement parameters used for fixed and live cell confocal and STED imaging of PSMA, PSMA
inhibitors and components of the endosomal pathway.
pixel size [nm] dwell time [µs] line accumulation
confocal, fixed samples 50 30-50 1
STED, fixed samples 20 30 1
confocal, live samples 50 20 1
STED, live samples 20 20 1
III.4.8 Determination of Vesicle Diameter
The vesicle diameter was measured for different internalization times (30, 45, 60 min) by fitting a two-
dimensional ring function to the raw fluorescence signal of individual vesicles
( , ) = + +
( − ) + ( − )
2
( ) ( )
(III-5)
with fit parameters  to . The fit algorithm is implemented in the custom application software
(LabVIEW, National Instruments) of the STED system.
III.4.9 Time and Concentration Dependence
To study the time dependence of the internalization process via fluorescence imaging, LNCaP cells
were incubated with 50 nM Glu-urea-Lys-HBED-CC-PEG2-STAR RED in RPMI+++ for 5, 15, 30 and 45 min
at RT. To analyze the concentration dependence of internalization, the PSMA inhibitor was incubated
for 45 min at the concentrations 50, 100, 250 and 500 nM in RPMI+++. After incubation, cells were
washed with PBS and fixed for 10 min with 2% PFA in PBS at RT. Following three PBS washing steps,
the samples were mounted in ProLong Diamond Antifade Mountant containing DAPI (Thermo Fisher
Scientific).
III.4.10 Live Cell Imaging
For live cell imaging, LNCaP and PC3 cells were washed once with PBS and were incubated with 50 nM
or 100 nM Glu-urea-Lys-HBED-CC-PEG2-STAR RED in RPMI+++ for 20 min on ice to prevent premature
internalization. After washing three times with PBS on ice, the cells were immediately imaged in
FluoroBrite++. To verify specific uptake of Glu-urea-Lys-HBED-CC-PEG2-STAR RED, the cells were
additionally co-incubated with 500 μM 2-PMPA in block experiments. Confocal time series were
recorded with 0.5 fpm or 1 fpm for a total time of 2 h.
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III.4.11 Live Cell Immunofluorescence
III.4.11.1 Antibodies
For live cell IF staining of PSMA, the primary monoclonal mouse antibody anti-PSMA (clone 107-1A4,
SAB4200257, Sigma-Aldrich/Merck, 1:50, 1 h) was used in combination with the secondary antibodies
goat anti-mouse-IgG coupled to STAR 600 (Abberior, 1:50, 1 h) and goat anti-mouse-IgG coupled to
STAR RED (Abberior, 1:50, 1 h).
III.4.11.2 Immunofluorescence Staining
The following live cell IF protocol selectively stains the membrane bound PSMA fraction. The entire
protocol was performed on ice to prevent premature internalization of PSMA. After washing once with
ice-cold 10% goat serum in PBS, LNCaP and PC3 cells were incubated for 1 h with the primary antibody
in 10% GS in PBS. After washing three times with ice-cold 10% GS in PBS, the secondary antibody was
incubated for 1 h in 10% GS. After washing three times with ice-cold 10% GS in PBS, PSMA
internalization was triggered by incubation at 37°C in humidified air with 5% CO2 for various times.
III.4.12 Colocalization Experiments
III.4.12.1 Clathrin/PSMA Inhibitor Colocalization
To stain clathrin in living LNCaP cells, the cells were transiently transfected with the N-terminal fusion
construct SNAP-tag/clathrin light chain (SNAP-CLC). The plasmid was kindly provided by Francesca
Bottanelli12 [259].
Transient transfection was performed 24 h prior to imaging with 300 ng of the SNAP-CLC plasmid using
the Effectene Transfection Reagent Kit (Qiagen) according to the manufacturer’s protocol. On the day
of the experiment, the cells were stained with a 1 µM staining solution of the live dye 610CP-BG
(BG = SNAP-tag ligand) [29] in RPMI+++ for 45 min at 37°C in humidified air with 5% CO2. The live dye
was kindly provided by Dr. Alexey Butkevich13 and Dr. Vladimir Belov14. After washing three times with
preheated RPMI+++, the cells were incubated with 50 nM Glu-urea-Lys-HBED-CC-PEG2-STAR RED for
different durations (10, 15, 20 min) at 37°C in humidified air with 5% CO2.
To visualize the colocalization between Glu-urea-Lys-HBED-CC-PEG2-STAR RED and clathrin, live dual-
color confocal images were recorded. Single-color stainings were used to quantify minor crosstalk
between the two color channels. Color correction was performed with the linear unmixing algorithm
12 Yale University School of Medicine, Rothman Laboratory, New Haven, USA;
current address: Freie Universität Berlin, Department of Biology, Chemistry, Pharmacy, Bottanelli Group – Membrane
trafficking, Berlin, Germany
13 Max Planck Institute for Biophysical Chemistry, Department of NanoBiophotonics, Göttingen, Germany;
current address: Max Planck Institute for Medical Research, Department of Optical Nanoscopy, Heidelberg, Germany
14 Max Planck Institute for Biophysical Chemistry, Department of NanoBiophotonics, Göttingen, Germany;
Facility for Synthetic Chemistry at the Max Planck Institute for Biophysical Chemistry in Göttingen, Germany
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implemented in the data analysis section of the custom application software (LabVIEW, National
Instruments) of the STED system. To quantify the colocalization, the PCC was calculated for the
corrected images using the ImageJ plugin JACoP [470, 695].
III.4.12.2 LysoTracker/PSMA Colocalization
To visualize endosomal PSMA recycling, the protein was first immunolabeled according to III.4.11.2.
After secondary antibody (STAR 600-labeled) incubation, LNCaP cells were washed three times with
10% GS in PBS and incubated with 500 nM LysoTrackerTM Green DND-26 (Thermo Fisher Scientific) or
1 µM SiR-Lysosome (Spirochrome) in FluoroBrite++ at 37°C in humidified air with 5% CO2 to allow for
endosomal/lysosomal staining and trigger internalization simultaneously. For selected experiments,
the LysoTracker was co-incubated with 500 µM 2-PMPA, 50 nM Glu-urea-Lys-HBED-CC-PEG2-STAR RED
or 50 nM Glu-urea-Lys-HBED-CC-PEG2-STAR 635P.
After 1 h and after > 20 h of internalization time, colocalization was visualized in live cell dual-color
confocal and STED experiments. STED (confocal) time series were recorded for a total time of up to
15 min (up to 30 min) with 1.1 and 1.2 fpm (2.1 and 2.6 fpm).
Single-color stainings confirmed the absence of crosstalk between the two color channels. Color shift
correction between the 470 nm excitation channel (LysoTrackerTM Green DND-26) and the 600 nm
excitation channel (immunolabeled PSMA) was performed as described in I.2.2.2. The PCC of the
corrected images was calculated with the ImageJ plugin JACoP [470, 695].
III.4.12.3 PSMA/PSMA Inhibitor Colocalization
To analyze colocalization between Glu-urea-Lys-HBED-CC-PEG2-STAR RED/-STAR 635P and PSMA,
LNCaP cells were first immunolabeled for PSMA according to III.4.11.2. The primary antibody was co-
incubated with 100 nM Glu-urea-Lys-HBED-CC-PEG2-STAR RED/-STAR 635P. After secondary antibody
(STAR 600-labeled) incubation, the samples were washed three times with 10% GS in PBS and the cells
were either directly fixed for 10 min with 3.7% PFA in PBS at RT or subjected to internalization. For
internalization, the cells were incubated for 30 min, 45 min, 1 h, 3 h, 6 h or 24 h in RPMI+++ at 37°C in
humidified air with 5% CO2. After fixation with 3.7% PFA in PBS for 10 min at RT and three subsequent
PBS washing steps, the samples were mounted in ProLong Diamond Antifade Mountant containing
DAPI (Thermo Fisher Scientific). The absence of crosstalk between the two color channels was
confirmed by single-color stainings of Glu-urea-Lys-HBED-CC-PEG2-STAR RED, Glu-urea-Lys-HBED-CC-
PEG2-STAR 635P, STAR 600-immunolabeled PSMA and STAR RED-immunolabeled PSMA prepared
under the same conditions as the dual-color stainings.
Images with a maximum fluorescence intensity < 20 counts were excluded from colocalization analysis.
Background subtraction of two counts was performed prior to PCC calculation to correct for
homogeneous background. The ImageJ plugin JACoP [470, 695] was used to calculate the PCC of the
corrected images. For calculation of the average PCC for each time point, all results scattering by more
than double the SD were excluded.
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Pixel fluorograms (hereinafter referred to as fluorograms) can be generated to illustrate colocalization
trends in dual-color fluorescence images [861]. Each pixel in a fluorogram represents the number of
pixels in the corresponding dual-color fluorescence image that shows an intensity of dye 1 (dye 2)
according to the x-axis (y-axis) of the fluorogram. Pixels with similar intensities in both channels of the
fluorescence image (colocalization) appear in the diagonal area of the fluorogram. In contrast, pixels
close the x-axis (y-axis) of the fluorogram represent pixels with single-color staining of dye 1 (dye 2).
Time-dependent changes in colocalization were visualized in dual-color image fluorograms calculated
with the custom application software (LabVIEW, National Instruments) of the STED system. Below a
phasor line of 20° slope, all pixels in the fluorogram are considered single staining of the PSMA
inhibitor. Above a phasor line of 70° slope, all pixels in the fluorogram are considered single staining
of PSMA. All pixels falling between these lines are considered colocalized. The area below the quarter
circle in the fluorogram indicates the fluorescence image background defined as the average intensity
of Glu-urea-Lys-HBED-CC-PEG2-STAR RED in the cytoplasm after 24 h of internalization. Colocalization
can be quantified by calculating the integral of the fluorescence intensities in the area between the
phasor lines divided by the total fluorescence intensity [861].
The time-dependent changes of the relative integrated fluorescence intensity for each channel were
calculated on smoothed images for each of the resulting six sections
· PSMA signal only foreground
· PSMA signal only background
· colocalizing signal foreground
· colocalizing signal background
· PSMA inhibitor signal only foreground
· PSMA inhibitor signal only background
as well as in the entire foreground and in the entire background. For calculating the average integrated
relative fluorescence intensity for each time point, channel and section, all results differing by more
than double the SD were excluded. The ratio between the integrated fluorescence intensities of both
channels in the entire image was calculated and compared for each time point to assess potential
photobleaching and externalization.
III.4.13 Cytotoxicity Studies
The duration and frequency of LNCaP cell division was analyzed via holographic time-lapse imaging
using a HoloMonitor® M4 cytometer (Phase Holographic Imaging) to assess potential cytotoxicity of
Glu-urea-Lys-HBED-CC-PEG2-STAR RED and –STAR 635P. Two days prior to the experiment, LNCaP cells
were seeded in RPMI+++ in poly-L-Lysine (Sigma-Aldrich/Merck) coated lumox® 24-well plates
(Sarstedt) and kept at 37°C in humidified air with 5% CO2 until the experiment. Holographic imaging
was conducted at 37°C in humidified air with 5% CO2 in the absence or presence of either 100 nM Glu-
urea-Lys-HBED-CC-PEG2-STAR RED or 100 nM Glu-urea-Lys-HBED-CC-PEG2-STAR 635P in RPMI+++ for
a total of 48 h with 15 min between image captures. During the experiment, PHI HoloLidsTM (Phase
Holographic Imaging) were used to close the well plate to ensure optimal image quality. Data analysis
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was performed with the HstudioM4 software (Phase Holographic Imaging) including cell segmentation,
tracking of dividing cells, confluency measurement, and cell counting.
III.4.14 Flow Cytometry Studies
III.4.14.1 PSMA Binding Affinity
Using flow cytometry, the binding affinity was determined as the half maximal effective concentration
( ). An ascending series of concentrations (0, 0.5, 1, 2.5, 5, 10, 25, 50, 100, 500 nM) of Glu-urea-
Lys-HBED-CC-PEG2-STAR RED and -STAR 635P was diluted in RPMI+++ and LNCaP cells were incubated
with the respective concentrations for 45 min. After centrifugation (800 rpm, 2 min), the supernatant
was decanted, and the cells were resuspended in RPMI+++. This procedure was repeated twice but the
cells were resuspended in PBS in each case. Finally, propidium iodide solution (PI, 1 mg/ml) was added
as a nucleic acid intercalator marking dead cells. For PSMA inhibitor concentrations of 0.5, 5 and
50 nM, 500 µM 2-PMPA was additionally co-incubated to demonstrate the specificity of the binding.
The samples were measured using a BD FACS Canto II Flow Cytometer (BD Biosciences) and 2×103 living
cells were selected for analysis in the forward scatter (FSC) vs. side scatter (SSC) plot. The mean
fluorescence intensities (as median fluorescence intensities) of the PSMA inhibitors were measured
and the binding affinity was determined at least three times. The data are presented as  ± SD.
III.4.14.2 PSMA Binding pH Dependence
The pH dependence of the binding to PSMA on LNCaP cells was analyzed for Glu-urea-Lys-HBED-CC-
PEG2-STAR RED and -STAR 635P and the antibody complex consisting of primary antibody decorated
either with STAR 600- or STAR RED-labeled secondary antibody (refer to III.4.11.1). The incubation
scheme is summarized in Table III-4. Both incubation steps (incubation 1 and 2) were conducted in a
volume of 50 μl on ice for 1 h; the cells were washed by centrifugation (800 rpm, 2 min) with 10% GS
in PBS between steps. After washing once with 10% GS in PBS and twice with PBS by centrifugation
(800 rpm, 2 min), the cells were resuspended with PBS and PI (1 mg/ml) was added.
The samples were measured using a BD FACS Canto II Flow Cytometer (BD Biosciences) and 2×103 living
cells were selected for analysis in the FSC-SSC plot. The mean fluorescence intensities (as median
fluorescence intensities) of the PSMA inhibitors and the secondary antibodies were assessed, and the
measurements were repeated at least three times. The data are presented as the percentage binding
at pH 4.6 normalized to binding at pH 7.4.
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Table III-4. Incubation scheme for the analysis of the pH dependence of PSMA binding for PSMA inhibitors and
antibody complex.
1stAB – primary antibody, 2ndAB – secondary antibody
sample incubation 1 incubation 2
control 1 10% GS in PBS pH 7.4 10% GS in PBS pH 7.4
control 2 10% GS in PBS pH 4.6 10% GS in PBS pH 4.6
control 3 10% GS in PBS pH 7.4 2
ndAB-STAR RED (1:50)
in 10% GS in PBS pH 7.4
control 4 10% GS in PBS pH 4.6 2
ndAB-STAR RED (1:50)
in 10% GS in PBS pH 4.6
control 5 10% GS in PBS pH 7.4 2
ndAB-STAR 600 (1:50)
in 10% GS in PBS pH 7.4
control 6 10% GS in PBS pH 4.6 2
ndAB-STAR 600 (1:50)
in 10% GS in PBS pH 4.6
Glu-urea-Lys-HBED-CC-PEG2-STAR RED
pH 7.4 50 nM in 10% GS in PBS pH 7.4 10% GS in PBS pH 7.4
Glu-urea-Lys-HBED-CC-PEG2-STAR RED
pH 4.6 50 nM in 10% GS in PBS pH 4.6 10% GS in PBS pH 4.6
Glu-urea-Lys-HBED-CC-PEG2-STAR 635P
pH 7.4 50 nM in 10% GS in PBS pH 7.4 10% GS in PBS pH 7.4
Glu-urea-Lys-HBED-CC-PEG2-STAR 635P
pH 4.6 50 nM in 10% GS in PBS pH 4.6 10% GS in PBS pH 4.6
1stAB + 2ndAB-STAR RED pH 7.4 1stAB (1:50) in 10% GS in PBS pH 7.4 2
ndAB-STAR RED (1:50)
in 10% GS in PBS pH 7.4
1stAB + 2ndAB-STAR RED pH 4.6 1stAB (1:50) in 10% GS in PBS pH 4.6 2
ndAB-STAR RED (1:50)
in 10% GS in PBS pH 4.6
1stAB + 2ndAB-STAR 600 pH 7.4 1stAB (1:50) in 10% GS in PBS pH 7.4 2
ndAB-STAR 600 (1:50)
in 10% GS in PBS pH 7.4
1stAB + 2ndAB-STAR 600 pH 4.6 1stAB (1:50) in 10% GS in PBS pH 4.6 2
ndAB-STAR 600 (1:50)
in 10% GS in PBS pH 4.6
III.4.15 Data Presentation
Detailed information on data presentation is given in I.2.2.2. Linear deconvolution of the STED
(confocal) data was performed by applying a Lorentzian PSF (refer to equation (I-5)) with
FWHM = 60 nm (FWHM = 200 nm) in lateral dimension. All line profiles were drawn on raw data and
averaged over 3 pixels.
If necessary, the single images of the live confocal and STED time series were corrected for
photobleaching using the ImageJ Plugin CorrectBleach V2.0.2 applying histogram matching as
correction mode [470, 862]. The images of all time series were corrected for background and the STED
data were additionally linearly deconvolved.
III.4.16 Statistical Aspects
Detailed information on general statistical aspects is given in I.2.2.3.
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III.5 RESULTS
III.5.1 Synthesis and Radiolabeling
For the design of dual-modality PSMA inhibitors suitable for 775 nm STED, derivatives based on Glu-
urea-Lys-HBED-CC-PEG2-IRDye800CW were chosen as an exemplary model. Compared to clinically
established molecules such as PSMA-11 or PSMA-617, Glu-urea-Lys-HBED-CC-PEG2-IRDye800CW
shows similar cell binding, internalization, and pharmacokinetic properties as well as comparable
specific tumor enrichment [48, 768, 769].
High-quality STED imaging depends, among other things, on photostable dyes with a low dark state
transition probability and a large cross section for stimulated emission. Due to their superior
performance in 775 nm STED, the commercially available Abberior dyes STAR RED and STAR 635P were
conjugated to the precursor Glu-urea-Lys[Fe(HBED-CC)]-PEG2-NH2. The chemical purity of the final
products
· Glu-urea-Lys-HBED-CC-PEG2-STAR RED (hereinafter referred to as `conjugate RED´) and
· Glu-urea-Lys-HBED-CC-PEG2-STAR 635P (hereinafter referred to as `conjugate 635P´)
was determined to be > 95%. Table VI-16 summarizes the analytical data of the final products and
Figure III-6a shows their chemical structure. The radiochemical yields of 68Ga-labeling exceeded 99%
and the molar activities of the radiolabeled conjugates measured 50 GBq/µmol. The lipophilicity was
determined as logD in octanol/PBS at pH 7.4 and ranged from -1.93 ± 0.44 for [68Ga]Ga-conjugate RED
to -2.88 ± 0.09 for [68Ga]Ga-conjugate 635P.
III.5.2 Fluorescence Properties
The absorbance and fluorescence emission of the STAR RED dye and STAR 635P dye underwent a slight
red-shift upon conjugation to Glu-urea-Lys[Fe(HBED-CC)]-PEG2-NH2. The absorbance of conjugate RED
peaked at 641 nm and the fluorescence emission at 660 nm in PBS at pH 7.4 (uncoupled dye
638 nm/655 nm in PBS pH 7.4); the absorbance of conjugate 635P peaked at 639 nm and the
fluorescence emission at 660 nm in PBS at pH 7.4 (uncoupled dye 638 nm/651 nm in PBS pH 7.4)
(Figure III-6b,c). The UV-active HBED-CC chelator moiety caused an additional absorbance peak around
280 nm, which was used to normalize the spectra and correct for slight variations in concentration
(Figure VI-7).
122 III.5 Results
Figure III-6. Chemical structures and spectral
properties of conjugate RED and
conjugate 635P.
(a) The conjugates consist of the PSMA binding
motif Glu-urea-Lys (green), the radiometal
chelator HBED-CC (purple) and the fluorescence
moiety conjugated via a PEG2 linker. (b)
Conjugate RED displays absorbance and
fluorescence emission maxima at 641 nm and
660 nm. (c) Conjugate 635P displays absorbance
and fluorescence emission maxima at 639 nm
and 660 nm. The conjugates were measured in
PBS at pH 7.4. The absorbance spectra are
baseline corrected. All spectra are normalized to
their maximum.
III.5.3 Specific Cell Binding and Internalization in vitro
Incubation of LNCaP cells with either 68Ga[Ga]-conjugate RED or 68Ga[Ga]-conjugate 635P (30 nM,
45 min, 37°C) resulted for both conjugates in significant and specific cell surface binding. Competitive
cell binding studies revealed high affinities to PSMA in the low nanomolar range (expressed as
values calculated from cellular  values). For both conjugates, a large fraction specifically
internalized in addition. Table III-5 summarizes the fractions of specifically bound and specifically
internalized 68Ga-radiolabeled conjugate RED and 68Ga-radiolabeled conjugate 635P.
Table III-5. Cell binding and internalization properties of 68Ga-radiolabeled conjugate RED and conjugate 635P.
Data are expressed as mean ± SD (n = 3), * 68Ga-radiolabeled conjugates. Specific cell uptake was determined by blockage
using 500 µM 2-PMPA. Values are expressed as % of applied radioactivity (IA) bound to 105 cells, † free inhibitors, competitive
cell binding against [68Ga]Ga-PSMA-10, ‡ free inhibitors, PSMA binding FACS study.
specifically cell surface bound
[%IA/105 cells]*
specifically internalized
[%IA/105 cells]*  [nM]†  [nM]
‡
conjugate RED 2.98 ± 0.66 8.94 ± 3.33 36.77 ± 2.28 30.36 ± 7.48
conjugate 635P 6.94 ± 1.51 17.15 ± 1.45 45.73 ± 3.15 63.19 ± 4.02
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III.5.4 Localization to LNCaP Xenograft Tumors in vivo
Biodistribution studies were performed to analyze the specific targeting ability of conjugate RED and
conjugate 635P to PSMA in vivo at 1 h p.i.. The performance of both conjugates was comparable. The
tumor uptake in PSMA-positive LNCaP xenograft tumors was high with a mean percent injected dose
per gram of tissue of around 5%ID/g. The liver uptake was negligible, whereas the kidney uptake was
high, suggesting elimination via the renal pathway (Figure III-7). The results of the biodistribution
studies are summarized Table VI-17.
Figure III-7. Organ distribution at 1 h p.i. of
68Ga-radiolabeled conjugate RED and
conjugate 635P.
(a) Organ distribution of 60 pmol 68Ga[Ga]-
conjugate RED (red) and 60 pmol 68Ga[Ga]-
conjugate 635P (blue) (data are expressed as
mean %ID/g tissue ± SD (n=3)) and (b)
corresponding tumor-to-organ ratios (T/O-
ratios). All plotted values including SDs and p-
values are summarized in Table VI-17.
As conjugate RED displayed higher photostability and better contrast in the fluorescence imaging
experiments (refer to III.5.6, III.5.7 and III.5.8), its specificity of in vivo tumor uptake was additionally
proven with PSMA-negative PC3 tumor xenografts. The uptake of conjugate RED was comparable for
PSMA-negative tumor tissue and muscle tissue (Table VI-18).
III.5.5 Small-Animal PET Imaging
In the next step of in vivo characterization, the performance of 68Ga-radiolabeled conjugate RED was
evaluated in small-animal PET imaging studies. High imaging contrast was observed at early time points
as [68Ga]Ga-conjugate RED combines selective tumor uptake in the LNCaP xenograft model with rapid
clearance from off-target tissue (Figure III-8a). High PSMA specificity was confirmed, as no measurable
[68Ga]Ga-conjugate RED uptake was detected in PSMA-negative PC3 xenografts during the
experiments (Figure III-8b). While the corresponding time activity curves illustrate rapid clearance from
tissues of liver, heart and muscle, they display continuous accumulation of [68Ga]Ga-conjugate RED in
the tissues of kidney and bladder. This observation agrees well with the biodistribution studies
indicating the renal pathway to be the most likely elimination mechanism (Figure III-8c,d).
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Figure III-8. Small-animal PET imaging study of [68Ga]Ga-conjugate RED.
Whole-body maximum intensity projections of small-animal PET imaging acquired 120 min p.i. of 0.5 nmol 68Ga-radiolabeled
conjugate RED (∼50 MBq) in (a) LNCaP- and (b) PC3-tumor-bearing (right trunk) athymic nude mice (SUV – standardized
uptake value). Corresponding time activity curves are shown in (c) for tumor and muscle (LNCaP and PC3) and in (d) for heart,
liver, kidney and bladder (LNCaP).
III.5.6 From Antigen Binding to Internalization and Cellular
Accumulation
In fluorescence imaging experiments, conjugate RED displayed superior contrast and photostability as
compared to conjugate 635P. Thus, all following confocal and STED data were acquired with this
conjugate. Confocal fluorescence imaging confirmed the time activity curves shown in Figure III-8c,d
by detecting an increasing accumulation of conjugate RED in LNCaP cells over time. Saturation of the
biological system was reached after 15 min of incubation. At later time points, neither further signal
increase of the membrane bound nor of the internalized fraction was detected (Figure III-9a).
The concentration of conjugate RED did not affect its cellular accumulation and for the tested
concentration range (50-250 nM), a blocking effect was not observed (Figure III-9b). The specificity of
PSMA binding and internalization was proven in confocal microscopy blocking studies in the presence
of 500 µM 2-PMPA and in confocal microscopy internalization experiments with PSMA-negative PC3
cells (Figure VI-8).
While in confocal imaging, the PSMA distribution in the cell membrane as visualized by conjugate RED
bound antigen appeared homogeneous, STED imaging resolved details of the antigen distribution.
Areas of higher and lower PSMA density were indicated by the heterogeneous distribution of the
fluorescence signal along the cell membrane. Round to oval-shaped antigen clusters of varying sizes
were detected located within the patches of high PSMA density (Figure III-10).
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Figure III-9. Time and concentration
dependence of conjugate RED internalization.
(a) Confocal imaging after 5/15/30 min of
conjugate RED incubation (50 nM) determined
cell saturation at 15 min of internalization time.
(b) Confocal imaging after incubation with
100/250/500 nM conjugate RED (45 min) did not
detect any apparent differences in membrane
binding and internalization in the concentration
range tested. All data shown are raw data and
were acquired using the same imaging
parameters. All scale bars are 10 µm.
Figure III-10. PSMA distribution in the cell
membrane.
Overview image of LNCaP cells after incubation
with conjugate RED (100 nM) for 45 min.
Comparing STED (top left) with confocal (bottom
left) demonstrates the gain in resolution. A
heterogeneous distribution of conjugate RED
bound PSMA with areas of higher and lower
antigen density is resolved by STED imaging. The
patches of high PSMA density consisted of round
to oval-shaped PSMA clusters of varying sizes.
Magnifications of the marked regions in the
overview are shown as STED close-ups on the
right. All STED data shown are background
corrected and linearly deconvolved. All confocal
data shown are raw data Scale bar overview is
5 µm, scale bar close-ups is 1 µm.
The relationship of internalized conjugate RED and PSMA was assessed by additional STAR 600-
immunolabeling of the antigen. We developed a novel antibody staining protocol that enabled us to
simultaneously target PSMA in living LNCaP cells with antibodies and dual-labeled PSMA inhibitors
(refer to III.4.11). The fluorescent signals of the putative PSMA/PSMA inhibitor complex were initially
localized to cytosolic vesicles visualized as blurred diffraction-limited spots by confocal imaging. In
contrast, STED imaging allowed for the nanometer resolution of defined, hollow, spherical structures
and revealed that the antigen-inhibitor complex was initially vesicle membrane bound. The vesicle
distribution in the cytosol was heterogeneous and regions of higher and lower vesicle density were
observed. In particular cellular filopodia accumulated increased concentrations of vesicles as opposed
to the nucleus, which always remained free of any conjugate RED signal (Figure III-11).
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Figure III-11. Distribution of PSMA/PSMA
inhibitor carrying vesicles in the cytosol.
After IF staining for PSMA (STAR 600, cyan) and
conjugate RED (red) incubation (100 nM) for 1 h
of internalization, STED (top) and confocal
(bottom) imaging visualize different vesicle
densities in the cytosol of LNCaP cells.
Accumulation was pronounced in filopodia. The
vesicles were resolved as defined, hollow,
spherical structures by STED imaging. While
conjugate RED has already started to disperse
homogeneously in the cytosol, a fraction of
internalized PSMA inhibitor was still PSMA bound
after 1 h of incubation. Distinct patches of round
to oval-shaped (non-colocalizing) PSMA signal
clusters of varying size on the cell membrane indicated recycled protein (white arrows). All STED data shown are
background corrected and linearly deconvolved. All confocal data shown are raw data. Scale bar is 5 µm.
The improvement in resolution gained by STED is illustrated by line profiles of vesicles derived from
raw confocal and STED data (Figure III-12). Describing the line profiles by Lorentzian fitting confirmed
a spatial resolution far below the diffraction limit allowing for determination of the average vesicle
diameter. As PSMA internalization is mediated by clathrin-dependent endocytosis [723, 758] and
clathrin-coated vesicles (CCVs) are characterized by a well-defined diameter, the degree of progress
along the endocytic pathway can be judged by the diameter of PSMA inhibitor carrying endocytic
vesicles. Thus, the vesicle diameter was computed by fitting a two-dimensional ring function (refer to
equation (III-5)) to the fluorescence signal of conjugate RED incubated for different internalization
times and imaged by STED nanoscopy. Within the first hour of internalization, the average diameter
did not differ significantly (Table III-6, Table VI-19). For later time points especially, the large SDs
represent a broad diameter distribution in the overall vesicle population ranging from  < 150 nm to
 > 500 nm (Figure VI-9). These results are in the range of but always lager than the CCV diameter of
~100 nm as previously determined by EM [863, 864].
To complement the fixed cell imaging data, the
internalization and cellular accumulation of conjugate RED
were additionally studied in live cell imaging experiments.
LNCaP cells were incubated with conjugate RED for 20 min
on ice. The low temperature prevented premature antigen
internalization during staining of the membrane bound
PSMA fraction. Confocal imaging of the washed samples
detected steady internalization confirming the fixed cell
data (Figure III-13). Neither significant externalization of
conjugate RED nor signs of impaired cell viability (e.g.
morphological changes) were observed during the
experiment.
Table III-6. Diameter of endocytic vesicles
carrying conjugate RED bound PSMA.
Data are expressed as mean ± SD (n = 50).
internalization time
[min]  [nm]
30 274 ± 71
45 262 ± 82
60 298 ± 97
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Figure III-12. STED imaging resolves endocytic vesicles after internalization of conjugate RED bound PSMA.
(a) Comparison of STED and confocal imaging of LNCaP cells stained with conjugate RED (100 nM) for 45 min of internalization
time. From left to right: overview image showing internalized vesicles in a lamellipodium (cell outline sketched with dashed
green line) imaged in confocal and STED mode; next: magnification of the vesicle marked in the overview as recorded in
confocal imaging; next: same vesicle as recorded in STED imaging; next: line profiles of the STED (red) and confocal (blue)
data as marked in the magnified vesicle images by white arrows. While confocal imaging did not resolve the vesicle, STED
imaging revealed a diameter of approx. 207 nm. Pixel size was identical for confocal and STED image (20 nm). Scale bar
overview is 2 µm, scale bars close-ups are 250 nm. (b) Additional examples of endocytic vesicles as resolved by STED imaging
with the corresponding line profiles depicted below the respective STED image, scale bars are 250 nm. The line profiles of (a)
and (b) were drawn on raw data (marked by white arrows), averaged over three pixels and fitted with a single (for confocal
data) or a double (for STED data) Lorentzian function. For the STED data, the FWHMs illustrate a resolution significantly below
the diffraction limit. Except for the insets displaying the direction of line profiles, which are background corrected only, all
STED data shown in (a) and (b) are background corrected and linearly deconvolved. All confocal data are raw data.
For rigorous exclusion of potential conjugate RED cytotoxicity, LNCaP proliferation was followed using
holographic time-lapse imaging. To determine the duration and frequency of cell division, cells were
imaged for 48 h in the presence of either conjugate RED or conjugate 635P. The results were compared
to the proliferation behavior of untreated cells. The data suggest absence of cytotoxicity for both
conjugates. Surprisingly, the presence of particularly conjugate RED even accelerated LNCaP
proliferation (Figure III-14, Figure III-15) (for details on cytotoxicity testing of live dyes in general, refer
to IV.3).
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Figure III-13. Live cell confocal imaging of conjugate RED internalization.
LNCaP cells were incubated on ice for 20 min with (a) 100 nM or (b) 50 nM conjugate RED. The focal plane was set into the
cell volume and confocal time series were recorded with a frequency of (a) 1 fpm or (b) 0.5 fpm for a duration of (a) 120 min
or (b) 90 min. Steady internalization was observed. To smooth the data and reduce the noise, all confocal images shown are
linearly deconvolved. Scale bars are 10 µm.
Figure III-14. Assessment of the cytotoxicity of conjugate RED and conjugate 635P.
Cytotoxicity data are based on holographic time-lapse series (duration 48 h, frequency 15 min) of LNCaP proliferation in the
absence (green) or presence of 100 nM conjugate RED (red) or 100 nM conjugate 635P (blue) (e.g. Figure III-15). (a) Duration
of cell division of untreated (n = 347), conjugate RED treated (n = 624) and conjugate 635P treated (n = 408) LNCaP cells. P-
values indicate no significant difference between the untreated and the conjugate 635P treated condition, but a significant
shortening in cell division duration by conjugate RED. (b) Frequency of cell division of untreated (n = 347), conjugate RED
treated (n = 624) and conjugate 635P treated (n = 408) LNCaP cells. The results display an increase in cell division frequency
for both conjugates (* p <0 .5, ** p <0 .05, ***p <0 .005). (c) Cell count and (d) confluency of untreated (n = 13),
conjugate RED treated (n = 16) and conjugate 635P treated (n = 14) LNCaP cells. Both measures were normalized to the first
frame (t = 0). The results were averaged and SDs are displayed as shadows in the graphs. P-values indicate no significant
difference between untreated and treated LNCaP cells. All data strongly support the absence of cytotoxicity. All results and
p-values are summarized in Table VI-20, Table VI-21 and Table VI-22.
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Figure III-15. LNCaP cell division in the absence and presence of PSMA inhibitors.
Using holographic time-lapse cytometry with a HoloMonitor® M4 microscope, LNCaP cell proliferation was followed for a
total of 48 h in the absence (control) and in the presence of either 100 nM conjugate RED or conjugate 635P. In the exemplary
sequences (duration 1.5 h, frequency 15 min), dividing cells round up and thus can be distinguished from non-dividing cells
by height (color coded). Scale bar is 50 µm.
III.5.7 Along the Endocytic Pathway
To study the PSMA inhibitor internalization pathway, colocalization of conjugate RED with clathrin was
assessed in live cell confocal experiments with LNCaP cells transiently transfected with a SNAP-tag
fusion of clathrin labeled with the live dye 610CP-BG [29]. For early time points of internalization, a
significant signal overlap between conjugate RED and clathrin was observed (Figure III-16). With
progressing internalization time, the degree of colocalization decreased. For quantitative analysis of
the colocalization, the PCC was calculated. From 10 min to 15 min of internalization, the PCC
significantly (p = 10-8) dropped from r = 0.70±0.08 (n = 7) to r = 0.23±0.11 (n = 14). This result indicates
clathrin-dependent endocytosis with rapid clathrin uncoating after internalization. Uncoated
endocytic vesicles can fuse with early endosomes (Figure III-17) [865, 866].
Figure III-16. Colocalization experiments confirming clathrin-mediated uptake of conjugate RED bound PSMA.
To prove clathrin-mediated uptake of PSMA inhibitors, colocalization between conjugate RED (red) and clathrin (gray) was
investigated. SNAP-CLC transiently transfected LNCaP cells were labeled with 610CP-BG and incubated with conjugate RED
(50 nM). Live cell confocal imaging showed strong colocalization after 10 min of internalization time. All confocal data shown
are background corrected. Scale bar is 5 µm.
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Figure III-17. Fusion of endocytic vesicles
carrying conjugate RED bound PSMA.
After cellular uptake and clathrin uncoating,
vesicles fuse along the endosomal pathway. STED
imaging resolved early stages (upper row),
intermediate stages (middle row) and late stages
(bottom row) of vesicle fusion in LNCaP cells
incubated with conjugate RED (100 nM) for 1 h of
internalization time. All data are background
corrected and linearly deconvolved. Scale bar is
250 nm.
In live cell confocal experiments,
endosomal colocalization of PSMA was
investigated for different internalization
times by co-staining with LysoTrackerTM
Green DND-26, which is selective for both endosomes and lysosomes. With progressing
internalization time, the degree of colocalization between the PSMA signal and the endosomal signal
increased. Additionally, non-colocalizing LysoTrackerTM Green DND-26 signal was detected. On the
one hand, the PSMA population of the samples was not comprehensively labeled due to the nature
of the IF staining approach. On the other hand, the samples also contained non-PSMA-carrying
lysosomes (Figure III-18a, Figure VI-10).
Figure III-18. Colocalization experiments confirming endosomal recycling of PSMA.
Colocalization between PSMA (cyan) and two commercially available endosomal/lysosomal probes (magenta) was analyzed
to confirm endosomal PSMA recycling. LNCaP cells were STAR 600-immunolabled for PSMA on ice and subsequently
incubated with (a) LysoTrackerTM Green DND-26 (500 nM) or (b) SiR-Lysosome (1 µM) at 37°C to trigger internalization and
allow for endosomal/lysosomal staining. After > 20 h of internalization time, strong colocalization was recorded between
PSMA and (a) LysoTrackerTM Green DND-26 in confocal mode and between PSMA and (b) SiR-Lysosome in STED mode. The
insets in (a) represent magnifications of the endosomes marked by white arrows in the confocal overview image. While the
PSMA signal is shown in STED mode, the endosome signal is diffraction-limited as LysoTrackerTM Green DND-26 is not STED
compatible. Scale bar overviews is 5 µm, scale bar close-ups is 500 nm. All confocal data shown are background corrected; all
STED data shown are additionally linearly deconvolved.
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Co-incubation with 2-PMPA, conjugate RED or conjugate 635P did not significantly affect the PCC for
endosomal colocalization of PSMA (Table VI-23). Average PCCs were thus taken over these four
different experimental conditions (+ nothing, + 2-PMPA, + conjugate RED, + conjugate 635P). From 1 h
to > 20 h of internalization, the PCC for endosomal colocalization of PSMA significantly (p = 10-15)
climbed from r = 0.39 ± 0.05 (n = 21) to r = 0.71 ± 0.11 (n=26) indicating endosomal PSMA recycling.
Live cell dual-color confocal and STED colocalization experiments with STAR 600-immunolabeled PSMA
and the SiR-Lysosome probe, which also targets both endosomes and lysosomes, confirmed the results
obtained with LysoTrackerTM Green DND-26 (Figure III-18b, Figure VI-11). Moreover, PSMA recycling
was additionally supported by the appearance of clustered, non-colocalizing antigen signal at the cell
membrane in STED imaging experiments after 45 min of internalization time (Figure III-11).
After live cell STED imaging, low light intensity confocal times-series of lysosomal dynamics were
recorded to exclude potential phototoxic influence during the STED imaging process. Compared to
control samples not exposed to high STED laser intensities, qualitative differences in lysosomal
dynamics were not detected (Figure VI-12, Figure VI-13 and Figure VI-14).
III.5.8 Intracellular Fate of PSMA Inhibitors
To investigate the intracellular continuance of the PSMA/PSMA inhibitor complex, the extent and
duration of colocalization of conjugate RED with PSMA was studied in dual-color STED experiments
during and after the internalization process. LNCaP cells were simultaneously incubated with
conjugate RED and STAR 600-immunolabeled for PSMA. After different internalization times, STED
imaging visualized the intracellular distribution of the PSMA inhibitor and PSMA. The internalization
times were well-defined by accurate temperature control of the endocytic process. No evidence of
mutual blocking effects was observed upon internalization of both conjugate RED and the
primary/secondary antibody complex.
In the following, qualitative trends are described rather than quantitative numbers stated due to
biological heterogeneity. At early times of internalization, the strongest colocalization was observed
with an average PCC peaking at 30 min with r = 0.65 ± 0.08 (n = 9).The signals continued to colocalize
at the vesicle membrane during the first 60 min of internalization with an average PCC of
r = 0.54 ± 0.09 (n = 43). After 60 min of internalization, colocalization progressively decreased as the
conjugate RED signal started to gradually disperse homogeneously inside the endocytic vesicles,
whereas the PSMA antibody signal remained at the vesicle membrane (Figure III-19). At later times of
internalization (6 h, 24 h), the degree of colocalization between conjugate RED and PSMA was
significantly reduced with an average PCC of r = 0.25 ± 0.12 (n = 18). The conjugate RED signal
displayed a homogenous cytosolic distribution. In contrast, the PSMA antibody signal was still localized
to the vesicle membrane. Additionally, new patches of dotted PSMA antibody signal appeared at the
cell membrane indicating recycled antigen (Figure III-11).
132 III.5 Results
Figure III-19. Vesicular fate of the
conjugate RED/PSMA complex.
LNCaP cells were STAR 600-immunolabeled for
PSMA (cyan) and incubated with conjugate RED
(100 nM, red). At early times of internalization,
PSMA and conjugate RED colocalized at the
vesicle membrane. Within the first hour of
internalization, conjugate RED detached from
PSMA and distributed homogeneously in the
vesicles before it diffused into the cytosol. All
STED data shown are background corrected and
linearly deconvolved. Scale bar is 250 nm.
As fluorograms nicely illustrate colocalization trends (refer to III.4.12.3), the dual-color STED data of
conjugate RED and STAR 600-immunolabeled PSMA were used to generate the corresponding
fluorograms to the fluorescence images of all internalization times. For describing the internalization-
time-dependent changes in the colocalization of conjugate RED and PSMA, all fluorograms were
segmented in three defined sections separating:
· The top section represents the PSMA signal only.
· The middle section represents the colocalizing signal.
· The bottom section represents the conjugate RED signal only.
The background (quarter circle in left corner) was defined as the value of the average conjugate RED
intensity after 24 h of internalization time (Figure III-20).
For short internalization times, the fluorograms displayed one colocalized fraction (white) falling into
the middle section of the fluorogram. This corresponds to strong colocalization between the
conjugate RED signal (red) and the PSMA signal (cyan) and represents specific binding of
conjugate RED to PSMA in the cell and vesicle membrane. At 45 min of internalization time, the relative
integrated intensity of the colocalizing fraction started to decline significantly in favor of an increasing
cyan fraction (PSMA) in the top section of the fluorograms. This represents PSMA gradually releasing
conjugate RED to recycle back to the cell membrane. In contrast, the red fraction (PSMA inhibitor)
slowly vanished into the background as conjugate RED initially distributed homogeneously in the
vesicles after detaching from PSMA to subsequently disperse in the cytosol of the cells (Figure III-21).
Taken together, the relative integrated intensities of conjugate RED and PSMA signal in the foreground
of the middle section of the fluorogram significantly receded with progressing internalization time.
While the relative integrated intensity of the conjugate RED signal in the entire background of the
fluorogram (all three background sections taken together) significantly increased, it declined in the
entire foreground (all three foreground sections taken together). On the contrary, the relative
integrated intensity of the PSMA signal was steady in both the entire foreground and the entire
background. No significant further changes of the signal distribution were detected after 6 h of
internalization time (Figure VI-15).
As the ratio of the integrated fluorescence intensities did not drastically change with progressing
internalization time (average of 1.17 ± 0.35 for PSMA to conjugate RED, n = 57), photobleaching and
externalization were negligible. Still, rigorous quantification is challenging as the third dimension was
ignored by the 2D imaging approach.
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Figure III-20. Intracellular fate of the
conjugate RED/PSMA complex.
LNCaP cells were STAR 600-immunolabeled for
PSMA (cyan) and incubated with conjugate RED
(100 nM, red). Exemplary dual-color STED images
(left) with their corresponding fluorograms (right)
are shown for 30 min, 45 min, 1 h, 3 h and 6 h of
internalization time. Each fluorogram is subdivided
into three defined sections representing PSMA
signal only (top, cyan), colocalizing signal (middle,
white) and conjugate RED signal only (bottom, red).
Background (quarter circle bottom left) was set to
the average conjugate RED fluorescence intensity
in the cytosol after 24 h of internalization time.
With progressing internalization time, the
colocalizing fraction declined and the PSMA
fraction increased as PSMA gradually released
conjugate RED and recycled back to the cell
membrane. The conjugate RED signal vanished into
the background due to homogeneous cytosolic
dispersion. All STED data shown are background
corrected and linearly deconvolved. Scale bars are
5 µm.
Exchanging the fluorescent labels between
the PSMA inhibitor and immunolabeled
PSMA (i.e. Glu-urea-Lys-HBED-CC-PEG2-
STAR 600 and STAR RED-immunolabeled
PSMA) would have been of great interest to
further exclude dye-dependent effects.
However, conjugation of the Abberior dye
STAR 600 to the precursor Glu-urea-
Lys[Fe(HBED-CC)]-PEG2-NH2 killed the
fluorescence properties of STAR 600.
Hence, conjugate 635P was used to
substantiate the results of conjugate RED.
As the spectral properties of the STAR RED
dye and the STAR 635P dye are very similar
though (refer to III.5.2), PSMA had to be
immunolabeled with STAR 600. The
colocalization data for conjugate 635P and
STAR 600-immunolabeled PSMA after
30 min of internalization support the
results for conjugate RED by displaying an
average PCC of r = 53 ± 0.09 (n = 10)
(Figure VI-16). For STAR RED-
immunolabeled PSMA, the intracellular localization had to be assessed individually in single-color
experiments due to non-fluorescent Glu-urea-Lys-HBED-CC-PEG2-STAR 600. The data confirm the
results for STAR 600-immunolabeled PSMA (Figure VI-16).
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Figure III-21. Cytosolic fate of conjugate RED.
(a) Exemplary confocal images of a LNCaP cells incubated with conjugate RED (100 nM) for either 30 min of internalization
time (right) or for 6 h of internalization time (left). The results illustrate the homogeneous cytosolic distribution of
conjugate RED at later internalization times. All confocal data shown are raw data. Scale bars are 5 µm. (b) Comparison of
the cytosolic and extracellular backgrounds of LNCaP cells for STED images after 30 min and 6 h of conjugate RED
internalization time (cytosol, 30 min n = 32; extracellular, 30 min n = 32; cytosol, 6 h n = 48; extracellular, 6 h n = 48). The
cytosolic fraction significantly (*** p < 10-25) increased over time. All results and p-values are summarized in Table VI-24.
III.5.9 pH Dependence of PSMA Binding
The decreasing pH in endosomes potentially promoted the separation of the PSMA/PSMA inhibitor
complex as suggested by the homogeneous cytosolic conjugate RED distribution for internalization
times < 3 h. To prove this hypothesis, the binding properties of conjugate RED, conjugate 635P and the
primary/secondary antibody complexes to PSMA on LNCaP cells were tested for the putative pH
dependence. The fluorescence signals of the PSMA inhibitors and secondary antibodies were exploited
in flow cytometry studies to determine the fraction bound at pH 4.6 in percent of the fraction bound
at pH 7.0. An acidic pH of 4.6 did not significantly affect the binding of the primary/secondary antibody
complexes to PSMA. However, for conjugate RED and conjugate 635P, the binding to PSMA was
reduced by up to a factor of five at pH 4.6 (Table III-7, Figure VI-17).
Additionally, potential changes in the
spectral properties of conjugate RED and
conjugate 635P were analyzed after
incubation at different pH and temperature
combinations to exclude pH and/or
temperature dependent fluorophore
degradation of the PSMA inhibitors. Neither
the absorbance nor the fluorescence
emission of conjugate RED and
conjugate 635P significantly changed at
acidic pH and elevated temperature (Figure
VI-18).
Table III-7. Influence of pH on the PSMA binding affinity of
conjugate RED, conjugate 635P and the antibody complex.
Fraction of PSMA inhibitor or antibody complex bound at pH 4.6
given in percent of fraction bound at pH 7.0, data are expressed
as mean ± SD (n = 3), p-values are given in Table VI-25.
% binding at pH 4.6
anti-PSMA-STAR 600 83.29 ± 12.58
anti-PSMA-STAR RED 102.08 ± 16.58
conjugate RED 20.14 ± 2.24
conjugate 635P 24.05 ± 1.36
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The clinical limitations of non-targeted molecular imaging agents for PCa underscore the urgent need
for reliable targeted probes for both PET and MRI of PCa [867]. Over the past decade, this awareness
has stimulated the development of a plethora of investigational targeted imaging agents in both
preclinical and clinical research [868]. Due to its remarkable efficacy in the detection, staging, and
active surveillance of PCa, especially targeted PET imaging outperforms conventional imaging
modalities strongly influencing further patient management and treatment regimen [713-717].
In particular, the discovery of strong PSMA upregulation on PCa cells has boosted seminal progress of
targeted molecular imaging strategies [869]. PSMA has emerged as one of the most promising key
players in targeted nuclear medicine. Its upregulation on PCa cells correlates with the stage and grade
of tumor progression, especially in androgen-independent, advanced and metastatic disease [718-
722]. Only a few organs physiologically express PSMA, but solely at significantly lower levels as
compared to cancer tissue [718, 723].
During the last years, research focus has shifted from monoclonal anti-PSMA antibodies to low
molecular weight PSMA-targeting probes, fueling the development and clinical translation of various
tracers for the detection and treatment of PCa by means of radioligand imaging, radioligand therapy
or radioguided surgery [870]. Low molecular weight inhibitors with high PSMA affinity inherently
combine fast tumor uptake and rapid excretion. The exponential increase of imaging and therapy
approaches based on these molecules has revolutionized the diagnosis and the treatment of
metastatic, hormone-refractory PCa patients. Especially for late stage mCRPCa patients beyond
established treatment options, endoradiotherapy based on α- or β-emitter radiolabeled PSMA
inhibitors offers a promising treatment approach [819, 820].
The diagnostic and therapeutic strength of PCa targeting probes is strongly affected by both their cell
binding and internalization properties as well as their subcellular localization. Certainly, strong and
specific probe internalization is desired as it guarantees not only enrichment in the target cells over
time but also protection of healthy tissue. Applied in endoradiotherapy, the probes’ intracellular
distributions co-determine the efficiency of the treatment. Potent DNA damage and subsequent
apoptosis is ensured by a more target-oriented application of effectively higher local radiation doses.
The relevant molecular framework is provided by cytosolic probe accumulation and localization in
nuclear proximity. For the application of sufficient radiation, for example with high linear energy
transfer α-particles, the enrichment adjacent to the nucleus is considered as particularly crucial.
III.6.1 Preclinical Characterization of STED Compatible Dual-
Labeled PSMA Inhibitors
Equipping PSMA inhibitors with an additional fluorescent moiety has successfully introduced a second
imaging modality to the established class of low molecular weight PSMA inhibitors in the clinical
routine [48, 724, 871]. These dual-labeled PSMA inhibitors preserve specific PSMA binding and
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internalization, high tumor uptake and favorable pharmacokinetic properties comparable to the
clinically applied agents PSMA-11 and PSMA-617 [48, 768, 769].
From the clinical perspective, the additional fluorescence property allows for intraoperative
fluorescence guidance during surgical resection of primary PCa and regional lymph node metastases.
From the preclinical research perspective, the additional fluorescence property allows for intracellular
tracking of these molecules. Combined with sophisticated fluorescence imaging approaches and
complemented with elaborate PSMA staining strategies, these dual-labeled PSMA inhibitors represent
attractive model compounds for studying the subcellular fate of low molecular weight PSMA inhibitors
at the nanoscale. To the best of our knowledge, the detailed subcellular fate of PSMA/PSMA inhibitor
complexes for low molecular weight PSMA inhibitors has so far not been investigated with
fluorescence nanoscopy. The only basic knowledge of PSMA internalization and its intracellular
distribution is based on diffraction-limited confocal microscopy studies [772, 872].
Certainly, the resolution of conventional diffraction-limited fluorescence microscopy is good enough
to visualize the coarse localization of PSMA and its inhibitors inside cells over time. However, it is not
sufficient for precisely investigating localization details such as cluster substructures and the molecular
colocalization of PSMA and its inhibitors. Here, STED nanoscopy is the method of choice. Indeed, it
provides the required spatial resolution; but moreover, STED nanoscopy is particularly valuable for
colocalization experiments as compared to other fluorescence nanoscopy and related resolution-
enhancing techniques. By using one STED donut to deplete both excitation channels, their signals are
inherently co-aligned. Since the STED zero defines the position of the fluorescently active molecules
and thus the position of effective excitation for all channels, the colocalization results are not altered
by residual chromatic aberrations [137].
To meet the special demands of STED imaging on the applied fluorophores such as high photostability,
large cross section for stimulated emission and low dark state transition probabilities [381], we
synthesized PSMA-11 based dual-labeled PSMA inhibitors conjugated with the STED compatible
Abberior dyes STAR RED and STAR 635P. For a start, we preclinically characterized our conjugates by
exploiting their radioactive properties. Conjugate RED as well as conjugate 635P displayed high binding
affinities specific to PSMA and large internalized fractions in PSMA-positive cells. In addition to these
promising targeting characteristics, the tumor uptake in PSMA-positive lesions was specific. The high
tumor-to-background ratios at early time points are comparable to those of the reference compounds
[48, 768, 769]. We thus conclude that the additional fluorescence moiety did not significantly alter the
important characteristics of our conjugates. As pharmacokinetic properties and tumor accumulation
remained unaffected, conjugate RED and conjugate 635P are suitable to mimic clinically applied PSMA
inhibitors for studying their intracellular fate using STED nanoscopy.
As a function of time, confocal and STED microscopy afforded the investigation of the intracellular
distribution of PSMA and of our PSMA inhibitors in PSMA-overexpressing cells. Independently of the
concentrations tested, the internalized PSMA inhibitor fraction increased with progressing incubation
time. The data obtained in the in vitro radioassays, namely cell binding and internalization studies with
our 68Ga-radiolabeled PSMA inhibitors, support the fluorescence imaging results. As we did not
observe any blocking effects between our PSMA inhibitors and the anti-PSMA antibody, we conclude
that the antibody binding site essentially differs from the substrate cavity binding the PSMA inhibitors.
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III.6.2 Visualizing PSMA Clustering
STED nanoscopy of our conjugates and/or of immunolabeled PSMA further revealed structural
subtleties of the membrane bound antigen fraction. Instead of being homogeneously distributed along
the cell membrane, the PSMA signal was rather spread into patches. These patches consisted of oval-
to round-shaped signals of different sizes and were observed both before internalization and after
PSMA recycling. We assume these single signals to comprise a varying number of PSMA molecules
grouped in antigen clusters at the cell surface.
Previous findings obtained in biochemical assays have suggested PSMA clustering at the cell
membrane. In these experiments, PSMA clustering was artificially induced with antibodies to study its
consequences. It has been concluded that PSMA clustering is crucial not only for PSMA activation and
subsequent antigen internalization. Additionally, it is involved in many downstream signaling pathways
that directly or indirectly affect cell proliferation [873-875].
Here, we visualized PSMA clustering at the cell membrane for the first time. It was either induced by
our PSMA inhibitors or by antibodies as consequence of PSMA IF. During our colocalization
experiments between immunolabeled PSMA and endosomal/lysosomal probes, endosomal PSMA
colocalization did not significantly differ, independently of the presence or absence of PSMA inhibitors
and 2-PMPA. This observation is indeed not surprising as IF of PSMA already induces antigen clustering
and thus PSMA activation and internalization. Moreover, antibody binding is not affected by 2-PMPA
as this compound specifically blocks the binding cavity of PSMA inhibitors, which differs from the
antibody binding site.
However, we speculate that the holographic cytometry studies indirectly revealed effects of PSMA
clustering. The proliferation of PSMA-positive cells was slightly but significantly accelerated in the
presence of our PSMA inhibitors as compared to the proliferation of untreated PSMA-positive cells.
While PSMA clustering and thus activation (together with its impact on cell proliferation) was induced
in the presence of our conjugates, it was not in the case of untreated cells.
III.6.3 Following the Endosomal Pathway
During the early phase of PSMA/PSMA inhibitor complex internalization, endocytic vesicle formation
was observed. Based on our colocalization studies, we assume that the PSMA-specific uptake of low
molecular weight PSMA inhibitors depends on clathrin-mediated endocytosis. Moreover, we
confirmed previous suggestions that PSMA itself travels the endosomal pathway to be either finally
degraded in lysosomes or recycled back to the cell surface [758, 872].
The endocytic vesicles were readily resolved by STED imaging allowing for their size quantification. The
average vesicle diameter of our samples is more than twice the value for the diameter of CCVs as
described in literature [863, 864]. However, the large SD indicates a very heterogeneous population of
endocytic vesicles in our samples. By targeting the extracellular domain of PSMA with both PSMA
inhibitor and antibodies, our labeling strategy rather underestimates the vesicle diameter (refer to
III.6.4, Figure III-22). Upon endocytosis of PSMA, invagination of the cell membrane locates the PSMA
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ectodomain and thus the fluorophores in the vesicle interior. Still, the FWHMs of selected vesicle line
profiles indicate an effective image resolution high enough to resolve vesicles with approximately
100 nm in diameter. Since CCVs rapidly uncoat, subsequently fuse and become early endosomes
featuring diameters larger than CCVs, we conclude that the recorded vesicle population mainly
consisted of early endosomes.
After PSMA inhibitor internalization, cellular retention without significant externalization is suggested
by both long-term internalization confocal and STED experiments as well as by biodistribution and
small-animal PET imaging studies. The in vivo time course of tumor accumulation not only confirms a
long-term accumulation of the PSMA inhibitors in PCa tumor cells, but additionally revealed a high
tumor-to-background ratio. The signal of the specifically internalized fraction remained, whereas the
non-specific signal of unbound PSMA inhibitors declined with progressing time. Off-target
internalization occured only for a very limited set of tissues, but for these cases, our holographic
cytometry data indicate absence of cytotoxicity.
III.6.4 The Subcellular Fate of PSMA Inhibitors
To visualize the subcellular distribution of our PSMA inhibitors in relation to PSMA at the molecular
level, we developed a novel non-standard live cell IF staining protocol (Figure III-22). We note that in
general, IF staining is restricted to fixed cells as it depends on cell membrane permeabilization. The
intact cell membrane of living cells is a permissive barrier for macromolecules such as antibodies and
can only be passed via active uptake by the cell.
Here, we exploited the metabolic peculiarity of LNCaP cells to withstand low temperatures while
pausing PSMA internalization. Hence, the membrane bound PSMA fraction could be comprehensively
labeled by incubating LNCaP cells on ice without impairing cell health. The internalization of the
complex consisting of PSMA, primary antibody, secondary antibodies and PSMA inhibitor was triggered
by a subsequent temperature increase.
Generally, IF provides a strong fluorescent signal amplification as the primary antibody recruits more
than one secondary antibody, which each in turn is decorated with more than one fluorophore. In
contrast, our PSMA inhibitors contribute only one fluorophore per PSMA molecule. Surprisingly, the
brightness and SNR of the PSMA inhibitor signal was only slightly reduced in comparison to the
immunolabeled PSMA signal despite the essential difference in fluorophore stoichiometry. We
conclude that in particular for conjugate RED, dye coupling to the PSMA inhibitor scaffold did not
significantly alter the photophysical properties of the bright and photostable STED dye STAR RED.
A rough sketch of PSMA and PSMA inhibitor trafficking could be drawn by diffraction-limited confocal
microscopy. However, to elucidate in detail the subcellular fate of PSMA and PSMA inhibitor after their
binding at the cell surface, STED nanoscopy was necessary.
At early time points of internalization, PSMA and the PSMA inhibitors strongly colocalized. With
progressing time, the degree of colocalization declined. At later time points of internalization,
colocalization eventually vanished. The PSMA inhibitors displayed a gradual cytosolic distribution over
time, whereas immunolabeled PSMA remained localized to the endocytic vesicle membrane to be
III.6 Discussion 139
either recycled back to the cell surface or to be degraded in lysosomes. Internalization and vesicle
formation of antibody-targeted PSMA has previously been reported on by Rajasekaran et al. after 2 h
of incubation [872]. Our results confirm these findings but additionally visualize PSMA localization at
later time points up to 24 h including antigen recycling.
Figure III-22. Sketch illustrating the labeling strategy for PSMA/PSMA inhibitor colocalization studies.
To assess the colocalization between our PSMA inhibitors and PSMA, live LNCaP cells were immunolabeled for PSMA and co-
incubated with either conjugate RED or conjugate 635P. As both affinity labels are not cell membrane permeable, only the
membrane fraction of PSMA was targeted. Passive passage through the cell membrane was impaired as antibodies are too
large and as PSMA inhibitors are too charged at neutral pH. Premature internalization of PSMA was prevented by labeling on
ice. Internalization of the antibody/PSMA/PSMA inhibitor complex was triggered by incubation at 37°C. Initially, PSMA
inhibitor and primary (1st, anti-PSMA) / secondary (2nd) antibody were PSMA bound. Upon endocytosis, invagination of the
cell membrane placed the extracellular domain of PSMA inside the endocytic vesicles. Thus, the PSMA inhibitor and the 1st/2nd
antibody complex pointed inwards. The size of the low molecular weight PSMA inhibitor can be neglected (approx. 2 nm),
but due to the non-negligible size of antibodies (1st/2nd antibody complex approx. 30 nm) and the PSMA ectodomain (amino
acids 44-750), the actual positions of the fluorophores and the vesicle membrane did not coincide. Thus, our labeling
approach rather underestimated the vesicle diameter. The pH decline along the endosomal pathway stimulated segregation
of the PSMA/PSMA inhibitor complex while the 1st/2nd antibodies remained attached to PSMA. After detaching, the PSMA
inhibitor homogeneously distributed inside the vesicle in a first step. The acidic pH in endosomes protonated the acidic
moieties of the PSMA inhibitor rendering it neutral and thus cell membrane permeable. In a second step, the PSMA inhibitor
diffused through the vesicle membrane and dispersed homogeneously in the cytosol. Due to a neutral cytosolic pH, the acidic
moieties of the PSMA inhibitor deprotonated again trapping the tracer inside the cytosol. In contrast, PSMA was either
recycled back to the cell surface or degraded in lysosomes.
III.6.5 Mechanistic Model for the Cytosolic Distribution of PSMA
Inhibitors
Strikingly, low molecular weight PSMA inhibitors apparently display an essentially different distribution
pattern on the subcellular level as compared to PSMA antibodies used in immunotherapy of PCa.
During the antigen recycling process, the PSMA/PSMA inhibitor complex dissociates in the endosomal
compartment.
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Remarkably, antibody complex and low molecular weight inhibitors display significant differences in
the pH dependence of their PSMA binding affinity. While PSMA binding of the anti-PSMA
antibody/secondary antibody complex remained unaffected at acidic pH, the interaction between
PSMA inhibitor and PSMA drastically suffered. We conclude that our low molecular weight PSMA
inhibitors detach from PSMA upon pH decrease in the endosomes after clathrin-based endocytosis to
initially distribute in endosomes but gradually disperse homogeneously in the cytosol without binding
to other structures. We further speculate our conjugates to be intrinsically inert to lysosomal digestion
as they are unnatural inhibitors of PSMA.
Reduction of the PSMA binding affinity of the PSMA inhibitors at acidic pH certainly shifts the
equilibrium between bound and unbound PSMA inhibitor towards the unbound state. For a closed
system and thus within an established steady-state equilibrium, the dynamic fraction of PSMA bound
PSMA inhibitor would simply shrink but in its diminished size continuing to exist. However, the
endosome appears to be a closed system only at first glance.
Due to their acidic moieties (Figure III-6a), our PSMA inhibitors are charged at neutral pH, rendering
the molecules membrane impermeable. Initially, the PSMA inhibitors thus cannot cross the cell
membrane from the cell medium into the cytosol specifically limiting their uptake to internalization
via PSMA. However, the acidic moieties of the PSMA inhibitors are mostly protonated at endosomal
acidic pH, rendering the molecules membrane permeable. Hence, the PSMA inhibitors can passively
diffuse through the endosome membrane and cytosolically disperse, a process simply driven by
entropy. By this, unbound PSMA inhibitors are continuously withdrawn from the PSMA
bound/unbound equilibrium inside the endosomes. Thereby, the position of the equilibrium is pushed
further and further towards the unbound state until finally the entire PSMA inhibitor population is
located inside the cytosol. The neutral pH inside the cytosol deprotonates the acidic moieties of the
PSMA inhibitors again rendering the molecules once more membrane impermeable and finally
trapping the PSMA inhibitors in the cytosol of the cell.
We exclude any dye-dependent effects as interchanging the fluorescent labels for immunolabeled
PSMA and PSMA inhibitor did not alter our results. Moreover, neither absorption nor fluorescence
emission properties of the PSMA inhibitors displayed sensitivity to acidic pH and/or elevated
temperatures.
The striking difference between the subcellular fate of PSMA antibodies and PSMA inhibitors will
presumably translate into an enhanced therapeutic efficiency of low molecular weight PSMA
inhibitors. For preventing off-target tissue effects and achieving high imaging contrasts, a long
retention in PCa cells is crucial in imaging and therapy approaches based on PSMA inhibitors. Of
particular interest for endoradiotherapy is the homogenous dispersion of low molecular weight PSMA
inhibitors in PCa cells after internalization, which we have demonstrated here for the first time.
Especially with α-particles, effectively high local radiation doses throughout the targeted cell are
afforded. By providing valuable insights for the design of improved PCa targeting strategies, we expect
our findings to stimulate further ligand development, not only in the field of PCa.
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PSMA-based diagnosis and treatment of PCa is the textbook example for the potential of targeted
imaging and therapy approaches to bridge the shortcomings of established cancer treatment. The
development of pharmaceuticals specifically targeting PSMA has evolved as one of the most vigorous
and vibrant radiopharmaceutical research fields during the last decade. Numerous applications have
already successfully demonstrated the efficient targetability of PSMA. Not only focused clinical
development programs but also industrial companies foster and encourage the academic research.
To date, the urea-based binding motif and the phosphonate-based binding motif characterize the two
main classes of PSMA inhibitors that offer the most promising properties. For PSMA-targeted imaging,
several different tracers are currently available. With respect to imaging characteristics, availability,
access and cost, the most suitable tracer must be still identified. However, a prosaic clinical and
chemical view might even conclude that the tracer improvement for PSMA-targeted imaging is almost
exhausted balancing the limits of chemical feasibility and the clinical necessity [870].
On the contrary, the efficiency of endoradiotherapy strategies will greatly benefit from further tracer
optimization. The major restriction among all PSMA inhibitors for their application in
endoradiotherapy are high binding affinities to kidneys and to salivary glands. These challenges are
currently addressed by different approaches stimulating the development of a `second generation´ of
PSMA inhibitors with optimized pharmacokinetic profiles and lower off-target uptake [876].
Optimized endoradiotherapy strategies most likely pave the way for α-particle therapy. Future
research must evaluate the potential of this treatment approach, develop selective and efficient
therapy strategies for improved patient care and explore the value of combination therapies with
antiandrogenic drugs. Additionally, longer follow-up periods are crucial to analyze the long-term
results and toxicities. To facilitate therapy response assessment, expanded insights into the effects of
various treatments on PSMA expression are needed. By that, current imaging and therapy protocols
will evolve and improve.
Inspired by the gap between the current state and the target state of radiopharmaceutical PCa
research, we designed a study to track and clarify the intracellular fate of PSMA/PSMA inhibitor
complexes. In particular, elucidating the subcellular PSMA inhibitor distribution is crucial for obtaining
a detailed understanding of the mechanism of action during endoradiotherapy.
Our study is the first to give insight into intracellular distribution patterns of PSMA and of low
molecular weight PSMA inhibitors at clinically relevant time points resolved up to the molecular level
by STED nanoscopy. The principles uncovered and the novel imaging method described in this work
offer extensive utility and contribute valuable knowledge to the field of PCa research. Our findings
hopefully boost the future design and development of novel radiopharmaceutical agents for refined
and/or new diagnostic and therapeutic approaches, acting as theranostics for molecular targeted PCa
therapy and aiming at selective and efficient therapy strategies for improved patient care.

IV – METHODOLOGY:
ASPECTS OF LIVE CELL STED NANOSCOPY
IV.1 INTRODUCTION
The potential of STED nanoscopy in live cell imaging is far from being fully exploited. While satisfying
demands regarding temporal resolution and optical sectioning, live cell STED imaging like any other
live cell fluorescence nanoscopy technique is challenged by phototoxicity mainly mediated through
photobleaching (refer to I.1.4). Thus, suitable fluorophores reliably withstanding high light
intensities/light doses are desperately required and it is the (bio)chemistry that must catch up with the
current state in optics.
Certain measures can be taken to reduce the risk of photodamage. Upfront, any stress prior to imaging
should be kept as low as possible. Experimental settings and conditions not only affect phototoxicity
but already by themselves potentially cause stress (e.g. overexpression) [272]. Therefore, cell health
of `dark´ controls should be additionally assessed and maximized. As light sensitivity is strongly sample
dependent and varies with the organism, developmental stage [877, 878], cell type [305], cell age and
cell cycle phase [289], the sample choice should be reasonably considered.
During imaging, experimental conditions (e.g. exposure to drugs) might increase the specimen’s
sensitivity to light. Therefore, optimal cell culture conditions should be provided to keep additional
stress at a minimum. Further biochemical measures include both scavenging and prevention of ROS
and ̇/  in the sample by removal of photosensitizing compounds (e.g. riboflavin, pyridoxal) from the
imaging medium [879] and addition of empirically determined antifading agents [880], antioxidants
(e.g. ascorbic acid [881], n-propyl-gallate [879, 882]), radical state quenchers, and reducing and
oxidizing systems (ROXS). ROXS buffers efficiently depopulate the reactive intermediate state (often
) and restore  via complementary electron transfer reactions [419, 880, 881, 883].  quenching is
additionally favorable for the SNR since the population of any dark state disengages fluorophores from
the image formation process. Ironically, oxygen is the main triplet quencher in biological samples [884,
885] but at the same a key player in phototoxicity.
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The build-up of ROS can potentially be prevented by either enzymatic [886, 887] or technical [888]
oxygen removal. Yet, oxygen must be replaced by an efficient triplet quencher (e.g. Trolox [889-891]
or cyclooctatetraene [882]) to prevent  accumulation and photon yield impairment. However, most
living specimens require oxygen for respiration and thus complete removal is usually not an option.
Furthermore, cytotoxicity sets limits on the additives’ concentrations. Indeed, to ensure efficient
scavenging, depletion and protection, any additive must be supplied in high concentration
guaranteeing frequent collisions with its target. This conflict can be avoided by strongly decreasing the
concentration via direct coupling of the additive to the fluorophore, as successfully demonstrated in
the concept of self-healing dyes [892].
The induced phototoxicity and the counteracting effects of additives heavily depend on the
fluorophore type, its cellular localization, local concentration, and on its biomolecular target.
Fluorophores with low photobleaching probabilities, low STED absorption cross sections of ,  and
, and low dark state population probabilities are desirable [893-895]. Certainly, illumination
conditions are decisive and exposure concepts that mitigate photobleaching in conventional
diffraction-limited microscopy are not necessarily ideal for STED nanoscopy. The following optical
measures go hand in hand with the biochemical approach and must be tailored to the particular dye
and its environment.
Photodamage is wavelength-dependent and more pronounced at shorter wavelengths due to higher
photon energy and increased absorbance by endogenous chromophores [298, 305, 896]. Thus,
excitation and depletion in the far-red spectral range are less harmful. Specifically adapting the STED
wavelength outside of the →  and →  bands is additionally favorable but quickly renders
multicolor STED imaging highly complex. Clearly, less light exposure is always advantageous and
conservative laser intensities should be used for tuning the spatial resolution only to the level
necessary to answer the biological question of interest. If applicable, limiting the light exposure only
to the focal plane of interest further reduces phototoxicity (refer to I.1.4). To better compare
phototoxicity between different experimental implementations, it is advisable to measure the
irradiance at the sample level.
As the cellular ROS buffering system can cope better with the same amount of ROS spread over a
longer period, exposure times should be extended at the expense of peak intensities. Indeed, this
measure reduces the temporal resolution and renders motion blur more likely. In summary, the total
light dose is not as important as the duration for which the total light dose is applied [292, 298, 877].
Here, pulsed or intermittent instead of continuous illumination is beneficial [301, 366, 897, 898].
Especially low-repetition-rate pulses allow the fluorophores in metastable dark states to relax back to
the ground state between pulses. Thus, dark state build-up and the rate of photobleaching via this
route are reduced [141, 238, 366, 898]. Yet, more time-efficient triplet state relaxation is possible via
ultrafast scanning as one fluorophore’s relaxation time is the other fluorophore’s excitation time. The
irradiation is distributed more evenly and the total exposure time is controlled by line or frame
accumulation [141, 249, 301].
Longer pulse durations lower the peak intensity and hence the probability of transitions to  and
without drastically decreasing the depletion efficiency [239]. In combination with time-gating, a similar
resolution as with shorter pulses can be maintained, yet at the expense of a lowered SNR [899]. Making
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compromises is necessary and different measures must be taken to counteract lower-order and
higher-order photobleaching. For low average powers (i.e. lower-order photobleaching) shorter pulses
guarantee the best temporal and spatial resolution. Dark state population is the main source of
photobleaching and best hindered via low-repetition-rate pulses or ultrafast scanning and additives.
For high average powers (i.e. higher-order photobleaching) longer pulses reduce multi-step and/or
multiphoton processes to  and  [302].
Besides rationally following these guidelines, the challenge of photobleaching and associated
phototoxicity must additionally be met with the design of refined and/or novel bright and photostable
live cell imaging probes (refer to IV.2). The sample health should receive the highest priority during
both sample preparation and image acquisition. Thus, to guarantee the recording of an unaltered
biological reality, first, potential cytotoxicity of these live dyes must be excluded (refer to IV.3) and
second, conservative live cell imaging parameters must be chosen. Due to the latter, live cell imaging
data often suffer a reduced SNR in comparison to fixed cell imaging data. To maximize the extraction
of biological information, the quality of such `degraded´ live cell images can be improved by image
restoration (refer to IV.4).
IV.2 NOVEL PROBES FOR LIVE CELL STED IMAGING
IV.2.1 Motivation
For all fluorescence nanoscopy methods, the focal switch represents the key that unlocks the
diffraction limit and renders the nanometer resolution regime accessible. Thus, further improvement
of the performance of current nanoscopy methods strongly depends on the development of new
and/or refined fluorophores with optimized (bio)chemical and photophysical properties [376-380]. In
particular, live cell STED nanoscopy can only exploit its full potential with fluorophores that combine
biocompatibility and membrane permeability with high photostability, low photobleaching
probabilities, a maximal number of switching cycles, low dark state transition possibilities, a high cross
section for stimulated emission, and a low cross section for excitation to  and  [381].
To date, no single fluorophore fulfills all requirements at once, and thus reasonable choices must be
made for each concrete application. Current research pushes especially for new organic dyes with the
optimal combination of (bio)chemical and photophysical properties to guarantee selective, sensitive,
and stable live cell STED imaging [29-34, 353, 354, 405].
In particular, the criterion of cell permeability limits the variety of organic dyes applicable for
intracellular labeling of living cells. Since their first synthesis by Fu et al. [900], silicon xanthenes and
the subsequently developed silicon rhodamines (SiR) [30] have drawn a lot of attention as promising
fluorescence labels penetrating the outer plasma membranes of intact cells and thus offering a broad
field of application. SiR dyes come close to the optimal live cell STED probe as they are bright,
photostable, fluorogenic, membrane permeable, essentially non-toxic, biocompatible, biologically
stable, and absorb and emit in the far-red spectral range. These properties render SiR dyes not only
attractive for live cell fluorescence nanoscopy [29-33, 36, 38, 901, 902], but likewise allow their
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application as direct probes for various biomolecules [403, 903-905], or as sensors for metal ions [906-
910], pH [908], voltage [911] or metabolites [912-915].
With the aim to control the dyes’ photophysical properties by rational design, correlations between
structural features and photophysical properties were investigated in several attempts partially
supported by DFT calculations [34, 914, 916, 917]. These studies resulted in new SiR derivatives with
optimized and fine-tuned photophysical properties. The introduction of methyl, methoxy or
dimethylamine groups into the benzene moiety of SiR dyes tunes the highest occupied molecular
orbital (HOMO) energy level and thereby affects the quantum yield while leaving absorption and
emission bands unchanged. The extent of the effect depends on the oxidation potential and the HOMO
energy level of the benzene moiety. Hence, the negative value of the HOMO energy level and/or the
oxidation potential are directly connected to the quantum yield [907]. Certainly, the quantum yield is
also influenced by other factors. Non-radiative quenching (e.g. via bond rotation) competes with
fluorescence emission and lowers the quantum yield by effectively contributing to the depopulation
of  [918]. Despite the theoretical and experimental efforts of the past years, the rational trends for
radiative and non-radiative decays remain difficult to predict [919].
In analogy to BODIPY fluorophores [920], we initially hypothesized that a constrained rotation around
the xanthene-aryl bond should lead to an improved quantum yield of SiR dyes. Table IV-1 together
with Figure IV-1 compile SiR dyes with high quantum yields and their structural analogues with lower
quantum yields.
Azetidine substituents at the xanthene moiety of dyes 5, 7 and 9
not only improve the quantum yield of these dyes but also red-
shift the spectral properties as compared to the N,N-
dimethylaniline analogue dyes 1, 3 and 4 (Table IV-1, entry 1 vs.
5, 3 vs. 7, and 4 vs. 9). On the contrary, the fluoroazetidine
moiety in dye 10 (JF635) does not affect the high quantum yield
but induces a hypsochromic shift as compared to the azetidine
analogue dye 9 (JF646) (Table IV-1, entry 9 vs. 10). However,
restricted rotation around the xanthene–benzene bond leads to
a drastic improvement of the quantum yield from 0.10 to 0.31
when comparing the phenyl substituted rhodamine dye 2 with
its 2’-methyl substituted analogue dye 3 (Table 1, entry 2 vs. 3).
Accordingly, 2’-substituents with A-values between a proton
and a methyl group (such as F and Cl) result in quantum yields
from 0.19 (for F) [915] to 0.30 (for Cl) [915] for rhodamines like
dyes 3, 4, 11 or 12 (Table IV-1, entries 3, 4, 11 and 12).
Remarkably, dye 1, dye 5 and dye 6 do not possess any benzene
moiety but display moderate to high quantum yields (Table IV-1,
entries 1, 5 and 6).
Figure IV-1. Chemical structures of SiR
derivatives belonging to Table IV-1.
Table IV-1 specifies the individual groups
R1, R2 and R3 and gives the respective
photophysical properties of the
corresponding SiR derivative.
To the best of our knowledge, dyes 11 and 12 feature the highest quantum yields known amongst SiR
dyes with values of 0.66 and 0.70 (Table IV-1, entries 11 and 12). This might be explained by the
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bulkiness of the ester group in the 2’-position (isopropyl ester derivative), and/or by the effects of the
fluorine atoms and the ester group on the HOMO energy level of the benzene moiety.
Table IV-1. Comparison of the photophysical properties of different SiR derivatives.
Figure IV-1 provides the corresponding chemical structures for this table.  – absorption wavelength,  – fluorescence
emission wavelength,  – quantum yield. * In PBS at pH 7.4; † cresyl violet in methanol used as reference dye; ‡ in PBS; ¥ in
HEPES at pH 7.3; ¤ in water; § quantum yield determined by absolute measurement; £  corresponding isopropyl ester showed
a quantum yield of 0.60; ‖ quantum yield determined in water with reference dye Atto AZ 237.
entry NR1R2 R3 dye l  [nm] l  [nm] reference
1 N(CH3)2 H
1
(SiP) 634 648 0.42*
,† [907]
2 N(CH3)2 Ph 2 646 667 0.10‡,† [921]
3 N(CH3)2 2-CH3-Ph 3 646 660 0.31*,† [907]
4 N(CH3)2 2-COOH-Ph 4 643 662 0.41¥,§ [34]
5 azetidine H 5 636 649 0.62¥,§ [922]
6 azetidine COOH 6 641 657 0.26¥,§ [922]
7 azetidine 2-CH3-Ph 7 649 663 0.47¥,§ [922]
8 azetidine 2-CH3-6-CH3-Ph 8 651 664 0.51¥,§ [922]
9 azetidine 2-COOH-Ph 9(JF646) 646 664 0.54
¥,§ [34]
10 3-F-azetidine 2-COOH-Ph 10(JF635) 635 652 0.56
¥,§ [916]
11 11 662 680 0.66¤,£,‖ [923]
12 12 663 680 0.70¤,‖ [923]
13 N(CH3)2 pyridin-4-yl 13 655 680 0.12‡,§ [924]
14 azetidine 3-CH3-pyridin-4-yl 14 656 670 0.48¥,§ [922]
Consequently, this work was based on a presumed positive correlation between quantum yield and
bulkiness of the phenylic 2’-substituent of SiR dyes and speculated that the 2’-substituent constrains
the rotation around the xanthene–benzene bond more strongly the larger it is. In detail, we strived for
the development of the pyridinyl-substituted SiR dye 15, which allows for the easy radiofluorination
of the 2-halopyridine moiety and thus the generation of the PET-active dye 16 (Figure IV-2).
Such PET-active NIR dyes allow for bimodal medical imaging (PET/optical imaging (OI)) and promise
huge advances in diagnostic and treatment regimens in the field of cancer as they combine precise
pre-operative imaging of lesions with medical interventions such as intra-operative guidance or
sentinel lymph node detection. The precise detection and resection of all malignant tissue directly
affect the treatment outcome and patient survival, and both can be strongly improved by using surgical
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guiding by dual-modality probes (refer to III.2.6). Moreover, the fluorescence modality can be
additionally exploited for histopathological analyses of biopsy material.
Figure IV-2. Retrosynthetic analysis of the dual-modality SiR dye 16.
This scheme depicts the retrosynthesis of the proposed small molecule dual-modality probe [18F]SiR dye 16 for hybrid medical
imaging (PET/OI) of cancer cells with up-regulated mitochondrial activity. For examples on radiolabeling of 2-halopyridines
(here 15 to 16) refer to [925-927].
Only two pyridinyl-substituted SiR dyes have been published to date. Dye 13 (Table IV-1, entry 13)
combines good water solubility with an intrinsic targeting ability to lysosomes, but only features a
quantum yield of 0.12 [924]. In contrast, dye 14 (Table IV-1, entry 14) displays an enhanced quantum
yield of 0.48 [922], presumably due to both the azetidine substituents at the xanthene moiety and the
restricted bond rotation owing to the 3’-methyl group (pyridine numbering).
The 2-chloropyridinyl moiety of dye 15 not only introduces a convenient fluorination option, but
presumably the additional intrinsic targeting ability to acidic cellular compartments analogously to the
lysosomal-selective dye 13. Due to its increased lipophilic nature as compared to dye 13 (Table IV-2),
we assumed that our proposed dual-modality fluorophore possesses better selectivity for
mitochondria. Driven by the mitochondrial plasma membrane potential, lipophilic cations such as the
phosphonium cation or rhodamines selectively accumulate within mitochondria [928, 929]. Diffusion
through the cell and mitochondrial membranes is facilitated by the lipophilicity of these cations. By
conjugating ten different amines with varying lipophilicity to the SiR core, Sung et al. recently
determined clogP values between 5.50 and 6.33 to be optimal for mitochondrial targeting and
developed a SiR dye (SiR-Mito 8) selectively staining mitochondria [930].
Mitochondria are bounded by an outer and an inner
membrane separated by the intermembrane space. The
inner membrane is highly convoluted and forms
invaginations (cristae) that extend into the
mitochondrial matrix (Figure IV-3). Mitochondria are
dynamic organelles that continuously undergo fission
and fusion events [931, 932]. Their morphology
depends on cell function and disease states and thus
can be exploited as a biological marker.
Table IV-2. Comparison of the lipophilicity of dye
13, SiR dye 15 and SiR dye 16.
* calculated logP values.
dye 13 SiR dye 15 SiR dye 16
clogP* 2.136 3.712 3.142
Medical imaging of mitochondrial activity is highly informative for various indications, including
neurodegenerative and metabolic diseases, ischemic injuries, necrosis, therapy response and cancer
[928, 929, 933-935]. With regard to bimodal medical imaging in the field of cancer, our proposed dual-
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modality probe will potentially achieve a reasonable tumor-to-background ratio, as many cancer cells
have a higher mitochondrial membrane potential than non-transformed cells [933, 936, 937].
Figure IV-3. Schematic illustration of a mitochondrion.
Mitochondria are enclosed by an outer and an inner membrane dividing these
organelles into a narrow intermembrane space and a larger internal matrix. The
inner membrane is highly convoluted forming numerous infoldings called
cristae. Mitochondria are responsible for the ATP synthesis of a cell and organize
into an extensive intertwined network in the cytoplasm.
Designing SiR dye 15 and its radiofluorinated analogue SiR dye 16, we chose a molecule with an
additional bulky 4’-substituent such as bromine, since the smaller 2’-fluorine substituent in SiR dye 16
should lead to a decrease in quantum yield as compared to SiR dye 15 featuring the larger 2’-chlorine.
The HOMO energy level of SiR dye 15 and SiR dye 16 should not be negatively altered by the presence
of a 4’-bromine atom. Moreover, the additional substituent can be further used for functionalization.
To date, no SiR dyes have been reported that feature two phenylic halogen substituents (any
combination of F, Cl, Br) at the positions adjacent to the xanthene-benzene bond. The same holds for
rhodamines bearing a dihalogenated pyridinyl motif, although halogenated pyridines are highly
interesting for further functionalization or vector conjugation by nucleophilic aromatic substitution.
For the introduction of the dihalogenated pyridine motif into the SiR scaffold, we decided on a halogen
dance (HD) reaction of 3-bromo-2-chloropyridine (compound 19) to compound 18 followed by a
condensation with silicon xanthone 17, which is accessible in a two-step reaction from 3-bromo-N,N-
dimethylaniline. Initially published and investigated by Mallet et al., the rearrangement of halo
pyridine 19, initiated by a halogen-metal exchange with n-BuLi, is also termed `homotransmetallation´
[938]. For the synthesis of highly substituted carbo- and heterocyclic systems (e.g. tetrasubstituted
pyridines [939]) with substitution patterns difficult to obtain otherwise [940-942], the HD
rearrangement reaction commonly offers an excellent approach.
IV.2.2 Aim
The performance of live cell STED nanoscopy strongly depends on the biochemical and photophysical
properties of the applied fluorophores. Those that provide many photons while reliably sustaining high
light intensities/light doses are most promising for further progress in the field of live cell STED imaging.
In this regard, silicon xanthenes and in particular the subsequently developed silicon rhodamines are
highly attractive starting points for further dye development. In recent years, several live cell STED
compatible SiR derivatives specifically labeling different cellular structures and organelles have been
reported [31, 353, 354, 423]. However, to the best of our knowledge, none of these new STED
compatible SiR probes target mitochondria.
Thus, the aim of this project was the design of a live cell STED compatible SiR derivative specifically
staining mitochondria. As medical imaging of these organelles is highly informative for various
indications, we further strived for additional applicability in multimodal (PET/OI) medical imaging.
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Therefore, a dihalogenated fluorinatable pyridinyl SiR dye was synthesized by the application of a
halogen dance rearrangement. The product was analytically and photophysically characterized. To
confirm its specific mitochondrial targeting ability, colocalization experiments with MitoTracker®
Green FM and LysoTrackerTM Green DND-26 were performed in two human cell lines. STED
compatibility was assessed in live cell imaging experiments. To exclude cytotoxicity, the potential
influence on the proliferation behavior of human cell lines was evaluated in long-term holographic
cytometry experiments.
The work presented in the following sections has recently been published as Matthias, J.,
Kanagasundaram, T., Kopka, K., Kramer, C. S., Synthesis of a di-halogenated pyridinyl silicon rhodamine
for mitochondrial imaging by a halogen dance rearrangement. Beilstein Journal of Organic Chemistry,
2019. 15: p. 2333-2343. [943].
IV.2.3 Methods
This project was conceived and conducted in close collaboration with Dr. Carsten S. Kramer15. The
synthesis and the analytical characterization were performed by Dr. Carsten S. Kramer. Detailed
information on materials is given in I.2.1.
IV.2.3.1 Synthesis
Unless otherwise stated, reactions requiring exclusion of oxygen and moisture were conducted in heat-
gun flasks dried under argon gas atmosphere using the Schlenk technique.
In a flame-dried flask and under argon, 3-bromo-2-chloropyridine (19 in Figure IV-2) (249 mg,
1.29 mmol, 20 eq.) was dissolved in 3.0 ml anhydrous tetrahydrofuran (THF). After cooling the solution
to -78°C, tert-butyllithium (t-BuLi) (1.7 M in pentane, 2.59 mmol, 1.52 ml, 40 eq.) was added dropwise.
CAUTION: solutions of t-BuLi react explosively with water and may ignite in moist air.
The mixture (brown-red) was stirred at -78°C and after 30 min, silicon xanthone (17 in Figure IV-2) [30]
dissolved in anhydrous THF (2.0 ml) was added drop-wise at the same temperature (mixture turned
deep red). After 2 min, the mixture was brought to RT (mixture turned dark) and the reaction was
stirred for 4 h. Subsequently, water and dichloromethane (DCM) were added. After adding some drops
of 1 N HCl (organic phase turned deep blue), the organic phase was separated, and the water phase
was extracted with DCM several times. Brine and sodium sulfate were used for drying of the organic
phase. Following filtration, the solvents were evaporated in vacuo. Flash column chromatography
(silica gel, 0.032 mm–0.062 mm, 1% to 10% methanol in DCM) was used for purification of the product
(15 in Figure IV-2) (deep blue solid) using manual techniques.
15 German Cancer Research Center, Division of Radiopharmaceutical Chemistry, Heidelberg, Germany
IV.2 Novel Probes for Live Cell STED Imaging 151
IV.2.3.2 Analytics
Nuclear magnetic resonance (NMR) spectra were acquired on an Avance III 400 MHz NMR
spectrometer (Bruker Daltonics) at RT. The chemical shifts are given relative to methanol-d4 in units of
 (  = 3.31;  = 49.0) [944]. For the first-order analysis, the following abbreviations were used: s –
singlet, d – doublet, t – triplet, dd – doublet of doublet, etc., m – multiplet. The coupling constants J
refer to H,H-couplings and are reported in Hz. Distortionless enhancement by polarization transfer
(DEPT) and heteronuclear single quantum correlation (HSQC) experiments were used for assignment
(CH, CH2, CH3, Cquart).
Mass spectra were acquired in the Department of Organic Chemistry, University of Heidelberg,
(Heidelberg, Germany) using the electrospray ionization (ESI) method with an Apex-Qe hybrid 9.4 T FT-
ICR mass spectrometer (Bruker Daltonics). High-resolution mass spectrometry (HRMS) was performed
with a JMS-700 MStation mass spectrometer (JEOL). The molecule fragments are given in mass-to-
charge (m/z) ratio.
Analytical thin-layer chromatography (TLC) was conducted on polygram-DC-plates (40 × 80 mm, SIL
G/UV254, 0.2 mm layer thickness, Machery-Nagel). UV light (254 nm or 366 nm) was used for
detection. Reversed-phase TLC was performed on alugram-DC-plates (40 × 80 mm, RP-18 W/UV254,
0.15 mm layer thickness, Machery-Nagel).
For computing clogP, ChemDraw Professional 16.0.1.4 (PerkinElmer) was used.
IV.2.3.3 Spectral Properties
The SiR dye 15 stock solution (4.67 mM in acetonitrile (MeCN)) was diluted in either PBS pH 7.4 or
MeCN to 15.5 µM for UV–vis/NIR absorbance recording or to 4.7 µM for fluorescence emission
recording. Dilutions were measured in standard 1 cm quartz cuvettes. The absorbance of SiR dye 15
was recorded in the 200-800 nm interval with a Varian Cary 500 UV-VIS NIR Spectrophotometer
(Agilent) equipped with the software Cary 500 (EPROM Version 8.01). With excitation at 600 nm, the
fluorescence emission of SiR dye 15 was measured in the 610-800 nm interval with a Varian Cary
Eclipse Fluorescence-Spectrophotometer (Agilent) equipped with the software Cary Eclipse (Version
1.1). The extinction coefficient  was calculated for the absorbance maximum according to
Lambert–Beer.
IV.2.3.4 Fluorescence Quantum Yield
Determination of the fluorescence quantum yield was performed via relative measurements following
the literature procedure [945, 946]. Nile blue (  = 0.27) was used as reference standard dye [947].
Considering an absorbance between 0.01 and 0.1 at the excitation wavelength of 600 nm, the stock
solutions of SiR dye 15 (4.67 mM in MeCN) and Nile Blue (1 mM in DMSO) were diluted as follows:
· SiR dye 15: 4-5 dilutions, 0.8 µM – 4.7 µM in PBS pH 7.4 or MeCN
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· Nile blue: 4-5 dilutions, 0.2 µM – 1.0 µM in 5% (v/v) 0.1 M HCl in EtOH
The absorbance of each dilution was measured in the 200-800 nm interval with a Varian Cary 500 UV-
VIS NIR Spectrophotometer (Agilent) equipped with the software Cary 500 (EPROM Version 8.01).
Subsequently, with excitation at 600 nm, the emission of the respective dilution was measured in the
610-800 nm interval with a Varian Cary Eclipse Fluorescence-Spectrophotometer (Agilent) equipped
with the software Cary Eclipse (Version 1.1). The measurement parameters were kept constant
throughout all measurements.
To determine the fluorescence quantum yield, the wavelength-integrated fluorescence intensity (∫ )
was plotted versus the absorbance at 600 nm ( ). The data were fitted by linear regression. The
slopes as determined by the linear fit were used to calculate the fluorescence quantum yield of SiR dye
15 according to
= (IV-1)
with  ( ) being the fluorescence quantum yield,  ( ) the slope of the linear regression and
 ( ) the refractive index of the solvent of SiR dye 15 (Nile Blue).
IV.2.3.5 Fluorescence Lifetime
Fluorescence lifetime was determined by time-correlated single photon counting (TCSPC) using a
FluoTime 300 Fluorescence Lifetime Spectrometer (PicoQuant). The stock solution of SiR dye 15
(4.67 mM in MeCN) was diluted to 4.7 µM in either PBS pH 7.4 or MeCN. The fluorescence intensity
decay ( ) was recorded with excitation at 640 nm and subsequently fitted using an additive
superposition of exponential functions
( ) = ( ′) ′ (IV-2)
with  being the (possibly)  different fluorescence lifetimes of SiR dye 15,  the corresponding
amplitudes of the individual exponential decays and  the instrument response function.
IV.2.3.6 Cell Culture
The cell lines HeLa and U2OS (Table I-16) were cultured in DMEM++ at 37°C in humidified air with 5%
CO2. HeLa cells were harvested with trypsin 0.25% (no phenol red, Gibco/Thermo Fisher Scientific);
U2OS cells were harvested with trypsin 0.05% EDTA 0.02% (with phenol red, Sigma-Aldrich/Merck). A
Countess II FL Automated Cell Counter (Thermo Fisher Scientific) was used to count cells and to assess
the live-to-dead cell ratio via Trypan Blue stain (0.4%). For live sample preparation, approximately 104
cells/well were seeded on 8-well chambered coverglasses one day prior to the experiment and kept at
37°C in humidified air with 5% CO2 until live cell staining.
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IV.2.3.7 Confocal and STED Microscopy
The custom-built STED system is described in detail in I.2.2.1. The power range for all lasers used during
live cell confocal and STED imaging is given in Table IV-3. Unless otherwise stated, live cell confocal and
STED imaging was performed with the measurement parameters given in Table IV-4. No frame
accumulation was used.
Table IV-3. Range of laser powers used for live cell confocal and STED imaging of SiR dye 15, MitoTracker® Green FM
and LysoTrackerTM Green DND-26.
The values given describe the estimated laser power in the sample focus based on laser power measurements in front of the
microscope body.
excitation STED
470 nm [µW] 650 nm [µW] 775 nm [mW]
confocal, live samples 140 (MitoTracker)20 (LysoTracker) 2.7 ---
STED, live samples --- 5.4 15
Table IV-4. Standard measurement parameters used for live cell confocal and STED imaging of SiR dye 15, MitoTracker®
Green FM and LysoTrackerTM Green DND-26.
pixel size [nm] dwell time [µs] line accumulation
confocal, live samples 50 10 (MitoTracker)20 (LysoTracker) 1
STED, live samples 20 10 1
IV.2.3.8 Colocalization Experiments
For assessing mitochondrial colocalization, HeLa and U2Os cells were stained for 30 min with 1 µM SiR
dye 15 and 100 nM MitoTracker® Green FM (Thermo Fisher Scientific) in FluoroBrite++ at 37°C in
humidified air with 5% CO2. After washing three times with prewarmed FluoroBrite++, the samples
were subjected to live cell dual-color confocal imaging.
For assessing endosomal/lysosomal colocalization, HeLa and U2OS cells were stained for 30 min with
1 µM SiR dye 15 in FluoroBrite++ at 37°C in humidified air with 5% CO2. After washing three times with
prewarmed FluoroBrite++, the samples were imaged live by confocal microscopy in FluoroBrite++
supplemented with 500 nM LysoTrackerTM Green DND-26 (Thermo Fisher Scientific).
For quantifying mitochondrial and endosomal/lysosomal colocalization, the color shift between the
470 nm excitation channel (MitoTracker® Green FM and LysoTrackerTM Green DND-26) and the 650 nm
excitation channel (SiR dye 15) was performed as described in I.2.2.2. The PCC of the corrected images
was calculated with the ImageJ plugin JACoP [470, 695].
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IV.2.3.9 Live Cell STED Imaging
HeLa cells were stained for 1 h with 1 µM SiR dye 15 in FluoroBrite++ at 37°C in humidified air with 5%
CO2. After washing three times with prewarmed FluoroBrite++, the cells were subjected to live cell
STED imaging.
IV.2.3.10 Cytotoxicity Studies
To assess potential cytotoxicity of SiR dye 15, the duration and frequency of cell division was followed
by holographic time-lapse imaging using a HoloMonitor® M4 cytometer (Phase Holographic Imaging).
One day prior to the experiment, U2OS cells were seeded in DMEM++ in lumox® 24-well plates
(Sarstedt) and kept at 37°C in humidified air with 5% CO2. On the day of the experiment, the old
medium of one half of the wells was replaced with fresh DMEM++ containing 1 µM SiR dye 15 and the
old medium of the other half of the wells was replaced with fresh DMEM++ without dye. After 1 h of
incubation at 37°C in humidified air with 5% CO2, all wells were washed three times with DMEM++
before holographic time-lapse imaging was started for a total of 14.5 h with 30 min between image
captures at 37°C in humidified air with 5% CO2. During the experiment, PHI HoloLidsTM (Phase
Holographic Imaging) were used to close the well plate to ensure optimal image quality. Data analysis
was performed with the HstudioM4 software (Phase Holographic Imaging) including cell segmentation,
tracking of dividing cells, confluency measurement, and cell counting.
IV.2.3.11 Data Presentation
Detailed information on data presentation is given in I.2.2.2. Linear deconvolution of the STED data
was performed by applying a Lorentzian PSF (refer to equation (I-5)) with FWHM = 40 nm in lateral
dimension. All line profiles were drawn on raw data and averaged over 5 pixels.
IV.2.3.12 Statistical Aspects
Detailed information on general statistical aspects is given in I.2.2.3.
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IV.2.4 Results and Discussion
IV.2.4.1 Approaches to Synthesize SiR Dye 15
The experimental procedure towards an optimized synthesis of the radiofluorinatable NIR SiR dye 15
is summarized in Table IV-5 and Figure IV-4. In the first step, 3-bromo-2-chloropyridine (compound 19)
was lithiated at -78°C to initiate the HD reaction. In the second step, the silicon xanthone 17 was added
after 30 min. Subsequently, the reaction mixture was brought to room temperature and stirred for
different durations . Using t-BuLi as a lithiation reagent provided the desired product SiR dye 15 as a
deep blue solid but only at 14% yield (Table IV-5, entry 1).
The HD rearrangement of compound 19 is usually performed with substoichiometric amounts of the
lithiating agent (0.5 eq. n-BuLi for 1 eq. compound 19) due to the homotransmetallation mechanism
[938, 940]. Therefore, in the second approach, we used 0.9 eq. of t-BuLi (Table IV-5, entry 2) and 0.5 eq.
of n-BuLi (Table IV-5, entry 3). However, SiR dye 15 was again obtained at poor yield together with
unreacted xanthone 17. The mechanism of the halogen–metal exchange with t-BuLi states that one
equivalent of the base is used for the lithiation, while a second equivalent of base eliminates hydrogen
bromide from the resulting t-BuBr. According to this, our second approach represents the use of
approximately 0.5 eq. of base for 1 eq. of compound 19 (Table IV-5, entry 2 and 3).
Optimization of the reaction was finally achieved by applying more equivalents of the base. After
lithiation of compound 19, the metallated intermediate (2-chloropyridin-3-yl)lithium reacts again with
unreacted compound 19. After several steps of the halogen dance, the lithiated pyridine intermediate
18 results, which can add to the silicon xanthone 17. If more equivalents of the base are used, low
temperatures are crucial for the HD reaction to maintain a coexistence of compound 19 and its
lithiated analogue. By using a large excess of compound 19, the reaction was forced to completeness.
The dihalogenated pyridinyl SiR dye 15 was obtained at 85% yield without monohalogenated
byproduct and without the need for purification (Table IV-5, entry 4). The analytical data of SiR dye 15
are summarized in Table VI-26, Table VI-27, Figure VI-19 and Figure VI-20.
Figure IV-4. Synthesis of SiR dye 15 via HD rearrangement of compound 19.
Optimization of the synthesis of SiR dye 15 is outlined in Table IV-5.
Although the bromine offers the option of further coupling or functionalization of SiR dye 15 via a
nucleophilic substitution, we additionally investigated if the ester analogue tert-butyl 5-bromo-6-
chloronicotinate undergoes a HD reaction and subsequent xanthone addition. The reaction did not
yield any product, neither with n-BuLi nor with t-BuLi. Also, HD reactions of nicotinic acids have not
been reported in the literature. In fact, only methyl groups are tolerated as carbon substituents when
using 2,3-dihalogenated pyridines as the starting material for the HD rearrangement.
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Table IV-5. Optimization of the synthesis of SiR dye 15 via HD rearrangement of compound 19.
Figure IV-4 provides the corresponding scheme of the chemical reaction for this table. * Reaction time after addition of 1 eq.
xanthone 17, † yield based on recovered starting material of xanthone 17.
entry eq. of lithiation reagent eq. of compound 19  [h]* yield of SiR dye 15 [%]
1 20 t-BuLi 10 1.5 14
2 9 t-BuLi 10 24 1428†
3 5 n-BuLi 10 5 11
4 40 t-BuLi 20 4 85
IV.2.4.2 Fluorescence Properties of SiR Dye 15
The dihalogenated pyridinyl SiR dye 15 displays an absorbance maximum at 665 nm with a
corresponding extinction coefficient of  = 34000 M−1cm−1 and a fluorescence emission maximum
at 681 nm with a corresponding fluorescence lifetime of  = 1.9 ns measured in PBS at pH 7.4 (Figure
IV-5,Figure VI-21, Table VI-28). Compared to the azetidine-substituted pyridinyl dye 14, SiR dye 15
shows a red-shift of approximately 10 nm in both absorption and fluorescence emission; compared to
the pyridinyl dye 13, SiR dye 15 shows a 10 nm red-shifted absorption with unchanged fluorescence
emission.
Figure IV-5. Absorbance and fluorescence emission of SiR dye 15.
The absorbance and fluorescence emission of SiR dye 15 in PBS at pH 7.4 peak
at 665 nm and 681 nm. The absorbance spectrum is baseline corrected. Both
spectra are normalized to their maximum.
With  = 0.34, the quantum yield of SiR dye 15 measured in PBS at pH 7.4 is remarkably higher than
that of pyridinyl dye 13 (Figure VI-22, Table VI-29). We assume that the increased quantum yield is
based on a rotation restriction around the pyridinyl–xanthene bond and/or on beneficial effects of the
halogens on the HOMO energy level. Due to the additional contributions of the azetidine rings, the
pyridinyl SiR dye 14 still displays an enhanced quantum yield as compared to SiR dye 15.
Figure VI-21, Figure VI-22, Figure VI-23, Table VI-28 and Table VI-29 comprise the photophysical
properties of SiR dye 15 measured in MeCN.
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IV.2.4.3 Mitochondrial Targeting Ability of SiR Dye 15
To study the predicted targeting ability of SiR dye 15 to mitochondria, HeLa and U2OS cells were co-
stained with SiR dye 15 and the mitochondria staining reagent MitoTracker® Green FM. In live cell
confocal experiments, the colocalization between these two probes was assessed (Figure IV-6). The
average PCC of each cell line was calculated based on the confocal data. With r = 0.85 ± 0.05 (n = 22)
for HeLa cells and r = 0.81 ± 0.05 (n = 27) for U2OS cells, the PCC results are reasonably high, which
confirms the predicted targeting ability of SiR dye 15 to mitochondria.
For selective mitochondria staining, PCCs of r > 0.8 have been correlated with an increased lipophilicity
of clogP > 5 of the respective mitochondrial probe. In this regard, the recently published SiR-Mito 8
especially stands out featuring a PCC of r ≥ 0.9 for mitochondrial colocalization [930]. SiR-Mito 8 offers
a comparable quantum yield to SiR dye 15
(  not available) but is not proven to be
STED compatible. In contrast, SiR dye 15
combines the advantages of further red-
shifted absorption and emission properties
with an increased photostability thus
making it suitable for application in live cell
STED nanoscopy of the mitochondrial
network (refer to IV.2.4.4).
Figure IV-6. SiR dye 15 specifically targets
mitochondria in living human cell lines.
Confocal colocalization experiments of SiR dye 15
(red) and MitoTracker® Green FM (cyan) in (a)
living HeLa and (b) U2OS cells. The results support
the application of SiR dye 15 as a specific NIR
mitochondrial probe. Confocal data are corrected
for color shift and background, scale bar is 5 µm.
In general, the 2-chloropyridinyl moiety in SiR dye 15 targets acidic cellular compartments. To exclude
a potential affinity of SiR dye 15 to endosomes or lysosomes, HeLa and U2OS cells were co-stained
with SiR dye 15 and the endosomal/lysosomal staining reagent LysoTrackerTM Green DND-26. The
colocalization of the two probes was visualized in live cell confocal experiments and the average PCC
of each cell line was calculated based on the confocal data (Figure IV-7).
With r = 0.35 ± 0.06 (n = 13) for HeLa cells and r = 0.38 ± 0.04 (n = 13) for U2OS cells, the PCC results
prove the absence of lysosomal targeting ability, confirming specific mitochondrial staining and
supporting the application of SiR dye 15 as a specific NIR mitochondrial probe (Figure IV-8). We
additionally note that the PCC for endosomal/lysosomal colocalization overestimates the lysosomal
targeting ability of SiR dye 15 as LysoTrackerTM Green DND-26 shows mild but additional mitochondrial
staining.
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Figure IV-7. SiR dye 15 displays no targeting
ability for endosomes or lysosomes in living
human cell lines.
Confocal colocalization experiments of SiR dye 15
(red) and LysoTrackerTM Green DND-26 (gray) in
(a) living HeLa and (b) U2OS cells. The results
strongly suggest the absence of an
endosomal/lysosomal targeting ability of SiR dye
15 and confirm its specificity for mitochondria.
Confocal data are corrected for color shift and
background, scale bar is 5 µm.
Figure IV-8. Pearson correlation coefficients of mitochondrial and
endosomal/lysosomal colocalization of SiR dye 15.
Average PCCs for SiR dye 15/MitoTracker® Green FM (blue, mito) and SiR dye
15/LysoTrackerTM Green DND-26 (gray, lyso) colocalization in HeLa and U2OS
cells. The PCC of each color shift corrected confocal image was calculated with
the ImageJ plugin JACoP [470, 695]. Data are expressed as mean ± SD.
Mitochondrial colocalization HeLa n = 22, U2OS n = 27; lysosomal colocalization
HeLa n = 13, U2OS n = 13; * p < 10-22. All results and p-values are summarized in
Table VI-30.
IV.2.4.4 STED Compatibility of SiR Dye 15
Medical agents must undergo an expensive regulatory process before they attain approval for the
market. Thus, medical imaging probes that can address multiple questions or be applied for different
purposes are highly interesting. In this regard, our probe design aimed not only for the combination of
PET imaging and macroscopic fluorescence imaging. Instead, we strived for a dual-modality PET tracer
that additionally offers the option for application in STED nanoscopy. Histopathological examinations
of biopsy material with subcellular detail require a sufficiently high image resolution and it has been
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shown that mitochondrial morphology constitutes a valid biomarker for cancer phenotype
classification and for drug response analysis [948].
To prove STED compatibility of SiR dye 15, HeLa cells were stained with SiR dye 15 and subjected to
live cell STED imaging. The tubular structure of mitochondria in living HeLa cells was successfully
resolved. We note that the STED power was set as low as possible to avoid photobleaching but as high
as necessary to resolve these structures. Figure IV-9 compares STED images of the mitochondrial
network with their corresponding confocal images. The STED data suggest that SiR dye 15 presumably
targets the outer membrane as it does not visualize cristae. We conclude that SiR dye 15 is a potent
probe for live cell STED imaging of mitochondria.
Figure IV-9. STED imaging of the mitochondrial network in living HeLa cells stained with SiR dye 15.
(a,b) Exemplary STED images (top) of the mitochondrial network in living HeLa cells stained with SiR dye 15 and their
corresponding confocal data (bottom). To the right of each overview image, a magnification of the marked region is shown
in STED (top) and confocal (bottom) mode. Pixel size (a) STED 20 nm, confocal 50 nm, (b) STED and confocal 20 nm. Scale bar
overviews are 5 µm, scale bar close-ups are 2 µm. Note that the overall structure of the mitochondrial network in the
corresponding STED and confocal images in (a) slightly differs due to mitochondrial dynamics and time-sequential recording
(confocal after STED). All STED data are background corrected and linearly deconvolved, all confocal data are background
corrected only. (c) Line profiles (as marked in the close-ups in (a) by white arrows) prove the gain in spatial resolution by STED
(red) compared to confocal (cyan). Line profiles were drawn on background corrected (not deconvolved) data and counts
were averaged over five pixels. The data were fitted with a single (confocal) or double (STED) Gaussian function. The STED
power was set as low as possible to avoid photobleaching but as high as necessary to resolve the tubular structure of
mitochondria.
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IV.2.4.5 Cytotoxicity of SiR Dye 15
In contrast to PET imaging, which only requires pico- to nanomolar amounts of the
radiopharmaceutical compound, medical applications of fluorescence imaging (e.g. fluorescence-
guided interventions) depend on larger amounts of the fluorescent probe. Thus, the absence of
cytotoxicity is a crucial requirement for our proposed dual-modality probe SiR dye 16. Therefore, we
evaluated the degree of cytotoxicity of its precursor, SiR dye 15, based on the frequency and duration
of cell division. U2OS cell proliferation was followed by holographic time-lapse imaging and
quantitatively compared for treated and untreated cells (Figure IV-10) (for details on cytotoxicity
testing of live dyes in general, refer to IV.3).
Neither the duration nor the frequency of U2OS cell division were significantly affected by the
treatment with SiR dye 15. This observation is additionally supported by cell count and confluency
analysis (Figure IV-11). As SiR dye 15 does not affect U2OS cell proliferation, we assume that SiR dye
15 does not induce significant cytotoxic effects in human cells and speculate the same for its
fluorinated derivative.
Figure IV-10. U2OS cell division after treatment with SiR dye 15.
Using holographic time-lapse cytometry with a HoloMonitor® M4 microscope, U2OS cell proliferation was followed for a total
of 14.5 h after 1 h treatment with 1 µM SiR dye 15. The exemplary image sequence (duration 2.5 h, frequency 30 min) displays
two subsequent cell divisions; dividing cells round up and thus can be distinguished from non-dividing cells by height (color
coded). Scale bar is 50 µm.
Figure IV-11. Assessment of the cytotoxicity of SiR dye 15.
Cytotoxicity data are based on holographic time-lapse series (duration 14.5 h, frequency 30 min) of the proliferation of U2OS
cells untreated (cyan) or SiR dye 15 treated (red). (a) Duration of cell division (untreated n = 494, SiR dye 15 treated n = 281).
P-values indicate no significant difference between the untreated and the SiR dye 15 treated conditions. (b) Frequency of cell
division (untreated n = 494, SiR dye 15 treated n = 281). P-values indicate no significant difference between the untreated
and the SiR dye 15 treated condition. (c) Cell count and (d) confluency of untreated (n = 11) and SiR dye 15 treated (n = 8)
U2OS cells. Both measures were normalized to the first frame (t = 0). The results were averaged and SDs are displayed as
shadows in the graphs. P-values indicate no significant difference between untreated and treated U2OS cells. All data strongly
support the absence of cytotoxicity. All results and p-values are summarized in Table VI-31.
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IV.2.5 Conclusion
To exploit the full potential of live cell STED imaging, (bio)chemical progress optimizing both targeting
strategies and fluorophore performance is indispensable. Extending the palette of bright, photostable,
cell permeable, and biocompatible far-red STED fluorophores with derivatives featuring novel
targeting abilities and exceptional characteristics such as dual-modalities, will not only broaden the
application of live cell STED nanoscopy in common life sciences research but also introduce STED
imaging to applications such as clinical diagnostics so far unexplored by STED nanoscopy.
Here, we synthesized and extensively characterized SiR dye 15, a pyridinyl silicon rhodamine dye
featuring the option of implementing a second modality. The application of a halogen dance
rearrangement allowed for the introduction of two halogen atoms adjacent to the xanthene–pyridine
bond of SiR dye 15. The chlorine atom in 2’-position allows for the introduction of the PET radionuclide
18F, potentially yielding a dual-modality PET tracer for hybrid medical imaging approaches (PET/OI).
The bromine atom in 4’-position not only constrains the rotation around the xanthene–pyridine bond
but also serves as a leverage point for further linkage. Our optimized synthesis procedure provided SiR
dye 15 at high yield and without the necessity of further purification.
The improved molecule rigidity introduced by the bulky bromine should reduce non-radiative decay
processes and thus raise the quantum yield of SiR dye 15. Surprisingly, despite being reasonably high,
the quantum yield of SiR dye 15 does not outperform the quantum yield of the monosubstituted
pyridine SiR 14. Additional experiments combined with DFT calculations must address the orbital
effects of both halogens and the nitrogen position in the pyridine ring to explain these findings with
confidence.
Just like the recently published squaraine dye variant MitoESq-635 [949], our SiR dye 15 provides the
option for live cell STED imaging of mitochondria without the necessity of an additional tagging step.
In contrast to MitoESq-635, SiR dye 15 presumably targets the outer membrane and does not visualize
cristae. Still, SiR dye 15 selectively stains mitochondria without background from unspecific membrane
staining as is the case for MitoESq-635. However, due to a higher photostability and a lower saturation
intensity  for STED, MitoESq-635 shows better performance in time-lapse live cell STED imaging of
mitochondria. Different from MitoESq-635, the recently published SiR-Mito 8 offers highly specific
mitochondrial targeting without background from unspecific membrane staining, but SiR-Mito 8 is not
proven to be STED compatible. Thus, our SiR dye 15 represents a valid compromise between MitoESq-
635 and SiR-Mito 8 by offering biocompatible, specific mitochondrial staining in live cell STED imaging.
Compared to other NIR SiR dyes with similar spectral properties [29, 31, 33], our SiR dye 15 displays
photophysical properties ( , , ) in the same range, but rather at the lower end. However, its
photophysical performance is in line with the group of SiR probes directly targeting certain cellular
structures or organelles [31, 353, 354, 423]. Amongst these STED compatible SiR probes, to the best of
our knowledge, none target mitochondria and thus SiR dye 15 is the first to extend the list of STED
compatible SiR probes for direct labeling with a NIR mitochondrial SiR probe.
Taken together, we synthesized and characterized a biocompatible, non-toxic, STED compatible NIR
SiR dye specifically targeting mitochondria in living cells. SiR dye 15 not only features excellent optical
properties for biomedical imaging but additionally provides the option of subsequent radiolabeling.
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Due to the intrinsic mitochondrial targeting ability of SiR dye 15, its radiolabeled analogue could be
applied for diagnostic and therapeutic purposes in medical multimodal (PET/OI) imaging of
mitochondria in, e.g., cancer patients. In this scenario, the STED compatibility would allow for the
histopathological examination of biopsy material with highest detail after the localization of lesions via
PET imaging. The (radio)fluorination of SiR dye 15 is the subject of current research.
IV.3 CYTOTOXICITY IN LIVE CELL STED IMAGING
IV.3.1 Motivation
Like any other live cell fluorescence nanoscopy technique, live cell STED imaging is confronted with
two main factors of potential cell damage. While phototoxicity accounts for any damage induced by
the light energy deposited in the sample (refer to I.1.4), cytotoxicity refers to the direct chemical
toxicity induced by the fluorescent label (ligand plus fluorophore) and the imaging buffer.
In both cases, the biological subject of interest is potentially affected and the imaging results are
altered, no longer describing the biological reality of a viable cell [272]. In general, the sample health
should be of major interest for any live cell imaging application and other imaging parameters must
certainly be optimized for the biological question but not overdone (refer to I.1.5). Both phototoxicity
and cytotoxicity are well-known aspects of fluorescence microscopy. However, phototoxicity has just
recently started to gain increasing attention in the live cell imaging community with particular focus
on fluorescence nanoscopy [289, 303, 305, 879, 891, 950, 951]. In comparison, cytotoxicity in live cell
fluorescence nanoscopy is still addressed insufficiently.
Comprehensive studies that systematically quantify the cytotoxicity of live dyes applicable in
fluorescence nanoscopy and further correlate the results to their structural features remain to be
reported. It is suggested that neutral, hydrophobic fluorophores and anionic fluorophores induce less
cytotoxicity than cationic fluorophores [952]. However, many positively charged lipophilic dyes display
membrane association and bind non-specifically [953]. Anionic fluorophores (usually sulfonates or
phosphates) are essentially restricted to fixed cell staining as these probes are not cell membrane
permeable. Hence, choosing the appropriate dye is crucial to prevent biasing effects of the dyes on
cellular interactions and processes eventually leading to misinterpretations when comparing data
obtained with different probes.
Most of the live dyes published during the last few years are electronically neutral, hydrophilic and
designed with particular attention to compatibility with living cells [29-36, 353, 354, 405, 916, 922] (refer
to I.1.6.1). Still, amongst this valuable flood of reports on novel probes for live cell fluorescence
nanoscopy, only a few studies have rigorously investigated the cytotoxicity of their newly proposed
live dyes [32, 353, 354, 954]. As the field is still in its infancy though, follow-up studies on the
cytotoxicity of already published live dyes can be expected.
The selected studies that include cytotoxicity assessment have evaluated the sample health
consequences of targeted labeling with their novel live dyes. Thus, the results always represent the
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combined cytotoxic effect of the dye itself and the affinity probe (e.g. docetaxel as a small molecule
binder for tubulin) [32, 353, 354, 954]. These insights are exceptionally valuable as it is eventually the
combination of dye and targeting strategy that must be non-toxic to the cell. However, for further dye
optimization and novel dye design, it is crucial to understand the dyes’ individual contribution to
cytotoxicity and relate it to specific features of the dyes’ chemical structure.
Cell viability refers to the fraction of healthy cells in a sample and numerous cytotoxicity assays have
been established to monitor this parameter. Many of these assays exploit general cell functions such
as enzyme activity, cell membrane integrity, NADH concentration and ATP production. The common
drawback of all metabolic assays is their inability to differentiate between actively dividing and
quiescent cells. Some of these methods even constitute terminal assays as they interfere with or
destroy the cell’s functioning [955].
In contrast, the non-invasive observation and the quantitative analysis of cell proliferation avoids these
downsides. Cell proliferation offers not only a universal but also a sensitive measure for cell viability.
The finely tuned coordination of different cell cycle checkpoints and in particular the transitions from
the growth phase 1 (G1) to the DNA synthesis phase (S) and from the growth phase 2 (G2) to mitosis
(M) are essential for maintaining genome integrity and thus represent crucial prerequisites for a
successful cell division. DNA replication itself is a delicate process requiring the highest fidelity as it is
orchestrated by a complex replisome that must ensure not only complete duplication of the genetic
material but also the maintenance and propagation of chromatin states [956].
Digital holographic microscopy provides the technique to observe cell proliferation over extended time
periods. Its technology is based on quantitative phase imaging and offers label-free, non-invasive
visualization and quantification of living cells without compromising cell integrity. Digital holographic
microscopy is an interferometric imaging technique that records amplitude and phase information of
an object wave in form of holograms. As living, unstained cells are rather translucent and do not
absorb, emit or scatter light to any significant extent, the amplitude change of a sample beam passing
through these cells can be neglected. However, as the refractive index of cells (especially of the
nucleus) differs from the surrounding medium, the cells imprint a phase-shift onto the sample beam.
From the hologram, this phase delay can be numerically reconstructed into a phase image displaying
the morphology and 3D optical properties of the cells (Figure IV-12) [957].
Figure IV-12. Schematic illustration of digital
holographic microscopy.
A low-intensity laser beam is split into a reference
beam and a sample beam. The phase of the
sample beam is delayed upon passing through
the sample as the cells’ interiors feature a
different optical density as compared to the
surrounding medium. Once combined, the
reference beam and the phase-shifted sample
beam interfere and create a hologram on the
image sensor, which is used to compute the 3D
phase image.
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IV.3.2 Aim
To not alter the imaging results by affecting the biological process, the biological structure or its
dynamics of interest, sample health should be treated as the essential parameter during live cell
experiments. Any impairment of cell viability might eventually lead to the acquisition of biological
artefacts. Besides phototoxicity, potential cytotoxicity of the applied fluorophores must be also
excluded to achieve thoroughly biocompatible imaging conditions. As DNA replication is a sensitive
process depending on a properly functioning cell proliferation machinery, the cell division frequency
and duration provide meaningful measures to assess cytotoxic effects.
The aim of this project was to evaluate potential cytotoxicity of several recently developed live cell
STED compatible dyes. Therefore, the influence of different concentrations of these probes on the
proliferation behavior of U2OS cells was investigated. To non-invasively assess the effect on the
frequency and duration of U2OS cell division, holographic cytometry studies were conducted, different
proliferation parameters quantified, and the results compared to those of proliferation measurements
of untreated U2OS cells.
The work presented in the following section has not been published yet but extends the already
published work of Butkevich, A.N., Belov, V. N., Kolmakov, K., Sokolov, V. V., Shojaei, H., Sidenstein, S.
C., Kamin, D., Matthias, J., Vlijm, R., Engelhardt, J., Hell, S. W., Hydroxylated Fluorescent Dyes for Live-
Cell Labeling: Synthesis, Spectra and Super-Resolution STED. Chemistry, 2017. 23(50): p. 12114-12119.
[32].
IV.3.3 Methods
Detailed information on materials is given in I.2.1.
IV.3.3.1 Cell Culture
The cell line U2OS (Table I-16) was cultured in DMEM++ at 37°C in humidified air with 5% CO2. The cells
were harvested with trypsin 0.05% EDTA 0.02% (with phenol red, Sigma-Aldrich/Merck). A Countess II
FL Automated Cell Counter (Thermo Fisher Scientific) was used to count cells and to assess the live-to-
dead cell ratio via Trypan Blue stain (0.4%). For sample preparation, approximately 105 cells/well were
seeded one day prior to the experiment in DMEM++ in lumox® 24-well plates (Sarstedt) and kept at
37°C in humidified air with 5% CO2 until holographic time-lapse imaging.
IV.3.3.2 Cytotoxicity Studies
To assess potential cytotoxicity of the new live dyes 580CP-BG/-Halo, 610CP-BG/-BC/-Halo, 640SiRH-
BG/-BC/-Halo [29, 32] (BG = SNAP-tag ligand, BC = CLIP-tag ligand, Halo = HaloTag ligand) and SNAP-
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Cell® 647-SiR (New England Biolabs) [404], the duration and frequency of U2OS cell division was
followed by holographic time-lapse imaging using a HoloMonitor® M4 cytometer (Phase Holographic
Imaging). The old medium was replaced with fresh DMEM++ containing either 1 µM or 5 µM of the
respective live dye and holographic time-lapse imaging was started for a total of 48 h with 15 min
between image captures at 37°C in humidified air with 5% CO2. During the experiment, PHI HoloLidsTM
(Phase Holographic Imaging) were used to close the well plate to ensure optimal image quality. Data
analysis was performed with the HstudioM4 software (Phase Holographic Imaging) including cell
segmentation, tracking of dividing cells, confluency measurement, and cell counting.
IV.3.3.3 Data Presentation
Detailed information on data presentation is given in I.2.2.2.
IV.3.3.4 Statistical Aspects
Detailed information on general statistical aspects is given in I.2.2.3.
IV.3.4 Results and Discussion
To evaluate potential cytotoxic effects of the popular SiR dye [30, 404] and of the recently published
live cell STED compatible dyes 580CP, 610CP [29] and 640SiRH [32], U2OS cells were incubated for 48 h
with 1 µM and 5 µM of the respective SNAP, CLIP and Halo derivatives. Holographic time-lapse
cytometry enabled concurrent observation of the cell proliferation. The system used (HoloMonitor®
M4) illuminates the sample with a 635 nm laser. At this wavelength, the absorption of 580CP is
negligible. However, 610CP absorbs mildly and 640SiRH and SiR absorb strongly at 635 nm. A
significant impact of phototoxicity on the measurement results can be excluded though as the laser
excites under non-saturating conditions (0.2 mW/cm2) (refer to I.1.4).
U2OS cell proliferation was observed for all tested conditions. Figure IV-13 shows exemplary
holographic image sequences of U2OS cell divisions in the presence of either 1 µM 610CP-BG or 1 µM
640SiRH-Halo. As dividing cells contract upon mitotic chromatin condensation, they can be
distinguished by shape and height from non-dividing cells. Cell segmentation of the corresponding 2D
data allowed for cell counting and cell tracking and thus the quantitative analysis of cell proliferation.
Based on the initial number of cells at the beginning of the experiment (t = 0) and the total number of
observed cell divisions during the experiment, the average frequency of cell division per cell and day
was computed for each condition. The results were compared to those of control measurements of
the proliferation of untreated U2OS cells (Figure IV-14a). At the tested concentrations of 1 µM and
5 µM, none of the investigated dye derivatives significantly reduced the U2OS cell division frequency.
Surprisingly, 1 µM 580CP-BG and 1 µM 640SiRH-BC even slightly increased the division rate. As these
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two derivatives share neither obvious commonalities in the dye moiety (carbopyronine vs. silicon
rhodamine) nor in the enzyme specific substrate moiety (benzylguanine vs. benzylcytosine), a direct
correlation between influence on division frequency and structural features could not be identified.
Figure IV-13. U2OS cell divisions in the presence of the live dyes 610CP-BG and 640SiRH-Halo.
Using holographic time-lapse cytometry with a HoloMonitor® M4 microscope, U2OS cell proliferation was followed for a total
of 48 h in the presence of the recently published [29, 32] live cell STED compatible dyes 610CP-BG (1 µM, top) and 640SiRH-
Halo (1 µM, bottom) (BG = SNAP-tag ligand, Halo = HaloTag ligand). In the exemplary image sequences (duration 1.75 h,
frequency 15 min), dividing cells round up and thus can be distinguished from non-dividing cells by height (color coded). Scale
bars are 50 µm.
Individual tracking of dividing cells enabled the quantitative analysis of the duration of U2OS cell
division. Figure IV-14b illustrates the results as histograms for each derivative binning the relative
number of divided cells into time windows of the length of the inverse image acquisition frequency
(15 min). Except for 5 µM 610CP-Halo, none of the tested derivatives significantly slowed down U2OS
cell division. In contrast, 1 µM 580CP-BG, 1 µM and 5 µM 610CP-BG, 1 µM 610CP-Halo and 1 µM
640SiRH-BG even decreased the division duration. Interestingly, most of these division accelerating
derivatives are carbopyronines coupled to benzylguanine. However, to correlate these characteristics
with certainty, further studies are pending.
As the results of the division duration do not entirely mirror the results of the division frequency, it is
evident that the rate and the duration of cell division are not necessarily dependent and can be
individually affected. Thus, these parameters are not redundant, and it is worthwhile analyzing both
to assess cytotoxic effects.
Based on the segmented phase images, the time series of the cell count (Figure IV-15) and of the
confluency (Figure VI-24) were computed for each condition. It should be noted that the time series of
the cell count is directly linked to the cell division frequency. Still, the analyses towards these
parameters differ and thus the time series of the cell count was used to confirm the results of the
division rate. The cell count itself further correlates with the confluency of the sample. However, the
cell area additionally affects the confluency and thus the time series of the cell count and of the
confluency are only redundant under the assumption of an unchanged cell area, which is not
necessarily given.
As expected from the results of the U2OS division rate analysis, the cell count time series of all tested
derivative conditions do not strongly deviate from the result of the control measurements. Due to the
increased frequency of U2OS cell division in the presence of 1 µM 580CP-BG and 1 µM 640SiRH-BC,
the data points of the cell count time series of these two conditions lie above the data points of the
control time series. The results of the U2OS cell division duration are not mirrored in the time series
of the cell count.
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Figure IV-14. Duration and frequency of U2OS cell division in the presence of various live cell STED compatible dyes.
Cytotoxicity data are based on holographic time-lapse series (duration 48 h, frequency 15 min) of U2OS cell proliferation in
the presence of 1 µM and 5 µM of SNAP (BG), CLIP (BC) and Halo derivatives of the popular SiR dye [30, 404] and the recently
published [29, 32] live cell STED compatible organic dyes 580CP, 610CP and 640SiRH. The data are compared to the control
measurements of the proliferation of untreated U2OS cells (gray). (a) Frequency of cell division. P-values indicate no
significant difference between the control and the dye treated conditions, except for the 1 µM 580CP-BG and 1 µM 640SiRH-
BC conditions (* p < 0.05, ** p < 0.005). (b) Duration of cell division. P-values comparing the average duration of the control
and the dye treated conditions indicate a retardation of U2OS cell divisions for the condition 5 µM 610CP-Halo and an
acceleration of U2OS cell divisions for the conditions 1 µM 580CP-BG, 1 µM and 5 µM 610CP-BG, 1 µM 610CP-Halo and 1 µM
640SiRH-BG. All results, n-values and p-values are summarized in Table VI-32.
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Figure IV-15. Time series of the U2OS cell count in the presence of various live cell STED compatible dyes.
Cytotoxicity data are based on holographic time-lapse series (duration 24/44.25/48 h, frequency 15 min) of U2OS cell
proliferation in the presence of 1 µM and 5 µM of SNAP (BG), CLIP (BC) and Halo derivatives of the popular SiR dye [30, 404]
and the recently published [29, 32] live cell STED compatible organic dyes 580CP, 610CP and 640SiRH. The data are compared
to the control measurements of the proliferation of untreated U2OS cells (dark gray data points). The cell count (#cells) was
normalized to the first frame (t = 0). The results were averaged and SDs are displayed as shadows in the graphs. Average p-
values indicate no significant difference between untreated and treated U2OS cells. All results, n-values and p-values are
summarized in Table VI-32.
To analyze significant differences between the cell count time series of the control measurements and
the cell count time series of the tested dye derivatives, the p-values were computed for each time
point and averaged over the experiment duration (Table VI-32). The average p-values suggest no
significant differences between the tested conditions and the control in the time series of the cell
count. However, in this approach, the correlation of the cell count over time is lost. As soon as the
curve of a time series of a certain condition constantly lies below or above the curve of the control
time series, it can be assumed that a significant difference exists. Consequently, the data displayed in
Figure IV-15 suggest that especially 5 µM 580CP-BG and 1 µM 610CP-BC slightly compromise U2OS cell
proliferation whereas especially 1 µM 580CP-BG, 1 µM 610CP-Halo and 640SiRH-BC slightly stimulate
U2OS cell proliferation.
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Overall, the confluency time series confirm the results of the cell count analysis (Figure VI-24). Minor
differences (e.g. 1 µM 580CP-BG) as well as the larger SDs are assigned to imprecise cell segmentation.
The confluency measure more strongly relies on precise cell segmentation than the cell count does.
The cell count solely requires the correct identification of individual cells whereas the confluency
additionally depends on a proper sketch of the cell outline. Changing image quality during a
measurement series can significantly hamper a consistently precise segmentation of the cell area,
which directly affects the confluency but not the cell count.
Taken together, the results of the holographic cytometry studies strongly suggest the absence of
pronounced cytotoxicity of SNAP, CLIP and Halo derivatives of the live cell STED compatible dyes
580CP, 610CP, 640SiRH and SiR at concentrations up to 5 µM. Literature only provides comparable
cytotoxicity data acquired with 5 µM of the free carboxylic acid dyes 580CP-COOH and SiR-COOH. In
the respective study, both dyes were also proven to be non-toxic in experiments analyzing the
population distribution over the cell cycle [954].
Although none of the tested dye derivatives unambiguously induced cytotoxic effects, namely severe
retardation of cell proliferation, inhibition of cell proliferation, apoptosis or necrosis, certain
derivatives influenced U2OS cell proliferation more than others. Table IV-6 provides an overview of
the results. In particular, 580CP-BG and 610CP-Halo affected the cell proliferation behavior the most,
whereas 580CP-Halo, 640SiRH-Halo and SNAP-Cell® 647-SiR did not significantly alter it. From these
results, the proliferation influence cannot be conclusively linked to a certain dye, dye type or enzyme
specific substrate. However, it must be emphasized that regardless of the direction of deviation from
the control (retardation or acceleration), changed cell proliferation behaviors are first signals of cell
stress. The cellular stress response includes an increased production of ROS. At low levels, ROS even
stimulate proliferation, while at higher levels they cause senescence or even cell death [958, 959].
Table IV-6. Summary of the results of the cytotoxicity study of SNAP, CLIP and Halo derivatives of selected live cell STED
compatible organic dyes.
Green – no apparent effect on U2OS cell proliferation, red – U2OS cell proliferation is slightly impaired, yellow – U2OS cell
proliferation is slightly stimulated; * SNAP-Cell® 647-SiR [404].
580CP 610CP 640SiRH SiR*
BG Halo BG BC Halo BG BC Halo BG
c [µM] 1 5 1 5 1 5 1 5 1 5 1 5 1 5 1 5 1 5
frequency
duration
#cells
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IV.3.5 Conclusion
Live cell STED nanoscopy is attracting an increasing amount of attention as it enables the extraction of
information at unprecedented detail as close as possible to biological reality given the absence of
phototoxicity and cytotoxicity (refer to I.1.5). In the early days of STED nanoscopy, live cell labeling
techniques were already available, but truly biocompatible organic dyes were missing [387]. In recent
years though, rapid progress in the field of live cell STED compatible organic dye development has
provided a color palette of photostable, bright and cell membrane permeable dyes [29-34, 353, 354,
916, 954]. If not conjugated to small molecule binders, these dyes are commonly applied as SNAP, CLIP
or Halo derivatives to specifically stain fusion constructs of the respective self-labeling protein tags.
So far, no study has systematically investigated potential cytotoxic effects of these live dye derivatives.
However, the absence of cytotoxicity is a prerequisite for drawing biologically meaningful conclusions
from live cell imaging data. Therefore, this project studied the influence of SNAP, CLIP and Halo
derivatives of the live cell STED compatible NIR dyes 580CP [29] 610CP [29], 640SiRH [32] and SiR [30]
on the proliferation behavior of U2OS cells. All tested dye derivatives did not induce pronounced
cytotoxic effects at concentrations up to 5 µM. However, certain derivatives, namely 580CP-BG and
610CP-Halo, slightly affected the proliferation behavior of U2OS cells. For sensitive specimens and
delicate biological questions, these dye derivatives should rather be avoided, favoring instead
derivatives such as 580CP-Halo, 640SiRH-Halo and SNAP-Cell® 647-SiR, which did not alter the
proliferation behavior in the present study.
The results only provide hints towards a general accelerating effect on the cell division duration by
carbopyronines conjugated to benzylguanine. To confirm this speculation and to potentially identify
other correlations between structural features and altered proliferation behaviors, further dedicated
studies are required. Moreover, repeating the experiments with other cell lines is necessary to confirm
the current results. Complementary cytotoxicity studies using the tested derivatives in the labeling of
well-selected cellular targets are crucial to understanding the individual contributions of the single
components of live cell sample preparations. Certainly, this also involves testing of the potential
cytotoxicity of sample preparation agents that are added to protect the fluorophores from
photobleaching (e.g. ROXS) or to prevent the cells from actively clearing their cytosol of dye (e.g.
verapamil).
As the field of live cell STED compatible organic dyes is still young and the awareness for the
importance of cell viability is continuously growing in the live cell imaging community, comprehensive
cytotoxicity studies of live dyes can be expected in the near future. The results of this current project
together with the results of these pending studies will facilitate the choice of the right dye for the
individual biological application. The more comprehensively the available live dyes are characterized,
the easier the choice, as it is not only the photostability, the brightness, the spectral properties, and
the cell permeability that matters in live cell STED nanoscopy.
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IV.4 IMAGE RESTORATION IN LIVE CELL STED IMAGING
IV.4.1 Motivation
The information content of fluorescence images is not only determined by the resolving power of the
optical system used. Indeed, the final image quality and the effective image resolution in live cell
fluorescence microscopy is strongly affected by several partially interdependent imaging parameters
comprising the temporal resolution, observation time, SNR, FOV, imaging depth, fluorophore
performance, fluorophore density and sample health [289, 951].
Simultaneous optimization of all imaging parameters is impossible, and trade-offs are thus inevitable.
To a certain extent, these compromises can be alleviated by optimizing hardware and data acquisition
strategies. However, physics sets limits that cannot easily be overcome with living and moving samples.
Rationally applied, computational approaches enhancing the final image quality can be used to restore
biological information. Sophisticated strategies comprise resolution-enhancing post-processing
algorithms as applied in the diverse variants of SIM [98], SOFI [333] and SRRF [335], deconvolution
[960-962], surface projection algorithms [963, 964], denoising methods [965-967] and image
restoration based on deep learning [308, 682-684]. It must be noted that in image processing terms
`super-resolution´ refers to algorithms performing resolution enhancing post-processing operations
(e.g. SIM, SOFI, SRRF) and should not be confused with the optical methods of nanoscopy. In the
remaining part of this section, `super-resolution´ is used in the sense of image processing.
The term `image restoration´ generally describes the recovery of the original signal from a degraded
observation. Image restoration differs essentially from image enhancement with the latter being
simply concerned with making the image look more pleasing to the observer without the scientific
intent to produce realistic data. In order to enhance the information content of an image, as is the
objective in image restoration, obviously this information must be provided from a source other than
the actual image of degraded quality. Thus, the typical image restoration problem is decomposed into
the question of accurately matching the structures in the image and into the question of reintroducing
as far as possible the information that was lost during the process of data acquisition (degradation). In
image processing terms, the former is referred to as achieving `data fidelity´ and the latter is referred
to as achieving `regularization´.
For the design of a restoration algorithm,
· a mathematical model for the degradation process must be formulated,
· a quality metric that sets the goal of the restoration process must be defined,
· a regularization procedure that accounts for typical detail structures of the images under
consideration must be developed, and
· a mathematical algorithm that achieves this goal must be implemented [968].
As a lens-based method, fluorescence microscopy is confronted with the phenomenon of diffraction
and thus with image degradation caused by optical blurring, which is characterized by the individual
PSF of the respective optical system (refer to I.1.1). Further sources of blur comprise sample motion
and out-of-focus signal. Acquired by photon-counting detectors such as APDs, fluorescence images are
usually degraded by noise with mixed Poisson-Gaussian statistics. Compared to photography (~105
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photons per pixel), the signal in fluorescence microscopy (~102 photons per pixel) is generally weak
and the fluorescence signal is quantized due to the discrete nature of photons. While Gaussian noise
dominates in photography, it is Poisson noise, also referred to as shot noise, that prevails in
fluorescence microscopy.
Poisson-Gaussian noise has been extensively addressed by numerous denoising methods [969-971],
and joint approaches additionally adding deconvolution [972-975] or super-resolution [976] have been
proposed. Most of these methods are designed within a maximum a posteriori (MAP) framework [971,
973-976]. MAP approaches require the manual adaptation of a regularization parameter defining the
trade-off between the data fidelity term and the regularization term to guarantee best performance.
This problem can be bypassed by approximating the minimum mean square error (MMSE) estimate
[969, 972] and Marnissi et al. have used variational Bayesian approximation to compute the MMSE
estimate and the regularization parameter [977].
Often, image restoration problems are treated through an application of Bayes’ theorem [978] relating
the conditional probabilities  between two separate events or logical conditions  and
( | ) =
( | ) ⋅ ( )
( )
(IV-3)
where ( | ) is the conditional probability that  occurs (is fulfilled) given that  has occurred (is
fulfilled) and vice versa for ( | ). Further, ( ) and ( ) are the probabilities of observing  and
independently without knowledge of prior events or conditions.
In the application of image restoration,  represents the true image to be approximated by the
restored image and  represents the acquired, degraded image. Note that ( ) can be ignored since
the availability of a degraded image can be assumed:
( | ) ∝ ( | ) ⋅ ( ) (IV-4)
Importantly, ( | ) is interpreted as the quantity to be maximized such that  becomes the most
probable estimate of the true image, i.e. the restored image, and is often referred to as the posterior
distribution. On the other hand, ( | ) represents the probability that the ideal image  leads to the
observed image , including degrading effects of noise, motion blur and PSF. The factor ( ), referred
to as the prior distribution, encodes correlations typical for true images in the relevant domain. This
includes the expected behavior of contrast, textures and colors.
A Bayesian MMSE estimate is statistically more sound than a MAP estimate as it is based on the whole
model distribution and thus exploits more information. For non-convex problems though, MMSE
estimate computing is difficult. A trained non-convex probabilistic generative image prior has been
applied in methods for denoising and deblurring of additive Gaussian noise [979, 980]. In these
approaches, an efficient block Gibbs sampler has been used to average model samples for
approximating the MMSE estimate. A regularization parameter has not been needed as the MMSE
estimation operates in a purely generative setting. Due to its more complex statistics, Poisson-
Gaussian noise cannot be addressed by the Gibbs sampler though.
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IV.4.2 Aim
Fluorescence microscopy is confronted with Poisson-Gaussian noise with a dominating Poisson
contribution due to its inherently weak signal. Particularly live cell data are affected by a degraded SNR
as sample health demands conservative imaging parameters. The performance of deconvolution or
denoising approaches that consider only one type of noise is usually insufficient for images suffering
from noise of mixed Poisson-Gaussian statistics.
Thus, the aim of this project was the validation of a novel Bayesian method that restores images with
mixed Poisson-Gaussian noise by simultaneously applying deconvolution, denoising as well as super-
resolution. The restoration model was conceived based on a likelihood approximated by a
superposition of Gaussians to model the statistics of Poisson-Gaussian noise and a generative Markov
random field image prior. For efficient inference, a block Gibbs sampler was defined, and image
restoration was performed by approximating the Bayesian minimum mean squared error estimate in
a sampling-based scheme. To characterize the performance of the newly developed method, it was
applied to live cell STED data of U2OS telomeres indirectly stained via a SNAP-tag/TRF2 fusion
construct.
The work presented in the following sections has been published as Gao, Q., Eck, S., Matthias, J., Chung,
I., Engelhardt, J., Rippe, K., Rohr, K. , Bayesian Joint Super-Resolution, Deconvolution, and Denoising of
Images with Poisson-Gaussian Noise. 2018 IEEE 15th International Symposium on Biomedical Imaging
(ISBI 2018), 2018: p. 938-942. [981].
IV.4.3 Methods
This project was conducted in close collaboration with the DKFZ Division of Biomedical Computer
Vision (Heidelberg, Germany), who initiated and directed the effort. Detailed information on materials
is given in I.2.1.
IV.4.3.1 Model Formulation and Sampling-Based Inference
For a detailed formulation of the model and an in-depth description of the sampling-based inference,
refer to the methods section in Gao et al. [981]. Briefly, the image restoration is based on the posterior
distribution in a Bayesian framework:
( | ) ∝ ( | ; ) ∙ ( ; ) (IV-5)
with ∈ ℝ  being the degraded (noisy, blurry, low-resolution) image, ∈ ℝ  being the true image
to be restored,  being the likelihood distribution parameters and  being the prior distribution
parameters. Above,  represents the number of pixels in the degraded image and > 1 represents
the linear super-resolution scaling factor. For super-resolution, every pixel in the degraded image is
mapped onto ×  pixels in the higher resolution image. Clearly, a meaningful increase in image
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resolution must draw on additional information not present in the degraded image. This role is taken
by the prior distribution .
The likelihood model is inferred by assuming Poisson-Gaussian noise. Thus, the intensity of each pixel
 in the observed image  can be described by:
= + (IV-6)
with  following a Poisson distribution,  being a gain factor that controls the Poisson noise strength
and ~ ( , ) being additive Gaussian noise. The convolution of  with the PSF  and the
discretization  into image pixels is represented by:
=
1
( ⨂ ) =
1
(IV-7)
where  represents a linear operator combining the effects of the PSF  and the downsampling ∈
ℝ × . With pixels in  assumed to being mutually independent, the likelihood model is defined by:
( | ; ) = ( | ) (IV-8)
For the prior model, a filter-based, high-order Markov random field (MRF) image prior is used as
described previously [982]. The model parameters  of the prior distribution are obtained from
unsupervised learning from training images.
The image  is restored to the best estimate  from the degraded image  by using the Bayesian MMSE
estimate
E( | ) = arg min | − | ( | ; , ) (IV-9)
Sampling-based approximation of the MMSE is necessary as it cannot be expressed in a closed form.
The likelihood is approximated by a superposition of Gaussians. Together with the MRF image prior, it
allows to define a block Gibbs sampler for efficient inference.
IV.4.3.2 Cell Culture
U2OS cells (Table I-16) were cultured in DMEM++ at 37°C in humidified air with 5% CO2. The cells were
harvested with trypsin 0.05% EDTA 0.02% (with phenol red, Sigma-Aldrich/Merck). A Countess II FL
Automated Cell Counter (Thermo Fisher Scientific) was used to count cells and to assess the live-to-
dead cell ratio via Trypan Blue stain (0.4%). For live sample preparation, approximately 104 cells/well
were seeded on 8-well chambered coverglasses one day prior to transfection and kept at 37°C in
humidified air with 5% CO2 until transfection.
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IV.4.3.3 Live Cell Staining
One day prior to live cell imaging, the cells were transiently transfected at 40-60% confluency with the
N-terminal fusion constructs pSNAPf-TRF2 (refer to II.4.1) using the Effectene Transfection Reagent Kit
(Qiagen) according to the manufacturer’s protocol. At 24 h post transfection, the cells were incubated
for 30 min with a 1 µM staining solution of SNAP-Cell® 647-SiR (New England Biolabs) in DMEM++ at
37°C in humidified air with 5% CO2. Following a 10 min washing step with prewarmed FluoroBrite++ at
37°C in humidified air with 5% CO2, the cells were subjected to live cell STED imaging.
IV.4.3.4 Live Cell STED Microscopy
The custom-built STED system is described in detail in I.2.2.1. The samples were excited at 650 nm with
10 µW and depleted at 775 nm with 54 mW. The values given describe the estimated laser power in
the sample focus based on laser power measurements in front of the microscope body (refer to
I.2.2.1). The pixel size was set to 15 nm and the dwell time to 100 µs. No frame or line accumulation
was used.
IV.4.4 Results and Discussion
Image restoration with the novel method was applied to both synthetic images and actual STED
images. A 3×3 MRF was used as prior and eight filters were learned from natural images as described
previously [982]. Retraining of the prior parameters on the STED data did not improve the results
suggesting that the local image structures of natural and fluorescence microscopy images are similar.
The likelihood was approximated by a superposition of three Gaussians. For the synthetic data, the
image noise parameters , µ ,  and  were assumed to be given. For the actual STED data, the
parameters were estimated. No additional parameter adaptation was required. To evaluate the novel
image restoration method, its performance was compared to that of popular denoising and
deconvolution methods using synthetic images. The essence of the comparison is presented here; for
further details on the results of the validation, refer to the experimental section of Gao et al. [981].
For denoising,  represents an identity matrix. The superposition of three Gaussians for likelihood
approximation offered a peak SNR gain of up to 0.45 dB as compared to the application of a single
Gaussian likelihood. Thus, the restoration performance crucially depends on the accuracy of likelihood
modelling. In comparison to the popular Poisson-Gaussian denoising method PURE-LET [972] and
especially for strong noise, the present approach generated fewer artefacts in the restored images.
For deconvolution,  represents a convolution matrix generated from a blur kernel. In comparison to
GLIAM [983], a deconvolution method for Poissonian images, the novel method was robust with
respect to increased Gaussian noise contribution.
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For super-resolution,  represents a Gaussian blurring and downsampling matrix allowing for
additional denoising. In comparison to a sequential scheme of denoising with the present approach (
as identity matrix) and subsequent bicubic interpolation, the joint scheme of super-resolution and
denoising yielded sharper edges in the restored images.
To validate the performance of the newly developed method with actual fluorescence microscopy
data, image restoration of live cell STED telomere data was conducted. In such practical applications,
the noise parameters , µ  and  are not accessible. Thus, they must be estimated from the original
images and different methods are available that offer the direct estimation [984, 985]. For joint super-
resolution (scaling factor  = 2), deconvolution and denoising of the live cell STED telomere images,
the noise parameters were estimated to be ≈ 3.2 and ≈ 4.9. Both noise and blur were
significantly reduced by the joint image restoration process. In comparison to the raw data, the image
resolution of the restored images increased by a factor of two (Figure IV-16).
Figure IV-16. Super-resolution, deconvolution
and denoising of live cell telomere STED data.
Application of the joint scheme for the
restoration of live cell STED images of U2OS
telomeres indirectly stained via a SNAP-tag/TRF2
fusion construct labeled with SNAP-Cell® 647-
SiR. The top row shows the original images, the
bottom row shows the corresponding restored
images. The noise parameters were estimated as
previously suggested [985]: ≈ 3.2, ≈ 4.9.
Scale bar is 250 nm. Adapted from [981].
To test if the biological information content became more accessible for subsequent image analysis,
the restored images as well as the raw images were subjected to segmentation and shape analysis of
telomeres using a previously proposed model fitting approach [986]. This approach analytically
describes the shape and intensity of heterochromatin foci and its model is based on a Fourier
representation. The Fourier coefficients reflecting the foci shape are determined by fitting the model
to the image intensities. Application of the model fitting approach to restored and raw data revealed
that the determination of the Fourier coefficients was more accurate and robust for the restored
images as compared to the raw images. Thus it was concluded that the novel Bayesian method for
joint deconvolution, denoising and super-resolution is able to efficiently recover information from
noise and blur degraded live cell STED images.
IV.4.5 Conclusion
The newly developed Bayesian method introduces a joint restoration model for super-resolution,
deconvolution, and denoising of images with mixed Poisson-Gaussian noise.
The statistics of Poisson-Gaussian noise are well described by a superposition of Gaussians, which thus
can be used to approximate the likelihood. The use of a generative probabilistic image prior renders
an additional regularization parameter unnecessary. The likelihood and the prior allow for the design
IV.4 Image Restoration in Live Cell STED Imaging 177
of an efficient Gibbs sampler for inference. Degraded images are restored by computing the MMSE
solution. The method can be directly adjusted to image restoration problems with other types of noise
by the usage of an application-neutral generative image prior. Additionally, super-resolution is
integrated into the model framework to simultaneously afford super-resolution, deconvolution and
denoising.
The strength of this novel image restoration method was successfully demonstrated on different types
of synthetic data in direct comparison to established methods. The joint scheme is superior to a
sequential application of denoising and super-resolution. Especially the deconvolution performance
can compete with state-of-the-art methods. The application of the joint scheme to actual STED data
underlined its ability to restore biological information in degraded live cell fluorescence microscopy
images and to make this information available to further sophisticated image analysis methods.

V – PERSPECTIVE
This thesis exemplifies the power of an integrated design approach for fluorescence nanoscopy
imaging studies. Pooling the expertise of (bio)chemistry, biology, (photo)physics and (bio)informatics
and uniting this knowledge into a coordinated workflow from sample preparation to image acquisition
and finally data analysis creates a reliable platform for deriving meaningful conclusions in complex
biological questions. This work demonstrates the value of iterative adaptation of individual
components in the operational chain to optimize the significance of the output in the respective
biological field. Creatively combining the strengths of existing methods and approaching biological
questions with wide-ranging perspectives and techniques strongly boosts the quality of the results.
This thesis addresses hot topics in biomedical research in the spirit described. The individual projects
in this work treat different aspects of cancer research of both direct and indirect clinical interest, while
sharing methodological commonalities. Live cell STED imaging was achieved in different fashions
confirming the results of sophisticated fixed staining methods. However, potential phototoxicity was
not rigorously assessed as the structures of interest were not obviously affected during imaging. While
this relaxed attitude might be partially justifiable, it cannot be ignored that photodamage begins prior
to any visual indication.
To ultimately judge the relevance and extent of phototoxicity measures, the photophysical background
must be understood to the best possible extent. Yet, comprehensive information on the relationship
of photobleaching and phototoxicity in STED is difficult to assess as numerous parameters heavily
influence the results while being only partially controllable. In particular, biological, biochemical,
photophysical and photochemical heterogeneity demand the acquisition of enormous amounts of data
for a tightly restricted set of variables under extremely well-defined conditions to generate meaningful
statistics. Moreover, technical heterogeneity renders the deduction of the absolute importance of
different imaging parameters and conditions from disparate STED experiments and STED
implementations highly intricate.
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Although phototoxicity is a known aspect of fluorescence microscopy, widely witnessed and
substantially understood, it is generally covered insufficiently [950]. A more comprehensive and
quantitative approach is required but difficult to draft as phototoxicity is the result of complex,
nonlinear photophysical and biochemical processes. Qualitative knowledge has been collected
abundantly but no common agreement on a universal measure of cell health and phototoxicity has
been established to date. Two different conceptions regarding the assessment of phototoxicity
presently challenge one another. The less rigorous notion considers imaging non-damaging if the
structure or process of interest remains undisturbed during and directly after imaging. Yet,
photodamage does not necessarily become evident during the experiment itself and short-term
monitoring neglects long-term effects on cell viability [300, 305, 878, 987]. The more rigorous notion
takes these long-term effects into account even though they do not affect the actual imaging results.
In the future, phototoxicity assessments will be increasingly in demand as mandatory additions to live
cell imaging. This raises the requirement for some sort of measurement standard. To evaluate and
compare established and newly introduced imaging techniques, specification of dose and illumination
intensity at standardized samples is desirable. However, to assess potential phototoxicity in biological
studies, establishing a universal assay is impossible as phototoxicity strongly varies with the sample,
the setup and the biological question.
Still, common principles and guidelines should be shared in the live cell imaging community and first
attempts have already been taken [877, 988]. Global changes like cell blebbing, nuclear fragmentation
and cell death are often chosen to assess photodamage, but these only offer soft criteria as the sample
physiology is long affected before any morphological changes or obvious photobleaching become
visible [272, 298, 300, 951]. In contrast, species and stage specific dose-response curves of the
structure or process of interest provide a phototoxicity threshold that reflects the point where the
sample’s ROS scavenging capacity is exceeded [299, 877, 987]. As this approach is complex and highly
individual, a more general approach could consider the timing of the cell cycle, or in case of whole
organisms, the timing of developmental stages. Since DNA replication is a delicate process relying on
a properly functioning cell proliferation machinery, observing the division frequency and mitosis length
should be a sensitive figure of merit and thus a harsher criterion [951, 989-995]. However, these
parameters are not immediately observable and more direct disclosure is given by changed
cytoskeletal dynamics, a slowed metabolism, an increased intracellular calcium level or the activation
of stress-sensitive transcription factors [288, 305, 992, 996-998].
In the long run, the live cell imaging community benefits from a common perception and evaluation of
phototoxicity. Different imaging approaches will be more comparable, the choice of the right approach
will be easier, the risk of producing artefacts will be reduced, reliable and reproducible data will be
generated, and the quality of biologically meaningful discovery will be improved.
VI – APPENDICES
VI.1 SUPPLEMENTARY MATERIAL FOR PART II
VI.1.1 Histogram Similarity Measure
To compare the results of the NN classification for individual telomere conformations between the
different cell lines, it is crucial to have a measure of significance. While the inference provides a
predicted frequency for each conformation and each cell line, the NN training provides the frequency
of false positives and false negatives for each conformation. These three values are histogrammed as
a footprint of the NN performance for each conformation of each cell line. To establish a measure of
similarity between the footprints of a given conformation between the different cell lines, we chose a
normalized weighted least squares sum (normalized weighted ). Weighting in the terms of the sum
comes from the statistical uncertainty associated with the finite training set of the NN [999].
Our training data set  consists of ( ) = 286 telomere STED images manually sorted into the four
predefined conformations (Table VI-1):
( ) = ( ) (VI-1)
where ( ) is the number of manually sorted images (ground truth) for class (= conformation) . Table
VI-1 provides ( ) under `support´. During training, the NN classified each of these images into exactly
one class. For a given class , the ground truth images ( ) are thus given by the number of true
positives ( ) and false negatives ( ):
( ) = ( ) + ( ) (VI-2)
182 VI.1 Supplementary Material for Part II
Consequently, false positives ( ) from class  must be `missing´ from other classes ′ as false
negatives ( ):
( ) = ( ) (VI-3)
Assuming that repetitions of generating additional ground truth data of the same nature and training
the network on it would lead to a distribution of results of ( ) , ( ) and ( ) that follows counting
statistics (Poisson statistics), the absolute errors on the quantities would be given by:
Δ ( ) = ( ) (VI-4)
Δ ( ) = ( ) (VI-5)
Δ ( ) = ( ) (VI-6)
and the relative errors by:
( ) =
Δ ( )
( ) =
1
( )
(VI-7)
( ) =
Δ ( )
( ) =
1
( )
(VI-8)
( ) =
Δ ( )
( ) =
1
( )
(VI-9)
Next, we consider the quantities of true positives, false negatives and false positives in the application
of the NN to the data to be classified. As noted above, the performance of the NN on a given image in
our data set is characterized by ( ), ( ) and ( ) for the conformation  and the cell line . While
( ) is a direct result of the inference, the estimated values of ( ) and ( ) must be scaled from
the results of the NN training:
( ) = ( )
( )
( )
(VI-10)
( ) = ( )
( )
( )
(VI-11)
The relative uncertainties in ( ), ( ) and ( ) are given by (Gaussian error propagation):
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( ) =
Δ ( )
( ) =
1
( )
(VI-12)
( ) = ( ) + ( ) + ( ) (VI-13)
( ) = ( ) + ( ) + ( ) (VI-14)
In the following, we define the three histogram channels and their uncertainties to which we will apply
our similarity analysis:
ℎ( )(1) =
( )
( )
(VI-15)
ℎ( )(2) =
( )
( )
(VI-16)
ℎ( )(3) =
( )
( )
(VI-17)
where the histogram channels ∈ {1, 2, 3} are normalized by ( ), the total number of images per cell
line . Due to the statistical uncertainties in the finite training set and also in the classified data set, the
absolute uncertainties in the histogram channels are given by:
Δℎ( )(1) = ℎ( )(1) ( ) + ( ) (VI-18)
Δℎ( )(2) = ℎ( )(2) ( ) + ( ) (VI-19)
Δℎ( )(3) = ℎ( )(3) ( ) + ( ) (VI-20)
where ( ) = Δ ( )/ ( ) and Δ ( ) = √ ( ) (Poisson statistics of data sample).
The simple difference between two corresponding histogram channels  of two different cell lines
and ′ for the conformation  is:
, ( ) = ℎ( )( ) − ℎ ( ) (VI-21)
with its corresponding uncertainty:
Δ , ( ) = Δℎ( )( ) + Δℎ( )( ) (VI-22)
This distance measure is finally used to construct the weighted similarity measure :
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( ) , =
, ( )
Δ ( , )( )
=
ℎ( )( ) − ℎ ( )
Δℎ( )( ) + Δℎ( )( )
(VI-23)
When normalizing  by the number of data points, we obtain the measure
( ̂) , =
( ) ,
3
(VI-24)
for which values on the order of unity indicate significant similarity and values ≫ 1 indicate significant
differences between the cell lines  and ′ for the conformation . The results are given in Table VI-3.
When the different telomere conformations are compared between free and encased U2OS
telomeres, the above formalism can be used to assess significant differences between free and
encased telomeres for a given conformation . Here,  and ′ represent free and encased telomeres.
The results are given in Table VI-13.
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VI.1.2 Supplementary Figures
Figure VI-1. Heterogeneous TRF2 coverage of telomeres in a U2OS nucleus.
(a) Exemplary U2OS nucleus with telomeres stained via TelC-KK114 PNA FISH (cyan) and TRF2 stained via STAR 600-IF (red).
Dual-color STED imaging revealed a heterogeneous decoration of telomeres by TRF2. (b) Magnifications of the telomeres
marked in (a) by white arrows. The close-ups are arranged by increasing PCC from r(1) = -0.02 to r(12) = 0,721. All STED data
shown are background corrected and linearly deconvolved. Scale bar overview is 1 µm, scale bar close-ups is 250 nm.
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Figure VI-2. Heterogeneous TRF2 coverage of individual U2OS telomeres.
Dual-color STED close-ups of exemplary U2OS telomeres stained via TelC-KK114 PNA FISH (cyan) and bound by STAR 600-
immunolabeled TRF2 (red) illustrate a heterogeneous decoration of telomeres by TRF2. All STED data shown are background
corrected and linearly deconvolved. Scale bar is 250 nm.
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Figure VI-3. Exemplary results of the synthetic STED data generated by Monte Carlo simulations.
Representative images of the synthetic STED data generated by Monte Carlo simulations of nucleosome chains (4, 10, 20,
50 kb) and subsequent PNA FISH labeling (10, 20, 30, 60% labeling degree). The synthetic STED data were sorted identically
to the NN training data and display significantly reduced loop frequencies of around 2% as compared to the actual STED data.
This result confirms the biological control experiment. Together, these controls render the contribution of randomly formed
DNA loops and/or false positives to the observed t-loop frequencies of our actual STED data assessable. Scale bar is 500 nm.
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Figure VI-4. PML nuclear bodies in a living U2OS cell.
(a) Representative nucleus of a live U2OS cell expressing a SNAP-tag fusion construct of PML labeled with the STED compatible
live dye 610CP [29]. PML-NBs appear as diffraction-limited spots in confocal (top). STED imaging reveals their hollow nature.
Aggregation of several PML-NBs might promote telomere clustering as exemplified by the close-up of the PML-NB marked in
the overview. (b) Line profiles of the confocal and STED data of the close-up shown in (a) illustrating the gain in structural
information by STED. The line profiles were drawn on raw data and averaged over 5 pixels. All confocal data shown are raw
data. All STED data shown are background corrected and linearly deconvolved, except for (b) showing only background
corrected STED data. Scale bar nucleus is 2 µm, scale bar close-ups is 500 nm.
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Figure VI-5. U2OS nucleus containing the four main structural classes of APBs stained by PNA FISH and IF.
(a) Exemplary U2OS nucleus displaying the four main structural classes of APBs as well as non-associated telomeres (TelC-
KK114, cyan) and PML-NBs (IF STAR 600, magenta). (b) Magnifications of the APBs marked by white arrows in (a). Cell cycle
dependent appearance of APB types can be excluded since globular (1), partially hollow (2-4), clustered (5, 6) and granular
APBs (7) are simultaneously present in the same U2OS nucleus. For clustered APBs, the two telomeres are marked by white
arrows. All STED data shown are background corrected and linearly deconvolved. Scale bar overview is 1 µm, scale bar close-
ups is 250 nm.
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Figure VI-6. U2OS nucleus containing three of the four main structural classes of APBs stained by IF.
(a) Exemplary U2OS nucleus displaying three of the four main structural classes of APBs as well as non-associated telomeres
(STAR 600-immunolabeled TRF2, cyan) and PML-NBs (IF STAR 635P, magenta). (b) Magnifications of the APBs marked by
white arrows in (a). Cell cycle dependent appearance of APB types can be excluded since globular (1-5), partially hollow (6-8)
and clustered (8-12) are simultaneously present in the same U2OS nucleus. For clustered APBs, the two (three) telomeres are
marked by white arrows. Note that a single APB can comprise characteristics of two structural classes (8). All STED data shown
are background corrected and linearly deconvolved. Scale bar overview is 2 µm, scale bar close-ups is 500 nm.
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VI.1.3 Supplementary Tables
Table VI-1. Report of the NN training for telomere classification.
TP – true positives, FP – false positives, FN – false negatives, SD – standard deviation.
#images
precision recall TP FP FN support
loop 0.81 0.74 0.77 29 7 10 39
rod 0.71 0.71 0.71 17 7 7 24
coil 0.80 0.88 0.84 66 17 9 75
globule 0.93 0.90 0.91 133 10 15 148
average 0.81 0.81 0.81
SD 0.08 0.08 0.08
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Table VI-2. Results of the NN classification of telomere/STR conformations for HeLa VST/NT/LT, U2OS and F6B2 cells.
FP (false positives) and FN (false negatives) are calculated according to equations (VI-10) and (VI-11) and rounded to the
nearest integer.
#images frequency
loop rod coil globule loop rod coil globule
He
La
 V
ST
predicted 38 62 4 595 0.054 0.089 0.006 0.851
FP 7 18 1 42 0.011 0.026 0.001 0.060
FN 11 18 0 62 0.015 0.026 0.001 0.089
He
La
 N
T
predicted 28 29 17 353 0.066 0.068 0.040 0.827
FP 5 8 3 25 0.013 0.020 0.008 0.058
FN 8 8 2 37 0.018 0.020 0.004 0.087
He
La
 L
T
predicted 87 34 18 558 0.125 0.049 0.026 0.801
FP 17 10 4 39 0.024 0.014 0.005 0.056
FN 24 10 2 59 0.035 0.014 0.003 0.084
U
2O
S
predicted 191 126 428 927 0.114 0.075 0.256 0.554
FP 37 37 88 65 0.022 0.022 0.052 0.039
FN 53 37 46 97 0.032 0.022 0.028 0.058
F6
B2
predicted 2 16 113 4 0.015 0.119 0.837 0.030
FP 0 5 23 0 0.003 0.035 0.171 0.002
FN 1 5 12 0 0.004 0.035 0.091 0.003
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Table VI-3. similarity measure for the NN classification results.
All values on the order of unity and below indicate significant similarity (shaded red) and values ≫ 1 indicate significant
differences (shaded progressively green) between the cell lines for the given conformation.
loop HeLa VST HeLa NT HeLa LT U2OS F6B2
HeLa VST --- --- --- --- ---
HeLa NT 0.23 --- --- --- ---
HeLa LT 6.90 3.89 --- --- ---
U2OS 8.47 3.84 0.15 --- ---
F6B2 4.23 4.89 15.85 20.54 ---
rod HeLa VST HeLa NT HeLa LT U2OS F6B2
HeLa VST --- --- --- --- ---
HeLa NT 0.57 --- --- --- ---
HeLa LT 2.98 0.65 --- --- ---
U2OS 0.36 0.10 2.20 --- ---
F6B2 0.37 1.09 2.28 0.85 ---
coil HeLa VST HeLa NT HeLa LT U2OS F6B2
HeLa VST --- --- --- --- ---
HeLa NT 6.66 --- --- --- ---
HeLa LT 5.29 0.86 --- --- ---
U2OS 110.71 58.59 82.17 --- ---
F6B2 26.16 23.90 24.85 12.40 ---
globule HeLa VST HeLa NT HeLa LT U2OS F6B2
HeLa VST --- --- --- --- ---
HeLa NT 0.04 --- --- --- ---
HeLa LT 0.21 0.04 --- --- ---
U2OS 11.23 6.64 8.29 --- ---
F6B2 97.51 62.91 93.11 130.42 ---
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Table VI-4. Measures of telomere size for the entire telomere populations.
 – area of fluorescent signal, ℎ  – convex hull area,  – radius of gyration, ℎ  – convex hull volume, SD – standard
deviation.
HeLa VST HeLa NT HeLa LT U2OS
n 699 427 697 712
[104 × nm2]
mean 1.9 2.5 3.4 6.2
SD 0.7 0.8 1.3 4.7
[104 × nm2]
mean 2.1 2.9 3.8 7.3
SD 0.8 1.0 1.5 5.6
[nm]
mean 58 68 77 103
SD 12 13 16 36
[106 × nm3]
mean 3.2 5.1 7.7 23.3
SD 1.9 2.6 4.8 30.6
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Table VI-5. P-values for the measures of telomere size of the entire telomere populations.
 – area of fluorescent signal, ℎ  – convex hull area,  – radius of gyration, ℎ  – convex hull volume.
HeLa VST HeLa NT HeLa LT U2OS
HeLa VST --- --- --- ---
HeLa NT 5×10-41 --- --- ---
HeLa LT 8×10-132 2×10-34 --- ---
U2OS 2×10-181 8×10-99 2×10-57 ---
HeLa VST --- --- --- ---
HeLa NT 4×10-46 --- --- ---
HeLa LT 7×10-128 1×10-25 --- ---
U2OS 2×10-183 2×10-96 4×10-65 ---
HeLa VST --- --- --- ---
HeLa NT 1×10-37 --- --- ---
HeLa LT 3×10-108 2×10-21 --- ---
U2OS 8×10-171 3×10-90 4×10-63 ---
HeLa VST --- --- --- ---
HeLa NT 4×10-46 --- --- ---
HeLa LT 7×10-128 1×10-25 --- ---
U2OS 2×10-183 2×10-96 4×10-65 ---
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Table VI-6. Measures of telomere size for the individual telomere conformations.
(a) HeLa VST, (b) HeLa NT, (c) HeLa LT, (d) U2OS.  – area of fluorescent signal, ℎ  – convex hull area,  – radius of
gyration, ℎ  – convex hull volume, SD – standard deviation.
(a) loop rod coil globule
HeLa VST n 38 62 4 595
[104 × nm2]
mean 2.6 2.4 3.0 1.8
SD 0.8 0.7 0.6 0.6
[104 × nm2]
mean 3.0 2.8 3.6 1.9
SD 0.9 0.9 0.8 0.7
[nm]
mean 70 74 79 56
SD 11 15 7 10
[106 × nm3]
mean 5.4 5.0 7.0 2.8
SD 2.6 2.4 2.4 1.5
(b) loop rod coil globule
HeLa NT n 28 29 17 353
[104 × nm2]
mean 3.0 2.9 3.0 2.4
SD 0.9 1.0 1.0 0.7
[104 × nm2]
mean 3.6 3.7 3.9 2.7
SD 1.0 1.3 1.1 0.9
[nm]
mean 75 82 80 66
SD 10 21 13 11
[106 × nm3]
mean 7.0 7.3 7.9 4.7
SD 3.0 3.9 3.2 2.2
continued on next page
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(c) loop rod coil globule
HeLa LT n 87 34 18 558
[104 × nm2]
mean 4.2 3.5 6.0 3.1
SD 1.1 1.0 1.4 1.1
[104 × nm2]
mean 4.6 4.3 7.2 3.5
SD 1.3 1.5 1.9 1.3
[nm]
mean 85 91 111 73
SD 12 21 21 13
[106 × nm3]
mean 10.2 9.3 19.7 6.8
SD 4.3 5.2 7.7 4.0
(d) loop rod coil globule
U2OS n 98 26 222 366
[104 × nm2]
mean 5.1 4.3 10.0 4.3
SD 1.6 2.0 6.2 2.3
[104 × nm2]
mean 5.9 5.5 12.0 4.9
SD 1.9 3.0 7.4 2.6
[nm]
mean 95 102 134 86
SD 16 36 42 21
[106 × nm3]
mean 1.5 1.4 4.7 1.2
SD 0.7 1.1 4.4 1.1
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Table VI-7. P-values for the measures of telomere size of the coil and globule telomere conformations.
Comparison of the measures of telomere size of the (a) coil conformation and (b) globule conformation between the four cell
lines studied. (c) Comparison between the measures of the coil and globule telomere size within each cell line.  – area of
fluorescent signal, ℎ  – convex hull area,  – radius of gyration, ℎ  – convex hull volume.
(a) coil vs. coil HeLa VST HeLa NT HeLa LT U2OS
HeLa VST --- --- --- ---
HeLa NT 0.823 --- --- ---
HeLa LT 0.003 3×10-6 --- ---
U2OS 0.002 3×10-9 0.009 ---
HeLa VST --- --- --- ---
HeLa NT 0.622 --- --- ---
HeLa LT 0.003 3×10-6 --- ---
U2OS 0.002 6×10-9 0.006 ---
HeLa VST --- --- --- ---
HeLa NT 0.823 --- --- ---
HeLa LT 0.003 6×10-6 --- ---
U2OS 0.003 1×10-8 0.016 ---
HeLa VST --- --- --- ---
HeLa NT 0.622 --- --- ---
HeLa LT 0.003 3×10-6 --- ---
U2OS 0.002 6×10-9 0.006 ---
continued on next page
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(b) globule vs. globule HeLa VST HeLa NT HeLa LT U2OS
HeLa VST --- --- --- ---
HeLa NT 1×10-40 --- --- ---
HeLa LT 9×10-116 2×10-26 --- ---
U2OS 1×10-109 4×10-52 3×10-20 ---
HeLa VST --- --- --- ---
HeLa NT 6×10-46 --- --- ---
HeLa LT 3×10-115 1×10-20 --- ---
U2OS 4×10-112 3×10-51 2×10-24 ---
HeLa VST --- --- --- ---
HeLa NT 3×10-41 --- --- ---
HeLa LT 7×10-104 7×10-18 --- ---
U2OS 2×10-106 2×10-48 3×10-24 ---
HeLa VST --- --- --- ---
HeLa NT 6×10-46 --- --- ---
HeLa LT 3×10-115 1×10-20 --- ---
U2OS 4×10-112 3×10-51 2×10-24 ---
(c) coil vs. globule HeLa VST HeLa NT HeLa LT U2OS
0.001 0.001 7×10-11 1×10-42
7×10-4 1×10-5 2×10-11 2×10-46
7×10-4 2×10-6 1×10-11 2×10-47
7×10-4 1×10-5 2×10-11 2×10-46
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Table VI-8. Ratio of volume densities of the entire telomere populations.
The SDs (standard deviations) were calculated by Gaussian error propagation using the computed SDs of the radii of gyration
and the following SD estimates for the average telomere lengths: HeLa VST 2.0 ± 0.5 kb (TRF analysis), HeLa NT 7.0 ± 0.5 kb
(TRF analysis), HeLa LT 20 ± 1 kb (TRF analysis), U2OS 26 ± 13 kb (rectangular telomere length distribution between 2-50 kb);
HeLa VST n = 699, HeLa NT n = 427, HeLa LT n = 697 and U2OS n = 712.
HeLa VST HeLa NT HeLa LT U2OS
HeLa VST
mean --- --- --- ---
SD --- --- --- ---
HeLa NT
mean 2.2 --- --- ---
SD 2.0 --- --- ---
HeLa LT
mean 4.4 2.0 --- ---
SD 4.0 1.7 --- ---
U2OS
mean 2.4 1.1 0.5 ---
SD 3.2 1.4 0.7 ---
Table VI-9. Ratio of volume densities of the coil and globule telomere conformations.
(a) Coil-to-globule ratio of volume densities for each cell line. (b) Ratio of volume densities between the coil (globule)
conformation of each cell line and the U2OS coil (globule) conformation. The SDs (standard deviations) were calculated by
Gaussian error propagation using the computed SDs of the radii of gyration and the following SD estimates for the average
telomere lengths: HeLa VST 2.0 ± 0.5 kb (TRF analysis), HeLa NT 7.0 ± 0.5 kb (TRF analysis), HeLa LT 20 ± 1 kb (TRF analysis),
U2OS 26 ± 13 kb (rectangular telomere length distribution between 2-50 kb); coil conformation HeLa VST n = 4, HeLa NT
n =  17, HeLa LT n =  18, U2OS n = 222; globule conformation HeLa VST n = 595, HeLa NT n =  353, HeLa LT n =  558, U2OS
n = 366.
(a) HeLa VST HeLa NT HeLa LT U2OS
coil-to-globule
mean 0.3 0.6 0.3 0.3
SD 0.2 0.4 0.2 0.4
(b) HeLa VST HeLa NT HeLa LT U2OS
U
2O
S coil-to-coil mean 2.7 0.8 0.7 ---
globule-to-globule SD 2.8 0.8 0.9 ---
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Table VI-10. Results and p-values of ellipse fitting and t-loop circumference  calculation.
 – semi-major axis,  – semi-minor axis,  – circumference, data are expressed as mean ± SD.
p-values
 [nm]  [nm]  [nm] HeLa VST HeLa NT HeLa LT U2OS
HeLa VST 55 ± 17 36 ± 9 267 ± 74 --- --- --- ---
HeLa NT 48 ± 13 34 ± 10 241 ± 62 0.092 --- --- ---
HeLa LT 63 ± 22 44 ± 14 312 ± 99 0.017 4×10-4 --- ---
U2OS 68 ± 19 49 ± 13 342 ± 87 4×10-7 3×10-9 0.010 ---
Table VI-11. Estimation of the maximum error of t-loop circumference introduced by 2D projection.
 – circumference calculated from results of ellipse fitting,  – circumference of circular t-loop with radius  (semi-major
axis of ellipse fitting), data are expressed as mean ± SD.
 [nm]  [nm] =  [nm] /
HeLa VST 55 ± 17 267 ± 74 343 ± 109 0.78
HeLa NT 48 ± 13 241 ± 62 302 ± 82 0.80
HeLa LT 63 ± 22 312 ± 99 395 ± 135 0.79
U2OS 68 ± 19 342 ± 87 429 ± 119 0.80
Table VI-12. Results of the NN classification of telomere conformations for free and encased U2OS telomeres.
FP – false positives, FN – false negatives.
#images frequency
loop rod coil globule loop rod coil globule
fr
ee
predicted 80 96 83 521 0.103 0.123 0.106 0.668
FP 16 28 17 36 0.020 0.036 0.022 0.047
FN 22 28 9 55 0.028 0.036 0.012 0.070
en
ca
se
d
predicted 13 4 123 50 0.068 0.021 0.647 0.263
FP 3 1 25 3 0.013 0.006 0.133 0.018
FN 4 1 13 5 0.019 0.006 0.070 0.028
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Table VI-13. similarity measure for the NN classification results for free and encased U2OS telomeres.
All values on the order of unity and below indicate significant similarity (shaded red) and values ≫ 1 indicate significant
differences (shaded progressively green) between free and encased telomere for the given conformation.
loop rod coil globule
free vs. encased 1.00 13.97 21.14 19.44
Table VI-14. Measures of telomere size for free and encased U2OS telomeres without discrimination of conformations.
 – area of fluorescent signal, ℎ  – convex hull area,  – radius of gyration, ℎ  – convex hull volume, SD – standard
deviation, free n = 780, encased n = 190.
free encased p-values
[104 × nm2]
mean 3.0 11.7
6×10-81
SD 2.0 6.8
 [104 × nm2]
mean 3.8 14.3
6×10-79
SD 2.6 8.6
 [nm]
mean 75 146
6×10-77
SD 24 46
 [106 × nm3]
mean 8.6 60.9
6×10-79
SD 10.2 59.3
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Table VI-15. Measures of telomere size for the individual conformations of free and encased U2OS telomeres.
 – area of fluorescent signal, ℎ  – convex hull area,  – radius of gyration, ℎ  – convex hull volume, SD – standard
deviation.
loop rod coil globule
free encased free encased free encased free encased
n 80 13 96 4 83 123 521 50
[104 × nm2]
mean 3.6 5.3 2.8 3.6 5.9 14.0 2.5 8.4
SD 1.3 1.5 1.4 1.5 3.3 7.0 1.5 4.0
[104 × nm2]
mean 4.4 6.2 3.9 5.1 7.8 17.3 3.1 9.7
SD 1.6 1.7 2.0 2.6 4.2 9.0 1.8 4.4
[nm]
mean 81 97 81 96 107 163 67 119
SD 15 14 25 31 27 45 19 29
[106 × nm3]
mean 9.7 16.0 8.4 12.3 23.7 78.7 6.1 32.6
SD 5.3 6.4 6.5 8.8 21.1 65.5 5.6 22.6
p-
va
lu
es
8×10-5 --- 6×10-22 9×10-26
3×10-4 --- 1×10-20 4×10-25
0.001 --- 1×10-20 2×10-24
3×10-4 --- 1×10-20 4×10-25
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VI.2 SUPPLEMENTARY MATERIAL FOR PART III
VI.2.1 Supplementary Figures
Figure VI-7. Absorbance of Glu-urea-Lys-HBED-CC-PEG2 with Fe 3+ and
without Fe3+.
UV/vis absorbance was recorded in PBS at pH 7.4. Raw data were baseline
corrected and normalized to the peak around 280 nm, which is attributed to the
UV-active HBED-CC chelator moiety.
Figure VI-8. PC3 cell incubation and PMPA
blocking confirm conjugate RED specificity.
The negative controls confirm specific PSMA
binding and internalization of conjugate RED. (a)
PSMA binding and internalization specificity of
conjugate RED was confirmed by staining PSMA-
negative PC3 cells via IF for PSMA (STAR 600,
cyan, right) and incubation with conjugate RED
(100 nM, red, left) for 1 h of internalization time
with subsequent PFA fixation. Confocal imaging
did not detect significant binding or
internalization of conjugate RED with PC3 cells.
Scale bar is 10 µm. (b) Left: LNCaP cells were co-
incubated with conjugate RED (50 nM) and 2-
PMPA (500 µM) on ice. Internalization of the
PSMA/PSMA inhibitor complex should be
triggered by subsequent temperature increase,
but live confocal imaging did not detect
significant binding or internalization of
conjugate RED after 20 min. Right: Positive
control showing live LNCaP cells incubated with
conjugate RED (50 nM) for 15 min of
internalization time. Scale bars are 5 µm. All
confocal data shown are raw data.
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Figure VI-9. Average diameter  of endocytic vesicles carrying conjugate RED bound PSMA.
LNCaP cells were incubated with conjugate RED (100 nM) for 30 min (top), 45 min (middle) or 60 min (bottom). The vesicle
diameter was assessed by fitting a two-dimensional ring function (refer to equation (III-5)) to the raw fluorescence signal of
individual vesicles. The results were averaged for every internalization time (n = 50). The average diameter  of the different
internalization times did not differ significantly (p > 0.05). The large SDs of the results suggest a broad diameter distribution
in the samples. The STED data shown in the user interface of the fit program are smoothed with a Gaussian low pass filter
(width of one pixel), the remaining STED data are background corrected and linearly deconvolved. Scale bar is 250 nm.
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Figure VI-10. STED/confocal time-lapse sequence of PSMA/LysoTrackerTM Green DND-26 colocalization experiment.
To assess endosomal/lysosomal colocalization of PSMA, LNCaP cells were STAR 600-immunolabeled for PSMA (cyan) and
imaged in the presence of LysoTrackerTM Green DND-26 (500 nM, magenta) after > 20 h of internalization. Live STED (anti-
PSMA STAR 600) and confocal (LysoTrackerTM Green DND-26) time-lapse sequences were recorded for 10 min with 1.2 fpm.
The green and yellow arrows follow two dual-labeled endosomes/lysosomes. STED and confocal data are background
corrected and linearly deconvolved. Scale bar is 5 µm.
Figure VI-11. STED time-lapse sequence of PSMA/SiR-Lysosome colocalization experiment.
To assess endosomal/lysosomal colocalization of PSMA, LNCaP cells were STAR 600-immunolabeled for PSMA (cyan) and
stained with SiR-Lysosome (1 µM, magenta) after > 20 h of internalization. Live STED time-lapse sequences were recorded for
13.5 min with 1.1 fpm. The yellow arrow follows a dual-labeled endosome/lysosome. STED data are photobleaching and
background corrected and linearly deconvolved. Scale bar is 5 µm.
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Figure VI-12. Confocal time-lapse sequence of SiR-Lysosome stained endosomes and lysosomes.
Low light confocal control time-lapse series (28.8 min, 2.1 fpm) of LNCaP cells stained with SiR-Lysosome (1 µM). Sequences
of five consecutive images are displayed for the beginning (1st column), the middle (2nd column) and the end (3rd column) of
the time-lapse data. Red and blue arrows follow two rather stationary endosomes/lysosomes with only local dynamics; green
arrows mark a region of increased dynamics with more mobile endosomes/lysosomes. The dynamics were qualitatively
compared to those of low light confocal time-lapse series after STED imaging (Figure VI-13). Confocal data are background
corrected. From left to right/top to bottom, the minimal and maximal (min/max) counts are 19/196, 19/192, 19/192, 19/198,
18/189, 18/180, 19/190, 18/180, 18/181, 182/180, 16/168, 16/169, 16/166, 16/168, 16/166. Scale bar is 10 µm.
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Figure VI-13. Confocal time-lapse sequence of PSMA/SiR-Lysosome colocalization after STED imaging.
To evaluate cell viability after PSMA/SiR-Lysosome STED colocalization experiments, low intensity confocal time-lapse series
were recorded for 10 min with 2.6 fpm after STED imaging. Anti-PSMA STAR 600 is shown in cyan, SiR-Lysosome is shown in
magenta. Sequences of five consecutive images are displayed for the beginning (first column), the middle (second column)
and the end (third column) of the time-lapse data. Red and yellow arrows follow two rather stationary dual-labeled
endosomes/lysosomes with only local dynamics; green arrows mark a region of increased dynamics with more mobile
endosomes/lysosomes. The dynamics were qualitatively compared to confocal control time-lapse series (Figure VI-12). No
significant differences were observed. Figure VI-14 shows the corresponding live cell dual-color STED image. Confocal data
are background corrected. From left to right/top to bottom, the minimal and maximal (min/max) counts for the STAR 600
and SiR channel (STAR 600//SiR) are 5/54//5/54, 5/58//4/49, 6/68//5/51, 6/66//5/55, 6/61//4/49, 5/52//5/52, 5/52//5/56,
5/55//5/57, 5/54//5/56, 6/67//4/44, 6/64//4/47, 5/50//5/53, 5/56//4/44, 5/54//4/49, 5/50//5/50. Scale bar is 5 µm.
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Figure VI-14. Corresponding live cell dual-
color STED image to the confocal time-lapse
sequence shown in Figure VI-13.
Dual-color STED image of a live LNCaP cell
STAR 600-immunolabeled for PSMA and stained
with SiR-Lysosome (1 µM) after > 20 h of
internalization time. After STED acquisition, the
lysosomal/endosomal dynamics were followed
via low light intensity confocal time-lapse
imaging to evaluate potential phototoxicity. The
corresponding image sequence is shown in
Figure VI-13. The STED data shown are
background corrected and linearly deconvolved.
Scale bar is 5 µm.
Figure VI-15. Corresponding time curves to the fluorogram analysis of conjugate RED/PSMA colocalization.
The time curves represent the internalization time-dependent changes of the relative integrated fluorescence intensity of
STAR 600-immunolabeled PSMA and conjugate RED in the different sections of the fluorograms shown in (Figure III-20). Upon
progressive segregation of the PSMA/PSMA inhibitor complex, the relative integrated fluorescence intensity of (a)
conjugate RED (red) and of (b) PSMA (blue) declines in the colocalizing section of the fluorogram. (c) Consequently, the area
of colocalizing signal decreases. (d) Simultaneously, the relative integrated fluorescence intensity of conjugate RED in the
background increases upon cytosolic conjugate RED distribution. (e) In contrast, the relative integrated fluorescence intensity
of PSMA increases in the `PSMA signal only´ section of the fluorogram since the primary/secondary antibody/PSMA complex
remains intact. All changes in the relative integrated fluorescence intensity from 30 min to 45 min and from 1 h to 6 h (except
for (d)), are significant (p <0 .005). No significant changes occur from 45 min to 1 h (30 min n = 8, 45 min n = 11, 1 h n = 24,
6 h n = 10, 24 h n = 4). (f) Exemplary confocal image of conjugate RED after 24 h of internalization time confirming cytosolic
distribution and long-time retention of conjugate RED. Raw data are shown. Scale bar is 5 µm.
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Figure VI-16. Excluding dye dependence of
PSMA/PSMA inhibitor colocalization.
(a) Exemplary dual-color STED image with its
corresponding fluorogram is shown for LNCaP
cells STAR 600-immunolabeled for PSMA (cyan)
and incubated with conjugate 635P (100 nM, red)
for 30 min of internalization time. The fluorogram
is subdivided into three defined sections
representing PSMA signal only (top, cyan),
colocalizing signal (middle, white) and
conjugate 635P signal only (bottom, red).
Background (quarter circle bottom left) was set to
the average conjugate RED fluorescence intensity
in the cytosol after 24 h of internalization time.
The quantification of conjugate 635P/PSMA
colocalization via fluorogram analysis supports
the results obtained for conjugate RED. (b)
Exemplary STED image of LNCaP cells after 1 h of
internalization STAR RED-immunolabeled for
PSMA. Between STAR-600- and STAR RED-
immunolabeled PSMA, qualitative differences
could not be observed. Taken together, these
results indicate the absence of dye dependent
effects on the PSMA/PSMA inhibitor
colocalization results. All STED data shown are
background corrected and linearly deconvolved.
Scale bars are 5 µm.
Figure VI-17. Influence of pH on the PSMA binding affinity of
conjugate RED, conjugate 635P and the antibody complex.
Characterization of pH dependent binding of the primary/secondary antibody
complexes (primary anti-PSMA antibody + secondary IgG-STAR 600, primary
anti-PSMA antibody + secondary IgG-STAR RED antibody, all antibodies 1:50), of
conjugate RED (50 nM) and of conjugate 635P (50 nM) to PSMA on LNCaP cells.
Flow cytometry determined the binding percentage at pH 4.6 normalized to the
binding percentage at pH 7.0. Data are expressed as mean ± SD (n = 3). The
antibody complexes did not show a strong pH dependence of PSMA binding,
whereas both PSMA inhibitors displayed significantly weaker PSMA binding at
acidic pH.
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Figure VI-18. Influence of pH and temperature on the spectral properties of conjugate RED and conjugate 635P.
Conjugate RED and conjugate 635P (both 10 µM) were incubated for 6 h in the dark at different pH and temperature
combinations (PBS pH 7.4 at 25°C, PBS pH 7.4 at 37°C, NaAc buffer pH 4.6 at 25°C, NaAc buffer pH 4.6 at 37°C). During the
experiment, (a) the conjugate RED absorbance did not display strong pH and/or temperature dependence and the
conjugate RED fluorescence emission was not affected by temperature but slightly increased upon acidification. (b) The
conjugate 635P absorbance did not show strong temperature dependence but a small hypsochromic shift of 3 nm upon
acidification, and the conjugate 635P fluorescence emission did not display a strong temperature dependence but a small
hypsochromic shift of 4 nm upon acidification. All absorbance spectra are baseline corrected, individually normalized on the
HBED-CC concentration and collectively normalized on the absorbance maximum at pH 7.4, 25°C. All fluorescence emission
spectra are individually normalized on the HBED-CC concentration and collectively normalized on the fluorescence emission
maximum at pH 7.4, 25°C.
VI.2.2 Supplementary Tables
Table VI-16. Analytical data of conjugate RED and conjugate 635P.
Conjugate RED – Glu-urea-Lys-HBED-CC-PEG2-STAR RED, conjugate 635P – Glu-urea-Lys-HBED-CC-PEG2-STAR 635P, * mass
spectrometry of non-labeled ligand, † chemical yields refer to the dye conjugation to Glu-urea-Lys[Fe(HBED-CC)]-PEG2,
‡ lipophilicity at pH 7.4 of 68Ga-radiolabeled ligand.
m/z
(g/mol, Mcalc)
m/z*
(Mfound)
chemical yield [%]† lipophilicity logDn-octanol/PBS‡
conjugate RED 1850.9 1851.1 9 -1.93 ± 0.44
conjugate 635P 1882.8 1882.7 29 -2.88 ± 0.09
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Table VI-17. Organ distribution of [68Ga]Ga-conjugate RED and [68Ga]Ga-conjugate 635P in LNCaP-tumor bearing BALB/c
nu/nu mice 1 h p.i..
Conjugate RED – Glu-urea-Lys-HBED-CC-PEG2-STAR RED, conjugate 635P – Glu-urea-Lys-HBED-CC-PEG2-STAR 635P, data are
expressed as mean %ID/g tissue ± SD (n=3) and tumor-to-organ ratios.
[68Ga]Ga-
conjugate RED
[%ID/g]
[68Ga]Ga-
conjugate 635P
[%ID/g]
p-values
[68Ga]Ga-
conjugate RED
tumor-to-organ
ratio
[68Ga]Ga-
conjugate 635P
tumor-to-organ
ratio
p-values
blood 1.81 ± 0.35 3.13 ± 0.43 0.797 3.19 ± 1.19 1.43 ± 0.14 0.027
heart 1.55 ± 0.31 1.25 ± 0.25 0.820 3.57 ± 0.78 3.61 ± 0.25 0.178
lung 3.14 ± 0.62 3.02 ± 0.44 0.699 1.91 ± 0.89 1.49 ± 0.17 0.069
spleen 29.83 ± 9.34 14.50 ± 2.06 0.094 0.21 ± 0.10 0.32 ± 0.08 0.781
liver 1.37 ± 0.46 1.45 ± 0.32 0.581 4.41 ± 1.82 3.10 ± 0.07 0.003
kidney 126.09 ± 43.10 86.96 ± 16.05 0.244 0.05 ± 0.01 0.05 ± 0.00 ---
muscle 1.32 ± 0.50 1.58 ± 1.32 0.251 4.57 ± 1.75 3.92 ± 1.58 0.927
intestine 1.06 ± 0.40 1.11 ± 0.36 0.895 5.66 ± 1.95 4.30 ± 1.32 0.651
brain 0.24 ± 0.05 0.33 ± 0.08 0.781 24.54 ± 10.11 13.61 ± 1.32 0.034
tumor 5.65 ± 2.33 4.53 ± 1.07 0.356 --- --- ---
Table VI-18. Organ distribution of [68Ga]Ga-conjugate RED in PC3-tumor bearing BALB/c nu/nu mice 1 h p.i..
Conjugate RED – Glu-urea-Lys-HBED-CC-PEG2-STAR RED, data are expressed as mean %ID/g tissue ± SD (n=3).
blood heart lung spleen liver kidney muscle intestine brain tumor
[68Ga]Ga-
conjugate RED
[%ID/g]
0.63
±
0.35
0.52
±
0.16
1.54
±
0.59
6.69
±
2.38
0.51
±
0.15
84.94
±
30.91
0.82
±
0.37
0.67
±
0.16
0.12
±
0.05
0.89
±
0.17
Table VI-19. P-values of average diameters of endocytic vesicles carrying conjugate RED bound PSMA.
internalization time 30 min 45 min 60 min
30 min --- --- ---
45 min 0.448 --- ---
60 min 0.169 0.054 ---
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Table VI-20. Results and p-values of the duration of LNCaP cell division.
Conjugate RED – Glu-urea-Lys-HBED-CC-PEG2-STAR RED, conjugate 635P – Glu-urea-Lys-HBED-CC-PEG2-STAR 635P, data are
expressed as mean ± SD.
untreated + 100 nM conjugate RED + 100 nM conjugate 635P
n 347 624 408
cell division duration [min] 33 ± 34 29 ± 18 40 ± 107
p-
va
lu
es
untreated --- --- ---
+ 100 nM conjugate RED 0.040 --- ---
+ 100 nM conjugate 635P 0.228 0.015 ---
Table VI-21. Results and p-values of the frequency of LNCaP cell division.
Conjugate RED – Glu-urea-Lys-HBED-CC-PEG2-STAR RED, conjugate 635P – Glu-urea-Lys-HBED-CC-PEG2-STAR 635P, data are
expressed as mean ± SD.
untreated + 100 nM conjugate RED + 100 nM conjugate 635P
n 347 624 408
cell division frequency
[divisions per cell per day] 0.17 ± 0.07 0.28 ± 0.10 0.24 ± 0.08
p-
va
lu
es
untreated --- --- ---
+ 100 nM conjugate RED 0.003 --- ---
+ 100 nM conjugate 635P 0.035 0.195 ---
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Table VI-22. Results and p-values of the cell count and confluency of LNCaP cell proliferation.
(a) Results and average p-values of the cell count given as mean ± SD, (b) results and average p-values of the confluency given
as mean ± SD. * Given as fold change comparing the value at t = 48 h to the value at t = 0 h. Conjugate RED – Glu-urea-Lys-
HBED-CC-PEG2-STAR RED, conjugate 635P – Glu-urea-Lys-HBED-CC-PEG2-STAR 635P.
(a) untreated + 100 nM conjugate RED + 100 nM conjugate 635P
cell count [fold change]* 1.56 ± 0.19 1.67 ± 0.22 1.70 ± 0.35
p-
va
lu
es
untreated --- --- ---
+ 100 nM conjugate RED 0.698 ± 0.207 --- ---
+ 100 nM conjugate 635P 0.644 ± 0.240 0.629 ± 0.216 ---
(b) untreated + 100 nM conjugate RED + 100 nM conjugate 635P
confluency [fold change]* 1.85 ± 0.31 1.95 ± 0.21 2.02 ± 0.28
p-
va
lu
es
untreated --- --- ---
+ 100 nM conjugate RED 0.580 ± 0.178 --- ---
+ 100 nM conjugate 635P 0.446 ± 0.303 0.436 ± 0.290 ---
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Table VI-23. PCCs and p-values of endosomal colocalization between PSMA and LysoTrackerTM Green DND-26.
Conjugate RED – Glu-urea-Lys-HBED-CC-PEG2-STAR RED, conjugate 635P – Glu-urea-Lys-HBED-CC-PEG2-STAR 635P, PCC –
Pearson correlation coefficient, * data are expressed as mean PCC r ± SD, † without any additive (1 h n = 4, +20 h n = 8), ‡ with
500 µM 2-PMPA (1 h n = 3, +20 h n = 8), ¤ with 50 nM conjugate RED (1 h n = 7, +20 h n = 4) or conjugate 635P (1 h n = 7,
+20 h n = 6).
Pearson r r(1h)* r(+20h)* p-values
w/o† 0.38 ± 0.02 0.64 ± 0.11 2×10-3
+  2-PMPA‡ 0.42 ± 0.02 0.76 ± 0.09 3×10-4
+  conjugate RED¤ 0.39 ± 0.04 0.77 ± 0.04 4×10-7
+  conjugate 635P¤ 0.39 ± 0.07 0.71 ± 0.10 7×10-5
p-values 1 h w/o† +  2-PMPA‡ +  conjugate RED¤ +  conjugate 635P¤
w/o† --- 0.145 0.815 0.883
+  2-PMPA‡ --- --- 0.413 0.571
+  conjugate RED¤ --- --- --- 0.990
+  conjugate 635P¤ --- --- --- ---
p-values +20 h w/o† +  2-PMPA‡ +  conjugate RED¤ +  conjugate 635P¤
w/o† --- 0.051 0.080 0.308
+  2-PMPA‡ --- --- 0.922 0.389
+  conjugate RED¤ --- --- --- 0.375
+  conjugate 635P¤ --- --- --- ---
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Table VI-24. Results and p-values of the cytosolic and extracellular background determination.
Conjugate RED – Glu-urea-Lys-HBED-CC-PEG2-STAR RED, conjugate 635P – Glu-urea-Lys-HBED-CC-PEG2-STAR 635P, data are
given as mean ± SD (0.5 h n = 32, 6 h n = 48).
0.5 h
internalization time
6 h
internalization time
cytosol extracellular cytosol extracellular
background
[counts] 0.24± 0.06 0.14± 0.18 1.27 ± 0.36 0.18± 0.05
p-
va
lu
es
0.5 h
internalization
time
cytosol --- --- --- ---
extracellular 1×10-13 --- --- ---
6 h
internalization
time
cytosol 7×10-26 1×10-28 --- ---
extracellular 3×10-7 5×10-5 2×10-36 ---
Table VI-25. P-values of the influence of pH on the PSMA binding affinity of conjugate RED, conjugate 635P and the
antibody complex.
The fractions of PSMA inhibitor or antibody complex bound at pH 4.6 are compared. Conjugate RED – Glu-urea-Lys-HBED-CC-
PEG2-STAR RED, conjugate 635P – Glu-urea-Lys-HBED-CC-PEG2-STAR 635P.
anti-PSMA-STAR 600 anti-PSMA-STAR RED conjugate RED conjugate 635P
anti-PSMA-STAR 600 --- --- --- ---
anti-PSMA-STAR RED 0.731 --- --- ---
conjugate RED 0.062 0.036 --- ---
conjugate 635P 0.023 0.013 0.539 ---
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VI.3 SUPPLEMENTARY MATERIAL FOR PART IV
VI.3.1 Supplementary Figures to IV.2
Figure VI-19. 1H NMR spectrum of SiR dye 15.
The 1H NMR (400 MHz, methanol-d4) spectrum of SiR dye 15 is shown. The data are summarized in Table VI-27.
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Figure VI-20. 13C NMR spectrum of SiR dye 15.
The 13C NMR (101 MHz, methanol-d4) spectrum of SiR dye 15 is shown. The data are summarized in Table VI-27.
Figure VI-21. Fluorescence intensity decay of SiR dye 15.
The fluorescence intensity ( ) decay of SiR dye 15 is shown in blue as measured in (a) PBS at pH 7.4 and in (b) MeCN. The
fluorescence lifetime is determined by fitting the data with an additive superposition of exponential functions revealing a
mono-exponential decay in both solvents. The fit results are summarized in Table VI-28. The instrument response function is
shown in red.
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Figure VI-22. Relative measurement of the
quantum yield of SiR dye 15.
The quantum yield  of SiR dye 15 in (a) PBS at
pH 7.4 and in (b) MeCN was determined in
relative measurements using Nile Blue as
reference standard. The wavelength-integrated
fluorescence intensity ∫  is plotted versus the
absorbance at 600 nm  and fitted by linear
regression. The linear fit results are summarized
in Table VI-29.
Figure VI-23. Spectral properties of SiR dye 15 in MeCN.
The absorbance and fluorescence emission of SiR dye 15 in MeCN peak at
667 nm and 683 nm. The absorbance spectrum is baseline corrected. Both
spectra are normalized to their maximum.
VI.3.2 Supplementary Tables to IV.2
Table VI-26. Analytical data of SiR dye 15.
* Calculated for C24H26BrClN3Si [M+], † ESI-HRMS, ‡ retardation factor (methanol : DCM = 1 : 9), ¥ calculated logP.
m/z*
(g/mol, Mcalc)
m/z†
(Mfound)
chemical yield [%] Rf‡
lipophilicity
clogP¥
SiR dye 15 498.0768 498.0722 85 0.44 3.712
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Table VI-27. NMR data of SiR dye 15.
Chemical shifts  are given relative to methanol-d4 (  = 3.31,  = 49.0). Analysis followed first (s – singlet, d – doublet, dd
– doublet of doublet). Coupling constants J refer to H,H-couplings. Assignment was done via DEPT and HSQC experiments.
1H NMR (400 MHz) 13C NMR (101 MHz)
multiplets J [Hz] assignment assignment
8.55 d 4.8 1H 163.4 Cquart
7.41 d 2.8 2H 155.9 Cquart
7.38 d 4.8 1H 153.55 Cquart
7.01 d 9.7 2H 153.3 Cquart
6.84 dd 9.6, 2.9 2H 149.4 Cquart
3.38 s --- 12H 149.0 CH
0.63 s --- 3H 141.2 CH
0.60 s --- 3H 126.69 Cquart
126.0 CH
123.0 CH
122.1 Cquart
115.8 CH
41.1 CH3
-1.0 CH3
-1.5 CH3
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Table VI-28. Fit parameter of the exponential fit of the fluorescence decay of SiR dye 15.
The fluorescence lifetime  of SiR dye 15 was determined by TCSPC in PBS pH 7.4 and in MeCN. Fitting of the fluorescence
intensity ( ) decay with an additive superposition of exponential functions revealed a mono-exponential decay (  = 1) for
both solvents.  – instrument response function.
solvent PBS pH 7.4 MeCN
equation ( ) = ( ′) ′
 [counts] 12251 ± 61 11556 ± 54
 [ns] 1.933 ± 0.007 3.425 ± 0.012
background
decay [counts] 9.14 ± 0.86 18.04 ± 1.19
background
 [counts] 1.79 ± 0.11 2.15 ± 0.09
shift  [ns] 0.021 ± 0.002 -0.013 ± 0.003
 scat [counts] 3390 ± 1260 6040 ± 1550
0.991 1.000
Table VI-29. Fit parameter of the relative measurement of the quantum yield of SiR dye 15.
The quantum yield  of SiR dye 15 was determined relative to the reference standard Nile Blue in PBS pH 7.4 and in MeCN.
COD – coefficient of determination, ∫  – wavelength-integrated fluorescence intensity,  – absorbance at 600 nm.
PBS pH 7.4 MeCN
SiR dye 15 Nile Blue SiR dye 15 Nile Blue
equation = +
weight no weighting
intercept 743 ± 273 1249 ± 179 1700 ± 470 1517 ± 818
slope (2.34 ± 0.02)×106 (1.80 ± 0.01)×106 (4.11 ± 0.04)×106 (1.85 ± 0.03)×106
residual sum
of squares 257461 80813 190738 941642
Pearson’s r 0.99988 0.99998 0.99989 0.99973
R2 (COD) 0.99977 0.99997 0.99978 0.99945
adjusted R2 0.99969 0.99996 0.99967 0.99918
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Table VI-30. Results and p-values of the PCC calculation for mitochondrial and endosomal/lysosomal colocalization of
SiR dye 15.
Data are expressed as mean ± SD. Note that the PCC for endosomal/lysosomal colocalization overestimates the lysosomal
targeting ability of SiR dye 15 as LysoTrackerTM Green DND-26 mildly stains mitochondria additionally.
mitochondrial colocalization endosomal/lysosomal colocalization
cell lines n PCC n PCC p-value
HeLa 22 0.85 ± 0.05 13 0.35 ± 0.06 3×10-23
U2OS 27 0.81 ± 0.05 13 0.38 ± 0.04 3×10-26
Table VI-31. Results and p-values of the duration and frequency of U2OS cell division and of the cell count and
confluency of U2OS cell proliferation after treatment with SiR dye 15.
Data are expressed as mean ± SD. * Given as fold change comparing the value at t = 14.5 h to the value at t = 0 h, † Average
p-value expressed as mean ± SD.
untreated + 1 µM SiR dye 15 p-value
n(divisions) 494 281 ---
n(experiments) 11 8 ---
cell division duration [min] 40 ± 37 38 ± 18 0.300
cell division frequency
[divisions per cell per day] 0.53 ± 0.10 0.50 ± 0.08 0.555
cell count [fold change]* 1.44 ± 0.10 1.39 ± 0.14 0.521 ± 0.204†
confluency [fold change]* 1.47 ± 0.23 1.41 ± 0.22 0.574 ± 0.262†
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VI.3.3 Supplementary Figures to IV.3
Figure VI-24. Time series of U2OS confluency in the presence of various live cell STED compatible dyes.
Cytotoxicity data are based on holographic time-lapse series (duration 24/44.25/48 h, frequency 15 min) of U2OS cell
proliferation in the presence of 1 µM and 5 µM of SNAP (BG), Halo and CLIP (BC) derivatives of the popular SiR dye [30, 404]
and recently published [29, 32] live cell STED compatible organic dyes. The data are compared to the control measurements
of the proliferation of untreated U2OS cells. The confluency was normalized to the first frame (t = 0). The results were
averaged and SDs are displayed as shadows in the graphs. Average p-values indicate no significant difference between
untreated and treated U2OS cells. All results, n-values and p-values are summarized in Table VI-32.
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VI.3.4 Supplementary Tables to IV.3
Table VI-32. Results and p-values of the duration and frequency of U2OS cell division and of the cell count and
confluency of U2OS cell proliferation in the presence of selected SNAP, CLIP and Halo live dye derivatives.
Data are expressed as mean ± SD and p-values compare the dye treated condition with the untreated control; div – division,
exp – experiment. * Fold change comparing the value at t = 24 h to the value at t = 0 h, ** Fold change comparing the value
at t = 44.25 h to the value at t = 0 h, *** Fold change comparing the value at t = 48 h to the value at t = 0 h,† Average p-value
expressed as mean ± SD.
n cell division
div. exp. duration[min]
frequency
[divisions per
cell per day]
cell count
[fold change]
confluency
[fold change]
untreated
(control) results 507 12 31 ± 27 1.16 ± 0.41
1.6 ± 0.2*
3.0 ± 0.7**
3.4 ± 0.8***
1.5 ± 0.4*
3.3 ± 1.2**
3.7 ± 1.3***
+ 1 µM
580CP-BG
results 555 6 23 ± 14 1.90 ± 0.41 1.8 ± 0.5*4.0 ± 0.7***
1.5 ± 0.7*
3.1 ± 0.6***
p-values --- --- 5×10-9 0.004 0.338 ± 0.246† 0.594 ± 0.237†
+ 5 µM
580CP-BG
results 332 4 29 ± 21 1.27 ± 0.16 1.6 ± 0.2*2.8 ± 0.6***
1.5 ± 0.3*
2.2 ± 0.5***
p-values --- --- 0.237 0.631 0.537 ± 0.238† 0.397 ± 0.308†
+ 1 µM
580CP-Halo
results 241 4 33 ± 27 1.18 ± 0.21 1.6 ± 0.1*3.1 ± 0.2***
1.9 ± 0.4*
2.9 ± 0.4***
p-values --- --- 0.338 0.936 0.633 ± 0.211† 0.638 ± 0.227†
+ 5 µM
580CP-Halo
results 333 4 29 ± 14 1.29 ± 0.22 1.5 ± 0.2*3.1 ± 0.3***
1.5 ± 0.4*
2.5 ± 0.7***
p-values --- --- 0.132 0.594 0.560 ± 0.242† 0.365 ± 0.239†
+ 1 µM
610CP-BG
results 130 4 25 ± 15 1.12 ± 0.29 1.9 ± 0.5* 2.2 ± 0.7*
p-values --- --- 0.010 0.848 0.442 ± 0.306† 0.635 ± 0.231†
+ 5 µM
610CP-BG
results 160 4 24 ± 14 1.08 ± 0.35 1.9 ± 0.4* 1.7 ± 0.4*
p-values --- --- 0.001 0.744 0.251 ± 0.176† 0.764 ± 0.161†
+ 1 µM
610CP-BC
results 186 6 29 ± 22 1.01 ± 0.31 1.6 ± 0.3*2.7 ± 0.8***
1.7 ± 0.9*
2.2 ± 1.2***
p-values --- --- 0.416 0.448 0.424 ± 0.273† 0.459 ± 0.311†
+ 5 µM
610CP-BC
results 193 6 31 ± 20 1.25 ± 0.59 1.6 ± 0.3*3.3 ± 1.5***
1.8 ± 0.7*
3.5 ± 2.1***
p-values --- --- 0.868 0.732 0.693 ± 0.236† 0.567 ± 0.263†
+ 1 µM
610CP-Halo
results 194 4 23 ± 12 1.26 ± 0.09 2.2 ± 0.2* 2.1 ± 0.4*
p-values --- --- 5×10-5 0.684 0.085 ± 0.177† 0.348 ± 0.227 †
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n cell division
div. exp. duration[min]
frequency
[divisions per
cell per day]
cell count
[fold change]
confluency
[fold change]
+ 5 µM
610CP-Halo
results 137 5 44 ± 55 1.01 ± 0.16 1.7 ± 0.3*2.7 ± 0.3**
1.9 ± 0.4*
3.6 ± 1.5**
p-values --- --- 2×10-4 0.446 0.656 ± 0.210† 0.593 ± 0.251†
+ 1 µM
640SiRH-BG
results 226 4 25 ± 12 1.20 ± 0.24 2.1 ± 0.3* 1.7 ± 0.1*
p-values --- --- 0.001 0.896 0.260 ± 0.291† 0.727 ± 0.184†
+ 5 µM
640SiRH-BG
results 166 4 32 ± 23 1.30 ± 0.29 1.9 ± 0.4*3.1 ± 0.8**
2.0 ± 0.6*
3.1 ± 1.2**
p-values --- --- 0.582 0.573 0.536 ± 0.247† 0.656 ± 0.250†
+ 1 µM
640SiRH-BC
results 276 6 29 ± 24 1.73 ± 0.61 2.1 ± 0.6*4.2 ± 1.6***
1.9 ± 0.7*
4.6 ± 2.2***
p-values --- --- 0.313 0.044 0.225 ± 0.176† 0.436 ± 0.238†
+ 5 µM
640SiRH-BC
results 160 4 35 ± 28 1.03 ± 0.21 1.7 ± 0.1*2.9 ± 0.1***
1.9 ± 0.7*
2.9 ± 0.5***
p-values --- --- 0.107 0.555 0.540 ± 0.232† 0.534 ± 0.238†
+ 1 µM
640SiRH-Halo
results 201 5 35 ± 44 1.00 ± 0.24 1.8 ± 0.2*3.1 ± 0.5***
1.6 ± 0.4*
3.2 ± 1.1***
p-values --- --- 0.128 0.433 0.598 ± 0.222† 0.532 ± 0.235†
+ 5 µM
640SiRH-Halo
results 158 4 35 ± 26 1.31 ± 0.18 1.7 ± 0.1*3.4 ± 0.4**
1.7 ± 0.1*
3.7 ± 0.4**
p-values --- --- 0.094 0.525 0.455 ± 0.255† 0.644 ± 0.233†
+ 1 µM
SNAP-Cell®
647-SiR
results 148 4 35 ± 29 1.14 ± 0.16 1.8 ± 0.2*2.9 ± 0.1**
1.7 ± 0.2*
2.2 ± 0.5**
p-values --- --- 0.102 0.911 0.435 ± 0.304† 0.503 ± 0.247†
+ 5 µM
SNAP-Cell®
647-SiR
results 216 4 34 ± 36 1.21 ± 0.06 1.9 ± 0.1*2.9 ± 0.2**
1.8 ± 0.3*
2.4 ± 0.4**
p-values --- --- 0.253 0.852 0.447 ± 0.257† 0.633 ± 0.228†
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abbreviation meaning
%IA percent of applied radioactivity
%ID/g percent injected dose per gram of tissue
(f)BALM (fluctuation-assisted) binding-activated localization microscopy
(F)PALM (fluorescence) photoactivated localization microscopy
(m)PH (motorized) pinhole
[18F]FDG 2-[18F]fluoro-2-deoxy-D-glucose
[68Ga]Ga-PSMA-11 Glu-NH-CO-NH-Lys(Ahx)-[[68Ga]Ga(HBED-CC)]
2D two dimensions, two-dimensional
2PE two-photon excitation
2-PMPA 2-(phosphonomethyl)-pentanedioic acid
3D three dimensions, three-dimensional
4D four dimensions, four-dimensional
abs absorption
AEG N-(2-aminoethyl)glycine
AF594 Alexa Fluor 594
AFM atomic force microscopy
AI (computer science) artificial intelligence
AI (optics) adaptive illumination
ALT alternative lengthening of telomeres
AOTF acousto-optical tunable filter
APB ALT-associated promyelocytic leukemia nuclear bodies
APD avalanche photodiode
278
abbreviation meaning
ATM ataxia-telangiectasia mutated
ATP adenosine triphosphate
ATRX alpha thalassemia/mental retardation syndrome X-linked
BC benzylcytosine
BG benzylguanine
BLAST biophotonic laser-assisted surgery tool
BNID BioNumbers ID
BP bandpass filter
BSA bovine serum albumin
CCV clathrin-coated vesicle
CLC clathrin light chain
CNN convolutional NN
COD coefficient of determination
CP carbopyronine
CRISPR clustered, regularly interspaced, short palindromic repeats
CRPCa castration-resistant prostate cancer
CT computed tomography
CTCF CCCTC-binding factor
ctrl control
CW continuous wave
DARPin designed ankyrin repeat protein
DBS directional beam splitter
DCM dichloromethane
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abbreviation meaning
DDR DNA damage response
DEPT distortionless enhancement by polarization transfer
det detection
DFT density functional theory
DIPEA N,N-diisopropylethylamine
DKFZ Deutsches Krebsforschungszentrum (German Cancer Research Center)
DL deep learning
DMEM Dulbecco's modified Eagle medium
DMF N,N-dimethylformamide
DMSO dimethyl sulfoxide
DNA deoxyribonucleic acid
DOTA 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
DOTAGA 1,4,7,10-tetraazacyclododececane,1-(glutaric acid)−4,7,10-triacetic acid
DRE digital rectal exam
D-Rex dark state relaxation
dsDNA double-stranded DNA
dSTORM direct stochastic optical reconstruction microscopy
DyMIN dynamic intensity minimum
EC electron capture
EC50 half maximal effective concentration
ECTR extrachromosomal telomeric repeat
eDHFR Escherichia coli dihydrofolate reductase
EDTA ethylenediaminetetraacetic acid
280
abbreviation meaning
EM electron microscopy
em emission
ER endoplasmatic reticulum
ESI electrospray ionization
EtOH ethanol
exc excitation
ExSTED expansion stimulated emission depletion microscopy
Fab antibody fragment
FAP fluorogen activating protein
FbFP flavin-based fluorescent protein
FBS fetal bovine serum
FCol fiber collimator
FCp fiber coupler
FDA Food and Drug Administration
FISH fluorescence in situ hybridization
FlAsH fluorescein arsenical hairpin binder
FN false negative
FN3 fibronectin type III domain
FOLH1 folate hydrolase I
FOV field of view
FP (biology) fluorescent protein
FP (image processing) false positive
FPGA field-programmable gate array
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abbreviation meaning
fpm frames per minute
FR Faraday rotator
FSC forward scatter
FWHM full width half maximum
G1 growth phase 1
G2 growth phase 2
G4 quadruplex
GCP II glutamate carboxypeptidase II
GFP green fluorescent protein
GS goat serum
GSD ground state depletion
GSDIM ground state depletion with individual molecular return
GSH glutathione
GSSG glutathione disulfide
HBED-CC N,N'-bis-[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N'-
diacetic acid
HD halogen dance
HEPES 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid
HILO highly inclined and laminated optical sheet
HOMO highest occupied molecular orbital
HP1 heterochromatin protein 1
HPLC high performance liquid chromatography
HRMS high-resolution mass spectrometry
HSQC heteronuclear single quantum correlation
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abbreviation meaning
I&F imaging and fluorescence
I&S imaging and surgery
I&T imaging and therapy
IC50 half maximal inhibitory concentration
ICG indocyanine green
IF indirect immunofluorescence
IFP1.4 infrared fluorescent protein 1.4
iLOV improved light, oxygen or voltage-sensing
IRF instrument response function
iRFP near-infrared fluorescent protein
ITL interstitial telomere loop
ITS interstitial telomere sequences
JF Janelia Fluor
L lens
LLSM lattice light sheet microscopy
LOR line of response
LP longpass filter
LSFM light sheet fluorescence microscopy
LT long telomeres
M (biology) mitosis
M (optics) mirror
m/z mass-to-charge
MALDI-MS matrix-assisted laser desorption/ionization mass spectrometry
283
abbreviation meaning
MAP maximum a posteriori
mbFISH molecular beacon FISH
mCRPCa metastatic castration-resistant prostate cancer
MeCN acetonitrile
MINFIELD minimized FOV and minimized fluorophore exposure to the STED beam
MINFLUX single molecule localization with minimal emission fluxes
miniSOG mini singlet oxygen generator
ML machine learning
MMS21 methyl methanesulfonate-sensitivity protein 21
MMSE minimum mean square error
MOST molecular states for multiple off-state transitions
MRF Markov random field
MRI magnetic resonance imaging
MS mass spectrometry
Mw molecular weight
NaAc sodium acetate
NAALADase N-acetyl-L-aspartyl-L-glutamate peptidase I
NAD(P)H nicotinamide adenine dinucleotide (phosphate)
n-BuLi butyllithium
NHEJ non-homologous end joining
NIR near-infrared
NMR nuclear magnetic resonance
NN neural network
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abbreviation meaning
NSOM near-field scanning optical microscopy
NT normal telomeres
NV nitrogen vacancy
OCT optical coherence tomography
OF optical fiber
OI optical imaging
OTF optical transfer function
p.i. post injection
PA NL-SIM patterned-activation nonlinear SIM
paFP photoactivatable fluorescent protein
PAINT point accumulation for imaging in nanoscale topography
PBL peripheral blood leukocyte
PBS (biochemistry) phosphate-buffered saline
PBS (optics) polarizing beam splitter cube
PCa prostate cancer
PCC Pearson correlation coefficient
pcFP photoconvertible fluorescent protein
PDB Protein Data Bank
PET positron emission tomography
PFA paraformaldehyde
PI propidium iodide
PIE pulse-interleaved excitation
PIP1 POT1-interacting protein 1
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abbreviation meaning
PML promyelocytic leukemia
PML-NB PML nuclear bodies
PMT photomultiplier tube
PNA peptide nucleic acid
POI protein of interest
POT1 protection of telomeres 1
PRR pulse repetition rate
PSA prostate-specific antigen
PSF point spread function
psFP photoswitchable fluorescent protein
PSMA prostate-specific membrane antigen
PSMA-10 [Glu-urea-Lys(Ahx)]2-HBED-CC
PTOP1 POT1 and TIN2 organizing protein 1
QD quantum dot
Q-FISH quantitative FISH
qPCR quantitative polymerase chain reaction
QS Quadscanner
Rap1 repressor/activator protein 1
RCY radiochemical yield
ReAsH resorufin arsenical hairpin binder
ReLU rectified linear unit
RESCue reduction of state transition cycles
RESOLFT reversible saturable/switchable optical linear (fluorescence) transitions
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abbreviation meaning
RhoBo rhodamine-derived bis-boronic acid
RIBE radiation-induced bystander effect
RNA ribonucleic acid
ROI region of interest
ROS reactive oxygen species
ROSE repetitive optical selective exposure
ROXS reducing and oxidizing systems
RP-HPLC reversed-phase high performance liquid chromatography
rpm rounds per minute
RPMI Roswell Park Memorial Institute
RT room temperature
S DNA synthesis phase
SC supercontinuum laser
scFv single-chain variable fragment
SD standard deviation
sgRNA single guide RNA
SIM (biology) SUMO interacting motif
SIM (optics) structured illumination microscopy
SiR silicone rhodamine
SLM spatial light modulator
SMLM single molecule localization microscopy
SNR signal-to-noise ratio
SOFI super-resolution optical fluctuation imaging
287
abbreviation meaning
SP shortpass filter
SP100 Speckled 100 kDa
SPEM saturated patterned excitation microscopy
SPIM selective plane illumination microscopy
SPM scanning probe microscopy
SPT single particle tracking
SRRF super-resolution radial fluctuation
SS safety shutter
SSC (biochemistry) saline sodium citrate
SSC (flow cytometry) side scatter
SSIM saturated structured illumination microscopy
STED stimulated emission depletion
STM scanning tunneling microscopy
STORM stochastic optical reconstruction microscopy
STR subtelomeric region
SUMO small ubiquitin-like modifier
SUV standardized uptake value
TAC thesis advisory committee
TAE tris-acetate-ethylenediaminetetraacetic acid
TALE transcription activator-like effector
TALEN transcription activator-like effector-based nuclease
t-BuLi tert-butyllithium
TCSPC time-correlated single photon counting
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abbreviation meaning
TERC telomerase RNA component
TERT telomerase reverse transcriptase
TeSLA telomere shortest-length assay
TFA trifluoroacetic acid
TFP tetrafluorophenyl
THF tetrahydrofuran
TIN2 TRF1-interaction nuclear factor 2
TINT1 TIN2-interacting protein 1
TIRF total internal reflection fluorescence
TLC thin-layer chromatography
TMM telomere maintenance mechanism
TP true positive
TPE telomere position effect
TPE-OLD telomere position effect over long distances
TPP1 TINT1/PIP1/PTOP1
T-Rex triplet state relaxation
TRF terminal restriction fragment
TRF1/2 telomeric repeat binding factor 1/2
T-SCE telomere sister chromatid exchange
UICC Union for International Cancer Control
UnaG Unagi green fluorescent protein
U-STELA universal single-telomere length analysis
UV ultraviolet
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abbreviation meaning
VHH camelid heavy-chain variable fragments
VST very short telomeres
WYSIWYG what you see is what you get
XRF X-ray fluorescence
Y-FAST yellow fluorescence-activating and absorption-shifting tag
ZFN zinc finger nuclease
ZFP zinc finger protein
α-NAAG N-acetyl-L-aspartyl-L-glutamate
λ/2 λ/2 plate
λ/4 λ/4 plate
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